[{"hadm_id": 27765450, "discharge_summary": "History of Present Illness: 72-year-old man admitted emergently with acute on chronic systolic heart failure (I50.23) complicated by cardiogenic shock and type 2 myocardial infarction. Admission course was notable for acute tubular necrosis (AKI, N17.0), severe protein-calorie malnutrition, hyponatremia, and hepatic dysfunction. Prior history includes permanent atrial fibrillation and chronic ischemic heart disease.\n\nHospital Course: Patient required hemodynamic support with dobutamine infusion for cardiogenic shock and continuous telemetry. Over a 19.6-day hospitalization he was diuresed judiciously, received careful electrolyte and volume management, and required temporary renal support measures while AKI improved but did not fully normalize. Nutrition was optimized with dietitian involvement and oral nutrition supplements for severe malnutrition. Hyponatremia and hepatic chemistries trended toward baseline with supportive care. Antithrombotic strategy was implemented given atrial fibrillation and ischemic risk.\n\nKey Findings and Procedures: Echocardiography confirmed reduced LVEF consistent with systolic cardiomyopathy. Troponin elevation consistent with type 2 MI. Labs demonstrated acute kidney injury with improving creatinine and persistent electrolyte monitoring needs. Patient received temporary inotropic support (dobutamine) which was successfully weaned. No invasive coronary intervention performed during this admission.\n\nDischarge Condition and Functional Status: At discharge patient is hemodynamically stable, off inotropic support, euvolemic on oral diuretics, and on continuous telemetry until transfer. He ambulates with assistance and requires help with several activities of daily living due to deconditioning. Home health services arranged for skilled nursing visits for medication management, daily weights, vital signs, wound/skin assessment, assistance with ADLs, and coordination of outpatient labs.\n\nMedications and Follow-up: Discharge meds include apixaban, clopidogrel, atorvastatin, oral diuretics, potassium chloride as needed, pantoprazole, acetaminophen, stool regimen (polyethylene glycol, senna), and nutritional supplements. Dobutamine discontinued. Follow-up: Primary care in 3\u20135 days, cardiology within 7 days, nephrology within 1\u20132 weeks. Home health to monitor BMP/Na/K and report weight change or dyspnea promptly.", "diagnosis_codes": ["Z515", "I428", "Q6432", "Z955", "R570", "I2510", "I5023", "N170", "Z7901", "F4310", "Z20822"], "suggested_codes": ["E871", "I21A1", "E441", "I4891", "K769"], "accepted_codes": ["E871", "I21A1"], "rejected_codes": ["E441", "I4891", "K769"], "date": "2024-04-16T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 22205215, "discharge_summary": "History of Present Illness: 67-year-old man admitted under observation for acute on chronic systolic (congestive) heart failure with progressive dyspnea and lower extremity edema over 10 days. He has known ischemic cardiomyopathy, prior CABG/PCI, chronic kidney disease, and paroxysmal/unspecified atrial fibrillation. He presented with volume overload and was managed with intravenous diuretics.\n\nHospital Course: Five-day observation stay. Patient received IV loop diuresis with transition to oral torsemide; guideline-directed medical therapy for heart failure was optimized (continued carvedilol, initiation/continuation of spironolactone where renal function allowed, and lisinopril adjusted). Rate control for atrial fibrillation achieved with amiodarone; anticoagulation with warfarin continued given cardiac history. Renal function remained stable for baseline CKD. No evidence of acute coronary syndrome; telemetry identified atrial fibrillation without high-risk features. Transthoracic echocardiogram consistent with systolic dysfunction; chest radiograph improved with diuresis.\n\nKey Findings and Procedures: Diagnosis: acute on chronic systolic heart failure (primary). Other pertinent diagnoses: secondary pulmonary hypertension, atrial fibrillation, ischemic cardiomyopathy, nonrheumatic mitral regurgitation, CKD. Procedures/therapies: IV diuresis, transthoracic echocardiogram, telemetry monitoring, medication optimization and anticoagulation management.\n\nDischarge Condition and Functional Status: He is hemodynamically stable and euvolemic at discharge with improved dyspnea. Ambulates with steadying assistance and requires home support for some activities of daily living; independent with light grooming. Home health recommended for monitoring and to assist with medication management and safety.\n\nMedications and Follow-up: Discharge medications include torsemide, spironolactone, carvedilol, lisinopril, amiodarone, warfarin (with home INR monitoring), aspirin, simvastatin, omeprazole, multivitamin, and others as listed. Home health to initiate within 48 hours for daily weights, edema checks, vital signs, wound/skin assessment, and medication reconciliation. Follow-up with cardiology in 1 week and primary care in 1 week; anticoagulation clinic/INR within 48\u201372 hours. Return precautions reviewed.\n\nLength of stay: 5 days (observation).", "diagnosis_codes": ["N189", "E785", "Z955", "I4891", "I2510", "I255", "Z951", "I272", "I5023", "Z87891", "I252", "K219", "D649", "Z7901", "I340", "I129", "F1021", "Z4502"], "suggested_codes": ["I110"], "accepted_codes": [], "rejected_codes": ["I110"], "date": "2024-06-26T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 25129064, "discharge_summary": "History of Present Illness: 61-year-old male with longstanding type 2 diabetes mellitus complicated by peripheral vascular disease presented on observation status with progressive right lower extremity ischemia and gangrene. Past medical history significant for end-stage renal disease on thrice-weekly hemodialysis, prior left above-knee amputation, hypertensive CKD stage 5, paroxysmal atrial fibrillation, coronary artery disease, hyperlipidemia and anemia of CKD.\n\nHospital Course: The patient was observed for 4 days. Vascular surgery evaluated and confirmed critical ischemia with nonviable tissue of the right distal lower extremity. He underwent operative debridement/partial amputation of necrotic tissue and placement of dressings with subsequent wound VAC management. He received empiric IV ceftriaxone, analgesia (acetaminophen, hydromorphone PRN), and peri-dialysis heparinization. Hemodialysis sessions were continued without complication. Epoetin alfa was administered for CKD-related anemia per dialysis clinic plan. Cardiology managed rate control for paroxysmal AF; no acute coronary event.\n\nKey Findings and Procedures: Imaging and vascular exam consistent with severe peripheral arterial disease and gangrene of the right leg. Procedures performed: surgical debridement/partial amputation of necrotic tissue and standard postoperative wound/VAC care. Hemodialysis performed with heparin per protocol. Wound cultures obtained; results pending at discharge.\n\nDischarge Condition and Functional Status: Patient is medically stable for discharge to home with home health services. Pain is controlled on oral regimen; he is hemodynamically stable and tolerating oral intake. Mobility is limited: baseline left above-knee amputation and current right-sided dressing limit independent ambulation \u2014 requires assistive devices/transfer assistance and skilled nursing for wound care and fall-risk precautions.\n\nMedications and Follow-up: Discharge meds include acetaminophen and hydromorphone PRN, aspirin and clopidogrel, atorvastatin, calcium acetate, epoetin alfa per dialysis, and heparin for dialysis sessions. Continue IV antibiotic plan transitioned per infectious disease recommendations if oral therapy indicated; wound-culture-directed therapy will be provided. Follow-up: vascular surgery within 7 days, nephrology/dialysis as scheduled, home health nursing for wound care/dressing changes 3x weekly, and cardiology/primary care within 1\u20132 weeks. Pending culture results will be communicated to outpatient team.", "diagnosis_codes": ["E1152"], "suggested_codes": ["D631", "E785", "I120", "I2510", "I480", "N186", "Z7901", "Z89612", "I739"], "accepted_codes": ["D631", "E785", "I120", "I2510", "I480", "N186", "Z7901", "Z89612"], "rejected_codes": ["I739"], "date": "2024-06-01T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 27869814, "discharge_summary": "History of Present Illness: 75-year-old man admitted for observation for complicated Type 2 diabetes mellitus with an infected right foot ulcer and progressive peripheral gangrene. He presented with increased drainage, exposed fat of the right forefoot, erythema, and pain. Past medical history notable for hypertension, atherosclerotic coronary disease, diabetic neuropathy, and chronic antithrombotic therapy.\n\nHospital Course: Patient was observed for 6.8 days. Initial evaluation included xrays and MRI consistent with osteomyelitis of the right ankle/foot and arterial insufficiency to the right lower extremity. Vascular and infectious disease were consulted. He underwent operative surgical debridement of the right foot with intraoperative wound cultures and received empiric IV antibiotics, then was transitioned to targeted oral antibiotic therapy based on cultures. Pain was managed with scheduled acetaminophen and PRN hydromorphone. Insulin therapy was used inpatient with sliding scale and basal coverage; oral hypoglycemic therapy was adjusted prior to discharge. Anticoagulation was continued per cardiology/vascular recommendations.\n\nKey Findings and Procedures: Imaging consistent with acute osteomyelitis (right ankle/foot). Procedure: operative debridement of right foot wound with intraoperative cultures; wound care included postoperative dressing changes and negative-pressure therapy while inpatient. Positive wound cultures informed antibiotic selection.\n\nDischarge Condition and Functional Status: At discharge the patient is hemodynamically stable, afebrile, pain controlled on oral regimen, and able to transfer and ambulate short distances with a rolling walker. Requires assistance with wound dressing changes and activities of daily living due to right lower extremity pain and offloading requirements. Home health services arranged for wound care, medication management, and nursing surveillance.\n\nMedications and Follow-up Plan: Discharge medications include apixaban and aspirin (per cardiology), insulin regimen for glycemic control with oral glipizide held/adjusted as outpatient, ciprofloxacin and doxycycline to complete an extended course for osteomyelitis (total planned ~6 weeks per ID), hydrochlorothiazide, stool softener (docusate) and bisacodyl PRN, acetaminophen for analgesia. Follow-up: primary care in 7 days, vascular surgery and wound clinic within 1 week, infectious disease and endocrinology as outpatient, and anticoagulation clinic as indicated. Clear instructions given for strict foot offloading, daily glucose monitoring, and urgent return precautions.", "diagnosis_codes": ["L97512", "E11621", "Z7902", "M86171", "I2510", "E1152", "E1140", "E1169", "I70261"], "suggested_codes": ["I10"], "accepted_codes": ["I10"], "rejected_codes": [], "date": "2024-04-27T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 26152108, "discharge_summary": "Brief history of present illness: 33-year-old female admitted emergently for symptomatic hyperglycemia with labile glucose levels and symptoms related to diabetic autonomic neuropathy and gastroparesis. She reported poor oral intake, progressive weakness, nausea, and documented nonadherence to outpatient insulin regimen.\n\nHospital course: Over a 9.8-day stay the patient was managed by the medicine and endocrinology teams. Initial management included frequent point-of-care glucose monitoring, subcutaneous insulin titration (basal-bolus regimen), intermittent IV dextrose and glucagon for symptomatic hypoglycemia events, and VTE prophylaxis with heparin. Gastroenterology-assisted management of gastroparesis included metoclopramide and a short course of erythromycin with dietary modification. Nutrition services implemented a high-protein, small-volume feeding plan and treated mild protein-calorie malnutrition. Pain management for chronic fibromyalgia/neuropathic pain included duloxetine and topical lidocaine as adjuncts. Physical and occupational therapy evaluated deconditioning and assisted with mobility and ADL training.\n\nKey findings and procedures: Laboratory trends demonstrated hyperglycemia with variable excursions requiring insulin adjustments; BMP monitored and electrolytes repleted as needed. No invasive procedures were required. Education on insulin administration, hypoglycemia recognition and treatment, gastric symptom management, and medication reconciliation were completed with patient and caregiver.\n\nDischarge condition and functional status: Patient is medically stable for discharge to home with home health. She is ambulatory with supervision/assistive device for short distances and requires assistance with some ADLs due to generalized weakness and recent deconditioning. Home health RN to assist with insulin administration, glucose monitoring, medication adherence, and wound/skin checks as indicated. Home PT recommended to continue mobility and strengthening.\n\nMedications and follow-up plan: Discharged on basal-bolus insulin regimen (as adjusted in hospital), lisinopril for HTN, duloxetine for neuropathic pain, metoclopramide and short erythromycin course for gastroparesis, stool softener/bisacodyl PRN, acetaminophen PRN, multivitamins. Provided glucose gel and hypoglycemia rescue education. Follow up with PCP in 3\u20137 days, endocrinology in 1\u20132 weeks, and gastroenterology as outpatient. Labs (BMP, glucose trend, A1c) to be obtained within one week.", "diagnosis_codes": ["E1143", "I10", "Z794", "E1165", "K224"], "suggested_codes": ["K3184", "M797", "E11649", "E46", "E6609", "R5381"], "accepted_codes": ["K3184", "M797"], "rejected_codes": ["E11649", "E46", "E6609", "R5381"], "date": "2024-02-11T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 20129683, "discharge_summary": "Brief history of present illness: 61-year-old male with history of hypertensive chronic kidney disease (CKD), hypothyroidism, myelodysplastic syndrome, asthma, spinal stenosis and peripheral polyneuropathy presented with 5 days of cough, fever and progressive dyspnea. SARS-CoV-2 PCR was positive on admission. He was observed for hypoxemia and supportive care.\n\nHospital course: The patient was admitted to observation for 2.9 days for hypoxemic COVID-19. He required low-flow supplemental oxygen via nasal cannula (maximum 4 L/min) and was treated with intravenous remdesivir (completed inpatient course), dexamethasone, nebulized albuterol, prophylactic subcutaneous heparin, and supportive IV fluids. A short course of levofloxacin was given for concern of possible superimposed bacterial infection. Cyanocobalamin and gabapentin were continued for chronic conditions. Chest radiograph demonstrated bilateral patchy airspace opacities consistent with viral pneumonitis. Renal function remained at baseline for his CKD; no transfusion was required for his myelodysplastic syndrome during this stay. Mobility was limited by baseline spinal stenosis and neuropathy; he ambulated short distances with a cane and required minimal assistance with transfers.\n\nKey findings and procedures: Positive SARS-CoV-2 PCR; chest x-ray with bilateral opacities; oxygen therapy and administration of remdesivir and dexamethasone were the primary interventions. Vitals stabilized, afebrile for >24 hours, and oxygen requirement weaned to room air prior to discharge.\n\nDischarge condition and functional status: Patient is clinically improved, hemodynamically stable, afebrile, and on room air. Ambulates with baseline assistive device and requires only minimal assistance with ADLs; home health is arranged for medication reconciliation, safety/fall risk assessment, mobility support and pulse oximetry monitoring.\n\nMedications and follow-up: Discharge meds include acetaminophen PRN, albuterol inhaler/neb prn, levothyroxine daily, gabapentin for neuropathic pain, guaifenesin PRN, senna PRN, ramelteon PRN for sleep, and completion of outpatient levofloxacin as prescribed. Remdesivir and inpatient dexamethasone completed. Follow-up with primary care in 48\u201372 hours, pulmonology in 7\u201310 days, nephrology in 2 weeks, and hematology as outpatient in 4 weeks. If new or worsening dyspnea or oxygen saturation < 92%, seek ED evaluation or contact home health immediately.", "diagnosis_codes": ["N189", "R7401", "D630", "R0902", "N400", "D46Z", "D72819", "U071", "E039", "I129", "J45909", "G629", "M4800"], "suggested_codes": ["J1289", "Z734", "Z791"], "accepted_codes": [], "rejected_codes": ["J1289", "Z734", "Z791"], "date": "2024-10-16T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 29693186, "discharge_summary": "Reason for admission: 36-year-old female admitted to observation for evaluation and management of pleural effusion (ICD-10 J90). Relevant history includes known pericardial effusion (noninflammatory), type 1 diabetes mellitus, prior CABG, atherosclerotic heart disease, history of nicotine dependence, and opioid dependence in remission. She also had documented contact with COVID-19; testing was performed during admission.\n\nHistory of present illness: Patient presented with progressive dyspnea and right greater-than-left pleuritic chest discomfort. Chest radiograph and point-of-care ultrasound confirmed moderate right pleural effusion without sonographic evidence of complex loculations. Echocardiography demonstrated a small, stable pericardial effusion without tamponade physiology.\n\nHospital course: Over a 4-day observation stay the patient underwent ultrasound-guided thoracentesis (ICD-10-PCS 0W9B30Z) with removal of approximately 650 mL serous fluid. Fluid analysis was consistent with a transudative effusion. She received diuresis with furosemide with clinical improvement in dyspnea. Diabetes was managed with a basal-bolus insulin regimen and bedside glucose monitoring. Anticoagulation with apixaban was continued given history of CABG and chronic anticoagulant use. Pain was controlled with acetaminophen and short-interval opiates as needed; no procedural complications occurred. COVID-19 testing during admission was negative.\n\nKey findings/procedures: Chest x-ray/ultrasound confirming pleural effusion; echo with stable small pericardial effusion; ultrasound-guided thoracentesis, uncomplicated. Labs stable; no evidence of infection.\n\nDischarge condition and functional status: Patient is hemodynamically stable, ambulatory with a steady gait, and able to perform most ADLs independently but will require assistance with medication administration/diabetes teaching initially at home. Oxygen not required on discharge.\n\nMedications at discharge: Apixaban, Aspirin, Atorvastatin, Furosemide, Basal-bolus insulin regimen with glucose gel PRN, Docusate, Famotidine, Acetaminophen as needed. (Detailed med list provided separately.)\n\nFollow-up: Pulmonology within 1 week, cardiology within 1\u20132 weeks, primary care in 3\u20135 days, and anticoagulation clinic per protocol. Return precautions for fever, worsening dyspnea, chest pain, or bleeding.", "diagnosis_codes": ["J90"], "suggested_codes": ["E109", "F1121", "I2510", "I313", "Z87891"], "accepted_codes": ["E109", "F1121", "I2510", "I313", "Z87891"], "rejected_codes": [], "date": "2024-07-22T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 28813442, "discharge_summary": "Brief history of present illness: 76-year-old female admitted to observation for 36 hours with fever, cough, malaise and subjective weakness. Initial working diagnosis was viral infection (ICD-10: B34.9). Relevant comorbidities on admission include hypertension, hyperlipidemia, solitary pulmonary nodule, chronic pelvic pain/dyspareunia, and mood disorder.\n\nHospital course: Patient received supportive care with IV fluids (Lactated Ringers), antipyretic therapy (acetaminophen), antiemetic (ondansetron) and electrolyte repletion (potassium chloride, magnesium sulfate) with clinical improvement. Enoxaparin was administered for venous thromboembolism prophylaxis. HydrOXYzine provided pruritus/anxiety control as needed. Polyethylene glycol was used for constipation. Oral vancomycin liquid was administered per consult for suspected C. difficile history (course completed as indicated). No invasive procedures were required. She remained hemodynamically stable, afebrile for >24 hours, and tolerated oral intake prior to discharge.\n\nKey findings and procedures: Physical exam notable for mild dehydration on admission, resolved after IV fluids. Baseline labs showed mild metabolic acidosis which corrected with fluids and supportive care. Chest imaging performed for cough/pulmonary nodule evaluation; no acute cardiopulmonary process requiring inpatient intervention. No procedures performed.\n\nDischarge condition and functional status: Patient discharged in stable condition, alert and oriented, able to perform transfers with assistance. Ambulates short distances with a walker and requires caregiver support for some activities of daily living. Home health services arranged for nursing visits and physical therapy to assist with medication reconciliation, wound/skin checks, mobility training and fall-risk mitigation.\n\nMedications at discharge: Acetaminophen as needed, Enoxaparin (prophylactic dosing per discharge instructions), Hydroxyzine as needed, Multivitamins, Ondansetron PRN, Polyethylene Glycol PRN, Potassium Chloride, Sodium Chloride 0.9% flushes (for IV access if applicable), Vancomycin oral liquid as prescribed, Amlodipine for blood pressure control.\n\nFollow-up: PCP appointment in 48\u201372 hours for clinical reassessment and repeat labs (BMP, CBC). Pulmonology follow-up within 1\u20132 weeks for solitary pulmonary nodule evaluation. Gynecology and mental health follow-up as outpatient for pelvic pain and mood disorder management.", "diagnosis_codes": ["F419", "R911", "R509", "F329", "N9410", "K589", "N94819", "M8580", "I10", "R7303", "N8110", "E041", "E785", "B349", "Z20822", "E872"], "suggested_codes": ["E860", "K590", "Z795"], "accepted_codes": [], "rejected_codes": ["E860", "K590", "Z795"], "date": "2024-06-23T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 29189472, "discharge_summary": "History of Present Illness: 61-year-old male presented to the ED with 48 hours of progressive right ear pain, decreased hearing, and purulent otorrhea. He reported prior chronic sinus complaints. Past medical history notable for essential hypertension, hyperlipidemia, gastroesophageal reflux disease, and prediabetes. Social history significant for history of nicotine dependence. On presentation he was hemodynamically stable but in discomfort and had right external ear canal debris with purulent drainage. Ear exam suggested tympanic membrane perforation on the right.\n\nHospital Course: Patient was evaluated by emergency medicine and otolaryngology. Point-of-care otoscopic exam and culture of discharge were obtained. Bedside right ear canal irrigation and removal of debris with topical antibiotic instillation were performed (procedure documented). He received IV ampicillin-sulbactam and analgesia with acetaminophen; DVT prophylaxis with heparin was given while inpatient and discontinued at discharge. Blood pressure and glucose were monitored and remained controlled on home regimens.\n\nKey Findings and Procedures: Right otitis media with associated unspecified perforation of the right tympanic membrane and purulent otorrhea. Chronic sinusitis noted on history. Procedure: right external ear canal irrigation and topical antibiotic application with specimen sent for culture.\n\nDischarge Condition and Functional Status: Patient is discharged in stable condition, ambulatory at baseline with no new mobility limitations. He requires assistance from home health for IV antibiotic administration, wound/ear care (ear drop instillation and dressing changes), and medication reconciliation. He is independent with activities of daily living but would benefit from short-term nursing visits for education and follow-up.\n\nMedications and Follow-up Plan: Discharged with plan for home health-administered IV ampicillin-sulbactam to complete a 7-day course, ciprofloxacin 0.3% otic drops for right ear as directed, acetaminophen PRN, fluticasone nasal spray, loratadine, pantoprazole, metoprolol succinate XL and nifedipine XR for blood pressure, and instructions on continuing statin therapy per PCP. ENT follow-up within 3\u20135 days, primary care in 7 days for BP and metabolic review, and audiology if hearing does not improve. Return to ED for worsening pain, fever, increasing drainage, dizziness, or new neurologic symptoms.", "diagnosis_codes": ["H6691"], "suggested_codes": ["J329", "H7293", "Z79899"], "accepted_codes": ["J329"], "rejected_codes": ["H7293", "Z79899"], "date": "2024-03-10T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 23682845, "discharge_summary": "History of present illness: 46-year-old female admitted to observation for four days for complications following prior bariatric surgery, presenting with progressive abdominal pain, distention, altered mental status, and one witnessed generalized seizure. Past medical history notable for alcoholic cirrhosis with ascites and prior bariatric procedure. Initial evaluation demonstrated ascites with peritoneal fluid consistent with spontaneous bacterial peritonitis (SBP) and imaging concerning for small-bowel fistula and partial obstruction related to prior bariatric surgery.\n\nHospital course: Patient was managed in observation status with IV antibiotics for SBP, electrolyte repletion for hypo-osmolality/hyponatremia, and seizure control with levetiracetam. She underwent image-guided peritoneal drainage (procedure 3E0336Z) and a surgical intervention/management procedure (3E0G76Z) for source control of intra-abdominal collections and fistula management. Nutrition support was initiated with parenteral nutrition (amino acids/dextrose formulation) while bowel rest was maintained. Pain was controlled with short-interval opioid analgesia as needed. Encephalopathy was treated with lactulose. Hyponatremia and magnesium were corrected; no recurrent seizures occurred prior to discharge.\n\nKey findings/procedures: Ascitic fluid analysis positive for SBP; CT abdomen/pelvis consistent with small-bowel fistula and partial obstruction. Image-guided peritoneal drain placed and surgical management performed. Parenteral nutrition and IV/transition-to-oral antibiotics initiated. Seizure disorder addressed and stabilized on levetiracetam.\n\nDischarge condition and functional status: Patient is medically stable, afebrile, hemodynamically stable, pain controlled on oral/PRN regimens, and neurologically at baseline. Ambulates with minimal assistance and requires assistance with complex wound/drain care and parenteral nutrition administration at home. Cognition improved but continues to require monitoring for hepatic encephalopathy.\n\nMedications and follow-up: Discharged with oral ciprofloxacin to complete antibiotic course, levetiracetam, lactulose, escitalopram, folic acid, heparin prophylaxis plan, stool regimen (bisacodyl PRN), and parenteral nutrition via home infusion. Home health nursing arranged for drain/wound care, TPN management, medication administration, and daily weights. Follow-up: surgical clinic within 7\u201310 days, hepatology/GI within 1\u20132 weeks, neurology in 2 weeks, and outpatient labs (CMP, CBC, electrolytes) within 48\u201372 hours and then weekly. Return precautions given for fever, worsening abdominal pain, increased drain output, or neurologic change.", "diagnosis_codes": ["F419", "K632", "K652", "K7031", "K219", "Z6830", "E781", "K7290", "R5382", "R569", "K589", "K9589", "E860", "E669", "Y929", "K56699", "Z87891", "F329", "Y833", "Y832", "K3184", "E871"], "suggested_codes": ["G931", "Z7521", "Z92820"], "accepted_codes": [], "rejected_codes": ["G931", "Z7521", "Z92820"], "date": "2024-11-26T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 29594531, "discharge_summary": "History of Present Illness: 63-year-old male admitted for observation with known metastatic malignancy to bone (C79.51) and progressive focal pain and functional decline. He presented with weakness of the right upper extremity and was found to have imaging consistent with bone metastasis and multiple medical issues including recent ischemic cerebrovascular event. Length of stay: 15 days.\n\nHospital Course: During admission the patient underwent diagnostic imaging and an image-guided bone biopsy. He received multidisciplinary care including oncology, neurology, and rehabilitation. Medical management included pain control with acetaminophen and gabapentin, correction of electrolyte abnormalities (hyponatremia and hypokalemia) with appropriate replacement, DVT prophylaxis, and optimization of cardiac and blood pressure medications. Neurology monitored for stroke sequelae and consulted for nonruptured cerebral aneurysm. Physical and occupational therapy worked on transfers, safety, and right upper extremity compensatory strategies.\n\nKey Findings and Procedures: Imaging confirmed secondary malignant bone disease and prior cerebral infarct. Procedures performed: image-guided bone biopsy and placement of percutaneous central venous access for infusion and blood draws. Relevant labs showed resolving hyponatremia and hypokalemia after replacement. NIHSS score 2; persistent monoplegia of the dominant right upper extremity.\n\nDischarge Condition and Functional Status: Patient is medically stable for discharge to home with home health services. He is ambulatory with a steady gait and independent with transfers but has persistent right upper extremity weakness limiting fine motor tasks and ADLs; requires assistance with dressing and grooming of the dominant arm. Home health will provide skilled nursing for medication management and wound/vessel access care, and PT/OT for continued strengthening, adaptive equipment training, and ADL support.\n\nMedications and Follow-up: Discharge medications include acetaminophen, aspirin, atenolol, atorvastatin, gabapentin, docusate, bisacodyl PRN, calcium carbonate, fish oil, and potassium supplementation as directed. Follow-up: oncology within 7 days, primary care and neurology within 1\u20132 weeks, and home health initiation immediately for skilled nursing and therapy. If new neurologic deficits or worsening pain occur, return to ED.", "diagnosis_codes": ["E83110", "R29702", "E861", "F17200", "K219", "E039", "I671", "I639", "Z96643", "G8321", "E785", "E876", "D638", "C7951", "G9519", "C228", "D509", "C792", "F319", "E871"], "suggested_codes": ["Z76839", "Z94829"], "accepted_codes": [], "rejected_codes": ["Z76839", "Z94829"], "date": "2024-05-26T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 21599769, "discharge_summary": "History of present illness: 60-year-old male with history of relapsed myeloid leukemia and prior allogeneic stem cell transplant (Z94.84) was admitted to observation for persistent fever, neutropenia (D70.9), and progressive dyspnea. He developed hypoxemia and new infiltrate on chest imaging consistent with pneumonia (J18.9) and concurrent bacteremia. Past medical history includes myelodysplastic features, essential hypertension, type 2 diabetes, and prior neurocognitive complaints.\n\nHospital course: The patient was managed over an 18-day observation stay with broad-spectrum IV antibiotics transitioned to targeted therapy after culture data, antipneumococcal coverage, and supportive care. He received myeloid-directed evaluation including hematology consultation and bone marrow studies confirming disease relapse. Blood cultures were positive during admission and subsequently cleared with therapy. He was treated for febrile neutropenia, had episodes of hypoxemia requiring short-term supplemental oxygen, and developed a neutrophilic skin eruption treated with topical steroid. He remained hemodynamically stable and afebrile for 48 hours prior to discharge.\n\nKey findings and procedures: Initial labs notable for profound neutropenia with ANC below critical threshold, positive blood cultures, and chest radiograph consistent with pneumonia. Procedures included placement of central venous access for antimicrobial administration, diagnostic bone marrow evaluation, and serial blood cultures.\n\nDischarge condition and functional status: Patient is medically stable, afebrile, and ambulatory with minimal assistance due to deconditioning. He requires skilled home health nursing for central line care, IV antibiotic administration/infusion management, and monitoring of vital signs and daily labs (CBC) until neutrophil recovery.\n\nMedications and follow-up: Discharged on atovaquone suspension for PCP prophylaxis, oral ciprofloxacin to complete therapy, acetaminophen PRN, folic acid, cyanocobalamin, and topical clobetasol for skin lesions. Home health to provide line care and medication administration. Follow-up appointments: hematology/oncology within 3\u20135 days, infectious disease within 7 days, and primary care within 7\u201310 days. Return precautions given for fever, worsening dyspnea, new bleeding, or other acute concerns.", "diagnosis_codes": ["Z86718", "J189", "D709", "C92Z2", "R51", "Z87891", "F329", "R110", "R0902", "L982", "I10", "E039", "Z85819"], "suggested_codes": ["B958", "E118", "Z79890", "Z9129", "Z944"], "accepted_codes": [], "rejected_codes": ["B958", "E118", "Z79890", "Z9129", "Z944"], "date": "2024-10-30T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 21242559, "discharge_summary": "History of Present Illness: 35-year-old female with prior bariatric surgery presented to ED with 48 hours of worsening crampy abdominal pain, nausea, vomiting and obstipation. CT abdomen/pelvis demonstrated small bowel obstruction with ascites consistent with adhesive obstruction. She was admitted under observation status for operative management.\n\nHospital Course: The patient underwent attempted diagnostic laparoscopy that was converted to open exploratory laparotomy with lysis of adhesions (ICD-10-PCS: 0DNA0ZZ, 0DNN0ZZ, 02HV33Z). Small bowel was examined and found viable; no bowel resection was required. Postoperatively she was managed with IV fluids (LR, D5 1/2NS, 0.9% NaCl as indicated), parenteral analgesia (hydromorphone initially, transitioned to oral acetaminophen), famotidine for gastric protection, and subcutaneous heparin for DVT prophylaxis. Influenza quadrivalent vaccine was administered during the stay. Her pain was controlled on oral regimen, bowel function returned on postoperative day 2 with flatus and tolerating a regular diet. Vital signs and labs remained stable. Surgical wounds were clean, dry and intact; any temporary drains were removed prior to discharge.\n\nKey Findings and Procedures: CT-confirmed small bowel obstruction due to adhesive disease with associated ascites. Operative lysis of adhesions with conversion from laparoscopic to open approach; no bowel ischemia or resection required.\n\nDischarge Condition and Functional Status: Patient discharged hemodynamically stable, afebrile, ambulatory with assistance and able to perform basic ADLs with occasional support. Tolerating oral intake and bowel function resumed. Wound healing appropriate; needs home health for dressing changes and ambulation support.\n\nMedications and Follow-up Plan: Discharge meds: acetaminophen 500\u20131000 mg PO every 6 hours PRN pain (do not exceed 3 g/24 hr), famotidine 20 mg PO twice daily, docusate 100 mg PO twice daily PRN for stool softening. Resume home antithrombotic/antiplatelet therapy as instructed by surgeon/PCP. Home health referral for wound care, medication reconciliation, ambulation assistance and monitoring of bowel function and incision. Surgical clinic follow-up in 7\u201310 days; PCP follow-up in 3\u20137 days. Return immediately for fever, increasing abdominal pain, redness/drainage from wound, vomiting or inability to tolerate oral intake.", "diagnosis_codes": ["K5650"], "suggested_codes": ["K566", "R197"], "accepted_codes": [], "rejected_codes": ["K566", "R197"], "date": "2024-04-11T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 28765431, "discharge_summary": "History of Present Illness: 25-year-old female presented via emergency with fever, rigors, dyspnea and pleuritic chest pain. Blood cultures grew methicillin-resistant Staphylococcus aureus (MRSA). Imaging demonstrated multiple bilateral septic pulmonary emboli. Transthoracic echocardiogram and subsequent transesophageal study were consistent with acute infective endocarditis with small mobile vegetations. She developed sepsis with associated coagulopathy and transient hyponatremia during admission. Social history notable for homelessness and active stimulant and opioid use disorder.\n\nHospital Course: Hospitalized 7 days for sepsis due to MRSA bacteremia with infective endocarditis and septic pulmonary emboli. She was stabilized with IV fluids, broad-spectrum antibiotics transitioned to IV vancomycin after sensitivities returned, and supportive care for hyponatremia. Coagulation parameters and platelet count were monitored and optimized. Withdrawal symptoms were managed with methadone oral solution and clonidine; lorazepam used as needed. A peripherally inserted central catheter (PICC) was placed for long-term IV antibiotic administration. She received counseling and social work involvement for discharge planning and housing resources.\n\nKey Findings and Procedures: Positive blood cultures for MRSA; echo consistent with acute/subacute infective endocarditis; CT chest showing septic emboli. Procedures: PICC placement for IV antibiotics and central access care. Laboratory abnormalities included transient hypo-osmolality/hyponatremia and a coagulation defect which improved with treatment.\n\nDischarge Condition and Functional Status: Patient is hemodynamically stable, afebrile for >48 hours, ambulatory with deconditioning \u2014 ambulates with supervision and tolerates activities of daily living with intermittent assistance. Requires skilled nursing for IV antibiotic administration, PICC care, wound/skin checks, and medication management. Home health will assist with mobility training and fall-risk mitigation.\n\nMedications and Follow-up: Continue IV vancomycin via home health per infectious disease-directed regimen; PICC maintenance with 0.9% sodium chloride flushes. Methadone oral solution and clonidine for opioid withdrawal; lorazepam PRN; acetaminophen and short-course morphine IR PRN for pain; stool regimen with docusate and senna; ferrous sulfate for anemia. Labs: baseline and twice-weekly vancomycin levels, CBC and BMP during IV therapy. Follow-up: Infectious Diseases and Cardiology within 1 week, primary care/social work and home health nursing for daily IV therapy and case management.", "diagnosis_codes": ["E8342", "D689", "Z590", "A4102"], "suggested_codes": ["E871", "I330", "D509", "F1120", "F1520", "I2699"], "accepted_codes": ["E871", "I330"], "rejected_codes": ["D509", "F1120", "F1520", "I2699"], "date": "2024-09-19T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 26663822, "discharge_summary": "History of Present Illness: 83-year-old female presented to ED with left lower quadrant abdominal pain, low-grade fever and change in bowel habits. CT abdomen performed in ED demonstrated diverticulitis of the sigmoid colon without perforation or abscess. She was admitted to observation for pain control, hydration and monitoring given comorbid cardiopulmonary and renal disease.\n\nHospital Course: During a 48-hour observation stay the patient was managed conservatively with IV fluids, bowel rest initially, transition to a soft, low-residue diet as tolerated, scheduled acetaminophen for analgesia and a bowel regimen with polyethylene glycol. She received short-term inpatient DVT prophylaxis per protocol. Pain and oral intake improved; no peritoneal signs or hemodynamic instability developed. Cardiac evaluation (ECG and troponin monitoring) showed no acute ischemia. Oxygenation remained stable on baseline; no escalation of respiratory support was required. Creatinine and electrolytes remained at baseline for her chronic kidney disease.\n\nKey Findings and Procedures: CT abdomen confirming uncomplicated diverticulitis. No drainable collection, no surgical intervention required. Routine labs and cardiac markers without acute ischemic pattern. No procedures performed beyond imaging and standard observation care.\n\nDischarge Condition and Functional Status: Patient is discharged clinically stable, afebrile, tolerating oral intake and ambulating with baseline assistive device. Baseline mild cognitive impairment and somnolence noted; requires assistance with medication management and occasional ADL support. Home environment appropriate for assistance; home health arranged for nursing and therapy evaluation.\n\nMedications and Follow-up: Continue home medications (acetaminophen PRN, anastrozole, aspirin, atorvastatin, citalopram, furosemide, levothyroxine, mirtazapine, multivitamin, oxybutynin, polyethylene glycol, pramipexole, ramelteon). Discontinue inpatient heparin. Home health to provide nursing visits for medication reconciliation, vital signs, weight checks, and education; PT/OT evaluation for safety as needed. Follow-up with primary care within 3\u20135 days, GI or general surgery clinic in 7\u201314 days, cardiology for heart-failure/HTN management within 1\u20132 weeks and nephrology as outpatient for CKD monitoring. Return to ED for worsening abdominal pain, fever, vomiting, shortness of breath or new neurologic changes.", "diagnosis_codes": ["F419", "I5030", "G4733", "E039", "G3184", "I082", "R0902", "I2720", "F32A", "I130", "N3281", "Z853", "Z20822", "I2510", "D509", "N1832", "G4700", "K5792", "R400"], "suggested_codes": ["Z790"], "accepted_codes": [], "rejected_codes": ["Z790"], "date": "2024-01-13T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 28673189, "discharge_summary": "History of present illness: 67-year-old female admitted emergently with sustained ventricular tachycardia (I47.2) on presentation with palpitations, lightheadedness and progressive dyspnea. Past cardiac history notable for dilated cardiomyopathy, prior myocardial infarction, atherosclerotic coronary disease, and prosthetic heart valve; chronic anticoagulation established prior to admission. She also has COPD with acute exacerbation on presentation.\n\nHospital course: Patient was monitored on telemetry. Initial management included rate control, antiarrhythmic therapy, and guided diuresis for acute on chronic systolic heart failure. She underwent successful acute cardioversion for unstable VT and was evaluated by electrophysiology. Device therapy planning was initiated. COPD exacerbation was treated with nebulized bronchodilators, azithromycin and short course of systemic steroids with improvement in wheeze and oxygenation. Diuresis with IV then oral furosemide improved volume status. Anticoagulation was continued; no bleeding complications occurred. The patient remained hemodynamically stable and afebrile prior to discharge.\n\nKey findings and procedures: ECG-confirmed ventricular tachycardia responsive to synchronized cardioversion. Elevated BNP consistent with heart failure exacerbation; chest exam and imaging consistent with COPD exacerbation. Procedures included synchronized electrical cardioversion and electrophysiology consultation with device planning and temporary pacing support as indicated.\n\nDischarge condition and functional status: Patient discharged in stable condition, ambulatory with assistance for increased fall risk and deconditioning. Home health services requested for medication management, wound/device site checks as applicable, assistance with ADLs and reinforcement of activity precautions. Requires inhaler and nebulizer technique reinforcement and evaluation for supplemental oxygen if home oxygen saturation monitoring indicates need.\n\nMedications and follow-up: Discharged on home regimen including furosemide, atorvastatin, aspirin, continued chronic anticoagulation, inhaled fluticasone-salmeterol, inhaled ipratropium and levalbuterol/nebulizers as needed, azithromycin short course, famotidine and PRN acetaminophen. Follow-up: cardiology within 7 days, electrophysiology within 2 weeks for device planning, primary care in 1 week, pulmonology as outpatient. Return to ED for recurrent syncope, chest pain, progressive dyspnea, or bleeding.", "diagnosis_codes": ["I472", "Z96653", "I2510", "Z87891", "I252", "Z955", "I5023", "Z7901", "D696", "I253", "I420", "I110", "J441", "Z952"], "suggested_codes": ["R54"], "accepted_codes": [], "rejected_codes": ["R54"], "date": "2024-07-03T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 29021855, "discharge_summary": "History of Present Illness: 29-year-old G?P? female at 23 weeks gestation presented on observation status for severe, intractable migraine with nausea/vomiting, superimposed on systemic lupus erythematosus (SLE) and chronic hypertension complicating pregnancy. Symptoms progressed over several days with inadequate outpatient control despite usual therapy. No focal neurologic deficits, no seizure activity.\n\nHospital Course: She was observed for 4 days. Initial evaluation included maternal vital sign monitoring, focused neurologic exams, and fetal heart rate checks; fetal assessment remained reassuring. IV fluids (LR) and antiemetics (prochlorperazine) were administered. A short course of IV methylprednisolone was given for headache/inflammatory flare with transition to oral steroid as indicated. Analgesic regimen included acetaminophen-caffeine-butalbital and a planned outpatient taper. Cyproheptadine was used as adjunct migraine prophylaxis. Hydroxychloroquine was continued for SLE. Bronchodilator therapy (albuterol) and inhaled fluticasone were continued for asthma. Blood pressures remained controlled on her baseline regimen; no evidence of preeclampsia or other obstetric complications during stay.\n\nKey Findings and Procedures: Neurologic exam non-focal; no neuroimaging performed due to clinical stability and pregnancy. Routine labs and inflammatory markers without acute abnormality. Continuous maternal-fetal monitoring showed reactive fetal heart tracings. Medication reconciliation completed.\n\nDischarge Condition and Functional Status: Patient is medically stable and afebrile at discharge. Ambulates with minimal limitation from headache; independent with ADLs but requires assistance/resources for medication administration and symptom monitoring at home. Pain improved but not fully resolved; outpatient management plan in place.\n\nMedications and Follow-up Plan: Discharge meds: acetaminophen-caffeine-butalbital (per schedule/taper), cyproheptadine, hydroxychloroquine, low-dose aspirin, albuterol inhaler PRN, fluticasone inhaler daily, pantoprazole, prenatal vitamins, prochlorperazine PRN, oxazepam PRN, topical sarna PRN, ranitidine as prescribed. Home health nursing to visit within 48 hours for medication reconciliation, BP and headache assessment, inhaler education, and fetal movement guidance. Follow-up with OB within 3\u20135 days, neurology in 1 week, and rheumatology as scheduled. Return immediately for severe worsening headache, visual changes, sustained BP elevation, decreased fetal movement, or respiratory distress.", "diagnosis_codes": ["O99353"], "suggested_codes": ["J45909", "G43909", "I10", "M3210"], "accepted_codes": ["J45909"], "rejected_codes": ["G43909", "I10", "M3210"], "date": "2024-01-26T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 27451900, "discharge_summary": "History of present illness: 75-year-old man admitted under observation for symptoms related to a symptomatic cecal mass (diagnosed malignant neoplasm of cecum, ICD-10 C18.0). He presented with abdominal pain, decreased bowel function and partial bowel obstruction/ileus. Pertinent comorbidities include chronic diastolic congestive heart failure, hypertensive heart disease with heart failure, chronic atrial fibrillation on long-term anticoagulation, benign prostatic hyperplasia with urinary retention, and prior episodes of diarrhea.\n\nHospital course: The patient underwent operative management of the cecal lesion (ICD-10-PCS 0DTF0ZZ). Postoperatively he had a transient ileus that resolved with bowel rest, IV fluids, and gradual diet advancement. He developed a brief postprocedural fever that responded to empiric antibiotics and supportive care. Rate control for chronic atrial fibrillation was achieved with diltiazem and metoprolol; heart failure managed with diuresis (furosemide) with stabilization of volume status. Anticoagulation was managed perioperatively with enoxaparin. Urinary retention was managed with intermittent catheterization and medical therapy (doxazosin, finasteride); voiding improved prior to discharge.\n\nKey findings and procedures: Pathology consistent with malignant neoplasm of the cecum; operative resection performed as above. Imaging and labs trended to baseline; no ongoing sepsis, hemodynamically stable at discharge.\n\nDischarge condition and functional status: Patient is stable and afebrile, tolerating oral intake, with return of bowel function. Ambulates with assistance and requires help with medication management and wound care. Home health recommended for nursing wound checks, medication administration/education, vital sign monitoring, fall-risk and toileting assistance given age, diuretic use and anticoagulation.\n\nMedications and follow-up: Discharged on acetaminophen, diltiazem (and extended-release as indicated), metoprolol succinate, furosemide, enoxaparin (as bridge), doxazosin, finasteride, potassium chloride, famotidine, ondansetron PRN, oxycodone or hydromorphone PRN for pain, simethicone. Follow-up appointments: surgical clinic in 7\u201314 days, oncology for staging/therapy planning, cardiology within 1 week for anticoagulation/heart failure management, and primary care in 1 week. Home health to begin immediately for nursing follow-up, medication reconciliation, wound care, and ADL support.", "diagnosis_codes": ["R5082", "Z87891", "R197", "C180", "K567", "N401", "I482", "I5032", "M5430", "I110"], "suggested_codes": ["N390", "R102", "Z7401", "Z9181"], "accepted_codes": [], "rejected_codes": ["N390", "R102", "Z7401", "Z9181"], "date": "2024-12-26T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 23610735, "discharge_summary": "History of present illness: 56-year-old female presented via emergency department after an accidental overdose of beta\u2011adrenoreceptor antagonist. On arrival she was hypotensive and bradycardic with complaints of lightheadedness and near-syncope. Family reported medication error at home (private residence). Past medical history notable for atrial fibrillation, hypertension, obesity and nicotine dependence.\n\nHospital course: Length of stay 1.2 days (emergency admission). Patient received supportive care with continuous cardiac monitoring, intravenous fluids (0.9% sodium chloride and lactated Ringers), electrolyte repletion (potassium chloride, magnesium sulfate), and calcium gluconate administration. Serial ECGs demonstrated atrial fibrillation with slow ventricular response. Labs revealed mild metabolic acidosis which improved with supportive therapy. Anticoagulation was transitioned from inpatient heparin to apixaban prior to discharge. No intubation or invasive cardiac procedures were required. Patient remained hemodynamically stable and alert with improving heart rate and blood pressure prior to discharge.\n\nKey findings and procedures: Initial ECG: atrial fibrillation with slow ventricular response; vitals improved with fluids and monitoring. Labs: transient acidosis and electrolyte abnormalities corrected. Procedures: continuous telemetry monitoring, IV access for medication and fluids. No central lines, cardioversion, or dialysis performed.\n\nDischarge condition and functional status: Patient discharged in stable medical condition, ambulatory with baseline assistance, cognitively intact for home care. Home health nursing recommended for medication reconciliation, daily vital sign and orthostatic checks, and assistance with activities of daily living during early recovery.\n\nMedications and follow-up: Discharged on apixaban for atrial fibrillation anticoagulation, flecainide for rhythm management (per cardiology), acetaminophen PRN for pain, and bowel regimen (senna, bisacodyl) as needed. Home health to confirm medication administration and monitor for recurrent bradycardia, hypotension, dizziness or bleeding. Follow-up with cardiology within 7 days and primary care within 3\u20135 days. Return to ED for recurrent syncope, chest pain, severe dyspnea, or worsening hemodynamics.", "diagnosis_codes": ["I952", "R9439", "Y92009", "I4891", "Z7902", "Z87891", "R001", "E669", "I10", "Z8249", "T447X1A", "E872"], "suggested_codes": ["Z794"], "accepted_codes": [], "rejected_codes": ["Z794"], "date": "2024-12-17T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 25820516, "discharge_summary": "Brief HPI: 84-year-old female admitted urgently with chest pain and dyspnea and found to have a non\u2013ST-elevation myocardial infarction (NSTEMI). Significant past history includes chronic systolic heart failure, hypertension, hyperlipidemia, and peripheral arterial disease. On presentation she was hypotensive and developed features consistent with cardiogenic shock.\n\nHospital course: Over a 12-day admission she was stabilized in the ICU. Initial evaluation demonstrated elevated cardiac biomarkers and reduced LVEF on transthoracic echocardiography consistent with acute on chronic systolic dysfunction. She underwent coronary angiography with percutaneous coronary intervention. She required brief vasopressor/inotropic support for cardiogenic shock and received transfusion for acute posthemorrhagic anemia. Intermittent atrial arrhythmia was managed with rate control and amiodarone as indicated. She received aggressive diuresis for congestive failure, chest physiotherapy for atelectasis, and prophylaxis/treatment as indicated for exposure to COVID-19. Nutritional and electrolyte abnormalities were corrected; vitamin K (phytonadione) was administered prior to procedures.\n\nKey findings and procedures: NSTEMI with multivessel coronary disease treated by left heart catheterization and percutaneous intervention; acute on chronic systolic heart failure (reduced EF); cardiogenic shock requiring short-term hemodynamic support; packed red blood cell transfusion for acute anemia; central venous access for vasoactive infusions; pulmonary toilet for atelectasis.\n\nDischarge condition and functional status: The patient is clinically improved and hemodynamically stable off vasopressors, with adequate oxygenation on room air. She remains deconditioned and requires assistance with transfers and ADLs; ambulates short distances with a walker and supervision. Home health nursing is arranged for medication reconciliation, daily weights, edema and wound checks, IV line care if still present, and reinforcement of heart-failure self-management.\n\nMedications and follow-up: Discharge medications include aspirin EC, atorvastatin, carvedilol (beta-blocker), furosemide, amiodarone (short course as directed), omeprazole, docusate, bowel regimen, lidocaine 5% patch PRN, magnesium supplementation PRN, and acetaminophen PRN. Cardiology follow-up within 7 days; primary care within 7\u201310 days; home health nursing to begin immediately.", "diagnosis_codes": ["R410", "I4891", "I2510", "Z87891", "R001", "J9811", "Z7901", "Z20822", "R791", "E785", "I214"], "suggested_codes": ["D62", "I469", "I500", "I524"], "accepted_codes": ["D62"], "rejected_codes": ["I469", "I500", "I524"], "date": "2024-09-27T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 23374514, "discharge_summary": "28-year-old female admitted electively for symptomatic cholelithiasis (ICD-10 K80.70) without cholecystitis or obstruction. Relevant history includes morbid obesity (BMI 40\u201344.9, E66.01), prior nicotine dependence, and GERD without esophagitis. She presented for planned laparoscopic cholecystectomy.\n\nHospital course: The patient underwent attempted laparoscopic cholecystectomy which was converted to an open cholecystectomy due to limited visualization and technical difficulty related to body habitus (procedure codes 0FT40ZZ, 0FJ44ZZ, BF101ZZ). Intraoperative findings included multiple gallstones with no gross acute cholecystitis. Estimated blood loss was minimal; no intraoperative complications. Postoperatively she was monitored on the surgical ward for 36\u201348 hours. Pain was managed with IV acetaminophen, scheduled oral acetaminophen, short courses of IV hydromorphone and oral oxycodone PRN, and ibuprofen as tolerated. She received DVT prophylaxis with subcutaneous heparin and famotidine for reflux prophylaxis. Influenza quadrivalent vaccine was administered prior to discharge.\n\nKey findings and procedures: Successful removal of the gallbladder containing gallstones; conversion to open procedure documented. Pathology pending. No bile duct injury, no evidence of retained stones on intraoperative assessment.\n\nDischarge condition and functional status: Patient is hemodynamically stable, afebrile, tolerating oral intake, ambulating with minimal assistance, and performing basic activities of daily living with encouragement for graded activity. She will require home health for incision/wound care and assistance with mobility and activity progression for approximately 1\u20132 weeks. Weight-bearing and lifting restrictions given (no heavy lifting >10 lbs until follow-up).\n\nMedications at discharge: acetaminophen scheduled, ibuprofen suspension PRN, oxycodone IR PRN for breakthrough pain, famotidine BID for GERD. Heparin discontinued. Encourage smoking cessation.\n\nFollow-up: Surgical clinic in 7\u201310 days for wound check and suture/staple removal, primary care for BMI/weight management and GERD, and GI as needed. Patient instructed on wound care, signs of infection, VTE warning signs, and when to seek urgent care.", "diagnosis_codes": ["Z5331", "Z6841", "E6601", "Z87891", "K219", "K8070"], "suggested_codes": [], "accepted_codes": [], "rejected_codes": [], "date": "2024-05-16T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 22453080, "discharge_summary": "History of Present Illness: 20-year-old female presented to the emergency department with a painful, erythematous postprocedural wound of the left lateral thigh with purulent drainage and systemic symptoms (fever, nausea). Past psychiatric history notable for borderline personality disorder. She reported recent outpatient minor skin procedure at an unspecified facility. Initial evaluation suggested wound infection with possible abscess and concurrent diarrheal illness.\n\nHospital Course: Patient was admitted emergently for incision and drainage/debridement of the wound (ICD-10 procedure 0C9D0ZZ) with wound culture obtained. Empiric IV ampicillin-sulbactam was initiated. Cultures grew Streptococcus group A (B95.0) and antibiotics were narrowed. The patient developed gastrointestinal intolerance to an initial antibiotic prompting change to oral amoxicillin-clavulanate prior to discharge, which she tolerated. She received fluid resuscitation (Lactated Ringers, 0.9% NaCl) and symptomatic treatment for toxic gastroenteritis/colitis (K52.1). Hemoglobin trended low (anemia, D64.9) but stable without transfusion. No evidence of deep tissue involvement on exam or imaging; afebrile for >48 hours prior to discharge.\n\nKey Findings and Procedures: Wound incision and drainage/debridement performed at bedside/OR with purulent fluid; wound cultures positive for group A Streptococcus. No retained foreign body. Patient received venous thromboembolism prophylaxis during stay.\n\nDischarge Condition and Functional Status: Patient medically stable and afebrile. Pain controlled on oral regimen; ambulatory with normal gait and independent with transfers. Home health recommended for daily wound dressing changes, medication administration/monitoring, and assistance with wound hygiene and activity as needed.\n\nMedications at Discharge: Amoxicillin-clavulanate 875/125 mg PO twice daily for 10 days; acetaminophen 500\u20131000 mg PRN; ibuprofen 200\u2013400 mg PRN; oxycodone IR short course PRN for severe pain; docusate 100 mg daily; continue fluoxetine 20 mg daily and oxcarbazepine as outpatient. Chlorhexidine 0.12% oral rinse PRN. Follow-up: Surgical clinic in 7 days, PCP in 3\u20135 days, and Infectious Disease if concerns for nonresponse. Return sooner for increasing pain, fever, spreading erythema, or gastrointestinal bleeding.", "diagnosis_codes": ["L7682", "Y838", "T3695XA", "K521", "F603"], "suggested_codes": ["B950", "D649", "L03116"], "accepted_codes": ["B950", "D649"], "rejected_codes": ["L03116"], "date": "2024-09-05T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 29938054, "discharge_summary": "History of present illness: 66-year-old female with history of mantle cell lymphoma status post recent stem cell transplant complicated by graft-versus-host disease, chronic kidney disease, atrial fibrillation, and diastolic heart failure was admitted to observation for sepsis from a central venous catheter. She developed Enterococcus bloodstream infection (T80.211A) with hypotension and acute on chronic heart failure exacerbation. The catheter was determined to be the source.\n\nHospital course: Over a 22-day admission the patient underwent removal of the implicated central venous catheter with placement of a new peripherally inserted central catheter for ongoing therapy. Blood cultures grew Enterococcus initially; subsequent cultures cleared after targeted IV antibiotic therapy with daptomycin and supportive care. She required diuresis with intravenous then oral furosemide for volume management and rate control/anticoagulation for persistent atrial fibrillation. Her thrombotic microangiopathy and hematologic issues were managed in coordination with hematology/oncology. Renal function remained chronically impaired but stable without need for dialysis. She remained afebrile and hemodynamically stable at discharge.\n\nKey findings and procedures: Positive blood cultures for Enterococcus; removal of infected central venous catheter; PICC placement for long-term IV antibiotics; imaging and laboratory monitoring consistent with resolving sepsis. Consults: Infectious Disease, Cardiology, Hematology/Oncology, Nephrology.\n\nDischarge condition and functional status: Patient discharged clinically improved and hemodynamically stable, afebrile for >48 hours. Functional status: ambulatory with assistance at baseline; requires home health support for medication administration and activities of daily living due to deconditioning and ongoing IV therapy needs.\n\nMedications and follow-up plan: Discharged on home IV daptomycin via home infusion for a planned course per ID; apixaban for atrial fibrillation; furosemide, famotidine, acyclovir, allopurinol, folic acid and supportive topical agents as indicated. Home health to provide daily IV antibiotic administration, PICC dressing care/heparin flushes, wound/line assessment, medication reconciliation, vital sign and weight monitoring, and ADL assistance. Follow-up with Infectious Disease in 3\u20137 days, Cardiology in 1 week, Hematology/Oncology in 1\u20132 weeks, and primary care with labs (CBC, BMP) twice weekly initially then as directed.", "diagnosis_codes": ["T80211A"], "suggested_codes": ["N189", "D8981", "I4891", "I5032", "I5043", "R6521", "Z431"], "accepted_codes": ["N189"], "rejected_codes": ["D8981", "I4891", "I5032", "I5043", "R6521", "Z431"], "date": "2024-05-17T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 22845711, "discharge_summary": "51-year-old female admitted under observation for sepsis (A41.89) secondary to community-acquired pneumonia with acute hypoxic respiratory failure. Past medical history notable for end-stage renal disease on chronic hemodialysis, prior kidney transplant with concern for rejection, COPD, coronary artery disease, atrial fibrillation, and history of ovarian malignancy with metastatic disease. She presented with fever, cough, dyspnea, and progressive hypoxia requiring supplemental oxygen and short period of ventilatory support. Blood/respiratory cultures were obtained; broad-spectrum IV antibiotics were initiated and narrowed based on clinical response.\n\nHospital course: Patient completed supportive care and a course of antibiotics with clinical improvement. Respiratory status improved from acute hypoxic failure to low-flow oxygen requirement and then to room air at rest. Hemodynamics remained stable without vasopressor support. She continued scheduled hemodialysis without complication. Pain and nausea were controlled. Anticoagulation for atrial fibrillation was held while inpatient for procedural considerations and restarted per cardiology recommendations prior to discharge. No acute surgical interventions were required.\n\nKey findings and procedures: Positive imaging consistent with multilobar pneumonia; transient acute respiratory failure (J96.01) managed conservatively. ICD-10-PCS 5A1D70Z performed for short-term mechanical ventilatory support. Labs showed leukocytosis on admission that trended down; renal function at baseline for ESRD on dialysis. No new acute cardiac ischemia.\n\nDischarge condition and functional status: Patient is hemodynamically stable and clinically improved to baseline respiratory status with ambulation tolerated with assistance for short distances. Mild deconditioning persists; requires assistance with activities of daily living and medication management. Home health nursing and home physical therapy are arranged for medication reconciliation, wound/vital sign monitoring, dialysis coordination, and mobility training.\n\nMedications and follow-up: Discharged on oral antibiotic regimen (azithromycin and cefpodoxime as directed), inhaled bronchodilator (albuterol PRN), home heart and renal medications (metoprolol, furosemide adjustments made per nephrology), acid suppression as needed, analgesics (acetaminophen). Labs (CBC, BMP) within 48\u201372 hours. Follow-up: PCP in 3\u20135 days, nephrology/dialysis clinic per schedule, infectious disease within 7\u201310 days, oncology/transplant clinic as outpatient. Return precautions and education provided.", "diagnosis_codes": ["A4189", "E785", "I480", "Z955", "J189", "I2510", "Z87891", "D84821", "I959", "K219", "I2720", "N186", "M19012", "C799", "J441", "Z8673"], "suggested_codes": ["T8604", "Z7489"], "accepted_codes": [], "rejected_codes": ["T8604", "Z7489"], "date": "2024-11-23T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 26196402, "discharge_summary": "31-year-old G?P? female admitted urgently at 39 weeks\u2019 gestation for breech presentation. Presenting complaint was decreased tolerance of attempt at external cephalic version and concern for malpresentation; decision made for operative delivery. Past medical history noncontributory for pregnancy complications. No drug allergies documented.\n\nHospital course: Patient underwent operative delivery for persistent breech presentation (procedure codes 10D00Z1 and 10907ZC documented). Intraoperative and immediate postoperative course were uncomplicated. Estimated blood loss within expected range for the procedure; no transfusion required. Pain was managed postoperatively with multimodal analgesia including acetaminophen, ibuprofen and a short course of oxycodone PRN. Antiemetics (ondansetron, metoclopramide) were used as needed. Bowel regimen initiated (docusate, bisacodyl, milk of magnesia as indicated) with simethicone for gas. Influenza vaccine (quadrivalent) administered prior to discharge.\n\nKey findings and procedures: Term singleton liveborn infant delivered at 39 weeks; maternal vital signs remained stable. Surgical incision clean, dry and intact; lower abdominal wound without erythema or drainage at discharge. Voiding and bowel function established prior to discharge. Patient ambulated with steady gait and required minimal assistance initially; progressed to independent ambulation with activity as tolerated.\n\nDischarge condition and functional status: Patient is stable and medically optimized for discharge. Ambulates independently in home setting with occasional assistance for stair negotiation; able to perform activities of daily living with minimal assistance. Requires home health for wound checks, medication administration/education, pain assessment, and breastfeeding/lactation support.\n\nMedications at discharge: Acetaminophen, ibuprofen, oxycodone (short course PRN for severe pain), docusate sodium, bisacodyl PRN, milk of magnesia PRN, simethicone, ondansetron and metoclopramide PRN; naloxone provided per institutional opioid-safety protocol. \n\nFollow-up: OB postpartum visit in 1\u20132 weeks; wound check by home health nurse within 48\u201372 hours; newborn pediatrician follow-up within 48\u201372 hours; return earlier for fever >100.4\u00b0F, heavy vaginal bleeding, worsening wound symptoms, uncontrolled pain or respiratory symptoms.", "diagnosis_codes": ["Z3A39", "Z370", "O321XX0"], "suggested_codes": [], "accepted_codes": [], "rejected_codes": [], "date": "2024-08-19T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 23417381, "discharge_summary": "50-year-old female, admitted under observation for 20.7 days for management of hematopoietic stem cell transplantation\u2013associated thrombotic microangiopathy (HSCT-TMA) in the setting of recent allogeneic stem cell transplant with chronic graft-versus-host disease (GVHD) and treatment-related pancytopenia. She presented with progressive anemia, thrombocytopenia, rising LDH, schistocytes on peripheral smear, and renal dysfunction consistent with TMA. Active problems on admission included cytopenias, CMV viremia, immunodeficiency post-transplant, electrolyte disturbances (hypokalemia, phosphorus abnormality), and secondary infections managed during hospitalization.\n\nHospital course: The patient was managed by the transplant/hematology team with a multidisciplinary approach over a three-week hospitalization. Care included transfusion support (RBCs/platelets as indicated), antimicrobial and antiparasitic therapy (including targeted therapy for CMV and prophylaxis), optimization of immunosuppression for GVHD, aggressive electrolyte repletion, and close renal and hemodynamic monitoring. Central venous access was maintained for infusions and blood draws with routine heparin flushes. Blood counts and metabolic panels were trended; infectious disease and nephrology were involved. The patient required brief ICU-level monitoring for hemodynamic instability early in stay but improved with supportive care.\n\nKey findings/procedures: microangiopathic hemolysis on peripheral smear, elevated LDH, intermittent renal impairment; central venous access placed/maintained; serial transfusions and IV electrolyte repletion.\n\nDischarge condition and functional status: The patient is medically stable and afebrile at discharge, ambulatory with assistance due to deconditioning, and requires help with medication administration and central line care. Home health services arranged for skilled nursing visits for IV/heparin flushes, wound/line care, medication reconciliation, and assistance with ADLs.\n\nMedications and follow-up: Discharge medications include Atovaquone suspension, budesonide, cetirizine, cyanocobalamin, dexamethasone oral solution, escitalopram, folic acid, heparin flush syringes for line maintenance, lisinopril, magnesium supplementation, montelukast, and multivitamins. Outpatient follow-up with transplant hematology within 3\u20137 days, primary care in 1\u20132 weeks, and home health nursing for twice-weekly CBC/CMP and CMV PCR monitoring. Return precautions given for fever, bleeding, dyspnea, or new neurologic symptoms.", "diagnosis_codes": ["M3111"], "suggested_codes": ["B259", "D849", "E8339", "E876", "D6182", "N179", "T8601", "Z452", "Z7401"], "accepted_codes": ["B259", "D849", "E8339", "E876"], "rejected_codes": ["D6182", "N179", "T8601", "Z452", "Z7401"], "date": "2024-09-03T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 29922430, "discharge_summary": "Brief history of present illness: 54-year-old female with known Crohn\u2019s disease (small and large bowel) presented on observation status with worsening abdominal pain, increased stool frequency and low-grade fevers. She has a history of obesity status-post bariatric surgery, essential hypertension, hypothyroidism, obstructive sleep apnea on CPAP, asthma, nicotine dependence, alcohol use with anxiety disorder, vitamin D deficiency and depression. Hospital course: Observation stay 4.8 days. Initial evaluation included CBC, CMP, CRP, TSH and vitamin D level. She received IV fluids (LR and 5% dextrose) for dehydration and IV then oral antibiotics (ciprofloxacin and metronidazole) for suspected infectious colitis vs Crohn\u2019s flare with clinical improvement. Mesalamine was continued. She received venous thromboembolism prophylaxis with heparin and symptomatic treatment (acetaminophen, PRN lorazepam). Home medications including levothyroxine, lisinopril and fluoxetine were continued. No surgical interventions were required. Key findings and procedures: Vital signs normalized; abdominal exam improved with decreased tenderness and reduced stool frequency. Labs showed no leukocytosis at discharge; vitamin D deficiency identified and supplementation started. Procedures included peripheral IV infusions for fluids and antibiotics (administration codes documented). Imaging and endoscopic evaluation were deferred to outpatient GI. Discharge condition and functional status: Patient is hemodynamically stable and afebrile at discharge, ambulating with steady gait at baseline and able to perform most ADLs independently. Home health services are arranged for nursing visits for medication administration support (transition from IV to oral antibiotics as needed), wound-free IV access care if outpatient infusion required, monitoring of vitals and stool output, assistance with medication reconciliation, and reinforcement of CPAP adherence. Medications and follow-up: Discharged on oral ciprofloxacin (to complete prescribed course), metronidazole, mesalamine, levothyroxine, lisinopril, fluoxetine, folic acid and vitamin D supplementation; acetaminophen and lorazepam PRN. Follow-up with GI in 1 week for colon/therapy planning, PCP in 1 week, sleep medicine and endocrinology as outpatient. Labs (CBC, CMP, CRP, TSH, vitamin D) to be checked prior to GI visit. If symptoms worsen (fever, severe pain, bleeding), return to ED.", "diagnosis_codes": ["Z733", "K5080", "Z6834", "F329", "E039", "F558", "G4733", "E669", "I10", "Z9884", "Z9114", "K828", "E559", "F17210", "J45909", "F10980"], "suggested_codes": ["E860", "Z515"], "accepted_codes": [], "rejected_codes": ["E860", "Z515"], "date": "2024-08-11T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 25547119, "discharge_summary": "Brief history of present illness: 51-year-old man with long-standing type 1 diabetes mellitus complicated by diabetic neuropathy and retinopathy, hypertensive CKD and ESRD on maintenance hemodialysis, was admitted for deceased-donor renal transplant and perioperative management. Admission type: observation; length of stay 7.2 days.\n\nHospital course: The patient underwent renal transplant (ICD-10-PCS 0TY10Z0) with perioperative vascular access/line placement (0FYG0Z0). Induction immunosuppression included rabbit anti-thymocyte globulin (inpatient) and initiation of mycophenolate mofetil. Perioperative antibiotic prophylaxis and short-course levofloxacin and cefazolin were administered. Postoperative analgesia and antiemetic therapy provided; glycemic management adjusted with insulin. He remained hemodynamically stable without evidence of immediate graft rejection or surgical complication. Urine output increased postoperatively and serum creatinine trended down; dialysis was not required prior to discharge.\n\nKey findings and procedures: Operative note documented uncomplicated allograft implantation. Serial labs demonstrated improving renal function and stable electrolytes. No fever, wound infection, or thromboembolic event identified. Immunologic and infectious prophylaxis plans were completed per transplant protocol.\n\nDischarge condition and functional status: Patient discharged in stable condition, afebrile, hemodynamically stable. Ambulates independently with occasional use of a cane for endurance; able to perform light ADLs but requires assistance with medication administration, wound care, and frequent glucose monitoring. Home health nursing recommended for skilled post-transplant care, wound checks, and lab draws.\n\nMedications and follow-up: Discharge meds include mycophenolate mofetil, continuation of home insulin regimen with instructions for glucose monitoring and insulin adjustment, aspirin, carvedilol, short course of oral levofloxacin (per protocol), acetaminophen PRN, and other usual chronic meds (lipid therapy continued). Home health to administer/verify medications, monitor vitals and wound, and coordinate labs. Follow-up with transplant clinic and nephrology within 48\u201372 hours, primary care within 1\u20132 weeks, and daily labs initially with frequency to be guided by transplant team. Return precautions reviewed (fever, graft pain, decreased urine output, wound changes).", "diagnosis_codes": ["E785", "I120", "Z992", "Z794", "N186", "E1040", "E1022", "E10319"], "suggested_codes": ["Z515", "Z741", "Z911", "Z9482"], "accepted_codes": [], "rejected_codes": ["Z515", "Z741", "Z911", "Z9482"], "date": "2024-09-02T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 26370849, "discharge_summary": "History of Present Illness: 75-year-old female presented to the emergency department with 2 days of right upper quadrant abdominal pain, associated nausea and several loose stools. She reported generalized weakness but denied fever, vomiting, or jaundice. Emergency evaluation revealed abnormal serum enzyme elevations prompting further workup.\n\nHospital Course: Admitted for observation and diagnostic evaluation (length of stay 2.4 days). Initial labs demonstrated elevated hepatic enzymes (R74.8) and mild anemia consistent with iron deficiency (D50.9). CBC, CMP, and coagulation studies were obtained. RUQ ultrasound showed no acute cholecystitis or biliary obstruction. Patient received IV fluids, antiemetic therapy (ondansetron), analgesia (acetaminophen, oxycodone immediate release PRN), bowel regimen and antidiarrheal treatment (loperamide, senna, bisacodyl as indicated). Subcutaneous heparin was administered for DVT prophylaxis. Psychiatry medication (bupropion SR) and antihypertensive (losartan) were continued. Influenza vaccine (quadrivalent) was administered prior to discharge.\n\nKey Findings and Procedures: Elevated serum liver enzymes without sonographic evidence of obstructive pathology; RUQ tenderness on exam but no peritoneal signs. No invasive procedures performed. DVT prophylaxis provided. Immunization given.\n\nDischarge Condition and Functional Status: Patient is hemodynamically stable at discharge, tolerating oral intake, and pain controlled with oral medications. Ambulates with steadying assistance at baseline and requires help with medication management and grocery/meal preparation due to limited endurance and partial dental loss affecting chewing. Home health nursing recommended for medication reconciliation, wound-free skilled nursing assessments (labs: repeat LFTs and CBC), and assistance with ADLs as needed.\n\nMedications at Discharge: Acetaminophen PRN, OxyCODONE IR PRN short course for severe pain, Ondansetron PRN, Loperamide PRN, Senna and Bisacodyl as bowel regimen PRN, Lorazepam PRN, Losartan daily, Pravastatin daily, Wellbutrin SR daily, subcutaneous heparin discontinued at discharge. Saline flush supplies as applicable.\n\nFollow-up Plan: Primary care follow-up within 3\u20137 days; GI clinic appointment and repeat LFTs/CBC in 1 week. Continue home health nursing for 1\u20132 weeks or until stable. Return to ED for worsening pain, fever, jaundice, or new bleeding.", "diagnosis_codes": ["Z23", "D509", "R748", "F329", "Z9049", "K08409", "R197", "I10", "E785", "R1011"], "suggested_codes": ["Z794"], "accepted_codes": [], "rejected_codes": ["Z794"], "date": "2024-11-17T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 21173347, "discharge_summary": "History of Present Illness: 63-year-old male admitted under observation for 9.7 days for workup and management of newly diagnosed malignant neoplasm of the head of the pancreas (C25.0) with metastatic disease to the small intestine and other digestive organs. He presented with progressive abdominal pain, weight loss, poor oral intake and severe protein-calorie malnutrition (E43). Past medical history notable for type 2 diabetes mellitus, hyperlipidemia, and prior right total hip arthroplasty.\n\nHospital Course: Patient underwent placement of a central vascular access device for chemotherapy and supportive infusions. He received inpatient initiation of systemic therapy (fluorouracil, irinotecan, leucovorin) with antiemetic and supportive care, intravenous fluids (0.9% NaCl, D5), and heparin flushes for port maintenance. Pain was managed initially with parenteral opioids and later transitioned to scheduled oral morphine SR with immediate-release opioid for breakthrough pain; adjunctive acetaminophen used as needed. Nutrition consult addressed severe malnutrition and oral supplementation was recommended; enteral/parenteral nutrition was deferred pending outpatient oncologic plan. He had transient delirium managed with low-dose haloperidol and supportive measures. No acute cardiopulmonary events; COVID-19 exposure documented without active infection.\n\nKey Findings and Procedures: Imaging and clinical evaluation consistent with pancreatic head primary with metastatic disease. Procedures: central venous port/CVC placement for chemotherapy and infusion access, infusion therapies administered, and routine port maintenance (heparin flush). Pain control optimized; glycemic control addressed during stay.\n\nDischarge condition and functional status: Stable for discharge. Ambulatory with assistance due to deconditioning; requires home health nursing for port care, medication administration/education, wound assessment, glucose monitoring, and assistance with activities of daily living. Nutrition remains poor and will require close outpatient follow-up and home health weight monitoring.\n\nMedications and Follow-up: Discharge medications include morphine SR for baseline pain, immediate-release opioid for breakthrough, acetaminophen PRN, diabetes and lipid medications as listed. Heparin flush supplies arranged for port. Follow-up: oncology within 7 days for continuation of systemic therapy, primary care within 1 week, and home health nursing visit within 48 hours of discharge for port care, medication reconciliation, pain and nutrition assessment.", "diagnosis_codes": ["C250"], "suggested_codes": ["E119", "E43", "E785", "F05", "Z96641"], "accepted_codes": ["E119", "E43", "E785"], "rejected_codes": ["F05", "Z96641"], "date": "2024-06-08T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 21978017, "discharge_summary": "41-year-old male admitted under observation for acute exacerbation of alcohol-induced chronic pancreatitis with associated nausea, vomiting, abdominal pain and labile glycemia. History notable for chronic alcohol use, prior partial pancreatic loss, insulin-requiring diabetes with episodes of hypo- and hyperglycemia, moderate protein-calorie malnutrition (BMI \u226419.9) and anemia.\n\nHospital course: Patient received aggressive IV fluids (LR), antiemetics (ondansetron), PPI (pantoprazole), pancreatic enzyme replacement (Creon) and multimodal analgesia including acetaminophen, pregabalin and short-course opioid for breakthrough pain. Endocrine management included glucose monitoring, intermittent dextrose 50% and glucagon for hypoglycemia events and adjustment of inpatient insulin. Nutrition consult initiated and multivitamins started. Imaging and labs were consistent with chronic pancreatitis without necrosis or infection. There were no procedural interventions. Influenza vaccine given prior to discharge.\n\nKey findings/procedures: CT abdomen consistent with chronic pancreatitis; labs notable for iron deficiency/microcytic anemia and hypoalbuminemia consistent with malnutrition; intermittent hypoinsulinemia/hypoglycemia managed medically. No endoscopic or surgical procedures performed.\n\nDischarge condition and functional status: Patient is hemodynamically stable, afebrile, with pain controlled on oral regimen and tolerating oral intake with pancreatic enzymes prescribed at meals. Ambulates with steady gait but reports decreased endurance and recent weight loss; requires assistance with meal planning and diabetes medication administration during recovery. Home health is recommended to provide skilled nursing for glucose monitoring/insulin administration, medication reconciliation, nutrition support and weight/vital sign monitoring.\n\nMedications and follow-up: Discharge meds include Creon with meals, insulin regimen with glucose meter supplies and glucagon emergency kit, multivitamin, duloxetine, pregabalin, acetaminophen, docusate, pantoprazole, ondansetron PRN, and a short outpatient opioid PRN. Follow-up arranged with GI within 1\u20132 weeks, primary care within 7 days, and endocrinology and nutrition within 1\u20132 weeks. Labs (CBC, CMP, amylase/lipase) to be repeated prior to GI visit. Counseling provided for alcohol cessation; home health referral placed.", "diagnosis_codes": ["K860"], "suggested_codes": ["E119", "E162", "E43", "E8311", "R109", "R110", "R112", "R634"], "accepted_codes": [], "rejected_codes": ["E119", "E162", "E43", "E8311", "R109", "R110", "R112", "R634"], "date": "2024-11-24T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 26775845, "discharge_summary": "History of present illness: 67-year-old female admitted to observation for acute onset right lower extremity weakness and numbness. Symptoms began on day of presentation with gait difficulty and paresthesia. Past medical history notable for type 2 diabetes mellitus, hyperlipidemia, gastroesophageal reflux disease, obesity, and longstanding tobacco use.\n\nHospital course: Patient observed for approximately 24 hours. Neurologic exam demonstrated focal right lower limb weakness (monoplegia) and decreased sensation. Non-contrast head CT showed no hemorrhage. Clinical impression consistent with lacunar ischemic stroke due to small-vessel occlusion (I63.81). Blood glucose was reviewed and managed; no acute metabolic derangement. Cardiac monitoring during observation showed no arrhythmia. Vascular risk factors were optimized and secondary stroke prevention measures initiated.\n\nKey findings and procedures: Focal right lower extremity weakness and sensory disturbance on exam. CT head without acute hemorrhage. Laboratory evaluation notable for chronic diabetes and hyperlipidemia. No invasive procedures performed. Patient received antiplatelet therapy and statin initiation in hospital.\n\nDischarge condition and functional status: Patient discharged stable, neurologically unchanged from admission baseline with persistent right lower extremity weakness requiring standby assistance for ambulation and increased fall risk. Continues independent activities of daily living with difficulty negotiating stairs; home health recommended for skilled nursing and therapy services (PT/OT) to address mobility, gait training, and safety. Home health also to assist with medication administration and blood glucose monitoring.\n\nMedications at discharge: Aspirin 81 mg daily, Atorvastatin 40 mg nightly, insulin as per outpatient regimen with glucose monitoring supplies, Artificial tears preservative-free PRN, Erythromycin 0.5% ophthalmic ointment PRN, and supplies including dextrose 50%, glucose gel, glucagon for hypoglycemia rescue as indicated. Heparin flush and normal saline flush for IV access as needed.\n\nFollow-up: Primary care within 7 days, outpatient neurology within 1\u20132 weeks, vascular medicine/cardiology as indicated, and endocrinology for diabetes management. Home health to perform neuro checks, fall risk assessment, medication reconciliation, and therapy evaluation.", "diagnosis_codes": ["I6381"], "suggested_codes": ["E119", "E785", "F17210", "R2689", "Z6831", "Z7489"], "accepted_codes": ["E119", "E785"], "rejected_codes": ["F17210", "R2689", "Z6831", "Z7489"], "date": "2024-04-25T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 27243918, "discharge_summary": "21-year-old male admitted to observation for recurrent symptomatic hypoglycemia (primary DX E16.2). Presenting complaints included episodic diaphoresis, lightheadedness, and near-syncope. Past medical history notable for autism spectrum disorder, seizure disorder on levetiracetam, chronic glucocorticoid exposure with drug-induced adrenocortical insufficiency, vitamin D deficiency, osteoporosis with prior vertebral fracture, nutritional anemia, eosinophilic gastritis, and psychiatric diagnoses (major depressive disorder, generalized anxiety). Length of stay 3.1 days.\n\nHospital course: Patient received prompt correction of hypoglycemia with IV dextrose and maintenance IV 0.9% sodium chloride while glucose was monitored. Electrolytes and glucose stabilized; calcium gluconate administered for transient hypocalcemia. He received heparin prophylaxis and topical clindamycin for a localized skin lesion. Hematology recommended cyanocobalamin and folic acid for nutritional anemia; vitamin D repletion initiated. Psychiatric medications were continued (fluoxetine, buspirone) with behavioral precautions. Neurology continued levetiracetam; no seizures occurred during admission. Endocrinology was consulted for suspected secondary adrenal insufficiency related to chronic steroids and recommended outpatient endocrine follow-up and steroid medication reconciliation.\n\nKey findings/procedures: Blood glucose documented <50 mg/dL on presentation with prompt response to IV dextrose. Labs notable for anemia and vitamin D deficiency; transient eosinophilia and mild GI symptoms consistent with known eosinophilic gastritis. No imaging or invasive procedures were required.\n\nDischarge condition and functional status: Patient is clinically stable, hemodynamically stable, and alert/oriented. Ambulates with supervision due to back pain/functional limitation from prior vertebral fracture; requires assistance with medication management and monitoring of glucose at home. Home health nursing recommended for wound/skin care, glucose checks, medication administration support, and PT evaluation for mobility.\n\nMedications and follow-up: Discharged on outpatient regimen including levetiracetam, fluoxetine, buspirone, gabapentin for pain, cyanocobalamin, folic acid, vitamin D supplementation, acetaminophen PRN, and heparin prophylaxis discontinued on discharge. Follow-up appointments: PCP within 3\u20135 days, endocrinology within 1\u20132 weeks, neurology as scheduled, gastroenterology and hematology as outpatient. Education provided on hypoglycemia recognition, home glucose monitoring, and when to seek urgent care.", "diagnosis_codes": ["F419", "G40909", "F329", "E162", "F840", "M8088XS", "E559"], "suggested_codes": ["D509", "E271", "E8309", "K520"], "accepted_codes": [], "rejected_codes": ["D509", "E271", "E8309", "K520"], "date": "2024-03-21T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 22831861, "discharge_summary": "41-year-old female admitted under observation for exacerbation of Crohn\u2019s disease with colocutaneous fistula and associated sepsis-like physiology. On presentation she had abdominal pain, diarrhea, hypotension and acute kidney injury on chronic kidney disease. Length of stay was 9.2 days. Primary problems: Crohn\u2019s disease of the large intestine with fistula (K50.113), acute tubular necrosis/AKI (N17.0), CKD stage 4 (N18.4), hypertensive heart and chronic kidney disease with heart failure, and left fifth metatarsal fracture.\n\nHospital course: Initial resuscitation included IV fluids and hemodynamic support with close monitoring of electrolytes and acid-base status. She received broad-spectrum antibiotics with de-escalation to oral ciprofloxacin once cultures and clinical status allowed. Surgical and GI teams evaluated the fistula; endoscopic assessment was performed and conservative management pursued with local wound care. Nephrology was consulted for AKI on CKD and recommended adjustment of medications and outpatient follow-up. Cardiology optimized heart-failure regimen and blood pressure control. Orthopedics placed a controlled weight-bearing boot for the left fifth metatarsal fracture; no acute surgical fixation required.\n\nKey findings/procedures: AKI with improvement but creatinine remains above baseline; evidence of metabolic acidosis resolved with treatment; imaging confirmed fistulous tract without indication for immediate operative repair; left fifth metatarsal nondisplaced fracture managed conservatively. Inpatient procedures included central access for resuscitation and diagnostic endoscopy.\n\nDischarge condition and functional status: Patient clinically improved, afebrile and hemodynamically stable, tolerating oral intake. Ambulation is limited by left foot fracture; requires assistance with transfers and ambulation and benefits from home health PT/OT for gait training and fall prevention. Home health nursing requested for medication reconciliation, wound/fistula dressing changes, and monitoring renal function and vitals.\n\nMedications at discharge: metoprolol succinate, ciprofloxacin 500 mg PO BID x7 days, calcium acetate with meals, folic acid, gabapentin, magnesium oxide, acetaminophen PRN, diphenoxylate-atropine PRN for diarrhea, hydrocortisone enema as directed. DVT prophylaxis discontinued.\n\nFollow-up: GI within 1 week, Nephrology within 3\u20137 days, Cardiology 2 weeks, Orthopedics 1 week, Primary care within 3\u20135 days. Home health services arranged for nursing and PT/OT.", "diagnosis_codes": ["K50113"], "suggested_codes": ["I130", "N170", "N184", "S92555A"], "accepted_codes": ["I130", "N170", "N184"], "rejected_codes": ["S92555A"], "date": "2024-09-29T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 24860113, "discharge_summary": "History of Present Illness: 36-year-old man admitted under observation for acute upper gastrointestinal hemorrhage. He presented with melena, lightheadedness and a hemoglobin drop. Past history notable for nicotine dependence (Z87.891). Admission diagnoses: chronic/unspecified duodenal ulcer with hemorrhage (K26.4), acute posthemorrhagic anemia (D62), and an adverse serum reaction following transfusion (T80.61XA).\n\nHospital Course: Over a 3-day observation stay the patient was resuscitated with IV crystalloid and received packed red blood cell transfusion for symptomatic anemia. He was started on high-dose IV pantoprazole and transitioned to oral pantoprazole once tolerating PO. During transfusion he developed an acute serum reaction that was identified, treated supportively, and did not require escalation beyond observation. VTE prophylaxis with subcutaneous heparin was initiated. Bowel regimen with senna was provided. Pain was managed with acetaminophen PRN.\n\nKey Findings and Procedures: Initial labs confirmed acute anemia; hemoglobin stabilized following transfusion. Upper endoscopy with endoscopic hemostasis was performed demonstrating a bleeding duodenal ulcer; successful endoscopic therapy achieved hemostasis. Peripheral IV access was used for medication and fluid administration; routine saline flushes maintained line patency.\n\nDischarge Condition and Functional Status: Patient is hemodynamically stable, afebrile, ambulatory with minimal assistance, and able to perform basic activities of daily living independently. Home health services arranged for nursing visits to monitor vitals and wound/IV site, perform daily hemoglobin checks as ordered, administer/flush IV access if needed, and reinforce medication teaching.\n\nMedications and Follow-Up: Discharge meds include pantoprazole (PPI) for ulcer management, heparin as VTE prophylaxis per plan, acetaminophen for pain, senna for bowel regimen, and supplies for saline flushes. Follow-up with gastroenterology in 1 week for reassessment and H. pylori testing/treatment as indicated; primary care within 48\u201372 hours for anemia follow-up. Return to ED for recurrent hematemesis, melena, syncope, or worsening pain/fever.\n\n", "diagnosis_codes": ["K264"], "suggested_codes": ["D62", "T8061XA", "Z87891"], "accepted_codes": ["D62", "T8061XA", "Z87891"], "rejected_codes": [], "date": "2024-02-28T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 23228433, "discharge_summary": "History of present illness: 50-year-old man with known hypertensive chronic kidney disease (stage 5/ESRD) and type 2 diabetes mellitus on long-term insulin was admitted emergently with uremic symptoms, oliguria and acute kidney injury on chronic kidney disease. He was found to have bacteriuria/UTI and Clostridioides difficile enterocolitis on admission and had a history of prior sudden cardiac arrest with a permanent pacemaker in place.\n\nHospital course: Patient required initiation/continuation of intermittent in-hospital hemodialysis for volume and metabolic control; vascular access was managed with a dialysis catheter and standard catheter care. He received IV and oral antibiotics guided by cultures for UTI and completed targeted therapy for C. difficile (oral vancomycin regimen completed during admission). Glycemic control was optimized with his home insulin regimen. He remained hemodynamically stable without recurrent arrhythmia. Supportive measures included electrolyte correction, iron and vitamin supplementation, and prophylactic heparin catheter locks as indicated. Nutritional status was addressed with multivitamins and nephrology dietary counseling.\n\nKey findings and procedures: Laboratory and imaging consistent with ESRD and superimposed acute kidney injury; positive urine culture and stool testing positive for C. difficile toxin. Procedures included serial intermittent hemodialysis sessions and vascular access management. No operative interventions were required.\n\nDischarge condition and functional status: Patient is discharged in stable condition, afebrile and hemodynamically stable. He remains dialysis-dependent and requires outpatient hemodialysis thrice weekly. Functional status: ambulatory with a walker and requires assistance with toileting and medication administration; home health nursing is requested for vascular access assessment, medication administration, wound/catheter care, and ADL assistance for at least the next 2 weeks.\n\nMedications and follow-up: Discharge medications include insulin per home regimen, atorvastatin, metoprolol succinate XL, ferrous sulfate, folic acid, thiamine, nephrocaps, multivitamins, prednisone as indicated, tamsulosin, and heparin catheter lock instructions. Hepatitis B vaccine administered in hospital; continue outpatient series. Follow-up: Nephrology clinic within 7 days, infectious disease/primary care as indicated, dialysis unit coordination and home health nursing visit within 48 hours of discharge.", "diagnosis_codes": ["I120", "M0600"], "suggested_codes": ["N179", "N390", "Z950", "A047", "E119", "Z992"], "accepted_codes": ["N179", "N390", "Z950"], "rejected_codes": ["A047", "E119", "Z992"], "date": "2024-03-02T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 27703954, "discharge_summary": "History of present illness: 82-year-old female observed for 6.7 days for management of ileus (ICD-10 K56.7) in the setting of known ulcerative colitis and prior ileostomy. She presented with progressive abdominal distension, decreased oral intake, nausea and decreased ileostomy output. Past history notable for atrial fibrillation on chronic anticoagulation, prior TIA/stroke, moderate protein-calorie malnutrition and low BMI.\n\nHospital course: Patient was managed non-operatively with bowel rest, intravenous fluids, electrolyte repletion, antiemetics (ondansetron) and pantoprazole. Metoprolol was continued for rate control; rivaroxaban was held temporarily on admission and resumed prior to discharge when clinically appropriate. Ileus was monitored with serial abdominal exams and imaging consistent with nonobstructive ileus; no surgical intervention was required. Nutritional intake improved with initiation of oral supplementation and psyllium for ostomy consistency; loperamide was used to manage increased stoma output as needed. She received education on ostomy care and infection precautions given recent contact exposure history.\n\nKey findings and procedures: Imaging demonstrated nonmechanical bowel dysmotility without radiographic obstruction. Laboratory abnormalities (electrolyte derangements) were corrected during stay. No operative or endoscopic procedures were performed. Vascular access maintained without complication; ostomy intact without evidence of ischemia or infection.\n\nDischarge condition and functional status: Patient is medically stable for discharge to home with home health services. Functionally she requires assistance with ostomy care, medication management and intermittent assistance with activities of daily living due to decreased endurance and malnutrition; ambulation is steady with supervision.\n\nMedications at discharge: Acetaminophen as needed, loperamide for stoma output, metoprolol succinate XL daily, ondansetron PRN, pantoprazole daily, psyllium wafers for ostomy output management, rivaroxaban resumed for anticoagulation. Home health to provide ostomy care supplies and teach flushing/maintenance as indicated.\n\nFollow-up: Primary care within 3\u20135 days, GI follow-up in 1\u20132 weeks for ulcerative colitis/ostomy management and nutrition service for malnutrition evaluation. Cardiology as outpatient for AF and anticoagulation management. Return precautions reviewed for recurrent obstruction, bleeding, fever or worsening abdominal pain.", "diagnosis_codes": ["E440", "Z681", "Z932", "E7800", "I4891", "Z20828", "K5190", "K567", "Z7901", "Z2820", "Z8673"], "suggested_codes": [], "accepted_codes": [], "rejected_codes": [], "date": "2024-03-08T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 23991798, "discharge_summary": "History of Present Illness: 65-year-old male admitted under observation for post-procedural gastrointestinal bleeding and coagulopathy. He presented after a recent GI procedure with melena and anemia. Medical history significant for anticoagulant-related hemorrhagic disorder (D68.32), type 2 diabetes with hyperglycemia, peripheral polyneuropathy, essential hypertension, hyperlipidemia, prior CABG, hypothyroidism, and prior colon polyp.\n\nHospital Course: Patient was managed over a 2.5-day observation stay. Initial evaluation revealed acute posthemorrhagic anemia (D62) and active postprocedural hemorrhage (K91.840). Resuscitation included IV fluids (0.9% NaCl and Lactated Ringers) and targeted hemodynamic monitoring. Anticoagulation was reversed per hematology recommendations; coagulation studies were trended. Patient received transfusion support as clinically indicated and was observed for re-bleeding. Nausea was controlled with ondansetron; pain managed with acetaminophen. Glucose was treated with insulin and glucose gel as needed; endocrinology input obtained for diabetes management. No further overt GI bleeding while inpatient.\n\nKey Findings and Procedures: Positive for acute drop in hemoglobin consistent with postprocedural hemorrhage. Imaging/endoscopic report consistent with site of bleeding post-procedure. Procedure recorded: ICD-10-PCS 0W3P8ZZ. Hemodynamic status stabilized after fluids/transfusion and anticoagulation reversal. No new neurological deficit.\n\nDischarge Condition and Functional Status: Patient discharged hemodynamically stable, ambulatory with assist, and independent with basic ADLs but requires home support for medication management and blood glucose monitoring. Fall risk elevated due to anemia and peripheral neuropathy; home health recommended for safety and mobility evaluation.\n\nMedications and Follow-up: Discharge meds include levothyroxine, metoprolol tartrate, rosuvastatin, pantoprazole, gabapentin, acetaminophen, and diabetes regimen (insulin as prescribed) with instructions for glucose monitoring. Aspirin continuation to be determined by hematology. Home health to provide daily vitals, wound/stool checks, medication reconciliation, and fingerstick glucose for 48\u201372 hours. Labs (CBC, BMP, coagulation panel) in 48\u201372 hours. Follow-up with Hematology within 7 days and GI within 7\u201314 days; PCP follow-up in 1 week.", "diagnosis_codes": ["D6832"], "suggested_codes": ["D62", "E039", "E1165", "E785", "G629", "I10", "K91840"], "accepted_codes": ["D62", "E039", "E1165", "E785", "G629", "I10", "K91840"], "rejected_codes": [], "date": "2024-10-05T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 25136561, "discharge_summary": "History of Present Illness: 80-year-old female presented emergently with sudden onset right-sided weakness and expressive aphasia. NIHSS on arrival was 35. Imaging demonstrated an acute embolic infarction of the left middle cerebral artery (I63.412). Past medical history notable for atrial fibrillation, essential hypertension, recent diagnosis of right renal malignancy, anxiety disorder, and prior contact with suspected COVID-19 exposure.\n\nHospital Course: The patient was admitted to the neuro-ICU for close neurologic monitoring. She underwent urgent endovascular mechanical thrombectomy of the left MCA with partial reperfusion. She required brief endotracheal intubation for respiratory failure and hypoxia with subsequent successful extubation; transitioned to supplemental oxygen and pulmonary support as needed. Anticoagulation was held during the acute intervention and resumed with oral dabigatran once hemorrhagic conversion was excluded on follow-up imaging. She received DVT prophylaxis while inpatient, bowel regimen, topical and ophthalmic agents for symptom control, and high-dose influenza vaccination prior to discharge. Speech and swallow evaluations identified dysphagia with aspiration risk; diet was modified accordingly. PT/OT initiated inpatient with progressive mobilization; patient remains hemiparetic on the right.\n\nKey Findings and Procedures: Acute left MCA embolic infarct confirmed by imaging; endovascular thrombectomy performed; brief mechanical ventilation; central venous access and routine critical care procedures completed. No radiographic evidence of symptomatic intracranial hemorrhage post-procedure.\n\nDischarge Condition and Functional Status: Medically stable for discharge on hospital day 6.2. Neurologic deficits persist \u2014 right-sided hemiplegia with dependence for transfers and most ADLs; expressive aphasia and dysphagia requiring supervised/modified diet. Requires frequent assistance and rehabilitation services at home.\n\nMedications and Follow-up: Discharged on dabigatran for secondary stroke prevention, acetaminophen PRN, docusate sodium, lidocaine 5% patch PRN, fluticasone nasal spray, erythromycin ophthalmic ointment, and megestrol as indicated for appetite. Home oxygen PRN. Home health referrals placed for skilled nursing (medication/anticoagulation education), PT/OT, and speech therapy. Follow-up: neurology clinic within 1 week, cardiology (anticoagulation/AF) in 1\u20132 weeks, primary care within 7 days, and oncology/urology as outpatient per prior plan. Basic labs including BMP to assess renal function prior to anticoagulant dose maintenance.", "diagnosis_codes": ["R4701", "I63412", "I4891", "R29735"], "suggested_codes": ["F419", "G8191", "I10", "C649", "J9600", "R1310", "Z9981"], "accepted_codes": ["F419", "G8191", "I10"], "rejected_codes": ["C649", "J9600", "R1310", "Z9981"], "date": "2024-07-18T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 25192355, "discharge_summary": "History of present illness: 74-year-old female observed for 14.9 days for progressive prosthetic-related pain around an internal implant with associated poor oral intake, weight loss and progressive weakness. Past medical history notable for essential hypertension, GERD, vitamin B12 deficiency anemia, and chronic constipation. Presentation included intractable pain near prosthetic site, odynophagia/dysphagia and decreased PO tolerance.\n\nHospital course: During observation stay the patient received multimodal analgesia, antiemetic and bowel regimen optimization, DVT prophylaxis, and nutritional support. Pain was managed with scheduled acetaminophen and as-needed hydromorphone with adjunctive lidocaine 5% patches and viscous lidocaine for oropharyngeal discomfort. Speech-language pathology completed swallow evaluation with recommendations for texture-modified diet and compensatory strategies. Nutrition consult addressed severe protein-calorie malnutrition/cachexia and initiated calorie-dense oral supplements and a plan for B12 repletion. Physical and occupational therapy provided mobility and ADL training; she improved with therapy but required assistance for transfers.\n\nKey findings and procedures: Relevant diagnoses include pain due to internal prosthetic device (T85.848A), severe protein-calorie malnutrition (E43), BMI \u226419.9, cachexia, dysphagia, GERD, essential hypertension, and B12 deficiency anemia. Per chart, ICD-10-PCS procedures recorded include 3E0H76Z and 0DHA7UZ (therapeutic/diagnostic procedures for medication administration and further evaluation). Imaging and labs ruled out acute surgical complications; inflammatory markers trended down.\n\nDischarge condition and functional status: Patient stable for discharge to home with home health. Ambulates with a rolling walker and requires contact-guard assistance for transfers; independent with some light ADLs but needs help with meal preparation and medication management. Continues on a mechanically-modified diet per SLP recommendations and requires ongoing nutritional monitoring.\n\nMedications and follow-up: Discharge medications include acetaminophen (liquid) scheduled, hydromorphone PRN, pantoprazole, aluminum-magnesium hydroxide-simethicone, ondansetron PRN, polyethylene glycol, psyllium, loperamide PRN, hydroxyzine PRN, hyoscyamine, lidocaine 5% patch PRN, lidocaine viscous 2% PRN, multivitamin with minerals. Heparin given inpatient; no outpatient anticoagulation ordered. Begin B12 repletion outpatient per hematology/PCP. Home health orders: skilled nursing for med administration and wound/prosthetic site checks, PT/OT for mobility and ADLs, SLP for dysphagia follow-up, nutrition support. Follow-up with PCP in 3\u20135 days and prosthesis/surgical team in 1\u20132 weeks; outpatient labs (CBC, BMP, B12) in 1 week.", "diagnosis_codes": ["R64", "T85848A", "Z681", "Y838", "K219", "I10"], "suggested_codes": ["E538", "K5900", "R1310"], "accepted_codes": [], "rejected_codes": ["E538", "K5900", "R1310"], "date": "2024-09-04T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 21004671, "discharge_summary": "History of Present Illness: 56-year-old female admitted as a same-day surgical patient for elective management of a nonruptured cerebral aneurysm (ICD-10 I67.1). Past medical history notable for hypothyroidism, remote myocardial infarction with prior pacemaker placement, and epilepsy. She presented for planned endovascular treatment after outpatient evaluation and underwent procedure without evidence of rupture or new deficit.\n\nHospital Course: Patient had an uncomplicated endovascular aneurysm procedure (03VK3DZ) under general anesthesia. She was monitored in the neuro-observation unit postoperatively. No new focal neurological deficits were identified. Hemodynamics remained stable; pacemaker function confirmed intact. Seizure activity was not observed. Pain and nausea were controlled with short courses of morphine and ondansetron; bowel regimen initiated for opioid-associated constipation.\n\nKey Findings and Procedures: Pre- and postoperative neuro exams were at baseline with no signs of infarction or hemorrhage on immediate post-op CT. Vascular access site (femoral) was clean, without hematoma or active bleeding. Procedure achieved successful occlusion of the target aneurysm per angiographic assessment.\n\nDischarge Condition and Functional Status: Patient is discharged in stable condition, neurologically at baseline, and ambulatory with minimal assistance for balance and safety. She demonstrates adequate self-care for basic activities of daily living with planned home health support for medication management and access-site checks. Fall precautions and seizure precautions reviewed with patient and caregiver.\n\nMedications and Follow-up Plan: Continue home medications including levothyroxine and divalproex ER. Antiplatelet therapy (aspirin and clopidogrel) prescribed per neurointerventional recommendations\u2014continue as directed. Short course acetaminophen for analgesia; PRN ondansetron for nausea; docusate and bisacodyl for stool regimen. Cardiology follow-up for pacemaker as scheduled within 1 week. Neurosurgery/neurointerventional clinic follow-up in 1\u20132 weeks for wound check and imaging plan; neurology follow-up for seizure management in 2\u20134 weeks. Home health arranged for 7\u201314 days for vital sign monitoring, access-site inspection, medication reconciliation, and assistance with ADLs as needed.", "diagnosis_codes": ["I671"], "suggested_codes": ["E039", "G40909", "Z950", "K5900"], "accepted_codes": ["E039", "G40909", "Z950"], "rejected_codes": ["K5900"], "date": "2024-07-15T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 22725354, "discharge_summary": "History of Present Illness: The patient is a 58-year-old male admitted for observation with acute episodic vertigo. Symptoms began 24\u201348 hours prior to presentation with brief positional dizziness, nausea, and one episode of vomiting. He has known vertebral artery aneurysm and chronic hypertension and hypothyroidism.\n\nHospital Course: On evaluation, vitals were stable and neurologic exam showed no focal deficit. Dix\u2013Hallpike maneuver reproduced vertiginous symptoms with right-sided rotary nystagmus, consistent with benign paroxysmal positional vertigo (BPPV) of the right posterior canal (H81.11). Epley repositioning maneuvers were performed with significant symptomatic improvement. CT head without acute intracranial process. Labs including basic metabolic panel and TSH were unremarkable for acute derangement. The patient received antiemetic therapy and brief vestibular suppressant as needed. He was monitored for 24 hours in observation and demonstrated progressive improvement without recurrent emesis.\n\nKey Findings and Procedures: Positive right Dix\u2013Hallpike. Epley canalith repositioning maneuver performed with good response. No focal neurologic deficit; CT head negative for acute process. Comorbid diagnoses addressed: essential hypertension (I10), hypothyroidism (E03.9), history of vertebral artery aneurysm (I72.6).\n\nDischarge Condition and Functional Status: Patient discharged stable and afebrile, ambulatory with assistance due to residual imbalance. Independent with most ADLs but requires home health assistance for mobility safety and fall prevention during recovery. Home health will monitor vitals, assist with transfers, and implement balance training and home safety evaluation.\n\nMedications and Follow-up: Discharge medications include levothyroxine daily (continue preadmission dose), aspirin 81 mg daily, albuterol inhaler PRN, acetaminophen PRN for pain, senna and bisacodyl as bowel regimen, hydralazine PRN for hypertensive episodes. Medication reconciliation reviewed. Follow-up arranged with primary care within 3\u20135 days and ENT/vestibular clinic in 1 week; neurology if symptoms persist or new focal deficits develop. Return to ED for severe headache, focal weakness, recurrent prolonged vertigo, syncope, or new neurological signs.", "diagnosis_codes": ["H8111"], "suggested_codes": ["E039", "I10", "I726"], "accepted_codes": ["E039", "I10", "I726"], "rejected_codes": [], "date": "2024-06-25T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 21243652, "discharge_summary": "Brief history of present illness: 51-year-old woman admitted emergently for small bowel Crohn's disease complicated by intestinal obstruction and peritonitis. She presented with severe abdominal pain, emesis, fever, hypotension and progressive respiratory distress. Initial evaluation identified small-bowel obstruction with intra-abdominal abscess and bacteremia with Enterococcus, with subsequent severe sepsis and septic shock.\n\nHospital course: The patient required prolonged hospitalization (44 days) with ICU-level care. She underwent exploratory laparotomy with small-bowel resection and abscess drainage, repeated abdominal washouts/percutaneous drainage procedures, central venous access placement, and tracheostomy after prolonged intubation for acute respiratory failure. She developed acute tubular necrosis and required temporary renal replacement therapy; renal function gradually recovered and dialysis was discontinued prior to discharge. She had acute posthemorrhagic anemia requiring transfusion and a transient coagulopathy that was managed medically. Blood and operative cultures guided targeted antimicrobial therapy; infectious disease recommended a planned outpatient IV antibiotic course. She received nutritional support and physical therapy throughout admission.\n\nKey findings and procedures: CT and operative findings confirmed obstructing Crohn\u2019s stricture with adjacent abscess. Procedures: exploratory laparotomy with small-bowel resection and primary anastomosis, intra-abdominal abscess drainage (surgical and IR), tracheostomy, central line placement, and temporary hemodialysis access and sessions.\n\nDischarge condition and functional status: The patient is medically stable for discharge to home with home health services. She is hemodynamically stable, afebrile, and off vasopressors; respiratory status improved to spontaneous breathing via tracheostomy collar with effective secretion clearance but requires ongoing tracheostomy care. Renal function has recovered sufficiently to be off dialysis. Mobility is limited \u2014 ambulates short distances with a rolling walker and requires assistance with transfers and most ADLs; home health will provide nursing, wound/trach care, and physical therapy.\n\nMedications and follow-up: Discharge meds include scheduled acetaminophen, oral ciprofloxacin to complete IV-to-oral plan per ID, fluconazole as indicated, insulin regimen for steroid-associated hyperglycemia, inhaled albuterol and ipratropium-albuterol PRN, and short course opioids as needed. Plan: home health nursing for IV/PO antibiotic administration, tracheostomy and wound care, and PT. Clinic follow-up with colorectal surgery in 1\u20132 weeks, gastroenterology within 2 weeks, infectious disease and nephrology within 1\u20132 weeks, and pulmonology as needed.", "diagnosis_codes": ["K50012"], "suggested_codes": ["D62", "R6521", "A492", "D6889", "J9600", "K650", "N178", "Z741", "Z7901", "Z79899", "Z9911", "Z992"], "accepted_codes": ["D62", "R6521"], "rejected_codes": ["A492", "D6889", "J9600", "K650", "N178", "Z741", "Z7901", "Z79899", "Z9911", "Z992"], "date": "2024-09-11T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 22538455, "discharge_summary": "History of Present Illness: 71-year-old female presented to the ED after a fall at home with acute onset of positional vertigo, nausea, and lightheadedness. Symptoms were consistent with episodic rotational vertigo exacerbated by changes in head position. Past medical history notable for hypertension, prior concussion/postconcussional syndrome, and orthostatic symptoms. Initial evaluation identified a fall on same level at unspecified private residence.\n\nHospital Course: Patient was observed for 2.4 days. Neurologic examination and Dix\u2013Hallpike maneuver were positive for left-sided benign paroxysmal positional vertigo (BPPV). CT head was negative for acute intracranial process. Orthostatic vitals demonstrated clinically significant postural hypotension. Basic metabolic panel revealed hypo-osmolality with mild hyponatremia, addressed with careful fluid management and electrolyte repletion. Thromboprophylaxis with heparin was administered while inpatient. Brief physical therapy and fall risk assessment were performed; the patient required assistance to ambulate with a steadying device and had limitations with transfers and bathing.\n\nKey Findings and Procedures: Positive left Dix\u2013Hallpike; successful canalith repositioning maneuver (Epley) with symptomatic improvement. CT head without acute intracranial abnormality. Laboratory confirmation of hyponatremia; orthostatic hypotension on bedside testing. Fall risk evaluation performed; home safety recommendations provided.\n\nDischarge Condition and Functional Status: Patient is medically stable for discharge to home with home health services. Ambulates with assistance/steadying device and is at increased fall risk; requires assistance with ADLs, particularly transfers and bathing. Cognition baseline but requires monitoring for postconcussional symptoms and medication effects.\n\nMedications at Discharge: Acetaminophen, Benzonatate as needed, Docusate sodium, Heparin (per discharge plan), Hydrochlorothiazide, Lorazepam as needed for severe vertigo/anxiety, Meclizine, Potassium chloride, Ramelteon, Senna, and normal saline flush as prescribed.\n\nFollow-up Plan: Primary care follow-up within 3\u20135 days; ENT or neurology (vestibular) clinic within 1\u20132 weeks for persistent symptoms. BMP and sodium recheck in 48\u201372 hours. Home health to provide PT for gait and balance training, nursing for medication reconciliation, orthostatic vital checks, and home safety assessment. Return to ED for recurrent falls, worsening neurologic symptoms, or syncope.", "diagnosis_codes": ["Y92009", "H8112", "E871", "I10", "F0781", "I951", "W1830XA"], "suggested_codes": ["Z7401", "Z9181"], "accepted_codes": [], "rejected_codes": ["Z7401", "Z9181"], "date": "2024-10-16T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 22245753, "discharge_summary": "History of Present Illness: 66-year-old male admitted emergently with sepsis secondary to suspected biliary source. Past history notable for Type 2 diabetes mellitus with neuropathy, chronic hepatitis B, cirrhosis, known pancreatic head mass, essential hypertension, and prior ischemic heart disease. On presentation he was hypotensive and tachycardic with leukocytosis and abnormal liver function tests; imaging demonstrated a liver abscess and biliary dilation consistent with cholangitis.\n\nHospital Course: Patient required 7 days of inpatient care including aggressive IV fluids, broad-spectrum antibiotics, vasopressor support briefly for septic shock, glycemic management, and escalation to targeted therapy once cultures/imaging available. Interventional radiology performed percutaneous drainage of a hepatic abscess and biliary decompression (IR drain/ERCP-directed biliary drainage). A peripherally inserted central catheter (PICC) was placed for continued IV antibiotics. He stabilized off vasopressors, defervesced, and inflammatory markers trended down prior to discharge.\n\nKey Findings and Procedures: CT abdomen consistent with liver abscess and biliary obstruction; blood cultures and drain cultures guided antibiotic choice. Procedures: IR-guided percutaneous hepatic abscess drainage, endoscopic biliary decompression, and PICC placement for outpatient IV therapy.\n\nDischarge Condition and Functional Status: Patient is medically stable and afebrile, hemodynamically stable on room air. Functional status: decreased endurance and deconditioning after prolonged hospitalization\u2014requires assistance with ambulation and requires home health PT for gait and transfers. Ongoing issues: needs daily wound/drain care and PICC management; diabetic neuropathy increases fall risk and need for foot/skin checks.\n\nMedications and Follow-up Plan: Discharge meds include IV ceftriaxone to be administered via home infusion through PICC (duration per ID recommendation), entecavir for chronic HBV, aspirin, atorvastatin, gabapentin for neuropathic pain, famotidine, docusate, acetaminophen PRN. Home health arranged for daily nursing (IV antibiotic administration, PICC and drain care, wound assessment, vitals, glucose checks) and PT visits. Follow-up: Infectious Disease within 3\u20137 days, Gastroenterology/Hepatology within 1 week for biliary/drain reassessment and oncology/surgical clinic for pancreatic mass evaluation. Labs (CBC, CMP, blood cultures if indicated) to be drawn as outpatient per ID orders.", "diagnosis_codes": ["A4189", "K7469", "C250", "K830", "B1910", "K750", "I2510", "I252", "R0902", "E1140", "K219", "I10", "Z794", "E1165", "R6521", "E785", "F17210", "G893"], "suggested_codes": ["Z515", "Z9582"], "accepted_codes": [], "rejected_codes": ["Z515", "Z9582"], "date": "2024-10-10T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 24048569, "discharge_summary": "History of present illness: 71-year-old man with known liver cell carcinoma (C22.0) presented to our observation unit with progressive dyspnea, hypoxia and cough after an episode of emesis. He was found to have acute hypoxemic respiratory failure and aspiration pneumonitis. Significant comorbidities include nonischemic cardiomyopathy with left bundle branch block, atrial fibrillation, hypothyroidism, hyperlipidemia, polymyalgia rheumatica and gastroesophageal reflux disease.\n\nHospital course: He was observed for 2.8 days. Initial evaluation included chest radiograph and labs consistent with aspiration pneumonitis and hypoxemia; oxygen supplementation and nebulized bronchodilator therapy were started. He received intravenous fluids, empiric antibiotics for aspiration (amoxicillin\u2013clavulanate/Ampicillin\u2013sulbactam course initiated), bronchodilator and anticholinergic nebulizers, and symptomatic analgesia. Cardiac monitoring did not reveal hemodynamically significant arrhythmia; rate control medications were continued for atrial fibrillation. Thyroid replacement was continued. He improved clinically with weaning of oxygen to low-flow nasal cannula and was hemodynamically stable at discharge.\n\nKey findings and procedures: Imaging confirmed aspiration changes without focal lobar consolidation requiring drainage. Laboratory evaluation excluded acute hepatic decompensation; electrolytes and renal function remained stable. Interventions included supplemental oxygen, nebulized ipratropium\u2013albuterol, IV to oral antibiotic conversion, medication reconciliation, and initiation of home health services. Continuous telemetry and supportive care were provided.\n\nDischarge condition and functional status: Patient is medically stable for discharge. Ambulates with assistance due to deconditioning and reports baseline fatigue; requires assistance with some activities of daily living. He remains on low-flow oxygen at rest/intermittently for exertional desaturation and will have home oxygen evaluation and respiratory therapy.\n\nMedications and follow-up: Discharge medications include levothyroxine, carvedilol, aspirin, ezetimibe, gabapentin, short course oral amoxicillin\u2013clavulanate (as above), inhaled ipratropium\u2013albuterol PRN, acetaminophen PRN. Home health nursing to assist with medication administration, oxygen management, vital sign monitoring, and therapy referrals. Outpatient follow-up: oncology within 7 days, pulmonology within 7\u201310 days, cardiology 1\u20132 weeks, and primary care in 3\u20135 days. Return to ER for fever, worsening dyspnea, chest pain, new confusion, or bleeding.", "diagnosis_codes": ["I428", "E785", "I4891", "C220", "I447", "J9601", "K219", "J690", "Z5321", "J8489", "M353", "E039"], "suggested_codes": [], "accepted_codes": [], "rejected_codes": [], "date": "2024-11-23T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 25911925, "discharge_summary": "History of Present Illness: 45-year-old male with history of type 1 diabetes mellitus on long-term insulin presented to observation unit after an episode of syncope with documented hypoglycemia. On arrival he was diaphoretic and lethargic; point-of-care glucose was low and responded to oral glucose and subsequent IV dextrose. He reports several days of poor oral intake and intermittent vomiting prior to presentation.\n\nHospital Course: The patient was observed for 48 hours (LOS 1.9 days). Initial management included correction of hypoglycemia with oral glucose gel, IV D50 and a supplemental dose of glucagon for emergency rescue. He received IV fluids for volume depletion and supportive care. Creatinine was elevated on admission consistent with acute kidney injury on background chronic kidney disease stage 3; renal function trended toward baseline with hydration. Orthostatic vitals were monitored; no recurrent syncope occurred. Blood glucose was stabilized with reinstatement of his home insulin regimen with adjustments and education on sick-day management. Venous thromboembolism prophylaxis was given during hospitalization.\n\nKey Findings and Procedures: Primary diagnosis: Type 1 diabetes mellitus with hypoglycemia without coma (E10.649). Secondary: acute kidney injury, CKD stage 3, syncope. No procedures beyond peripheral IV placement and standard observation monitoring. EKG and basic labs obtained; no acute ischemic changes identified.\n\nDischarge Condition and Functional Status: Patient is alert, oriented, ambulatory with steady gait, independent with activities of daily living but with recent decreased endurance. He has an elevated fall risk related to recent syncope and hypoglycemia \u2014 home health nursing requested for early follow-up. Functional recommendations: assistance with medication administration/insulin dosing review and blood glucose monitoring until stable; home safety/fall risk assessment recommended.\n\nMedications and Follow-up: Discharged on his adjusted insulin regimen (basal-bolus with sliding scale \u2014 see med list provided), glucagon emergency kit, glucose gel PRN, docusate sodium 100 mg BID PRN, senna PRN, amlodipine for blood pressure. Home health: daily nursing visits initially for blood glucose checks, insulin administration education, medication reconciliation, wound/skin assessment for psoriasis, and BMP monitoring. Follow-up: Primary care & endocrinology within 1 week, nephrology within 2 weeks, or sooner for recurrent hypoglycemia.", "diagnosis_codes": ["E10649"], "suggested_codes": ["L409", "N179", "N183", "R55", "Z9181"], "accepted_codes": ["L409", "N179", "N183", "R55"], "rejected_codes": ["Z9181"], "date": "2024-07-15T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 22524335, "discharge_summary": "History of Present Illness: 25-year-old G?P? female presented urgently at 35 weeks gestation with preterm premature rupture of membranes (PPROM). She had a history of pre-existing hypertension noted in pregnancy and a prior low transverse cesarean section. Labor progressed and she delivered a single live infant vaginally. Delivery was complicated by a first-degree perineal laceration which was repaired at bedside.\n\nHospital Course: The patient was admitted for management of PPROM and labor. Fetal monitoring remained reassuring. She received oxytocin augmentation during labor. Maternal vital signs remained stable; there was no evidence of clinical chorioamnionitis. Blood counts and metabolic panel were within acceptable limits. Pain was managed with scheduled acetaminophen and PRN ibuprofen. Docusate and stool softeners were provided to minimize strain. She received Tdap vaccination prior to discharge. Perineal repair was uncomplicated. She was observed for 48\u201372 hours postpartum for bleeding, uterine involution, and blood pressure control given her history of hypertension; antihypertensive therapy was continued per obstetric plan.\n\nKey Findings and Procedures: Diagnosis: PPROM (third trimester), postpartum first-degree perineal laceration, history of pre-existing hypertension complicating childbirth, maternal care for cesarean scar, 35 weeks gestation, single liveborn. Procedures: spontaneous vaginal delivery with perineal laceration repair and intra-partum oxytocin administration. No surgical complications.\n\nDischarge Condition and Functional Status: Patient is hemodynamically stable, afebrile, with expected lochia and normal uterine involution. Ambulates independently with mild perineal discomfort; performing activities of daily living independently with assistance only for heavier lifting. Breastfeeding established with adequate latch; lactation support arranged.\n\nMedications and Follow-up Plan: Discharge medications include acetaminophen and ibuprofen for analgesia, docusate sodium and bisacodyl as bowel regimen, calcium carbonate as needed for reflux, simethicone for gas, topical Dermoplast spray for perineal discomfort, and oxytocin per inpatient protocol (if outpatient infusion not indicated, none prescribed). Tdap given prior to discharge. Home health to provide wound assessment, BP monitoring, lactation support, and assistance with ADLs as needed within 24\u201348 hours. Follow-up with obstetrics in 7 days, primary care for BP assessment in 3\u20137 days, and newborn pediatric visit within 48\u201372 hours.", "diagnosis_codes": ["O42913"], "suggested_codes": ["O109", "O701", "Z94819"], "accepted_codes": [], "rejected_codes": ["O109", "O701", "Z94819"], "date": "2024-01-19T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 21748550, "discharge_summary": "History of Present Illness: 58-year-old male admitted urgently with acute decompensated heart failure and acute-on-chronic respiratory failure with hypoxia on a background of hypertensive heart and chronic kidney disease (I130) and CKD stage 4. Admission precipitated by progressive dyspnea, lower extremity edema, decreased urine output and cellulitis of the left upper limb. Past medical history notable for type 2 diabetes with diabetic CKD, obesity (BMI ~40), prior vascular graft and device-related complications.\n\nHospital Course: Hospitalized 22.7 days. Patient responded to diuresis with improvement in volume status and oxygenation. Required supplemental oxygen intermittently and nightly; pulmonary status stabilized on baseline oxygen therapy. Treated for suspected/confirmed cellulitis with IV cefazolin via vascular access and local wound care; infectious complications related to prior vascular device were evaluated and managed in coordination with vascular surgery and infectious disease. Acute kidney injury on CKD 4 improved but did not return to baseline creatinine; nephrology involved for outpatient CKD management. Psychiatry/behavioral health consulted for depressive symptoms; fluoxetine continued. Nutrition consulted for diabetes and weight management.\n\nKey Findings and Procedures: Echocardiogram consistent with diastolic congestive heart failure. Imaging/labs consistent with chronic kidney disease stage 4 with superimposed AKI. Procedures performed included vascular access management (vascular device care and line placement for antibiotic administration) and debridement/wound care of left upper extremity cellulitis.\n\nDischarge Condition and Functional Status: Discharged hemodynamically stable, saturating adequately on home supplemental oxygen at rest with activity precautions. Ambulates short distances at home with a rolling walker and requires assistance for transfers due to deconditioning. Independent with light ADLs but requires nursing assistance for wound care and IV antibiotic administration.\n\nMedications and Follow-up: Discharge meds include cefazolin IV with home health nursing for administration, aspirin, allopurinol, calcitriol, fluoxetine, famotidine, fenofibrate, fluticasone-salmeterol inhaler, gabapentin and acetaminophen as needed. Instructions: daily weights, low-sodium diabetic diet, medication reconciliation at first clinic visit. Follow-up appointments: cardiology in 1 week, nephrology in 1 week, primary care/wound clinic in 3\u20135 days, infectious disease as outpatient. Home health to provide nursing for IV antibiotics, wound care, oxygen assessment, medication management and mobility support.", "diagnosis_codes": ["I130"], "suggested_codes": ["E6601", "F329", "N179", "J9601", "L03113"], "accepted_codes": ["E6601", "F329", "N179"], "rejected_codes": ["J9601", "L03113"], "date": "2024-05-15T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 28260748, "discharge_summary": "Chief complaint: Progressive abdominal distension and worsening fatigue in setting of known hepatic graft/stent disease.\n\nHPI: 42-year-old male admitted emergently for evaluation and management of stenosis of a vascular prosthetic device with portal hypertension and symptomatic ascites. Patient has history of Budd-Chiari syndrome, cirrhosis with recurrent ascites and known esophageal varices (no active bleeding), and nicotine dependence. Presentation included progressive abdominal fullness, weight gain, and dyspnea on exertion.\n\nHospital course: Patient underwent endovascular evaluation with venography and endovascular interventions including targeted angioplasty and revision of the affected vascular graft/stent. Therapeutic large-volume paracentesis was performed with albumin replacement. He received diuretic optimization (furosemide and spironolactone) and initiation/continuation of anticoagulation with apixaban for thrombotic risk related to Budd-Chiari/graft stenosis. Lactulose was used prophylactically for encephalopathy risk. Pain controlled with acetaminophen. Patient remained hemodynamically stable with improving abdominal discomfort and decreasing tense ascites.\n\nKey findings and procedures: Imaging and venography confirmed prosthetic graft stenosis contributing to hepatic outflow obstruction consistent with Budd-Chiari physiology. Procedures: endovascular graft/venous angioplasty and graft revision, therapeutic paracentesis with albumin administration, and procedural monitoring without immediate complications.\n\nDischarge condition and functional status: Patient discharged in stable condition. Functionally he is ambulatory with a cane for long distances, independent with most ADLs but requires assistance for stair negotiation and transportation. Home health nursing recommended for skilled monitoring (daily weights, diuretic titration guidance, medication reconciliation) and education.\n\nMedications at discharge: Apixaban, furosemide, spironolactone, lactulose, acetaminophen PRN, hydralazine, magnesium oxide, Neutra-Phos, simethicone, sodium chloride 0.9% flush as needed. Influenza vaccine administered prior to discharge.\n\nFollow-up: Outpatient hepatology within 1 week, interventional radiology in 2 weeks, primary care in 1 week. Labs (BMP, LFTs, CBC, coagulation) in 3 days and as directed. Home health to monitor daily weights, intake/output, signs of encephalopathy or variceal bleeding, and to coordinate outpatient appointments.", "diagnosis_codes": ["T82858A"], "suggested_codes": ["F17210", "K766", "R188", "I82890", "I8500", "K7460"], "accepted_codes": ["F17210", "K766", "R188"], "rejected_codes": ["I82890", "I8500", "K7460"], "date": "2024-04-18T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 24260078, "discharge_summary": "26-year-old male admitted emergently with infected left lower-extremity amputation stump (primary diagnosis T87.44). He required a prolonged 62.8-day hospitalization complicated by acute posthemorrhagic anemia, acute kidney injury, deep vein thrombosis of the left upper extremity, osteomyelitis of the residual limb, poorly controlled type 1 diabetes with autonomic neuropathy and gastroparesis, and cutaneous abscesses. Initial presentation included local erythema, purulent drainage, systemic inflammatory response, and hyperglycemia. Imaging confirmed soft tissue infection with concern for underlying osteomyelitis; wound cultures grew mixed organisms consistent with polymicrobial stump infection.\n\nHospital course: Patient underwent serial surgical debridements and incision-and-drainage procedures with placement of VAC therapy and removal of devitalized tissue. A PICC line was placed for long-term parenteral antibiotics and he received targeted IV antimicrobial therapy with Infectious Disease oversight. Anticoagulation with apixaban was initiated for upper-extremity DVT. Nephrology was consulted for AKI; renal function improved with supportive measures and medication adjustments. Endocrinology optimized an inpatient insulin regimen and diabetes education. Pain was managed primarily with scheduled acetaminophen and short-term opioid PRN; bowel regimen provided with docusate. Nutrition and glycemic control were addressed given gastroparesis.\n\nKey findings and procedures: serial wound debridement, I&D, VAC placement, PICC insertion, imaging-confirmed osteomyelitis, and management of acute anemia and AKI. Blood products were administered as indicated.\n\nDischarge condition and functional status: Patient is afebrile, hemodynamically stable, and clinically improved. He remains limited in ambulation and requires assistive device and caregiver support for transfers; home health nursing arranged for wound/VAC care, daily IV antibiotic administration, PICC care, insulin administration, and DVT monitoring.\n\nMedications at discharge include IV antibiotics via home infusion (per Infectious Disease plan), apixaban, insulin regimen with supplies, acetaminophen, atorvastatin, carvedilol, famotidine, docusate, furosemide as needed, and glucose gel. Follow-up: Infectious Disease within 7 days, surgical/plastic surgery in 2 weeks, endocrinology within 1\u20132 weeks, nephrology PRN, and home physical therapy for mobility/prosthesis evaluation.", "diagnosis_codes": ["T8744"], "suggested_codes": ["D62", "E1042", "N179", "G3184", "I82409", "L02419", "M86671"], "accepted_codes": ["D62", "E1042", "N179"], "rejected_codes": ["G3184", "I82409", "L02419", "M86671"], "date": "2024-05-16T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 27013167, "discharge_summary": "HPI: 30-year-old female admitted for observation with progressive dyspnea, orthopnea and lower extremity edema. Past medical history notable for hypertensive heart disease with heart failure, dilated cardiomyopathy, type 2 diabetes on insulin, and recent decrease in urine output prompting evaluation for acute kidney injury.\n\nHospital course: Patient was managed over an 8.8-day observation stay for acute on chronic systolic heart failure with volume overload and AKI. Diuresis with IV loop diuretics was administered with close electrolyte and renal function monitoring. Cardiology and nephrology were consulted. Echocardiogram demonstrated reduced left ventricular systolic function consistent with dilated cardiomyopathy. Blood glucose was managed with insulin adjustments; she experienced brief hypoglycemia treated with D50 and glucose gel and was given rescue glucagon education. Bronchodilator therapy (ipratropium nebulizer) administered for intermittent wheeze. Corticosteroid replacement was continued for adrenal insufficiency. No arrhythmic events requiring intervention occurred.\n\nKey findings and procedures: Reduced LVEF on echocardiogram, laboratory evidence of acute kidney injury (improving at discharge), chest radiograph consistent with pulmonary vascular congestion which improved with diuresis. Procedures included diagnostic echocardiography and continuous telemetry monitoring. Pharmacologic management included IV diuretics, insulin titration, and guideline-directed initiation/uptitration of ACE inhibitor (lisinopril) and beta-blocker (metoprolol succinate XL) as tolerated.\n\nDischarge condition and functional status: Patient is hemodynamically stable and euvolemic at discharge with improved breathing and decreased edema. Ambulates independently with exertional limitation due to deconditioning; requires assistance with medication administration and blood glucose monitoring. Home health nursing arranged for skilled follow-up to monitor vitals, daily weights, insulin administration education, medication reconciliation, and reinforcement of low-sodium/heart-failure diet.\n\nMedications and follow-up: Discharged on lisinopril, metoprolol succinate XL, home insulin regimen, allopurinol, acetaminophen PRN, stool regimen (docusate, bisacodyl) and inhaler/ipratropium as indicated. Follow-up: cardiology within 7 days, primary care within 7\u201310 days, nephrology in 2 weeks, and endocrinology as outpatient for insulin titration. Home health nursing to start within 48 hours.", "diagnosis_codes": ["I9581", "M549", "D72829", "T501X6A", "E119", "F17210", "J45909", "Y929", "I110"], "suggested_codes": ["I420", "N179", "E237", "I500", "R0602", "Z491"], "accepted_codes": ["I420", "N179"], "rejected_codes": ["E237", "I500", "R0602", "Z491"], "date": "2024-05-12T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 25631609, "discharge_summary": "History of present illness: 63-year-old man admitted through the emergency department for progressive abdominal distension, weight loss and worsening functional status. Imaging and fluid analysis during this admission confirmed malignant ascites and metastatic disease to the retroperitoneum/peritoneum (primary ICD-10: C78.6). He also presented with acute posthemorrhagic anemia and severe protein-calorie malnutrition (E43), together with pleural effusion and melena on admission.\n\nHospital course: Over a 10.5-day admission the patient underwent diagnostic and therapeutic paracenteses with symptomatic relief of ascites, thoracentesis for pleural effusion, and placement of a central venous access device for administration of systemic chemotherapy and parenteral fluids. He received two cycles of inpatient infusional chemotherapy (fluorouracil and irinotecan) and supportive care including IV fluids (0.9% NaCl, D5W), antiemetics, dexamethasone, analgesia (acetaminophen), and electrolyte repletion. He required transfusion support for acute posthemorrhagic anemia and nutritional consultation for severe malnutrition; enteral supplementation was initiated. He was evaluated by physical and occupational therapy for deconditioning.\n\nKey findings and procedures: Imaging consistent with secondary malignant neoplasm of retroperitoneum/peritoneum with malignant ascites and pleural effusion; labs notable for anemia and hypoalbuminemia. Procedures: paracentesis(s), thoracentesis, central venous access placement, and inpatient chemotherapy administration. \n\nDischarge condition and functional status: Patient is stable for discharge to home with home health services. He remains mildly to moderately deconditioned, requires assistance with transfers and ADLs, and will benefit from nursing support for IV line/port care and medication administration as well as PT/OT visits for mobility and safety training.\n\nMedications and follow-up: Continued on apixaban (per inpatient indication), furosemide as needed for volume management, dexamethasone, acetaminophen PRN, and scheduled antiemetics. He has heparin flush supplies for port care. Outpatient oncology follow-up in 7 days for chemotherapy planning, primary care in 1 week for labs (CBC, CMP, albumin), and home health nursing to monitor wound/port, IV fluids, nutritional status, and coordinate PT/OT.", "diagnosis_codes": ["C786"], "suggested_codes": ["D62", "E43", "J90", "K921", "Z741"], "accepted_codes": ["D62", "E43", "J90", "K921"], "rejected_codes": ["Z741"], "date": "2024-09-27T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 26528156, "discharge_summary": "History of Present Illness: 49-year-old man admitted under observation for decompensated cirrhosis secondary to chronic liver disease (ICD-10 K74.69) with known portal vein thrombosis, ascites, pancytopenia, and acute kidney injury. He presented with increasing abdominal distension, early satiety, fatigue, and oliguria. Past history notable for chronic hepatitis B, schistosomiasis exposure, and moderate protein-calorie malnutrition (BMI \u226419.9).\n\nHospital Course: Over a 22.7-day observation stay the patient underwent diagnostic evaluation and supportive care. Paracentesis was performed twice for symptomatic ascites with removal of tense fluid and symptomatic relief. A peripherally inserted central catheter was placed to facilitate IV access and infusions. He received diuretic adjustment, albumin replacement post-paracentesis, and careful volume management for AKI with transient rise in creatinine that improved with conservative measures. Pancytopenia and coagulation abnormalities were managed with hematology input; no major bleeding events occurred. Infectious disease recommended initiation/continuation of entecavir for chronic hepatitis B; praziquantel was given for schistosomal disease. Nutritional support with multivitamins and vitamin D and dietary consult were provided. Imaging confirmed portal vein thrombosis; anticoagulation decisions were individualized given coagulopathy.\n\nKey Findings and Procedures: Laboratory: pancytopenia, elevated markers consistent with chronic liver disease; renal function partially recovered. Imaging: cirrhosis with portal vein thrombosis and ascites. Procedures: therapeutic paracenteses x2 and PICC placement for vascular access.\n\nDischarge Condition and Functional Status: He is medically stable for discharge to home with home health. Functional status: ambulatory with assistance for transfers and gait instability due to deconditioning; requires assistance with ADLs and meal preparation. Home health to provide skilled nursing for IV access care, daily weights, abdominal girth checks, wound/PICC care, medication reconciliation, and assistance with bedside mobility as needed.\n\nMedications and Follow-up: Discharge meds include entecavir, nadolol, pantoprazole, ciprofloxacin as indicated, praziquantel, multivitamins, vitamin D, topical emollient (Sarna), and saline flushes for PICC. Follow-up: hepatology within 1 week, primary care within 3\u20135 days, infectious disease and hematology as outpatient; home health nursing to coordinate labs (CBC, CMP, INR) and urgent clinic contact for worsening encephalopathy, bleeding, fever, or increased abdominal pain/oliguria.", "diagnosis_codes": ["K7469"], "suggested_codes": ["B181", "B659", "E440", "I81", "N179", "R188", "D618", "Z792", "Z79899", "Z961"], "accepted_codes": ["B181", "B659", "E440", "I81", "N179", "R188"], "rejected_codes": ["D618", "Z792", "Z79899", "Z961"], "date": "2024-11-19T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 27100189, "discharge_summary": "History of present illness: 28-year-old female admitted electively for operative management of complicated Crohn\u2019s disease with enteric fistula and symptomatic disease of both the small and large intestine. She presented with abdominal pain, intermittent fever, tachycardia and evidence of anemia. Length of stay 8 days.\n\nHospital course: The patient was optimized preoperatively and taken to the OR for exploratory laparotomy. Intraoperative findings included diseased segments of small and large bowel with a fistulous tract and dense peritoneal adhesions. Procedures performed: resection of affected small and large bowel segments with fistula takedown, lysis of adhesions, creation of diverting ileostomy, placement of abdominal drains and PICC line for postoperative antibiotics. Postoperative course was complicated by acute posthemorrhagic anemia requiring 1 unit PRBC transfusion and transient sinus tachycardia that responded to fluid resuscitation and analgesia. She received broad-spectrum IV antibiotics (ertapenem and ciprofloxacin/metronidazole coverage as indicated), IV steroids with transition to an oral prednisone taper, bowel rest initially with advancing diet as tolerated, prophylactic heparin while inpatient, antiemetics and multimodal analgesia.\n\nKey findings and procedures: Crohn\u2019s disease with fistula involving small and large bowel, peritoneal adhesions, resection of diseased bowel, diverting ileostomy, drain placement, PICC for outpatient IV therapy.\n\nDischarge condition and functional status: Patient is hemodynamically stable, afebrile, tolerating oral intake, pain controlled on oral analgesics, ambulating with minimal assistance and independent with most basic ADLs. Wound and ostomy sites are intact with minimal drainage.\n\nMedications at discharge: Home IV ertapenem via PICC (daily) for planned 7\u201314 days, oral metronidazole, prednisone taper, acetaminophen and gabapentin for pain, ondansetron as needed, famotidine, oral ciprofloxacin if directed by infectious disease. DVT prophylaxis discontinued on discharge; follow-up recommendations made.\n\nFollow-up: Home health referral for wound/ostomy and PICC care, home IV antibiotics and PT evaluation. Clinic follow-up with colorectal surgery in 7\u201314 days, gastroenterology in 4\u20136 weeks. Labs (CBC, BMP) within 48\u201372 hours and weekly until stable. Return to ED for fever, worsening abdominal pain, increasing output or bleeding.", "diagnosis_codes": ["K50813", "D638", "R000", "D62", "K660"], "suggested_codes": ["Z452", "Z98890"], "accepted_codes": [], "rejected_codes": ["Z452", "Z98890"], "date": "2024-05-04T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 29916373, "discharge_summary": "History of Present Illness: 29-year-old female presented to the emergency department with acute worsening lower abdominal and pelvic pain. She has a history notable for endometriosis involving the fallopian tube (N80.2), chronic salpingitis (N70.11), and a remote lumbar compression fracture currently in routine healing (M48.56XD). She also carries a diagnosis of unspecified B-cell lymphoma (C85.10). Symptoms included severe cramping pelvic pain and limited mobility due to baseline lumbar discomfort.\n\nHospital Course: This was an observation/emergency stay (0.8 days). Evaluation included focused abdominal/pelvic imaging and laboratory testing, which showed no evidence of acute surgical abdomen or abscess. Gynecology and pain management were consulted. The patient received IV fluids, analgesia, and antiemetic therapy; peripheral IV was later discontinued. Her pain responded to multimodal oral analgesics and she remained hemodynamically stable throughout observation.\n\nKey Findings/Procedures: Pelvic imaging consistent with known endometriosis of the fallopian tube and chronic salpingitis; no acute intra-abdominal process requiring operative intervention. No invasive procedures performed. Peripheral IV access placed and then removed prior to discharge.\n\nDischarge Condition and Functional Status: Patient discharged in stable condition. She ambulates with some difficulty due to chronic lumbar pain and recent compression fracture; requires assistance with ambulation and some activities of daily living (ADLs). Home health nursing arranged for medication assistance, pain assessment, safe mobility training, and fall-risk precautions.\n\nMedications at Discharge: Acetaminophen (liquid) as needed for pain, ibuprofen as directed, acyclovir (per home regimen), calcium carbonate, vitamin D, multivitamin, and sodium chloride 0.9% flush for intermittent IV/catheter care if required by home nursing.\n\nFollow-up Plan: Outpatient gynecology within 7 days for endometriosis management; oncology follow-up in 1\u20132 weeks for lymphoma care; orthopedics/spine or physiatry in 2 weeks for lumbar fracture management; primary care within 1 week. Home health nursing to provide medication administration, pain/mobility support, and coordinate further outpatient care.", "diagnosis_codes": ["N802"], "suggested_codes": ["C8510", "M4856XD", "N7011"], "accepted_codes": ["C8510", "M4856XD", "N7011"], "rejected_codes": [], "date": "2024-02-21T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 22890049, "discharge_summary": "60-year-old female admitted emergently for fever, myalgias, sore throat, and left upper quadrant pain. Initial evaluation notable for positive gammaherpesviral serology consistent with gammaherpesviral mononucleosis (ICD-10 B27.00), splenomegaly on exam and imaging (R16.1), thrombocytopenia and anemia on CBC (D69.6, D64.9), and concern for possible arthropod-borne co-infection (A93.8). Past history includes colonic polyps (Z86.010). She was observed 36 hours for symptom control and diagnostic evaluation.\n\nHospital course: Patient received supportive care including antipyretics and analgesia (acetaminophen and a single dose ketorolac inpatient) and antiemetic (ondansetron ODT) with good symptomatic response. Doxycycline was initiated empirically pending additional infectious workup given exposure history; no invasive procedures were required. Hemodynamics remained stable, oxygenation normal on room air, and serial exams showed improving oral intake. Platelet count trended upward but remained below institutional normal; hemoglobin was stable without transfusion requirement. No evidence of splenic rupture.\n\nKey findings/procedures: Positive gammaherpesviral testing consistent with infectious mononucleosis; imaging-confirmed splenomegaly; laboratory-confirmed thrombocytopenia and anemia. No procedures performed.\n\nDischarge condition and functional status: Patient discharged clinically improved, afebrile, hemodynamically stable, and able to ambulate independently with baseline assistance for heavier tasks due to fatigue. Home health is arranged for nursing visits\u2014monitor vitals, medication administration, wound/IV site checks if vascular access is present, and assistance with medication reconciliation and safe activity progression. Recommend activity restriction (no heavy lifting or contact sports) while splenomegaly present.\n\nMedications and follow-up: Discharge medications include acetaminophen PRN for pain/fever, doxycycline hyclate (complete prescribed course), ondansetron ODT PRN for nausea, and supplies for 0.9% sodium chloride flush if home vascular access required. Follow-up with primary care in 3\u20135 days, hematology within 1\u20132 weeks for thrombocytopenia/anemia surveillance, and return sooner for worsening abdominal pain, sudden shoulder pain, new bleeding, syncope, or high fever.\n", "diagnosis_codes": ["D696", "A938", "Z86010", "B2700", "R161"], "suggested_codes": ["D649"], "accepted_codes": ["D649"], "rejected_codes": [], "date": "2024-12-18T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 23946717, "discharge_summary": "History of present illness: 68-year-old female admitted for observation for critical limb ischemia of the left lower extremity (ICD-10 I70.222) with rest pain. She has known peripheral arterial disease, chronic anticoagulation use, hypertension, hypercholesterolemia, COPD, mitral regurgitation, and nicotine dependence. Symptoms on presentation included progressive left foot/ankle pain at rest, pallor, and decreased ambulation due to pain.\n\nHospital course: Patient was observed for 2.7 days. Vascular surgery performed endovascular revascularization of the left lower extremity (percutaneous transluminal angioplasty of affected segment) without immediate complication. Peri-procedural anticoagulation and antiplatelet therapy were managed inpatient; parenteral heparin used per protocol and transitioned back to home oral anticoagulant. Pain and perfusion improved with decreased rest pain, warmer distal skin temperature, and improved Doppler signals.\n\nKey findings and procedures: Pre-procedure: diminished left dorsalis pedis/posterior tibial Doppler signals and rest pain consistent with I70.222. Procedures: endovascular left lower extremity revascularization (angioplasty) and adjunctive percutaneous interventions; peri-procedural hemostasis achieved without bleeding. Labs stable; no acute cardiac or pulmonary events. Smoking cessation counseling provided.\n\nDischarge condition and functional status: Patient is medically stable for discharge. Rest pain significantly improved; ambulates with a cane and requires minimal assistance for transfers. Homebound status anticipated temporarily; home health recommended for wound/vascular checks, medication management, and assistance with activities of daily living while mobility improves.\n\nMedications and follow-up: Discharged on apixaban (continue prior anticoagulation), aspirin 81 mg daily, clopidogrel 75 mg daily per vascular team recommendation, gabapentin for neuropathic pain as needed, acetaminophen for pain, and inhalers for COPD as previously prescribed. Patient instructed on wound care and foot checks, smoking cessation support, and signs of limb ischemia or bleeding prompting immediate return. Follow-up: vascular surgery within 7 days, primary care within 7\u201314 days, cardiology as outpatient if indicated. Home health nursing and PT arranged for medication reconciliation, wound surveillance, and gait training.", "diagnosis_codes": ["Z86718", "Z1159", "E7800", "I2510", "I7300", "M48061", "I70222", "I10", "Z7901", "I340", "F17210", "J449"], "suggested_codes": ["G6309"], "accepted_codes": [], "rejected_codes": ["G6309"], "date": "2024-11-29T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 25392990, "discharge_summary": "History of present illness: 85-year-old female admitted under observation for evaluation and treatment of urinary tract infection (ICD-10 N39.0). She presented with acute confusion and decreased oral intake on background of known dementia with behavioral disturbance (F03.91) and baseline urinary incontinence (R32). Urinalysis was consistent with infection and urine culture grew Escherichia coli. Delirium secondary to UTI was suspected (F05). Patient is DNR (Z66).\n\nHospital course: Patient was observed for 1.9 days. She received intravenous fluids initially, supportive care, and antimicrobial therapy directed at the urine culture with clinical improvement in mentation and volume status. No hemodynamic instability or respiratory compromise occurred. Diarrhea was addressed with supportive measures. Skin was inspected; topical corticosteroid ointments continued for chronic dermatitis as needed. No invasive procedures were required.\n\nKey findings and procedures: Positive urinalysis and urine culture for E. coli. Clinical diagnosis: acute UTI with associated delirium on a background of dementia. Basic labs and clinical monitoring showed improvement; blood cultures were not clinically concerning for sepsis. IV access placement for fluids/antibiotics; no imaging or operative procedures performed.\n\nDischarge condition and functional status: Patient discharged to home in stable, afebrile condition with resolution of acute delirium to near baseline but with persistent baseline cognitive impairment from dementia. Functional needs: requires assistance with activities of daily living, supervision for medication administration and toileting due to incontinence, and fall-risk precautions; home health will provide skilled nursing and home aid support.\n\nMedications and follow-up: Continue prescribed oral antibiotic to complete the course as directed. Home medications on discharge: acetaminophen, aspirin, betamethasone valerate 0.1% ointment, triamcinolone acetonide 0.025% ointment, calcium carbonate, potassium chloride, heparin (as directed for prophylaxis), normal saline flushes, vitamin D. Recommend PCP follow-up within 48\u201372 hours for medication reconciliation and culture result review. Home health to monitor vitals, mental status, hydration, ADL assistance, and wound/skin care; obtain labs (BMP/CBC) and report abnormalities. Return to ED for fever, recurrent confusion, worsening weakness, or decreased oral intake.", "diagnosis_codes": ["N390"], "suggested_codes": ["F0391", "F05", "R32", "Z66", "L309"], "accepted_codes": ["F0391", "F05", "R32", "Z66"], "rejected_codes": ["L309"], "date": "2024-03-23T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 29196120, "discharge_summary": "History of Present Illness: 77-year-old male admitted to observation for evaluation and treatment of urinary tract infection with fever, dysuria, nausea and decreased oral intake. Known history of metastatic pancreatic adenocarcinoma with liver metastases, insulin-treated diabetes mellitus, hypertension, hyperlipidemia and prior pathological fracture. Admission labs revealed hyponatremia and evidence of infection; urine culture subsequently grew Escherichia coli.\n\nHospital Course: The patient received IV fluids for symptomatic hyponatremia with progressive correction of serum sodium from 124 mmol/L to 134 mmol/L. Empiric IV antibiotics were initiated (ceftriaxone) and continued pending culture results; therapy was narrowed to oral antibiotic therapy once clinically improved and culture sensitivities were available. Antiemetics and analgesics were administered as needed. He received subcutaneous heparin for DVT prophylaxis. Orthopedics evaluated the known pathological fracture and recommended nonoperative management with pain control and mobility precautions. No invasive procedures were required.\n\nKey Findings and Procedures: Positive urinalysis and urine culture for E. coli; leukocytosis and hyponatremia on admission that normalized with treatment. No surgical interventions performed. Orthopedic consult documented stable pathological fracture without acute surgical indication.\n\nDischarge Condition and Functional Status: At discharge the patient is afebrile, hemodynamically stable, mentating at baseline, and ambulatory with a wheeled walker with caregiver assistance. He requires assistance with transfers and some activities of daily living; home health services arranged for skilled nursing and physical therapy to assist with medication management, mobility training, vital sign and glucose monitoring, and safety/fall mitigation.\n\nMedications and Follow-up: Discharged on an oral antibiotic to complete a total 7\u201310 day course, his home cardiac, statin and diabetes med regimen (including insulin) resumed as prior with adjustments as indicated. Arrange primary care follow-up within 3 days, oncology follow-up in 1 week, and repeat BMP/CBC within 48\u201372 hours. Return to ED for fever, worsening confusion, dyspnea, new focal pain, or inability to tolerate PO intake.", "diagnosis_codes": ["N390"], "suggested_codes": ["C259", "C787", "E119", "E871", "M845X9"], "accepted_codes": ["C259", "C787", "E119", "E871"], "rejected_codes": ["M845X9"], "date": "2024-01-09T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 22519228, "discharge_summary": "History of Present Illness: 30-year-old G?P? female admitted urgently for preterm premature rupture of membranes at approximately 23 weeks' gestation with onset of labor within 24 hours of rupture. Pregnancy complicated by documented cervical incompetence, obesity (BMI ~38), and chronic hypertension. Intrapartum course was notable for clinical chorioamnionitis.\n\nHospital Course: Patient was managed over a 2.4-day hospitalization. On admission she received IV fluids and broad-spectrum IV antibiotics (ampicillin and gentamicin initially; clindamycin added for continued concern for intrauterine infection). Analgesia and antipyretics (acetaminophen, ibuprofen as indicated) were provided. Maternal hemodynamics and fetal status were monitored. The patient delivered a single liveborn infant (23 weeks) during the admission; delivery was attended by obstetrics and neonatology teams. Estimated blood loss was within expected limits for the delivery, and no immediate surgical complications occurred. Patient remained hemodynamically stable and afebrile for >24 hours prior to discharge.\n\nKey Findings and Procedures: Positive clinical diagnosis of chorioamnionitis; PPROM with onset of labor; management included induction/management of labor and delivery, IV antibiotic therapy, and standard postpartum monitoring. Procedural interventions performed per operative and delivery documentation.\n\nDischarge Condition and Functional Status: Patient is stable for discharge, afebrile, and hemodynamically stable. Ambulates independently with some limitation from recent delivery; able to perform basic activities of daily living but will require home health support for medication reconciliation, blood pressure monitoring, and reinforcement of wound/breast care and newborn care education.\n\nMedications and Follow-up Plan: Discharged on oral analgesics (acetaminophen and ibuprofen PRN), stool softener (docusate), laxative PRN (bisacodyl or milk of magnesia as needed), calcium supplement, and simethicone for gas. Completed inpatient IV antibiotic course; no routine outpatient IV antibiotics prescribed. Home health ordered for daily nursing visit x 3 days for vitals (including BP), medication administration assistance, wound/incision or perineal care as indicated, and education/support with lactation/newborn care. Obstetrics postpartum clinic follow-up in 1 week; primary care for blood pressure management in 1 week; neonatology/NICU follow-up per discharge plan for the infant. Return precautions reviewed.", "diagnosis_codes": ["O411220", "O6989X0", "O770", "O3432", "Z6838", "E669", "O42012", "Z370", "Z3A23", "O1092", "O99214", "O321XX0"], "suggested_codes": [], "accepted_codes": [], "rejected_codes": [], "date": "2024-09-08T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 20069812, "discharge_summary": "54-year-old male with known chronic pancreatitis (K86.1), alcoholic cirrhosis, COPD, prior pulmonary embolism, CAD status post PCI, type 2 diabetes, hypothyroidism and bipolar disorder presented with 48 hours of worsening epigastric pain radiating to the back, nausea and poor oral intake. Imaging (CT abdomen) demonstrated chronic pancreatitis changes without acute necrosis or fluid collection. Lipase was elevated consistent with an acute flare on chronic disease. He was admitted to observation for pain control, fluid resuscitation, glycemic stabilization and medication reconciliation.\n\nHospital course: Patient received aggressive IV fluids, antiemetics and analgesia with transition from IV hydromorphone to oral hydromorphone and adjunctive gabapentin. Pancreatic enzyme replacement (Creon) was initiated to address exocrine insufficiency. Glycemia was managed with insulin; intermittent hypoglycemia during hospitalization was treated with D50% and glucose gel and glucagon kit provided/education given. Therapeutic enoxaparin was administered given prior PE and current indication; home nursing will continue injections and monitoring. COPD symptoms were managed with albuterol inhaler. Lactulose was continued for hepatic encephalopathy prophylaxis. Cardiac evaluation (ECG, troponins) showed no acute ischemia.\n\nKey findings and procedures: CT abdomen consistent with chronic pancreatitis without acute collections; elevated lipase; chronic liver disease pattern on LFTs; no endoscopic or operative intervention required during this observation stay.\n\nDischarge condition and functional status: Patient is afebrile, hemodynamically stable, tolerating oral intake and able to ambulate with baseline limitations from COPD. Pain is controlled on oral regimen. Home health services are requested for medication management, therapeutic enoxaparin administration and education, glucose monitoring and insulin teaching, and surveillance for encephalopathy or bleeding.\n\nMedications at discharge (selected): aripiprazole, divalproex, insulin regimen, therapeutic enoxaparin (subcutaneous), pancreatic enzymes (Creon), albuterol inhaler, gabapentin, hydromorphone PRN, lactulose, furosemide, hydroxyzine, multivitamin/ascorbic acid, glucagon kit and glucose gel.\n\nFollow-up: Primary care in 3\u20135 days, GI clinic in 1\u20132 weeks, cardiology 4\u20136 weeks, psychiatry as outpatient. Labs (CMP, lipase, CBC, coagulation studies, glucose) within 3\u20135 days and as instructed by PCP/GI.", "diagnosis_codes": ["F419", "I2510", "Z86711", "Z87891", "E1140", "K861", "I10", "N400", "Z794", "F319", "K769", "E1165", "Z9861", "K7030", "E039", "K2090", "J449"], "suggested_codes": ["E1602", "K9081", "Z51892", "Z7949"], "accepted_codes": [], "rejected_codes": ["E1602", "K9081", "Z51892", "Z7949"], "date": "2024-04-18T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 22472998, "discharge_summary": "56-year-old female admitted urgently for tumor lysis syndrome (TLS) in the setting of metastatic soft tissue malignancy with known secondary disease to lung and peritoneum. She presented with acute electrolyte abnormalities and declining renal function, and was found to have concurrent Clostridioides difficile enterocolitis and symptomatic hyponatremia. Length of stay: 5.9 days.\n\nHospital course: Patient received aggressive intravenous crystalloid resuscitation, urate-lowering therapy with allopurinol, close electrolyte correction, and monitoring of renal function. She required intermittent dextrose 50%/glucose support for insulin-related hypoglycemia; glucagon and glucose gel were available as rescue measures. DVT prophylaxis with heparin was continued. C. difficile infection was treated with guideline-directed therapy and symptomatic care. Hematologic abnormalities (anemia related to recent antineoplastic chemotherapy and leukemoid reaction) were managed conservatively without transfusion. Sodium was corrected gradually with specialist input; no dialysis was required.\n\nKey findings and procedures: Laboratory evidence consistent with TLS (elevated uric acid, electrolyte shifts) and acute kidney injury secondary to TLS; positive testing consistent with C. difficile enterocolitis. No invasive procedures were required beyond central access management; heparin flushes provided for line maintenance.\n\nDischarge condition and functional status: Patient is discharged clinically stable, afebrile, and hemodynamically stable. Mobility: ambulatory with intermittent assistance due to deconditioning; requires home health support for medication administration, IV line/heparin flush care, and assistance with ADLs as needed. Cognitive status intact for self-care planning.\n\nMedications and follow-up: Discharged on allopurinol, insulin regimen with hypoglycemia rescue supplies (dextrose 50%, glucagon, glucose gel), acetaminophen, aspirin, atorvastatin, docusate, mirtazapine, multivitamins, and heparin flush protocol for central line. Home health to monitor daily weights, intake/output, weekly (or more frequent) BMP/CBC/uric acid until renal function stabilizes. Follow-up: oncology within 3\u20135 days, nephrology within 7\u201314 days, PCP within 7 days, and GI/infectious disease as outpatient for C. difficile management. Return to ED for worsening shortness of breath, persistent fever, new confusion, or signs of severe electrolyte disturbance.", "diagnosis_codes": ["E883"], "suggested_codes": ["E871", "N179", "A047", "D630", "D7481", "E161"], "accepted_codes": ["E871", "N179"], "rejected_codes": ["A047", "D630", "D7481", "E161"], "date": "2024-04-12T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 20340685, "discharge_summary": "History of Present Illness: 27-year-old man admitted urgently for severe alcohol withdrawal with delirium and hypoxic respiratory failure (admit day 0). He had recent heavy alcohol and opioid use and presented altered with hallucinations and agitation. Past medical history notable for chronic hepatitis C and hypertension.\n\nHospital Course: Length of stay 6.2 days. On admission he required short-term invasive ventilatory support for hypoxic respiratory failure and was successfully extubated on hospital day 2. He manifested tremor, delirium with visual hallucinations and impaired attention consistent with alcohol withdrawal delirium. He was treated with a standardized alcohol withdrawal regimen including a phenobarbital taper (alcohol withdrawal dosing days 2\u20137), thiamine, folic acid, multivitamin supplementation and supportive care. Methadone was initiated for opioid dependence and coordinated with addiction services. He received prophylactic heparin, bowel regimen (docusate, senna, bisacodyl) for opioid/immobility-related constipation, and ramelteon and diphenhydramine as needed for sleep. Influenza vaccine was administered during the stay. Respiratory status improved, oxygenation normalized off supplemental oxygen. Hepatic labs were monitored for alcoholic hepatitis; clinical status improved without encephalopathy at discharge.\n\nKey Findings and Procedures: Primary diagnosis: alcohol dependence with withdrawal delirium (F10.231). Other active problems included acute respiratory failure with hypoxia (J96.01), opioid dependence (F11.20), toxic encephalopathy, alcoholic hepatitis, chronic hepatitis C. Procedures included short-term invasive mechanical ventilation (extubation hospital day 2) and central venous access for acute care.\n\nDischarge Condition and Functional Status: Patient is hemodynamically stable, oriented to person/place/time, with resolution of active hallucinations and delirium. Ambulates with supervision due to deconditioning and recent delirium; independent with basic ADLs but requires home health supervision for medication administration and fall-risk monitoring.\n\nMedications and Follow-up: Discharge meds: methadone (concentrated oral solution 10 mg/mL with dosing instructions), phenobarbital taper as outpatient days remaining per protocol, thiamine, folic acid, multivitamin liquid, docusate, senna, bisacodyl PRN, diphenhydramine PRN, ramelteon, heparin stopped at discharge (if outpatient VTE prophylaxis not indicated). Arrange home health nursing for medication administration, daily vitals, fall-risk checks, and coordination with outpatient addiction treatment. Follow-up: addiction medicine/OTP within 48\u201372 hours, primary care in 7 days, psychiatry/addiction psychiatry within 1 week, hepatology/ID for hepatitis C in 1\u20132 weeks. Labs (CBC, CMP, LFTs) to be drawn in 7 days. Patient counseled on alcohol abstinence and danger signs prompting ED return.", "diagnosis_codes": ["G249", "F419", "F10251", "J9601", "K7010", "I10", "G92", "F10231", "K5900", "F1120", "F410"], "suggested_codes": ["Z23", "Z5189", "Z79891"], "accepted_codes": [], "rejected_codes": ["Z23", "Z5189", "Z79891"], "date": "2024-12-02T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 23166682, "discharge_summary": "History of present illness: 53-year-old female presented emergently with progressive dyspnea on exertion, orthopnea, lower-extremity edema and weight gain over several days. She has known hypertensive heart disease and diastolic heart failure. Admission diagnosis: acute on chronic diastolic (congestive) heart failure secondary to uncontrolled hypertension (I110, I5033). Comorbidities: type 2 diabetes mellitus, secondary pulmonary hypertension, hypothyroidism, asthma, GERD, restless legs, and nicotine use history.\n\nHospital course: Over a 2.6-day inpatient stay she received guideline-directed acute heart failure management. She was diuresed with IV then oral furosemide with significant symptomatic improvement and 3\u20134 kg net fluid loss. Blood pressure was controlled using hydralazine and losartan; transient anticoagulant prophylaxis with heparin was given. Cardiac monitoring and chest radiography showed cardiomegaly with pulmonary vascular congestion consistent with volume overload. Transthoracic echocardiogram during admission confirmed diastolic dysfunction with evidence of elevated pulmonary pressures. Electrolytes and renal function were monitored; potassium supplementation provided as needed. Influenza vaccine was administered prior to discharge.\n\nKey findings/procedures: chest x-ray with pulmonary congestion, TTE confirming diastolic dysfunction/secondary pulmonary hypertension, aggressive diuresis (IV furosemide) and medical BP optimization. No invasive procedures required.\n\nDischarge condition and functional status: Patient is stable, euvolemic-appearing at rest, ambulates independently at baseline but reports reduced endurance with exertion. Home health recommended for short-term support: daily weight and blood-pressure monitoring, medication reconciliation and adherence support, and fall-risk/mobility assessment.\n\nMedications and follow-up: Discharge meds include furosemide, losartan, hydralazine, levothyroxine, duloxetine, fluticasone-salmeterol inhaler, fluticasone nasal spray, potassium chloride as needed, acetaminophen, lorazepam PRN, folic acid and routine diabetes therapy. Heparin discontinued. Labs (BMP) within 48\u201372 hours post-discharge to reassess electrolytes/renal function. Outpatient follow-up with PCP in 3\u20135 days and cardiology in 1 week; cardiology to reassess volume status and medications, repeat BNP/echo as indicated. Home health to contact cardiology/ED for weight gain >3 lb in 24 hours, worsening dyspnea, or syncope.", "diagnosis_codes": ["I110"], "suggested_codes": ["E039", "I5033", "J45909", "K219", "E119", "F17200", "G2589", "I2789"], "accepted_codes": ["E039", "I5033", "J45909", "K219"], "rejected_codes": ["E119", "F17200", "G2589", "I2789"], "date": "2024-11-07T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 20600010, "discharge_summary": "History of Present Illness: 58-year-old female admitted as a same-day surgical patient for management of malignant neoplasm of the cervix (ICD-10 C53.9). She has a history of uterine leiomyoma, recurrent HSV dermatitis, prior urinary tract infections, sciatica, anxiety, and insomnia. She underwent planned operative management with intraoperative findings consistent with cervical malignancy; final pathology pending.\n\nHospital Course: Hospitalized 4.7 days postoperative for pain control, monitoring, and recovery. Postoperative course was uncomplicated by hemorrhage or thromboembolic event. Pain was managed with multimodal therapy (scheduled acetaminophen, NSAID as tolerated, gabapentin, short-term opioid PRN). Antiemetics and bowel regimen were instituted for opioid-related nausea/constipation. Acyclovir continued for chronic herpes viral lesions. DVT prophylaxis with subcutaneous heparin was provided during the inpatient stay. Anxiety and sleep disturbance were addressed with brief lorazepam and sleep hygiene measures; psychiatry/behavioral health consulted by phone for medication recommendations.\n\nKey Findings and Procedures: Operative procedure(s) completed without intraoperative complications. Relevant diagnoses during stay: cervical cancer (C53.9), HSV dermatitis, leiomyoma, history of UTIs. Postoperative labs and imaging were within acceptable limits; no acute renal or hepatic dysfunction. Wound intact; no signs of infection.\n\nDischarge Condition and Functional Status: Patient is hemodynamically stable, afebrile, with controlled pain on oral medications. Ambulates with a cane intermittently for balance and reports assistance with stair climbing; requires home health for wound checks, medication administration assistance, and mobility/fall-risk assessment. Able to perform basic activities of daily living with intermittent assistance.\n\nMedications and Follow-up: Discharge meds include acetaminophen, ibuprofen (as tolerated), oxycodone IR PRN, gabapentin, lorazepam PRN for severe anxiety, acyclovir, stool softener and PRN laxatives, potassium chloride powder, magnesium oxide, ondansetron/promethazine PRN, loperamide PRN. Home health referral placed for nursing visits 3x/week for 2 weeks for wound care, medication reconciliation, pain and bowel management, and fall-risk mitigation. Follow-up with gynecologic oncology in 1\u20132 weeks for pathology review and treatment planning; PCP to follow in 1 week. Return precautions given for fever, uncontrolled pain, bleeding, or calf swelling.", "diagnosis_codes": ["C539"], "suggested_codes": ["D259", "F419", "B009", "G893"], "accepted_codes": ["D259", "F419"], "rejected_codes": ["B009", "G893"], "date": "2024-05-23T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 23145360, "discharge_summary": "History of present illness: 69-year-old male observed for 11 days for complications related to metastatic colon cancer (C18.9) with known secondary disease to liver and lung. He presented with progressive weakness, weight loss, hypoxia and cough. Imaging and clinical course were notable for pulmonary embolism and aspiration pneumonitis. He had severe protein-calorie malnutrition and deconditioning on admission.\n\nHospital course: The patient was managed on an observation/medical service. He received therapeutic anticoagulation with apixaban for pulmonary embolism and empiric antibiotics (levofloxacin) for aspiration pneumonitis, with clinical improvement in oxygenation and clearing of inflammatory markers. Nutritional support included multivitamin/mineral supplementation and caloric optimization; bowel regimen was initiated (polyethylene glycol and senna) for chronic constipation. He was evaluated by oncology and palliative care; hematology consulted for an acquired coagulation factor deficiency and anemia. A procedure coded 0FB13ZX was performed without immediate complication. Encephalopathy was monitored and improved with supportive measures. Pain was managed with acetaminophen and lidocaine 5% patches as needed; blood pressure managed with lisinopril.\n\nKey findings and procedures: metastatic colon cancer with liver and pulmonary metastases, pulmonary embolism, aspiration pneumonitis, severe protein-calorie malnutrition, acquired coagulation factor deficiency, anemia and thrombocytopenia. Underwent procedural intervention (ICD-10-PCS 0FB13ZX) during stay without peri-procedural complications.\n\nDischarge condition and functional status: Patient is medically stable for discharge. He remains deconditioned with reduced endurance and requires assistance with ambulation and most instrumental activities of daily living; cognition improved but intermittent confusion persists. Home health services are arranged for skilled nursing, medication administration/education, wound/procedure-site checks as indicated, nutrition support, and physical therapy to improve mobility.\n\nMedications and follow-up: Discharge meds include apixaban, acetaminophen PRN, levofloxacin (complete course as outpatient if indicated), lidocaine 5% patch PRN, lisinopril, multivitamin/minerals, polyethylene glycol and senna, and normal saline flush for any home IV access. Follow-up: oncology and hematology within 7\u201314 days, primary care in 7 days, and earlier for fever, worsening dyspnea, new bleeding or progressive confusion. Labs (CBC, CMP, coagulation panel) prior to clinic visits.", "diagnosis_codes": ["C189", "I2699", "Z681", "Z720", "R627", "D630", "D684", "J690", "G9340", "I10", "Z7901", "C7800", "I82452", "D696", "R634", "C787", "E43", "C779"], "suggested_codes": ["K590", "Z515", "Z740"], "accepted_codes": [], "rejected_codes": ["K590", "Z515", "Z740"], "date": "2024-07-20T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 28741882, "discharge_summary": "History of present illness: 71-year-old man with history of acute myeloblastic leukemia in remission after stem cell transplant complicated by chronic graft-versus-host disease (GVHD), hypertension, prior osteonecrosis, and chronic hepatitis B presented to the ED with productive cough, fever, and progressive dyspnea. Chest x-ray demonstrated right lower-lobe consolidation. He was admitted directly for treatment of pneumonia with hypoxemia (SpO2 nadir 88%).\n\nHospital course: Over a 48-hour hospitalization the patient was treated with IV meropenem and azithromycin, supplemental oxygen (titrated to maintain SpO2 >92%), and subcutaneous heparin for VTE prophylaxis. Blood and sputum cultures remained negative to date. Supportive therapies included acetaminophen, guaifenesin, benzonatate for cough, and continuation of baseline prophylactic/antimicrobial agents related to his transplant history: posaconazole, acyclovir, atovaquone, and entecavir for hepatitis B suppression. Prednisone for chronic GVHD was continued; topical metronidazole gel was applied for skin lesions. Labs showed mild transaminase elevation and expected post-treatment improvement in inflammatory markers. No invasive procedures were required beyond peripheral IV access and chest radiography.\n\nKey findings/procedures: Chest x-ray with RLL consolidation; negative blood/sputum cultures; SpO2 improved with supplemental oxygen. No bacteremia identified.\n\nDischarge condition and functional status: Patient medically stable for discharge on home oxygen (2 L/min nasal cannula at rest, use with activity and at night), ambulatory with a walker and requires assistance with ADLs due to deconditioning. Home health nursing arranged for medication administration, IV antibiotic infusion, wound/skin care for GVHD rash, daily vitals/oxygen checks, and PT evaluation.\n\nMedications and follow-up: Discharge meds include home IV meropenem (home infusion), oral azithromycin as directed, posaconazole delayed-release, acyclovir, atovaquone, entecavir, prednisone, gabapentin, benzonatate PRN, guaifenesin, omeprazole, topical metronidazole, and multivitamin. Labs: CBC/CMP within 48\u201372 hours and weekly while on IV antibiotics/posaconazole; monitor LFTs. Follow-up: PCP in 48\u201372 hours, oncology/hematology and pulmonary clinic within 7 days, infectious disease as outpatient for antimicrobial management, repeat chest x-ray in 4\u20136 weeks or sooner if symptoms worsen.", "diagnosis_codes": ["J189", "R740", "B1910", "D89811", "R0902", "I10", "C9201", "T865", "Z8619", "M87859", "R21"], "suggested_codes": ["Z4629", "Z7401", "Z991"], "accepted_codes": [], "rejected_codes": ["Z4629", "Z7401", "Z991"], "date": "2024-10-18T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 22630832, "discharge_summary": "History of present illness: 76-year-old male presented emergently with bright red lower gastrointestinal bleeding and symptomatic anemia. Past medical history notable for chronic atrial fibrillation, hypertensive heart disease with chronic systolic heart failure, metastatic malignancy to bone and intrapelvic nodes, prior TIA, diabetes, and chronic coagulation abnormality. On admission CT abdomen/pelvis demonstrated extensive colonic diverticulosis without perforation or abscess. Hemodynamically stabilized with resuscitation.\n\nHospital course: Over a 11-day admission the patient underwent volume resuscitation, blood transfusion(s) for symptomatic anemia, serial hematocrit monitoring, and endoscopic evaluation by GI which localized diverticular bleeding but did not require definitive surgical resection. Anticoagulation was held initially; multidisciplinary discussion (Cardiology, Hematology, GI, and Oncology) guided temporary modification of antithrombotic therapy. Diuresis was optimized for acute-on-chronic systolic heart failure. Arrhythmias were rate-controlled with metoprolol. Pain and bowel regimen were managed; glycemic control achieved with insulin as needed.\n\nKey findings and procedures: CT abdomen/pelvis: diverticulosis without perforation/abscess. Colonoscopy: stigmata of diverticular bleeding; no perforation. Transfusion of packed red blood cells administered. Echocardiogram consistent with reduced EF (chronic). No interventional radiology embolization required.\n\nDischarge condition and functional status: Patient is medically stable for discharge to home with home health. Ambulates with a rolling walker and requires assistance with transfers and medication administration. Heart failure symptoms improved with reduced peripheral edema; daily weight monitoring and diuretic adherence required. Diet: regular with sodium restriction; stool softener and bowel regimen in place to minimize recurrence risk.\n\nMedications and follow-up: Discharged on aspirin, enoxaparin (as per Hem/Caridology plan), metoprolol tartrate, furosemide, atorvastatin, insulin regimen, docusate, acetaminophen, bismuth subsalicylate PRN, topical nystatin. Planned outpatient follow-up: GI within 1 week, Cardiology in 2 weeks, Hematology/Oncology as outpatient within 1\u20132 weeks. Home health to provide daily medication management, wound/skin checks, weight/edema monitoring, and assistance with ADLs. Return precautions given for rebleeding, syncope, chest pain, or worsening dyspnea.", "diagnosis_codes": ["Z8546", "E119", "M069", "B009", "K521", "C775", "K5909", "Z7901", "K5731", "E785", "Z66", "Z923", "I471", "Z951", "I482", "G459", "C7951", "Z955", "I2510", "I5023", "N400", "R791", "Z9221", "I110"], "suggested_codes": ["D649"], "accepted_codes": [], "rejected_codes": ["D649"], "date": "2024-09-05T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 22895153, "discharge_summary": "History of Present Illness: 76-year-old woman admitted as a same-day surgical patient for evaluation and management of a right lung lesion consistent with a secondary malignant neoplasm (C78.01) with progressive cough. Past medical history notable for prior renal pelvis malignancy, acquired absence of a kidney, hypothyroidism, hyperlipidemia, monoclonal gammopathy, vascular dementia, prior MI/chronic ischemic heart disease, and nicotine use history.\n\nHospital Course: The patient underwent image-guided thoracic procedures for tissue diagnosis and pleural management (operative codes 0BBC4ZX, 0BTC4ZZ, 07B74ZX, 8E0W4CZ). Intraoperative and immediate postoperative course were uncomplicated. Pain was managed with scheduled acetaminophen and a short course of ketorolac; lidocaine 5% patches provided adjunctive topical relief. She tolerated oral intake, bowel regimen initiated (docusate, senna), and antiemetic ondansetron used PRN. No acute cardiopulmonary or thrombotic complications occurred. Heparin prophylaxis was provided inpatient and discontinued at discharge.\n\nKey Findings and Procedures: Pathologic tissue obtained for staging; final pathology pending. Procedural notes confirm successful sampling of right lung lesion and management of associated pleural fluid. No immediate surgical complications, minimal bleeding, and stable chest imaging postprocedure.\n\nDischarge Condition and Functional Status: Patient is hemodynamically stable and afebrile at discharge. Ambulates with supervision; baseline cognitive impairment from vascular dementia limits independent medication management and complex ADLs. Home health nursing arranged for wound and procedural site checks, medication reconciliation, and fall risk assessment. Physical therapy will provide short-term visits for gait training and transfer safety; occupational therapy for ADL support and adaptive equipment evaluation.\n\nMedications and Follow-up: Discharge meds include acetaminophen, ketorolac (short course), lidocaine 5% patch PRN, albuterol nebulizer PRN, docusate, senna, donepezil, memantine, sertraline, levothyroxine, metoprolol succinate, guaifenesin ER, ondansetron PRN, and routine IV flush supplies as needed. Heparin discontinued. Follow-up: Thoracic surgery/clinic in 7\u201314 days for wound check and pathologic review; oncology to be contacted for further staging and management pending pathology; primary care within 7 days. Home health to report any fever, increasing dyspnea, wound drainage, or significant decline in function immediately.", "diagnosis_codes": ["C7801"], "suggested_codes": ["D472", "E039", "E785", "F0150", "Z87891", "I2510", "N281"], "accepted_codes": ["D472", "E039", "E785", "F0150", "Z87891"], "rejected_codes": ["I2510", "N281"], "date": "2024-11-05T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 28779650, "discharge_summary": "Brief history of present illness: 27-year-old woman with end-stage renal disease on chronic dialysis presented on observation status with fever, rigors and positive blood cultures. She was found to have sepsis secondary to Staphylococcus species and acute infective endocarditis related to an infected intracardiac/vascular device (T82.7xxA). Hospital course: Over a 12-day admission she developed severe sepsis without shock. Blood cultures grew Staphylococcus species; thrombocytopenia and anemia were addressed with transfusion support as indicated and hematology consultation. She remained dialysis-dependent and received scheduled hemodialysis sessions during the admission. Infectious disease and cardiology were involved; transesophageal echocardiography confirmed valvular vegetation. The infected cardiac/vascular device was extracted with intraoperative debridement and appropriate cultures were obtained. She was treated with targeted IV antibiotics (cefazolin) and supportive care (IV fluids, glycemic control, analgesia). Renal and electrolyte abnormalities were managed with dialysis and medication adjustments (cinacalcet, doxercalciferol, epoetin alfa as part of anemia management). A tunneled dialysis catheter was maintained and heparin dwell protocol instituted per dialysis team.\n\nKey findings and procedures: positive blood cultures for Staphylococcus sp.; TEE demonstrating valvular vegetation; device extraction and debridement; ongoing hemodialysis access management. Procedures performed included device extraction and placement/management of dialysis access; multiple dialysis sessions completed.\n\nDischarge condition and functional status: Patient is clinically improved, afebrile for >48 hours, hemodynamically stable, with improving leukocytosis and platelet count. Ambulates short distances with minimal assistance and is independent with most activities of daily living but requires support for IV antibiotic administration, wound care and transport to outpatient dialysis.\n\nMedications and follow-up plan: Discharged on IV cefazolin via home infusion for planned course per Infectious Disease, heparin catheter dwell per dialysis protocol, cinacalcet and doxercalciferol, epoetin alfa as outpatient dialysis-based injections, aspirin, stool softener and PRN acetaminophen. Follow-up: Infectious Disease within 7 days, Nephrology/dialysis team within 3 days, Cardiology in 2 weeks, and Primary Care as needed. Home health to provide IV antibiotic administration, wound dressing changes, vascular access care, medication administration and assistance with ADLs.", "diagnosis_codes": ["Y841", "R6520", "Y92009", "F39", "I120", "I519", "I330", "T827XXA", "Z992", "D631", "D696", "Q211", "N186", "I071", "B957", "A411", "G43909"], "suggested_codes": ["Z792", "Z9115"], "accepted_codes": [], "rejected_codes": ["Z792", "Z9115"], "date": "2024-08-13T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 21938857, "discharge_summary": "History of Present Illness: 64-year-old male admitted via direct emergency for progressive weakness, dizziness and reduced oral intake for several days. Initial evaluation revealed clinical dehydration with associated hyperkalemia. History is notable for type 2 diabetes on long-term insulin, essential hypertension, ulcerative colitis, opioid and alcohol use disorders, and peripheral polyneuropathy.\n\nHospital Course: Patient received isotonic crystalloid resuscitation (0.9% NaCl) with clinical improvement in volume status. Hyperkalemia was treated acutely with IV dextrose 50% and insulin; magnesium and phosphate replacement were given as indicated. Antiemetic therapy (ondansetron) controlled nausea. Heparin prophylaxis was used while inpatient. Buprenorphine-naloxone therapy was continued for opioid dependence. Bowel regimen adjusted with psyllium and diphenoxylate-atropine for symptomatic control. Glucagon and glucose gel were available for hypoglycemia as needed. Blood glucose and electrolytes were monitored and trended to acceptable ranges prior to discharge.\n\nKey Findings and Procedures: Significant lab abnormalities on admission included elevated serum potassium and markers consistent with volume depletion; both corrected with therapy. No invasive procedures were required other than peripheral IV access and routine monitoring. No evidence of acute cardiac ischemia on telemetry/ECG during hospitalization.\n\nDischarge Condition and Functional Status: Patient is discharged in stable medical condition with improved hydration, normalized electrolytes, and stable glycemic control. He ambulates with mild unsteadiness related to baseline polyneuropathy and deconditioning; home health nursing and a short course of physical therapy are arranged to assist with safe mobility and ADL support. Cognitive status intact; able to participate in medication teaching.\n\nMedications and Follow-up: Discharge medications include Buprenorphine-Naloxone 8/2 mg per home regimen, home insulin regimen (continue and monitor), ondansetron PRN, diphenoxylate-atropine PRN, psyllium wafer daily, Neutra-Phos as directed, and standard supplies (0.9% NaCl flush, glucose gel). Arrange outpatient follow-up: primary care within 3\u20135 days, endocrinology for diabetes management, and addiction services/MAT within 1\u20132 weeks. Outpatient labs (BMP) within 48\u201372 hours and sooner if symptomatic. Home health nursing to monitor vitals, electrolytes, insulin administration, medication reconciliation, and fall risk mitigation.", "diagnosis_codes": ["G629", "F1010", "K5190", "E119", "E860", "I10", "Z794", "E875", "Z9889", "F1120"], "suggested_codes": ["Z596"], "accepted_codes": [], "rejected_codes": ["Z596"], "date": "2024-08-11T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 24392401, "discharge_summary": "HPI: 56-year-old male observed for 3.1 days for acute respiratory distress after an apparent aspiration event. He presented with cough, dyspnea and hypoxia following emesis and was diagnosed with aspiration pneumonitis (J69.0). Significant medical history includes metastatic lung disease (C78.00), prior radiation to the chest with resultant pulmonary manifestations, essential hypertension, hyperlipidemia, nicotine dependence, and prior mood disorder.\n\nHospital course: The patient was admitted to observation for respiratory support and monitoring. He received supplemental oxygen with improvement in saturations, bronchodilator nebulizer treatments (ipratropium-albuterol), systemic corticosteroid for airway inflammation, and empiric intravenous antibiotics later transitioned to oral levofloxacin to cover aspiration-related bacterial infection. DVT prophylaxis with heparin was administered. Pain was managed with short-acting oxycodone as needed; chronic pain regimen includes fentanyl patch. Gastroprotection was provided with pantoprazole/omeprazole as indicated. No invasive mechanical ventilation was required. Speech therapy evaluated dysphonia and recommended aspiration precautions and swallow safety measures.\n\nKey findings and procedures: Chest imaging consistent with aspiration pneumonitis versus radiation changes; oxygenation improved to baseline with therapy. Procedures coded include peripheral IV access and bedside respiratory therapy interventions (nebulized treatments, oxygen titration). No acute surgical procedures performed.\n\nDischarge condition and functional status: Patient discharged in stable condition, afebrile and hemodynamically stable. Respiratory status: improved oxygen saturation at rest on room air; mild exertional dyspnea persists. Functional status: ambulatory with baseline assistance for some ADLs; requires support for medication administration and activity pacing. Home health nursing requested for daily medication reconciliation, vital sign and oxygen monitoring as needed, and assistance with ADL support.\n\nMedications and follow-up: Discharged on prescribed home meds including levofloxacin (complete course), inhaled ipratropium-albuterol PRN, pantoprazole/omeprazole, docusate, atenolol, fluoxetine, fentanyl patch (per prior regimen), alprazolam PRN, topical betamethasone as needed, and analgesics (oxycodone PRN). Follow-up with primary care within 48\u201372 hours, pulmonology within 1\u20132 weeks, and oncology as scheduled. Home health will coordinate swallow precautions and monitor for recurrent aspiration.", "diagnosis_codes": ["Y842", "R490", "J690", "C7800", "E785"], "suggested_codes": ["I10", "F1721", "F339"], "accepted_codes": ["I10"], "rejected_codes": ["F1721", "F339"], "date": "2024-08-22T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 25991123, "discharge_summary": "91-year-old male admitted under observation for acute influenza (ICD-10 J09X3) with predominant gastrointestinal symptoms. He presented with fever, cough, nausea and diarrhea of 24\u201348 hours\u2019 duration. Past medical history notable for atherosclerotic coronary artery disease with prior CABG (I25.10, Z95.1), unspecified atrial flutter (I48.92), and chronic thrombocytopenia (D69.6). There was reported difficulty with medication adherence at baseline (Z91.19).\n\nHospital course: Patient observed for approximately 24 hours. Rapid influenza testing positive; started on oseltamivir and supportive care including acetaminophen for symptom control, nebulized ipratropium-albuterol for wheeze, and subcutaneous heparin for VTE prophylaxis. Hydration and antiemetic measures were provided; bowel regimen initiated with docusate and senna. Thrombocytopenia was noted on admission labs; counts were stable and trended without bleeding signs during stay. Cardiac rhythm showed atrial flutter without hemodynamic instability. No invasive procedures were required. Influenza quadrivalent vaccine was administered prior to discharge per institutional protocol.\n\nKey findings/procedures: Positive influenza A, stable CBC with chronic thrombocytopenia, telemetry without acute ischemic changes, no supplemental oxygen requirement, peripheral IV for fluids removed prior to discharge.\n\nDischarge condition and functional status: Patient clinically improved, afebrile, hemodynamically stable and ambulatory with assistance. Cognitive baseline intact; requires home support for medication management and short-distance ambulation due to deconditioning and fall risk. Home health services recommended for nursing visits to monitor vitals, respiratory status, platelet count, and medication reconciliation.\n\nMedications at discharge: Oseltamivir (complete 5-day course as outpatient), acetaminophen PRN, docusate sodium, senna, guaifenesin, ipratropium-albuterol nebulizer PRN, subcutaneous heparin (per local protocol), sodium chloride 0.9% flush supplies as needed, and documentation of influenza vaccine given.\n\nFollow-up: Primary care visit within 48\u201372 hours for clinical re-evaluation and CBC, cardiology follow-up for atrial flutter/anticoagulation management within 1\u20132 weeks, and urgent return precautions for fever, worsening dyspnea, bleeding or syncope.", "diagnosis_codes": ["J09X3"], "suggested_codes": ["D696", "I2510", "I4892", "Z9119", "Z951"], "accepted_codes": ["D696", "I2510", "I4892", "Z9119", "Z951"], "rejected_codes": [], "date": "2024-05-04T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 22929361, "discharge_summary": "History of Present Illness: 78-year-old male admitted under observation for complications related to newly identified extranodal B-cell lymphoma (ICD-10 C85.19) and developed tumor lysis physiology with acute kidney injury. Admission was also notable for type 2 myocardial infarction and acute on chronic diastolic congestive heart failure exacerbation. Length of stay 10.9 days.\n\nHospital Course: Patient was managed with aggressive IV fluids, allopurinol and rasburicase consideration for tumor lysis prophylaxis, electrolyte repletion, and close urine output monitoring. Cardiac care included hemodynamic monitoring, guideline-directed medical therapy adjustments for heart failure (carvedilol and losartan held/adjusted as tolerated), and troponin trend consistent with type 2 MI; cardiology consulted. AKI improved with supportive care but did not fully normalize. Thrombocytopenia and anemia were monitored; transfusion was not required. Infectious disease/oncology recommended prophylactic antimicrobials (acyclovir, atovaquone) and filgrastim support per protocol pending outpatient chemotherapy planning. Pain and anxiety were controlled with short courses of lorazepam and topical lidocaine as needed.\n\nKey Findings and Procedures: Relevant labs demonstrated laboratory evidence of tumor lysis syndrome with elevated uric acid/creatinine at presentation and subsequent improvement. Imaging and cardiac testing consistent with non-ST elevation ischemic injury. Procedures included vascular access placement for IV therapy and central access as indicated, and diagnostic procedures per oncology workup (see chart for specific procedure codes 3E04305, 009U3ZZ, 3E0R305).\n\nDischarge Condition and Functional Status: Patient discharged hemodynamically stable, ambulatory with assistance, requires home health skilled nursing for IV medication administration, weekly lab draws (BMP, CBC, uric acid), and assistance with ADLs due to deconditioning. Fall risk moderate; requires cane/walker and caregiver supervision.\n\nMedications and Follow-up: Discharge medications include allopurinol, atorvastatin, atovaquone, carvedilol/losartan regimen adjustments as tolerated, famotidine, filgrastim-sndz per oncology plan, acyclovir, and PRN symptomatic meds. Follow-up: hematology/oncology within 3\u20137 days, cardiology within 7 days, nephrology PRN for persistent AKI. Home health to provide skilled nursing for IV therapy, medication administration, vital signs, and coordination of outpatient appointments.", "diagnosis_codes": ["I21A1", "Z20828", "E7800", "I2510", "I5033", "Z87891", "C8519", "D630", "M109", "N179", "I350", "N400", "E883", "D696", "N529", "E785", "T451X5A", "I110"], "suggested_codes": ["R5381", "Z515"], "accepted_codes": [], "rejected_codes": ["R5381", "Z515"], "date": "2024-10-16T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 21856949, "discharge_summary": "48-year-old female admitted emergently for acute kidney injury (AKI, N17.9) with associated dehydration and transient neurologic symptoms including aphasia. Admission: patient presented to ED with confusion/aphasia and presyncope; initial evaluation notable for hypotension/orthostatic changes and hypovolemia. Point-of-care glucose low requiring dextrose/glucose gel and glucagon in ED. CT head was without acute intracranial hemorrhage or infarct. EKG demonstrated known left bundle-branch block. Hospital length of stay 1.7 days; patient stabilized with isotonic and dextrose-containing IV fluids, electrolyte repletion, and targeted glycemic support.\n\nHospital course: Patient received aggressive volume resuscitation (IV normal saline and D10W as needed), potassium and magnesium replacement, and short-term insulin for hyperglycemia management. Heparin prophylaxis was administered while inpatient. Renal function improved with fluids; urine output adequate and no dialysis required. Neurologic deficits improved but residual mild expressive aphasia persisted at discharge. Orthostatic hypotension symptoms improved with increased oral intake and education on positional changes.\n\nKey findings/procedures: AKI secondary to pre-renal azotemia from dehydration with clinical response to fluids. No acute intracranial process on imaging. EKG with LBBB; no arrhythmia requiring intervention. No invasive procedures performed.\n\nDischarge condition and functional status: Medically stable for discharge. Ambulates with mild unsteadiness and requires assistance for some ADLs; home health recommended for medication administration, fall-risk precautions, orthostatic BP monitoring, daily weights, and urine output assessment. Cognitive/communication impairment improved but speech therapy evaluation recommended outpatient.\n\nMedications at discharge (selected): Atorvastatin, Clonazepam, Famotidine, Lamotrigine, Magnesium oxide, Potassium chloride (oral replacement as needed), Sertraline, Insulin (subcutaneous regimen), and instructions for oral glucose agents as previously used. IV therapies discontinued; supplies for SC insulin provided.\n\nFollow-up: PCP within 48\u201372 hours for medication review and BMP; nephrology clinic within 7 days for renal follow-up and repeat labs; cardiology within 2 weeks for LBBB/orthostasis; speech therapy outpatient referral. Home health to monitor vitals, labs, meds, and support ADLs.", "diagnosis_codes": ["N179"], "suggested_codes": ["E860", "I951", "E162", "R410", "Z794", "Z9189"], "accepted_codes": ["E860", "I951"], "rejected_codes": ["E162", "R410", "Z794", "Z9189"], "date": "2024-02-22T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 29666157, "discharge_summary": "Brief history of present illness: 53-year-old male presented emergently with 48 hours of fever, malaise, cough, and decreased oral intake. Significant history includes prior pancreas and kidney transplants (status post, on chronic immunosuppression with mycophenolate), essential hypertension, hyperlipidemia, and age-related osteoporosis.\n\nHospital course: This was a short ED observation admission (0.9 day). Initial exam showed fever and tachycardia; patient received acetaminophen, IV iso-osmotic dextrose for dehydration, ondansetron for nausea, and a single empiric dose of piperacillin-tazobactam in the ED prior to infectious assessment. Labs demonstrated mild lymphopenia but no leukocytosis; basic metabolic panel at baseline. Blood and urine cultures were obtained and are pending/returned without growth to date. Chest radiograph showed no focal consolidation. Given clinical improvement and low suspicion for bacterial focal infection, antibiotics were not continued. Heparin prophylaxis was given while in observation. Influenza quadrivalent vaccine was administered prior to discharge per protocol. Immunosuppressive therapy (mycophenolate mofetil) was continued per transplant team recommendation.\n\nKey findings and procedures: vital signs stabilized and patient was afebrile prior to discharge; no focal bacterial source identified; blood/urine cultures negative to date; transplant team concurrence to continue baseline immunosuppression; influenza vaccination administered.\n\nDischarge condition and functional status: Patient discharged in stable condition, afebrile, hemodynamically stable, tolerating oral intake. Ambulatory and independent with transfers and most activities of daily living; requires assistance from home health for medication reconciliation, monitoring for infection, and reinforcement of transplant-related precautions.\n\nMedications and follow-up plan: Continue home medications including mycophenolate mofetil, amlodipine, carvedilol, aspirin, atorvastatin, famotidine, omeprazole, magnesium oxide, brimonidine ophthalmic, and acetaminophen PRN. No outpatient antibiotics prescribed. Home health nursing arranged for wound/no-wound surveillance, daily vital sign checks and medication management for the next 48\u201372 hours with reassessment. Follow-up with transplant clinic within 48\u201372 hours for clinical review and laboratory monitoring (CBC, CMP, and immunosuppressant levels as directed by transplant team). Primary care follow-up in 1 week. Return to ED for fever >100.4\u00b0F, increased dyspnea, or other concerning symptoms.", "diagnosis_codes": ["Z940", "M810", "Z833", "I10", "E785", "B349", "Z9483"], "suggested_codes": ["E860", "R05", "R509", "R531", "R635", "Z79899"], "accepted_codes": [], "rejected_codes": ["E860", "R05", "R509", "R531", "R635", "Z79899"], "date": "2024-04-28T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 21373289, "discharge_summary": "History of Present Illness: 25-year-old woman with known overlap connective tissue disease on hydroxychloroquine and leflunomide presented to the ED with 48 hours of pleuritic, substernal chest pain worse when supine and improved when leaning forward, associated low-grade fever, myalgias and polyarthralgia. She reported recent contact with a person with suspected COVID-19. \n\nHospital Course: Admitted directly from the ED (length of stay 1.2 days). Initial evaluation demonstrated diffuse ST-segment elevations with PR depressions on ECG and elevated inflammatory markers (CRP/ESR); serial cardiac troponins were within normal limits. Bedside transthoracic echocardiogram showed no clinically significant pericardial effusion. Diagnosis of acute pericarditis was made in the setting of underlying inflammatory/overlap syndrome and known cryoglobulinemia. She was treated with high-dose ibuprofen, colchicine, and a short prednisone taper given her autoimmune background. Analgesia (ketorolac and short opioid doses) was used for breakthrough pain. She remained hemodynamically stable with improvement in pain and inflammatory markers prior to discharge.\n\nKey Findings and Procedures: 12-lead ECG consistent with acute pericarditis (diffuse ST elevation/PR depression), transthoracic echocardiogram without significant effusion, labs notable for elevated inflammatory markers and negative troponin series. IV access and routine laboratory monitoring were performed; no invasive procedures required.\n\nDischarge Condition and Functional Status: Patient discharged in improved clinical condition, hemodynamically stable, ambulatory with mild pain limiting endurance. Home health arranged to assist with medication administration, daily vital sign and symptom monitoring, and supervision/assistance with ambulation and activities of daily living as needed. Patient educated on red flags (worsening chest pain, dyspnea, syncope, fever).\n\nMedications and Follow-up: Discharged on colchicine, ibuprofen (scheduled), prednisone taper, hydroxychloroquine, leflunomide, potassium chloride, magnesium oxide, docusate sodium, senna, short PRN morphine sulfate and ketorolac for breakthrough pain, ramelteon for sleep, and sodium chloride 0.9% flushes as needed for IV line care. Follow-up: cardiology in 1 week, rheumatology in 2 weeks, primary care within 48\u201372 hours. Return to ED for worsening symptoms.", "diagnosis_codes": ["I309"], "suggested_codes": ["D898", "M350"], "accepted_codes": [], "rejected_codes": ["D898", "M350"], "date": "2024-05-27T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 21631933, "discharge_summary": "History of present illness: 54-year-old woman with a history of right knee post-traumatic osteoarthritis presented for elective right total knee arthroplasty (primary diagnosis M17.31). She has comorbid obesity (BMI 33), hypertension, and baseline chronic knee pain limiting ambulation and activities of daily living.\n\nHospital course: Patient underwent uncomplicated right total knee arthroplasty under general/regional anesthesia. Perioperative IV cefazolin was administered for surgical prophylaxis. Intraoperative blood loss was greater than anticipated, resulting in acute posthemorrhagic anemia (D62); she received one unit packed red blood cells with hemoglobin improvement and remained hemodynamically stable. Postoperatively she received multimodal analgesia including oral acetaminophen, gabapentin, scheduled ketorolac as tolerated, and short-acting IV hydromorphone for breakthrough pain. Aspirin was started for VTE prophylaxis. There was a brief postoperative wound seroma that was managed conservatively and resolved; no return to OR was required. She received influenza quadrivalent vaccine prior to discharge.\n\nKey findings and procedures: Right total knee arthroplasty (ICD-10-PCS 0SRC0J9) with revision/repair procedure code 0SPC04Z documented for intraoperative management of joint structures. Postoperative course notable for acute anemia treated with transfusion; otherwise no infectious complications. Vital signs remained within acceptable limits; final hemoglobin stable; surgical dressing intact with minimal drainage.\n\nDischarge condition and functional status: Patient is stable for discharge to home with home health services. Pain is controlled on oral regimen. Ambulates short distances with a rolling walker and requires assistance for stair negotiation and some transfers. Independent with light self-care with intermittent assistance; requires home health PT for gait training and OT for ADL support and wound care.\n\nMedications and follow-up: Discharge meds include acetaminophen, gabapentin, ketorolac PRN, aspirin 81 mg daily, stool softeners (docusate, bisacodyl PRN), calcium carbonate, home antihypertensive hydrochlorothiazide, and other usual home meds. Outpatient orthopedic follow-up in 10-14 days for wound check/suture removal; home health to begin PT/OT and daily wound assessment. Return precautions and emergency instructions provided.", "diagnosis_codes": ["M1731"], "suggested_codes": ["D62", "E669", "I10"], "accepted_codes": ["D62", "E669", "I10"], "rejected_codes": [], "date": "2024-05-04T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 26101893, "discharge_summary": "Brief HPI: 84-year-old female presented emergently after perioperative exposure to anesthesia with acute hypoxemia and cough consistent with chemical pneumonitis. She had progressive dyspnea and oxygen desaturation shortly after the event, prompting ED evaluation and admission. Past medical history notable for chronic kidney disease, hypertension, peripheral vascular disease, asthma, and prior benign colonic neoplasms.\n\nHospital course: Patient admitted for observation and respiratory support (length of stay 1.9 days). Initial chest radiograph demonstrated bibasilar and perihilar air\u2011space opacities consistent with aspiration/chemical pneumonitis. She required supplemental oxygen (up to 4 L NC) and improved to stable oxygenation on 2 L NC. Managed with bronchodilator therapy (nebulized albuterol and ipratropium-albuterol), inhaled corticosteroid/long-acting beta-agonist regimen, systemic corticosteroid taper, and empiric antibiotic therapy with clindamycin for suspected aspiration. Electrolyte abnormalities (hypokalemia) were corrected and IV fluids provided. Venous thromboembolism prophylaxis with subcutaneous heparin was administered. Bronchoscopy with airway toilet and bronchoalveolar lavage was performed for diagnostic sampling; cultures pending at discharge. No acute surgical intervention required.\n\nKey findings/procedures: hypoxemia responsive to low-flow oxygen; chest radiograph consistent with chemical pneumonitis; bronchoscopy with bronchoalveolar lavage performed (samples sent for gram stain, culture, and routine respiratory panel). Labs showed transient metabolic acidosis and hypokalemia which were corrected.\n\nDischarge condition and functional status: patient is medically stable and ambulates short distances with a rolling walker with supervision. Requires low-flow home oxygen (2 L NC) intermittently for exertional dyspnea and will need assistance with medication administration and nebulized treatments while home health completes initial teaching and safety/fall assessment.\n\nMedications and follow-up: discharged with albuterol inhaler and neb solution, ipratropium-albuterol neb, fluticasone-salmeterol inhaler, clindamycin oral to complete prescribed course, acetaminophen PRN, aspirin, diltiazem ER, hydrochlorothiazide, and instructions for home oxygen. Home health arranged for medication management, oxygen teaching, wound/fall risk and vitals monitoring. Follow-up with primary care in 48\u201372 hours, pulmonology within 1\u20132 weeks, and nephrology as outpatient for CKD management. Return sooner for fever, worsening dyspnea, or new confusion.", "diagnosis_codes": ["J954"], "suggested_codes": ["E872", "E876", "I739", "J45909", "N189", "I10", "Z7901", "Z85038", "Z9981"], "accepted_codes": ["E872", "E876", "I739", "J45909", "N189"], "rejected_codes": ["I10", "Z7901", "Z85038", "Z9981"], "date": "2024-06-19T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 28741164, "discharge_summary": "66-year-old male admitted to observation for acute pancreatitis presenting with acute epigastric pain, nausea and vomiting. Past medical history notable for hyperlipidemia, essential hypertension, type 2 diabetes mellitus, nicotine dependence, and prior dehydration episodes. On arrival he was hypoxemic and hyponatremic with elevated pancreatic enzymes and acute kidney injury. Imaging confirmed pancreatitis without necrosis or infection. Primary diagnosis: acute pancreatitis (K85.90) with comorbid AKI (N17.9), hyponatremia (E87.1) and hypoxemia/atelectasis (J98.11, R09.02).\n\nHospital course: Patient was managed with aggressive IV fluid resuscitation (Lactated Ringers), bowel rest initially, antiemetics, and analgesia (hydromorphone PRN, acetaminophen). Thromboprophylaxis with subcutaneous heparin was given. Oxygen supplementation and respiratory therapy (incentive spirometry) were provided for atelectasis and hypoxemia with marked improvement off supplemental oxygen prior to discharge. Electrolyte abnormalities and serum creatinine trended toward baseline; fluid balance was carefully adjusted to address transient fluid overload and subsequent euvolemia. Glycemic control addressed with insulin while inpatient. No endoscopic or surgical intervention was required.\n\nKey findings/procedures: elevated pancreatic enzymes and CT abdomen consistent with acute interstitial pancreatitis; no necrosis or collection. Supportive measures only. Serial labs showed improving renal function and sodium. No invasive procedures performed.\n\nDischarge condition and functional status: Patient is stable, afebrile, hemodynamically stable and euvolemic. Ambulates with minimal assistance due to deconditioning and will benefit from home health for skilled nursing and occupational support. Independent with light ADLs but requires assistance with medication management and monitoring; home health to provide short-term skilled nursing visits for IV/medication reconciliation, wound/skin checks as needed, and reinforcement of activity and breathing exercises.\n\nMedications and follow-up: Discharged on acetaminophen PRN, docusate, albuterol inhaler PRN, atorvastatin and fenofibrate for hypertriglyceridemia, carvedilol and aspirin for cardiac comorbidity, and insulin regimen as instructed. Outpatient follow-up with primary care in 3\u20135 days for repeat BMP and metabolic panel, GI clinic in 2 weeks, and nephrology if creatinine remains elevated. Smoking cessation counseling provided. Home health arranged for nursing visits and physical therapy referral as needed.", "diagnosis_codes": ["K8590"], "suggested_codes": ["E119", "E785", "E871", "I10", "J9811", "N179", "R0902", "F17210"], "accepted_codes": ["E119", "E785", "E871", "I10", "J9811", "N179", "R0902"], "rejected_codes": ["F17210"], "date": "2024-07-13T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 28327193, "discharge_summary": "History of Present Illness: 41-year-old male presented to the emergency department with acute substernal chest pain and diaphoresis. Emergency workup demonstrated ST-elevation myocardial infarction (STEMI). Past medical history notable for ischemic cardiomyopathy, chronic systolic heart failure, nicotine dependence, and prior coronary disease.\n\nHospital Course: Patient was admitted emergently and treated with antiplatelet therapy and anticoagulation. He underwent urgent percutaneous coronary intervention with placement of a drug-eluting stent to the culprit coronary lesion. He had transient ventricular arrhythmia in the early hospital course managed medically. He developed acute kidney injury on admission which improved toward baseline with IV fluids and optimization of perfusion. Heart failure was treated with diuretics and guideline-directed medical therapy was initiated/adjusted (beta-blocker, ACE inhibitor, nitrates \u00b1 hydralazine as tolerated). He received smoking cessation counseling and the influenza vaccine prior to discharge.\n\nKey Findings and Procedures: ECG on admission consistent with anterior/inferior STEMI. Coronary angiography identified an occlusive culprit lesion treated with successful PCI and drug-eluting stent (no immediate complications). Transthoracic echocardiogram showed reduced LVEF (~30\u201335%) with global hypokinesis, consistent with dilated cardiomyopathy. Creatinine peaked during admission and trended down to near-baseline. Brief episodes of ventricular tachycardia were controlled without further intervention.\n\nDischarge Condition and Functional Status: Patient is hemodynamically stable, chest pain-free, and ambulatory with assistance as needed. He requires home health nursing for early post-PCI monitoring (access site checks), daily weight and edema assessment, medication reconciliation, and reinforcement of heart-failure self-care and activity restrictions. He is independent with most ADLs but fatigues with exertion; anticipated progressive improvement with outpatient cardiac rehabilitation.\n\nMedications and Follow-up: Discharged on aspirin, clopidogrel (DAPT), atorvastatin, carvedilol, lisinopril, furosemide, isosorbide dinitrate \u00b1 hydralazine, and other home meds (acetaminophen, fluoxetine) as listed. Heparin stopped; morphine used only acutely. Follow-up: cardiology clinic in 1 week, primary care in 1 week, nephrology PRN for renal follow-up, baseline labs (BMP) within 48\u201372 hours, and referral to outpatient cardiac rehabilitation. Home health nursing arranged to begin within 24\u201348 hours.", "diagnosis_codes": ["I471", "F419", "Z86718", "I871", "I237", "F17200", "M79602", "I2129", "N179", "F430"], "suggested_codes": ["I4901", "I5022"], "accepted_codes": [], "rejected_codes": ["I4901", "I5022"], "date": "2024-04-27T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 22090037, "discharge_summary": "History of present illness: 25-year-old woman, 39 weeks gestation, presented urgently in presumed premature cervical change with advanced dilation and concern for cervical incompetence. She was GBS-positive on screening and had a history notable for a prior herpesviral infection (unspecified). Labor was managed with augmentation and intrapartum antibiotics for GBS prophylaxis.\n\nHospital course: Patient underwent spontaneous vaginal delivery of a single live term neonate (39 weeks). Labor was augmented with oxytocin; intrapartum penicillin/ampicillin administered for GBS prophylaxis. Maternal vital signs and bleeding were within expected limits postpartum. She received routine postpartum care including analgesia, antiemetic (ondansetron), stool softeners and laxatives for constipation prevention, topical perineal care (Dermoplast), and standard newborn care coordination. Influenza quadrivalent vaccine was administered prior to discharge. No surgical complications or retained products of conception were identified. Screening for postpartum mood was normal prior to discharge.\n\nKey findings and procedures: Maternal GBS carrier state documented; intrapartum antibiotics given. Oxytocin infusion for labor augmentation noted. Vaginal delivery uncomplicated; estimated blood loss within normal limits. No operative procedures beyond routine delivery interventions.\n\nDischarge condition and functional status: Patient is hemodynamically stable, afebrile, with pain controlled on oral medications. She ambulates independently with steady gait but requires assistance with newborn care tasks initially; able to perform personal hygiene and basic ADLs. Home health recommended for early postpartum home visit to assess breastfeeding support, perineal wound healing, pain control, medication reconciliation, and to assist with activity progression and newborn support.\n\nMedications at discharge: Acetaminophen and ibuprofen as needed for pain, docusate sodium and bisacodyl/milk of magnesia as needed for constipation, ondansetron PRN for nausea, calcium carbonate and simethicone PRN, Dermoplast topical perineal spray. Oxytocin discontinued prior to discharge.\n\nFollow-up: OB clinic appointment in 1\u20132 weeks for postpartum check (earlier if concerns). Return to ED for fever, heavy bleeding, severe pain, wound changes, or signs of infection. Home health to coordinate visit within 48\u201372 hours for wound check, medication assistance, breastfeeding support, and vital signs monitoring.", "diagnosis_codes": ["Z3A39", "Z370", "O3433", "O99824", "O9852", "B009"], "suggested_codes": [], "accepted_codes": [], "rejected_codes": [], "date": "2024-01-15T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 29814531, "discharge_summary": "Reason for admission: 47-year-old male admitted emergently for symptomatic secondary thrombocytopenia (ICD-10 D69.59) with associated drug-induced fever and headache. Brief HPI: Patient presented from home with fever, headache, easy bruising and petechiae. History notable for recent antimalarial use and prior infectious disease history. Past medical history significant for essential hypertension, irritable bowel syndrome with diarrhea, and nicotine dependence.\n\nHospital course: Initial evaluation showed thrombocytopenia and mild transaminase elevation. Blood cultures and focused infectious workup were obtained; imaging was nonfocal. Antimalarial therapy was identified as the likely offending agent and was discontinued. He received supportive care including IV fluids (Lactated Ringers), single-dose IV ceftriaxone in ED, and initiation of oral doxycycline for empiric coverage while awaiting cultures. Subcutaneous heparin was administered for VTE prophylaxis during hospitalization. Fever and headache resolved with discontinuation of the culprit drug and symptomatic management (acetaminophen, ondansetron PRN). Platelet count demonstrated an improving trend without need for platelet transfusion. Influenza vaccine was administered prior to discharge.\n\nKey findings and procedures: Positive findings included thrombocytopenia with improving platelet trend and transiently elevated AST/ALT. No invasive procedures were required beyond peripheral IV placement and routine blood draws. No blood product transfusion.\n\nDischarge condition and functional status: Patient is discharged hemodynamically stable, afebrile, and ambulatory at baseline with minimal assistance for ADLs. Home health nursing recommended for initial post-discharge period for medication reconciliation, daily vital sign and bleeding-precautions education, and repeat laboratory draws (platelet count, CBC, CMP) until hematology follow-up.\n\nMedications and follow-up plan: Discharge medications include: doxycycline 100 mg PO BID (complete course), acetaminophen PRN, polyethylene glycol and senna for bowel regimen, potassium chloride as indicated, amlodipine for BP, ramelteon nightly, ondansetron PRN. Avoid NSAIDs/antiplatelet agents. Hematology follow-up within 3\u20135 days for platelet management, primary care in 48\u201372 hours, and repeat labs in 48\u201372 hours or sooner if bleeding. Return to ED for any new bleeding, syncope, or recurrent fever.", "diagnosis_codes": ["Z87891", "G4440", "K580", "T372X5A", "I10", "D6959", "R502", "Y92019"], "suggested_codes": ["R740"], "accepted_codes": [], "rejected_codes": ["R740"], "date": "2024-12-28T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 29576020, "discharge_summary": "Hospital Discharge Summary\n\nHistory of Present Illness: 58-year-old female admitted urgently with fever, right upper quadrant pain, and septic physiology in the setting of known biliary prosthesis. Imaging and labs were consistent with obstructive cholangitis due to displacement/complication of a bile duct stent and infectious/inflammatory reaction to an internal prosthetic device. Relevant comorbidities include acute lymphoblastic leukemia not in remission with neutropenia, chronic hepatitis C, hypertension, and chronic anemia.\n\nHospital Course: Patient received broad-spectrum IV antibiotics with de-escalation based on cultures, volume resuscitation, and supportive care. Hematology/Oncology and GI were consulted. Filgrastim was administered to address neutropenia with good clinical response. She required transfusion for acute posthemorrhagic anemia. Interventional endoscopy (ERCP) was performed to evaluate and manage biliary stent complication; stent manipulation/adjustment was completed without immediate complication. Blood cultures were monitored; no ongoing bacteremia at discharge.\n\nKey Findings and Procedures: Imaging confirmed biliary obstruction and stent displacement. Labs notable for neutropenia (improved after filgrastim), anemia requiring transfusion, and inflammatory markers elevated on admission with subsequent decline. Procedure performed: endoscopic biliary stent evaluation and management (ERCP and stent manipulation).\n\nDischarge Condition and Functional Status: Patient is afebrile, hemodynamically stable, and ambulatory with assistance for longer ambulation. She remains functionally independent for basic activities of daily living but requires home health for medication administration (subcutaneous filgrastim) and monitoring given recent neutropenia and recent procedure.\n\nMedications at Discharge and Plan: Prescribed ciprofloxacin and metronidazole to complete antibiotic course, filgrastim 300 mcg subcutaneously per oncology orders (home health to administer), ferrous sulfate, docusate, gabapentin, lorazepam PRN, antihistamines as needed, and other chronic meds (allopurinol, furosemide, etc.). Follow-up: GI/Interventional Radiology within 7 days for stent reassessment, Hematology/Oncology within 48\u201372 hours, and primary care within 72 hours. Labs (CBC with differential, CMP) to be drawn by home health per orders.", "diagnosis_codes": ["T8579XA"], "suggested_codes": ["D62", "D709", "I10", "K830", "K831", "B182", "D649", "Z5112"], "accepted_codes": ["D62", "D709", "I10", "K830", "K831"], "rejected_codes": ["B182", "D649", "Z5112"], "date": "2024-05-26T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 21607181, "discharge_summary": "History of Present Illness: 42-year-old male admitted to observation for progressive weight loss, poor oral intake and functional decline consistent with adult failure to thrive (R62.7). Past medical history notable for metastatic malignancy (C79.9) with known primary bladder cancer (C67.9), severe protein-calorie malnutrition (E43), CKD stage 3 (N18.30), anemia of neoplastic disease (D63.0), benign prostatic hyperplasia, neuropathic symptoms, and prior urinary diversion/other artificial urinary tract opening status (Z93.6) with external collection bag.\n\nHospital Course: The patient was observed for 6.8 days for optimization of pain control, nutritional status, medication reconciliation and functional rehabilitation. He received IV fluids, serial laboratory monitoring, nutritional consultation with initiation of high-protein supplementation and appetite strategies, and VTE prophylaxis with enoxaparin. Pain regimen was optimized with scheduled acetaminophen, gabapentin and oral hydromorphone for breakthrough pain; lorazepam provided PRN anxiolysis. Bowel regimen (docusate, bisacodyl, milk of magnesia/glycerin suppositories) was implemented for opioid-associated constipation. Heparin flushes and urinary bag care maintained catheter patency.\n\nKey Findings and Procedures: Laboratory studies confirmed anemia and chronic kidney disease stage 3 with stable electrolytes. Nutritional status remained poor but improved incrementally with supplementation. ICD-10-PCS procedure 0T25X0Z was performed during the admission without immediate complication; documentation reflects endoscopic bladder intervention and management of urinary diversion. No acute cardiopulmonary events occurred.\n\nDischarge Condition and Functional Status: Patient is medically stable and afebrile at discharge. Pain is controlled on oral regimen. He remains deconditioned with decreased endurance and requires assistance for transfers and ADLs; home health nursing and PT are arranged for functional restoration and skilled wound/stoma/catheter care. He is independent with a few baseline tasks but needs assistance with medication administration and mobility.\n\nMedications and Follow-up: Discharge medications include acetaminophen, famotidine, gabapentin, oral hydromorphone PRN, enoxaparin (prophylaxis as directed), stool regimen (docusate, bisacodyl, milk of magnesia/glycerin), aluminum-magnesium hydroxide\u2013simethicone, magnesium sulfate as needed, and heparin flush supplies. Home health nursing, PT, and nutrition services initiated. Outpatient follow-up with PCP within 7 days, oncology/urology in 1\u20132 weeks, nephrology as outpatient and labs (CBC, BMP) in 48\u201372 hours.", "diagnosis_codes": ["Z936", "K5903", "Z87891", "R627", "N1830", "D630", "R319", "G893"], "suggested_codes": ["C799", "E43", "G632", "N40"], "accepted_codes": ["C799", "E43"], "rejected_codes": ["G632", "N40"], "date": "2024-10-22T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 20103067, "discharge_summary": "History of present illness: 76-year-old male admitted directly to the emergency department with acute chest pain and dyspnea. Initial evaluation demonstrated myocardial ischemia consistent with type 2 MI in the setting of known rheumatic mitral and aortic valve disease and chronic diastolic heart failure. He was also noted to have moderate protein-calorie malnutrition, acute post-hemorrhagic anemia, and hyponatremia due to SIADH.\n\nHospital course: Over a 10.9-day admission the patient underwent diagnostic coronary angiography with percutaneous coronary intervention and stent placement (presence of coronary angioplasty implant noted). He received packed red blood cell transfusion for symptomatic anemia and iron supplementation (ferrous gluconate). SIADH was managed with fluid restriction and adjustment of medications; serum sodium improved. Diuresis with guideline-directed therapy and optimization of heart-failure medications (metoprolol succinate XL, losartan potassium, isosorbide mononitrate ER) led to improved volume status. Nutritional status addressed with dietitian input and initiation of multivitamins/minerals and nutritional counseling. No peri-procedural complications were identified.\n\nKey findings and procedures: diagnostic coronary angiography with stent placement; transfusion for acute post-hemorrhagic anemia; treatment of SIADH and heart failure exacerbation; nutritional intervention for moderate protein-calorie malnutrition.\n\nDischarge condition and functional status: The patient is hemodynamically stable and euvolemic with improved dyspnea. Ambulates with a cane and requires assistance with some instrumental activities of daily living due to deconditioning; cognitive status intact. Home health referral placed for skilled nursing to assist with medication management, monitoring of vitals/weights, blood-draws for CBC and BMP, and guidance on dietary intake and activity progression.\n\nMedications and follow-up: Discharged on aspirin, clopidogrel, atorvastatin, metoprolol succinate XL, losartan potassium, isosorbide mononitrate ER, nitroglycerin SL PRN, acetaminophen, loratadine, omeprazole, senna, ferrous gluconate, and multivitamins. Home health to perform saline flushes as indicated for vascular access. Follow-up with cardiology within 7 days, primary care in 3\u20135 days, CBC and BMP within 48\u201372 hours and as directed; return to ER for recurrent chest pain, syncope, or worsening dyspnea.", "diagnosis_codes": ["I080"], "suggested_codes": ["E440", "D629", "E221", "I219", "I5039"], "accepted_codes": ["E440"], "rejected_codes": ["D629", "E221", "I219", "I5039"], "date": "2024-05-18T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 23576063, "discharge_summary": "History of Present Illness: 62-year-old female admitted urgently with acute kidney failure with tubular necrosis on background of hypertensive chronic kidney disease stage 5 (N17.0, I12.0, N18.5). She presented with decreased urine output, progressive fatigue, hypotension and encephalopathy concerns. She has known portal hypertension with portal vein thrombosis and ascites, history of pancytopenia and secondary thrombocytopenia. Initial labs showed severe azotemia, metabolic acidosis, and electrolyte abnormalities.\n\nHospital Course: Over a 2.8-day admission the patient received aggressive fluid resuscitation, correction of electrolyte disturbances, intravenous antibiotics for suspected urosepsis (ciprofloxacin), and bicarbonate therapy for metabolic acidosis. Hemodialysis was initiated emergently for uremia and refractory hyperkalemia; vascular access was placed (ICD-10-PCS 0DJ08ZZ). Hemodynamic status stabilized and mental status improved. Platelet counts and pancytopenia were monitored; transfusion was not required. Ascites management included diuretics adjustment and sodium restriction; no paracentesis required. Liver disease and portal hypertension were addressed with lactulose and rifaximin for encephalopathy prophylaxis.\n\nKey Findings and Procedures: acute tubular necrosis with CKD stage 5, portal vein thrombosis, ascites, and thrombocytopenia. Procedure: vascular access placement for dialysis (0DJ08ZZ) and initiation of inpatient hemodialysis.\n\nDischarge Condition and Functional Status: Patient discharged medically stable, hemodynamically stable and neurologically improved. Ambulates with assistance due to deconditioning; requires help with transfers and activities of daily living for 1\u20132 weeks and home health nursing support for medication administration and monitoring of intake/output and dialysis coordination.\n\nMedications at Discharge: Ciprofloxacin (complete course as outpatient as indicated), ferrous sulfate, levothyroxine, omeprazole, potassium chloride, sodium bicarbonate, lactulose, rifaximin, nystatin topical cream, insulin regimen as outpatient with glucose monitoring, and supplies for outpatient dialysis access care. Dextrose 50%, glucagon and glucose gel provided for hypoglycemia education and rescue use.\n\nFollow-up Plan: Nephrology within 48\u201372 hours to arrange ongoing dialysis and outpatient access care; hepatology for portal hypertension/varices within 2 weeks; hematology for pancytopenia within 1\u20132 weeks; primary care within 1 week. Home health to provide nursing visits, medication administration, wound/access care, and coordination of outpatient dialysis and labs (BMP, CBC, LFTs) per nephrology.", "diagnosis_codes": ["D61818", "K7469", "K766", "I8510", "R188", "I120", "N185", "N170", "E1122", "Z794", "I81", "E039", "Z9119", "D6959", "K3189"], "suggested_codes": ["E872", "E876", "Z91128"], "accepted_codes": [], "rejected_codes": ["E872", "E876", "Z91128"], "date": "2024-01-16T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 22375635, "discharge_summary": "57-year-old male admitted emergently for severe persistent asthma with acute exacerbation. He presented with progressive dyspnea, wheeze, chest tightness, and increased sputum production over several days with decreased exercise tolerance. Past medical history significant for congenital aortic valve insufficiency, thoracic aortic aneurysm, essential hypertension, obesity, adrenal disorder (history), and coronary atherosclerotic disease.\n\nHospital course: Patient received aggressive bronchodilator therapy (continuous and intermittent nebulized albuterol), systemic corticosteroids (prednisone taper), inhaled corticosteroid/long-acting beta-agonist therapy (fluticasone-salmeterol), supplemental oxygen as needed, and mucolytic/expectorant therapy (guaifenesin, saline nebulizations). He received prophylactic enoxaparin while inpatient. Airway clearance procedure performed (ICD-10-PCS 0CJS8ZZ) with removal of retained secretions. He was monitored for cardiac comorbidity-related issues; troponin and ECG were stable. No signs of infection requiring IV antibiotics; viral testing negative. He responded to treatment with progressive improvement in wheeze, respiratory rate normalization, and oxygenation maintained on room air at rest prior to discharge.\n\nKey findings/procedures: pulmonary exam notable for diffuse expiratory wheeze early with improvement; chest imaging without acute consolidation; procedure to clear airway secretions (0CJS8ZZ). Labs stable; no acute cardiac ischemia identified.\n\nDischarge condition and functional status: Discharged in stable condition. Respiratory status improved \u2014 ambulating independently with limited exertional tolerance and able to perform basic ADLs though requires pacing with activity. Home health services arranged for: inhaler/nebulizer technique training, serial pulse oximetry and symptom monitoring, assistance with medication reconciliation and activity progression.\n\nMedications at discharge: Prednisone (taper), fluticasone-salmeterol 250/50 BID, albuterol 0.083% neb solution PRN, montelukast nightly, benzonatate PRN cough, acetaminophen PRN, atorvastatin, pantoprazole, polyethylene glycol, senna PRN. Enoxaparin discontinued at discharge. Tdap administered during admission.\n\nFollow-up: Primary care within 1 week, Pulmonology clinic in 2\u20134 weeks, Cardiology as outpatient for valve/aneurysm surveillance. Return precautions given for worsening dyspnea, fever, chest pain, or hypoxia.", "diagnosis_codes": ["J398", "E669", "E279", "I712", "J4551"], "suggested_codes": ["I10", "I2510", "I350"], "accepted_codes": ["I10", "I2510"], "rejected_codes": ["I350"], "date": "2024-02-13T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 23362802, "discharge_summary": "Chief complaint: Abdominal pain, distension, nausea/vomiting and obstipation. Brief HPI: 83-year-old male admitted to observation for evaluation and management of presumed intestinal obstruction (K56.609). He presented with progressive abdominal distension, nausea, multiple episodes of emesis, and inability to tolerate oral intake. Past history notable for prior abdominal surgery with altered GI anatomy, chronic ascites, known esophageal varices, and B-cell lymphoma. Admission imaging and clinical exam were consistent with an obstructive process with associated aspiration pneumonitis on chest imaging.\n\nHospital course: Patient was managed conservatively over 8.8 days with bowel rest, IV fluids (NS/Lactated Ringers), serial abdominal examinations, nasogastric decompression as clinically indicated, and bowel regimen. Broad-spectrum coverage with ceftriaxone and metronidazole was administered for aspiration/possible intra-abdominal infection and discontinued prior to discharge per infectious disease guidance. He received DVT prophylaxis with subcutaneous heparin while inpatient. Diagnostic paracentesis was performed for ascites evaluation (no therapeutic drain required). Labs and repeat imaging demonstrated interval improvement in bowel dilation and resolution of obstructive symptoms; aspiration pneumonitis improved clinically with supportive care.\n\nKey findings/procedures: CT abdomen/pelvis showing features consistent with intestinal obstruction; chest x-ray with bibasilar infiltrates consistent with aspiration pneumonitis; diagnostic paracentesis; NG decompression and serial abdominal exams.\n\nDischarge condition and functional status: Discharged in stable condition, afebrile, hemodynamically stable, tolerating clear to low-residue diet advancing as tolerated. Mobility: ambulates with assistive device and requires assistance with basic ADLs and medication management \u2014 home health nursing recommended for daily visits initially.\n\nMedications and follow-up: Discharge medications include acetaminophen, aspirin, bisacodyl PRN, docusate, lactulose for bowel regimen, fenofibrate, finasteride, levothyroxine, lisinopril, and a short oral course of metronidazole as indicated. Home health to monitor vitals, abdominal exam, intake/output, bowel function, medication reconciliation, and assist with ADLs. Follow-up: General surgery within 7\u201310 days, gastroenterology within 1\u20132 weeks (varices/ascites management), oncology to follow B-cell lymphoma, and PCP in 1 week.", "diagnosis_codes": ["K56609"], "suggested_codes": ["J690", "R188", "C8339", "I8500"], "accepted_codes": ["J690", "R188"], "rejected_codes": ["C8339", "I8500"], "date": "2024-06-24T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 20237633, "discharge_summary": "62-year-old female admitted emergently for severe neoplasm-related pain secondary to metastatic malignancy to bone (primary diagnosis: neoplasm-related pain, ICD-10 G89.3; secondary: C79.51). Past medical history notable for coronary artery disease with prior MI and angioplasty, hyperlipidemia, GERD/esophagitis, history of neuroendocrine-type malignancy with recent radiotherapy.\n\nHistory of present illness: Patient presented with escalating, refractory axial and extremity bone pain despite home opioids. Pain was associated with decreased mobility and oral intake. No acute neurologic deficit or new cardiopulmonary complaints.\n\nHospital course: Admitted for analgesic optimization and short inpatient stabilization (LOS 1.7 days). She received IV fluids (lactated Ringer\u2019s), scheduled multimodal analgesia including IV hydromorphone titration, intermittent ketorolac, transition to transdermal fentanyl patch for baseline analgesia, and lidocaine 5% patches for localized pain. Heparin was administered for DVT prophylaxis. Antiemetic and stool softener (docusate) were provided. Cardiac status remained stable; troponin and ECG without acute ischemia. No invasive procedures performed. Pain improved from severe to moderate on regimen but remains present, requiring ongoing home opioid therapy and close follow-up.\n\nKey findings/procedures: Imaging consistent with known osseous metastatic disease; no acute surgical intervention indicated. Pain controlled to tolerable level after analgesic adjustments. Vitals stable at discharge. No complications from radiotherapy noted during stay.\n\nDischarge condition and functional status: Stable for discharge. Requires assistance with ambulation secondary to pain and deconditioning; home health recommended for skilled nursing visits for pain management, medication administration/education, fall-risk assessment, and assistance with ADLs. Continues to have moderate baseline analgesic requirements.\n\nMedications at discharge (partial list): transdermal fentanyl patch (per pain plan), hydromorphone PRN, acetaminophen, ketorolac PRN, lidocaine 5% patches, aspirin, atorvastatin, losartan, metoprolol succinate, docusate, topical/OTC throat lozenges, Maalox formulation as needed. Follow-up: oncology/palliative care within 3\u20137 days, primary care in 1\u20132 weeks, cardiology as outpatient for routine CAD management. Return precautions given for uncontrolled pain, new neurologic deficits, fever, or chest pain.", "diagnosis_codes": ["Y842", "E785", "Z955", "I2510", "Z87891", "I252", "F329", "C801", "E213", "K208", "K219", "M797", "C7A8", "C7951", "G893"], "suggested_codes": [], "accepted_codes": [], "rejected_codes": [], "date": "2024-06-30T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 29520901, "discharge_summary": "History of present illness: 64-year-old male admitted under observation for acute kidney injury (N17.9) with oliguria and rising creatinine in the setting of multiple comorbidities including chronic diastolic heart failure, stage CKD, prior liver transplant, chronic lymphocytic leukemia with pancytopenia, and suspected toxic encephalopathy. On arrival he had fatigue, decreased oral intake, and altered mentation. SIADH and volume derangements were considered contributors.\n\nHospital course: Over a 7.9-day observation stay the patient received careful volume management with judicious IV fluids and diuretic adjustments, antibiotic coverage for presumed infectious trigger (levofloxacin), antiviral prophylaxis (acyclovir), and nutrition optimization. Hematology and transplant teams were consulted for pancytopenia and transplant status. A temporary dialysis catheter was placed (procedure documented: 07DR3ZX) and maintained with heparin flushes; the patient did not require ongoing inpatient hemodialysis. Renal function improved from peak but did not fully return to baseline. Encephalopathy improved with correction of metabolic derangements. Midodrine was used intermittently for symptomatic orthostasis. Pharmacologic and nonpharmacologic measures addressed nausea, constipation/diarrhea, and pain.\n\nKey findings and procedures: acute kidney injury with partial recovery, toxic/metabolic encephalopathy improved, persistent cytopenias requiring hematology follow-up, nutrition assessment consistent with mild protein-calorie malnutrition. Procedure: placement of temporary dialysis/vascular access catheter (07DR3ZX). Relevant cultures and imaging were obtained; no focal surgical source identified.\n\nDischarge condition and functional status: Patient is medically stable for discharge to home. Ambulates with assistance intermittently due to deconditioning and orthostatic symptoms; requires help with some ADLs and supervision for medication administration and catheter care. Home health arranged for daily visits initially for wound/catheter care, vital sign and orthostatic monitoring, weight and fluid intake/output tracking, and medication assistance.\n\nMedications and follow-up: Discharge medications include acetaminophen, acyclovir, allopurinol, levofloxacin (if ongoing course), midodrine, PPI/H2 blocker, ondansetron as needed, antihistamines, stool agents, and heparin flushes for catheter. Labs (BMP, CBC) to be drawn 2\u20133\u00d7 weekly by home health. Follow-up: nephrology within 3\u20135 days, transplant clinic within 2 weeks, hematology within 1\u20132 weeks, and primary care in 1 week. Return promptly for fever, worsening confusion, hypotension, decreased urine output, or catheter concerns.", "diagnosis_codes": ["Z944", "N184", "E222", "K219", "G92", "I5032", "D61818", "R740", "Z20828", "I130", "E785", "T451X5A", "G620", "Z6823", "E860", "N179", "L508", "T367X5A", "Y929", "I2510", "Z87891", "F329", "E875", "C9110", "Z8505", "E441", "D469"], "suggested_codes": ["I951", "R4182", "R531", "Z7409", "Z743"], "accepted_codes": [], "rejected_codes": ["I951", "R4182", "R531", "Z7409", "Z743"], "date": "2024-06-15T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 25779923, "discharge_summary": "History of Present Illness: 50-year-old man admitted as a surgical same-day admission for repair of an incisional hernia (primary diagnosis K43.2). He has a history significant for separation of muscle (M62.08), prior abdominal surgery with acquired absence of portions of the digestive tract (Z90.49), essential hypertension (I10), hyperlipidemia (E78.5) and nicotine dependence (F17.210). He presented with symptomatic incisional hernia with progressive pain and bulge.\n\nHospital Course: The patient underwent operative repair with mesh reinforcement and fascial component release (ICD-10-PCS codes 0WUF0JZ, 0KNL0ZZ, 0KNK0ZZ). The immediate postoperative course was uncomplicated. He required short-term IV fluids (D5 1/2 NS, Lactated Ringers, 0.9% NaCl) and inpatient analgesia (hydromorphone then transitioned to oxycodone IR and scheduled acetaminophen). He received subcutaneous heparin for DVT prophylaxis and antihypertensive therapy as needed (labetalol, hydralazine inpatient; home oral lisinopril resumed). No signs of surgical site infection, obstruction, or bowel compromise were identified. Pain and bowel function improved; diet advanced to regular and he tolerated oral intake.\n\nKey Findings and Procedures: Successful open incisional hernia repair with mesh reinforcement and component separation. No intraoperative complications. Postoperative vitals and labs were stable; incision clean, dry and intact with minimal serosanguinous drainage.\n\nDischarge Condition and Functional Status: Patient is medically stable at discharge, ambulatory with assistance, independent with most activities of daily living but requires home health assistance for dressing changes and short-term mobility support. Pain is controlled on oral regimen; ambulation and breathing exercises initiated.\n\nMedications and Follow-up: Discharge meds include oxycodone IR PRN for breakthrough pain, acetaminophen scheduled/PRN, pantoprazole 40 mg daily, lisinopril for BP, calcium carbonate PRN antacid. Heparin was inpatient only. Home health to provide wound care, medication reconciliation, vital sign and blood pressure monitoring, ambulation support and smoking cessation counseling. Follow-up: surgical clinic in 10\u201314 days for wound check/staple removal; primary care in 7 days for BP and lipid management.", "diagnosis_codes": ["K432"], "suggested_codes": ["E785", "F17210", "I10", "M6208", "Z9049"], "accepted_codes": ["E785", "F17210", "I10", "M6208", "Z9049"], "rejected_codes": [], "date": "2024-12-27T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 20200839, "discharge_summary": "History of Present Illness: 56-year-old male admitted as a same-day surgical admission and remained inpatient for 7 days for operative management of a hepatic lesion (primary diagnosis D37.6 \u2014 neoplasm of uncertain behavior of liver/gallbladder/bile ducts) associated with obstructive cholestasis and portal hypertension. He presented with right upper quadrant pain, jaundice, pruritus, and abnormal liver function tests; imaging demonstrated a dominant hepatic mass with biliary dilation and gastric varices.\n\nHospital Course: The patient underwent operative resection of the hepatic lesion with intraoperative biliary exploration and placement of a surgical drain. Intraoperative findings confirmed a mass consistent with preoperative imaging and portal hypertension with varices; no uncontrolled hemorrhage occurred. Postoperative course was notable for expected pain managed with acetaminophen, nausea controlled with ondansetron, and glycemic management with basal-bolus insulin and continuation of metformin as tolerated. He received DVT prophylaxis with subcutaneous heparin while inpatient. No infectious complications, no re\u2011operation required. Pathology specimens sent; results pending.\n\nKey Findings and Procedures: Preoperative imaging: hepatic mass with biliary obstruction and signs of portal hypertension. Procedures: partial hepatic resection and intraoperative biliary decompression with drain placement. Labs: postoperative LFTs trending down from admission; stable hemoglobin and coagulation indices.\n\nDischarge Condition and Functional Status: Patient is clinically stable, afebrile, hemodynamically stable at discharge. Ambulates with assistance; requires help with stair negotiation and wound dressing but is independent with most basic ADLs. Home health recommended for wound/drain care, medication administration assistance (insulin if needed), and ongoing glucose monitoring.\n\nMedications and Follow-up: Discharged on acetaminophen, insulin regimen with oral metformin, lisinopril, omeprazole, fluticasone nasal spray, guaifenesin ER, lorazepam PRN, ondansetron PRN, and other home medications reconciled. Home health nurse to visit within 48 hours for wound/drain care, med reconciliation, glucose checks and nursing assessment; outpatient surgical clinic in 7\u201314 days, hepatology/oncology follow-up in 2 weeks for further management and staging, and primary care follow-up in 1 week for chronic disease management. Pathology results to be communicated at surgical follow-up.", "diagnosis_codes": ["F419", "K766", "I864", "Z5309", "F329", "E119", "I10", "K831", "E785", "D376"], "suggested_codes": ["L29", "R1011", "R17", "Z741"], "accepted_codes": [], "rejected_codes": ["L29", "R1011", "R17", "Z741"], "date": "2024-10-19T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 27678639, "discharge_summary": "History of present illness: 66-year-old male admitted to observation for 4.8 days with acute upper respiratory infection (J06.9) presenting with cough, increased sputum, dyspnea on exertion, and low-grade fever. Past medical history significant for end-stage renal disease on maintenance hemodialysis, chronic combined systolic and diastolic heart failure, ischemic heart disease, atrial fibrillation, type 2 diabetes with diabetic CKD, prior GI bleeding, and hypotension episodes.\n\nHospital course: Patient received supportive care including IV fluids and peripheral IV medication administration (procedure 3E1M39Z), targeted antibiotic therapy with doxycycline for presumed bacterial superinfection, inhaled corticosteroid therapy (fluticasone), analgesia/antipyretic as needed, and continuation of his outpatient cardiovascular and dialysis therapies. He underwent chest radiography showing bibasilar atelectasis without focal lobar consolidation. Hemodynamics stabilized after brief fluid resuscitation; no recurrent GI bleeding was identified. Cardiac rhythm remained atrial fibrillation, rate controlled on digoxin. Dialysis was continued per usual schedule during the stay.\n\nKey findings and procedures: CXR: atelectasis. Continued dependence on renal dialysis. Peripheral IV access established for medication/fluids (3E1M39Z). No acute surgical procedures required.\n\nDischarge condition and functional status: Patient is clinically stable, afebrile, and hemodynamically stable at discharge. Ambulates with steadying assistance and requires help with some activities of daily living; home health referral placed for assistance with ADLs, medication management, and post-discharge monitoring. Home health to monitor vital signs, respiratory status, access site for dialysis, and wound/skin integrity related to vascular access.\n\nMedications and follow-up plan: Continue home medications including doxycycline (complete course), fluticasone inhaler, digoxin, aspirin, calcium acetate and calcitriol for ESRD/mineral bone disease, stool softener PRN, acetaminophen PRN, and glucose gel for hypoglycemia as needed. Home health to assist with medication reconciliation. Follow-up with primary care within 3\u20135 days, nephrology within 7 days to coordinate dialysis, and cardiology in 1\u20132 weeks or sooner if symptoms worsen. Return to ED for fever, progressive dyspnea, chest pain, hypotension, or any signs of GI bleeding.", "diagnosis_codes": ["I739", "J9811", "K922", "Z7901", "Z794", "J069"], "suggested_codes": ["E1122", "I2510", "I4891", "N186", "I5043", "R55"], "accepted_codes": ["E1122", "I2510", "I4891", "N186"], "rejected_codes": ["I5043", "R55"], "date": "2024-09-20T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 28634240, "discharge_summary": "History of present illness: 50-year-old female admitted emergently for acute on chronic heart failure and worsening renal function in the setting of known hypertensive heart disease with chronic kidney disease and diabetes mellitus. She presented with progressive dyspnea, lower extremity edema, and reduced exertional tolerance. Hospital course: The patient was treated with diuresis (furosemide titrated to effect), rate control for atrial arrhythmias (metoprolol succinate optimized; digoxin continued for rate support), and close monitoring of renal function and electrolytes. Anemia related to chronic kidney disease was addressed with iron supplementation and cyanocobalamin. Acute kidney injury improved toward baseline with careful volume management and avoidance of nephrotoxins. Glucose was managed with scheduled insulin per sliding scale; hypoglycemia rescue agents (glucose gel, dextrose 50%, glucagon) were reviewed with patient/caregiver. No invasive cardiac procedures were performed during this admission. Key findings and procedures: Diagnostic evaluation confirmed acute on chronic diastolic (congestive) heart failure with paroxysmal atrial fibrillation/flutter. Labs notable for anemia of CKD and transient elevation in creatinine consistent with AKI on CKD that trended toward baseline with treatment. Echocardiography and telemetry supported rate-controlled arrhythmia without acute ischemic changes. Discharge condition and functional status: Patient is hemodynamically stable, euvolemic on oral diuretics, and ambulatory with a rollator/assistance for longer distances. Home health recommended for nursing follow-up for medication reconciliation, daily weight and edema assessment, and monitoring of blood pressure, heart rate, and blood glucose. Home health will also assist with education on fluid/salt restriction and recognition of decompensation (worsening dyspnea, orthopnea, rapid weight gain). Medications and follow-up plan: Discharge meds include furosemide, metoprolol succinate XL, digoxin, aspirin, insulin regimen, levothyroxine, pravastatin, fenofibrate, ferrous sulfate, cyanocobalamin, polyethylene glycol, senna as needed. Patient instructed to monitor daily weights and blood pressure; return precautions reviewed (weight gain >3 lb/24 hr, increasing dyspnea, lightheadedness). Follow-up with primary care within 7 days, cardiology and nephrology within 1\u20132 weeks for optimization of heart failure, rhythm management, anticoagulation consideration, and CKD care.", "diagnosis_codes": ["N189", "I4892", "I480", "E559", "I2721", "F419", "I5033", "N179", "E669", "E1122", "Z7901", "D631", "Z45018", "I130", "E785", "Z6832", "Z952"], "suggested_codes": ["E037", "Z791"], "accepted_codes": [], "rejected_codes": ["E037", "Z791"], "date": "2024-02-13T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 23159330, "discharge_summary": "History of present illness: 30-year-old G? at 19 weeks gestation (monochorionic/diamniotic twin pregnancy) presented to ED with acute onset right upper quadrant abdominal pain, nausea and vomiting. Imaging was consistent with cholelithiasis with acute cholecystitis. She was admitted emergently and managed medically and operatively.\n\nHospital course: Over a 2.7-day hospital stay the patient received IV fluids (0.9% NaCl, lactated Ringer), antiemetics (ondansetron), analgesia (morphine followed by oral oxycodone PRN), antibiotics (ampicillin\u2013sulbactam IV), stool regimen and DVT prophylaxis with enoxaparin. Maternal\u2013fetal medicine and general surgery consulted. She was taken to the OR for operative removal of the gallbladder (cholecystectomy) without intraoperative complications. Perioperative care included standard fetal monitoring as appropriate and continuation of her home thyroid replacement for hypothyroidism. No signs of preterm labor were noted; fetal heart tones were present and reassuring postoperatively.\n\nKey findings and procedures: Ultrasound demonstrated gallstones with sonographic features of acute cholecystitis. Procedure performed: cholecystectomy (ICD-10-PCS 0FT44ZZ). Pathology consistent with acute calculous cholecystitis. No intra-abdominal hemorrhage or bile leak identified.\n\nDischarge condition and functional status: Patient is medically stable at discharge, afebrile, tolerating oral intake, ambulating independently with mild activity limitation and pain controlled on oral regimen. She is able to perform basic ADLs but will benefit from short-term home health for incision care, administration of enoxaparin injections and medication reconciliation.\n\nMedications and follow-up: Discharge meds include acetaminophen scheduled, oxycodone IR short course PRN, docusate and polyethylene glycol for bowel regimen, oral antibiotic to complete the course (amoxicillin\u2013clavulanate or as directed by surgeon), potassium supplement PRN, and continuation of levothyroxine. Home health to assist with daily wound checks, enoxaparin administration, vital sign monitoring and education. Follow-up with general surgery in 7\u201310 days, maternal\u2013fetal medicine (MFM) within 7 days, and endocrinology/OB as outpatient. Return to ED for fever, increasing pain, wound erythema/drainage, vaginal bleeding, decreased fetal movement or signs of DVT.", "diagnosis_codes": ["O30032", "O99612", "Z3A19"], "suggested_codes": ["E039", "K810", "Z7901"], "accepted_codes": ["E039"], "rejected_codes": ["K810", "Z7901"], "date": "2024-07-23T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 29282866, "discharge_summary": "History of Present Illness: 88-year-old male admitted under observation for progressive erythema, swelling, and pain of the penis and groin for 3\u20134 days. Associated dysuria and urinary frequency. Past history notable for atrial fibrillation on chronic anticoagulation, prior prostate malignancy, intermittent urinary incontinence, hypertension, and insomnia. On admission noted acute delirium likely secondary to infection and acute illness.\n\nHospital Course: The patient was observed for 3.8 days. Initial evaluation demonstrated cellulitis of the corpus cavernosum and penis (primary diagnosis) with associated groin cellulitis and a urinary tract infection. He received intravenous antibiotics initially with clinical improvement and was transitioned to oral therapy. Delirium improved with treatment of infection and environmental measures; no sedating opioids were required. Rate control for atrial fibrillation was maintained on metoprolol; anticoagulation with warfarin was continued with INR monitoring. Influenza vaccine administered prior to discharge.\n\nKey Findings and Procedures: Physical exam notable for penile and inguinal erythema without fluctuance or necrosis. Labs showed mild transaminase elevation and leukocytosis which trended down with therapy. Urine studies consistent with UTI; blood cultures were negative. No surgical intervention required. Wound care performed with topical miconazole for associated dermatitis and daily local wound care.\n\nDischarge Condition and Functional Status: Patient discharged stable and afebrile, delirium largely resolved but requires supervision for safety and occasional cueing. Ambulates with a rolling walker and requires assistance with transfers and some ADLs; home health ordered for nursing support, wound care, medication reconciliation, and fall risk mitigation.\n\nMedications and Follow-up: Discharged on cephalexin and trimethoprim-sulfamethoxazole DS for continued antimicrobial coverage, miconazole 2% cream for local care, home warfarin with INR follow-up, losartan and metoprolol continued, ramelteon for sleep, and normal saline flush as needed per IV line policy. Follow-up arranged with primary care in 48\u201372 hours, urology in 1\u20132 weeks, and anticoagulation clinic for INR monitoring. Home health nursing referral placed for wound care, medication management, and safety evaluation.", "diagnosis_codes": ["N4822"], "suggested_codes": ["F05", "I4891", "N390", "L03319", "Z9181"], "accepted_codes": ["F05", "I4891", "N390"], "rejected_codes": ["L03319", "Z9181"], "date": "2024-02-16T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 23950874, "discharge_summary": "History of Present Illness: 42-year-old woman with morbid obesity (E66.01) and prior adjustable gastric band presented with progressive epigastric pain, increased reflux, and intolerance to oral intake. Imaging and clinical evaluation suggested band-related complication with associated peritoneal adhesions. She was admitted as a same-day surgical admission for operative management.\n\nHospital Course: Patient underwent laparoscopic removal of the adjustable gastric band and adhesiolysis. Intraoperative findings included dense peritoneal adhesions and partial band erosion; no bowel resection was required. Procedure codes included laparoscopic band removal and adhesiolysis; intra-abdominal drain was left in situ and removed prior to discharge when output was minimal. Postoperatively she was managed with multimodal analgesia (scheduled acetaminophen, gabapentin; short course oral hydromorphone for breakthrough pain; ketorolac as indicated), DVT prophylaxis with enoxaparin, famotidine for acid suppression, and glycemic management with insulin. Blood pressure control resumed with losartan and hydrochlorothiazide. No postoperative complications occurred. Vital signs and labs remained stable; patient tolerated advancing diet and ambulation with assistance.\n\nKey Findings and Procedures: Diagnostic imaging consistent with band complication; operative laparoscopic band removal and adhesiolysis performed without enteric injury. Pathology not required. Minimal blood loss; no transfusion.\n\nDischarge Condition and Functional Status: Patient is hemodynamically stable, afebrile, pain controlled on oral medications, ambulating with assistance and able to perform most ADLs independently but requires support with stair negotiation and wound care. Home health recommended for incision checks, medication administration support (including insulin teaching and glucose monitoring), and home safety/ambulation assistance.\n\nMedications and Follow-up: Discharge meds include oral acetaminophen, short course oral hydromorphone for breakthrough pain, ketorolac as indicated, gabapentin, famotidine, enoxaparin 40 mg SQ daily x7 days (DVT prophylaxis), resume losartan and HCTZ, and home insulin regimen with sliding scale adjustments. Follow-up with bariatric surgery clinic in 10\u201314 days, PCP in 7 days, endocrinology in 2 weeks, and sleep medicine/CPAP follow-up as outpatient. Return to ED for fevers, worsening abdominal pain, increasing incision erythema/drainage, leg swelling or shortness of breath.", "diagnosis_codes": ["G43709", "E6601", "M1990", "R110", "K9509", "E119", "G4733", "K219", "Y848", "I10", "Z6838", "K660", "E559", "E042", "K760"], "suggested_codes": [], "accepted_codes": [], "rejected_codes": [], "date": "2024-10-07T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 24379947, "discharge_summary": "History of Present Illness: 76-year-old female admitted under observation after a fall with neck pain and limited mobility. Imaging on arrival demonstrated an unspecified displaced fracture of the fourth cervical vertebra (C4, S12.300A) with associated displaced fracture of C5 (S12.400A) and an unspecified fracture of T5\u2013T6 (S22.059A). She also had symptoms consistent with a urinary tract infection and a prior history notable for gastrointestinal stromal tumor (GIST), chronic kidney disease, essential hypertension, spinal stenosis, gout, and orthostatic hypotension.\n\nHospital Course: During a 4.1-day observation stay the patient was managed nonoperatively with rigid cervical immobilization, analgesia (acetaminophen), fall precautions, bowel regimen, and DVT prophylaxis. She received targeted antibiotics for a urinary tract infection with clinical improvement and intravenous fluids as needed. Neurosurgery was consulted and recommended conservative management with cervical collar and close outpatient follow-up. Pain was controlled to a tolerable level and neurovascular exam remained stable without focal deficit.\n\nKey Findings & Procedures: CT and plain radiographs confirmed displaced fractures at C4 and C5 and compression-type fractures at T5\u2013T6. No acute spinal cord compression was identified. Consults: neurosurgery and physical therapy. DVT prophylaxis with heparin was administered while inpatient.\n\nDischarge Condition & Functional Status: Patient is medically stable for discharge to home but requires assistance with activities of daily living and is limited in cervical range of motion. She ambulates short distances with a rolling walker and requires caregiver assistance for transfers and toileting. Home health services arranged for skilled nursing visits and physical therapy to monitor mobility, pain control, medication administration, and fall-risk mitigation.\n\nMedications & Follow-up: Discharge medications include acetaminophen, allopurinol, colchicine, cyanocobalamin, ezetimibe, famotidine, folic acid, heparin (per discharge plan for DVT prophylaxis), multivitamin, Neutra-Phos, polyethylene glycol, and saline flush supplies. Follow-up: neurosurgery within 7 days, primary care within 7\u201310 days, nephrology within 4 weeks, and oncology/urology as outpatient for GIST/UTI care. Home health to coordinate medication reconciliation and progressive PT.", "diagnosis_codes": ["K219", "N390", "M4802", "Z7289", "W010XXA", "D696", "E785", "I951", "N189", "S12400A", "Y92008", "M109", "I10", "D539", "G629", "I129", "C49A0", "S12300A", "S22059A"], "suggested_codes": ["Z914"], "accepted_codes": [], "rejected_codes": ["Z914"], "date": "2024-07-21T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 24181545, "discharge_summary": "History of Present Illness: 51-year-old female admitted for elective left total knee arthroplasty for symptomatic unilateral primary osteoarthritis of the left knee (M17.12). Past medical history notable for obstructive sleep apnea, asthma, anxiety disorder, GERD, menstrual migraine, and tobacco use. She presented with progressive left knee pain and functional limitation refractory to conservative measures.\n\nHospital Course: Patient underwent left total knee arthroplasty (ICD-10-PCS 0SRD0J9) under general/spinal anesthesia without intraoperative complications. Postoperatively she required brief treatment for postprocedural hypotension that resolved with fluid bolus and monitoring. Pain was managed with multimodal analgesia (acetaminophen, gabapentin, scheduled tramadol and short-acting opioids as needed). DVT prophylaxis with enoxaparin was initiated. She had transient postoperative nausea controlled with ondansetron and scopolamine patch PRN. No respiratory events; CPAP use resumed overnight. Mild leukocytosis was observed and trended downward; no infectious source identified. Physical therapy began POD1; she progressed to ambulation with a rolling walker and demonstrated safe transfers with assistance.\n\nKey Findings/Procedures: Left total knee arthroplasty completed without complication. Postop X-rays satisfactory for implant position. Vitals stable at discharge. Labs notable for resolving leukocytosis. No surgical site infection, neurovascularly intact distal to the operative knee.\n\nDischarge Condition and Functional Status: Patient is medically stable for discharge. Ambulation: ambulating with a rolling walker, weight bearing as tolerated with assistance; requires home health PT for gait training and progressive strengthening. ADLs: requires assistance with household ambulation and some transfers; home health OT recommended for adaptive strategies and wound care instruction.\n\nMedications at Discharge (select): acetaminophen, tramadol, gabapentin, short course PRN hydromorphone, enoxaparin subcutaneous for DVT prophylaxis, albuterol inhaler PRN, omeprazole, clonazepam PRN, docusate/senna, HCTZ, magnesium oxide. Patient instructed on enoxaparin administration.\n\nFollow-up: Orthopedic clinic in 10\u201314 days for wound check/suture removal and postop assessment. PCP follow-up in 1\u20132 weeks for med reconciliation and optimization. Home health to provide PT/OT, wound checks, medication assistance, and vital sign monitoring with attention to orthostatic symptoms and wound status.", "diagnosis_codes": ["I9581", "F419", "M1712", "Z720", "G43829", "R0683", "D72829", "K219", "G4733", "R112"], "suggested_codes": ["J45909"], "accepted_codes": ["J45909"], "rejected_codes": [], "date": "2024-01-14T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 22034601, "discharge_summary": "History of Present Illness: 69-year-old male admitted under observation for acute kidney injury (AKI) with concurrent embolic disease and heart failure. He presented with oliguria, gross hematuria, progressive dyspnea, and anemia. Past medical history notable for congestive heart failure, hypertensive heart disease, benign prostatic hyperplasia, and prior bleeding risk.\n\nHospital Course: Patient observed for 7 days. Initial management focused on hemodynamic stabilization, volume optimization, and evaluation of hematuria. IV fluids and careful diuresis were titrated to balance renal perfusion and volume status. Apixaban was held on admission for active hematuria and resumed prior to discharge once bleeding source was controlled and urology concurred. A single packed red blood cell transfusion was administered for symptomatic posthemorrhagic anemia with improvement in hemodynamics. Foley catheterization was performed for urinary retention and hematuria management; catheter care and trial of void were performed before discharge. Renal function peaked during admission and subsequently improved with conservative measures; no dialysis was required. Evaluation included imaging consistent with pulmonary embolism without acute cor pulmonale; anticoagulation plan established. Cardiac status monitored and optimized with beta-blocker and guideline-directed heart failure therapy adjustments.\n\nKey Findings and Procedures: AKI (improving), pulmonary embolism (non\u2011acute cor pulmonale), acute posthemorrhagic anemia (transfused), bladder outlet obstruction with gross hematuria managed with Foley catheter, medication adjustments for congestive heart failure.\n\nDischarge Condition and Functional Status: Patient is clinically improved, hemodynamically stable, ambulatory with assistive devices for short distances, independent with most ADLs but requires assistance for medication management and home safety due to recent anemia and deconditioning. Home health recommended for skilled nursing and monitoring.\n\nMedications and Follow-up: Discharged with acetaminophen, apixaban, carvedilol, fexofenadine, lidocaine jelly, magnesium oxide, Neutra\u2011Phos, polyethylene glycol, ramelteon, sarna lotion, senna, normal saline flushes, sulfamethoxazole/trimethoprim DS, and tamsulosin. Follow-up: PCP within 3\u20135 days, nephrology 1 week, urology 1 week, cardiology 2 weeks, and home health to monitor vitals, weights, urine output, wound/catheter care, medication reconciliation, and labs (BMP/creatinine) as ordered.", "diagnosis_codes": ["R222", "N1330", "I428", "Z87891", "D62", "N179", "N323", "R310", "I5020", "N401", "R338", "R8271", "N320", "I110"], "suggested_codes": ["I2699", "Z510", "Z5181"], "accepted_codes": ["I2699"], "rejected_codes": ["Z510", "Z5181"], "date": "2024-06-27T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 27474788, "discharge_summary": "HPI: 32-year-old female admitted under observation for complications related to known malignant neoplasm of the right ovary with progressive malignant ascites and symptomatic decline. Prior history includes hysterectomy (acquired absence of cervix/uterus), essential hypertension, severe protein-calorie malnutrition, depression, and prior palliative care involvement. She was observed for management of ascites, symptomatic anemia/coagulopathy, pain, and optimization for discharge planning.\nHospital course: Patient remained in observation for 9.7 days. Diagnostic paracentesis with symptomatic large-volume ascites drainage was performed with clinical improvement in respiratory comfort and abdominal pain. Supportive care included intravenous fluids, antiemetics, short course dexamethasone for symptom control, electrolyte repletion (magnesium), and nutritional supplementation. Hemostasis was monitored given documented coagulation defect; transfusion was not required. Pain was managed primarily with acetaminophen and topical lidocaine; opioid-sparing measures prioritized. Anticoagulation was transitioned to apixaban on discharge for outpatient thrombosis prophylaxis per consult recommendations; inpatient enoxaparin/heparin were used for inpatient VTE prophylaxis and line flushes as indicated.\nKey findings/procedures: Imaging consistent with malignant ascites and known metastatic disease; paracentesis performed with symptomatic benefit. Labs notable for protein-calorie malnutrition and mild electrolyte abnormalities corrected prior to discharge. Multidisciplinary team included oncology, palliative care, nutrition, and social work.\nDischarge condition and functional status: Patient is hemodynamically stable, pain controlled on oral regimen, and ambulatory with assistance for transfers and ambulation. Requires home health skilled nursing for dressing/line care, medication administration oversight (apixaban), daily symptom monitoring, and assistance with ADLs and nutrition support.\nMedications and follow-up: Discharge medications include apixaban, acetaminophen as needed, dexamethasone short taper, famotidine, magnesium supplement, calcium carbonate, stool regimen (bisacodyl), multivitamin. Arrange home health nursing, oncology/palliative clinic follow-up within 7 days, primary care within 1\u20132 weeks, and outpatient labs (CBC, CMP, coagulation studies) prior to clinic visit. Patient/caregiver educated on signs of bleeding, worsening dyspnea/abdominal distension, and when to seek urgent care.", "diagnosis_codes": ["C561"], "suggested_codes": ["E43", "I10", "R180", "Z515", "Z90710", "C7889", "D6859", "F339"], "accepted_codes": ["E43", "I10", "R180", "Z515", "Z90710"], "rejected_codes": ["C7889", "D6859", "F339"], "date": "2024-08-20T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 29091191, "discharge_summary": "71-year-old female admitted to observation for 1.7 days for evaluation and management of acute constipation (K59.00) with concurrent urinary tract infection and multiple chronic comorbidities. History of present illness: patient presented with 3\u20135 days of decreased bowel movements, abdominal discomfort and bloating. She also reported dysuria and frequency. Past medical history notable for type 2 diabetes, hypothyroidism, hyperlipidemia, age-related osteoporosis, anxiety and insomnia. Patient had recent contact with COVID-19 but was asymptomatic for respiratory illness while inpatient.\n\nHospital course: initial evaluation included history and physical, point-of-care labs and urinalysis consistent with UTI. Supportive care and conservative bowel regimen were initiated. She received polyethylene glycol, senna and bisacodyl, and a saline enema with documented stool evacuation and symptom improvement. A single dose of ceftriaxone was given in the ED for presumed UTI; no parenteral antibiotic course was continued on discharge pending outpatient follow-up and culture results. Subcutaneous heparin was given for DVT prophylaxis while in facility. No imaging or invasive procedures were required.\n\nKey findings and procedures: positive urinalysis (pyuria) treated empirically; successful bowel disimpaction with enema and laxative regimen; vitals stable and pain controlled with acetaminophen as needed.\n\nDischarge condition and functional status: patient is medically stable, ambulatory with assistive device at baseline and independent with most activities of daily living but requests assistance with medication management and toileting at home. Home health referral placed for nursing visits to monitor bowel function, urinary symptoms, medication reconciliation, diabetes and thyroid medication monitoring, and fall-risk assessment.\n\nMedications and follow-up: continue home meds including levothyroxine, simvastatin, escitalopram, mirtazapine, ramelteon. Bowel regimen: polyethylene glycol daily, senna nightly, bisacodyl PRN, Fleet enema PRN, aluminum-magnesium hydroxide-simethicone for gas/indigestion PRN. Acetaminophen and ondansetron PRN. Heparin and ceftriaxone were administered inpatient only. Follow-up: primary care within 3\u20135 days, GI if constipation persists, PCP/urology for urine culture results and targeted antibiotics as indicated, and labs (BMP, TSH, A1c, lipid panel) as outpatient.", "diagnosis_codes": ["F419", "R195", "E119", "M810", "Z603", "G4700", "N390", "Z20822", "Z9181", "E785", "K5900", "E039"], "suggested_codes": ["Z751"], "accepted_codes": [], "rejected_codes": ["Z751"], "date": "2024-02-09T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 29764550, "discharge_summary": "Brief history of present illness: 29-year-old G?P? female at 38 weeks gestation presented urgently for premature rupture of membranes at term. She progressed to spontaneous vaginal delivery and sustained a second-degree perineal laceration requiring repair. Relevant comorbidities include hypothyroidism on chronic levothyroxine and antepartum anemia.\n\nHospital course: The patient had an uncomplicated labor and delivery. Membranes had ruptured prior to onset of labor (O42.92). She delivered a single live infant (Z37.0) without intrapartum complications. Perineal laceration was repaired in the delivery suite. Postpartum course was notable for mild anemia (D64.9/O99.02) monitored without transfusion; hemoglobin remained hemodynamically stable. Endocrine condition (E03.9) continued on home levothyroxine. Pain was controlled with multimodal therapy. No evidence of infection; afebrile throughout hospitalization. Length of stay 1.9 days; discharged in stable condition.\n\nKey findings and procedures: Physical exam post-delivery showed appropriate uterine involution and no excess vaginal bleeding. Perineal wound approximated after repair; no signs of infection. Procedures: spontaneous vaginal delivery with second-degree perineal laceration repair. Relevant orders included IV fluids (Lactated Ringers, 0.9% Sodium Chloride flushes) and routine postpartum monitoring.\n\nDischarge condition and functional status: Patient is medically stable, afebrile, hemodynamically stable. Ambulates with steady gait and transfers independently; requires intermittent assistance with perineal wound care and strenuous activities. Able to perform basic ADLs and provide newborn care with intermittent support; home health recommended for wound checks, vital sign monitoring, ambulation assistance as needed, and lactation support.\n\nMedications and follow-up: Discharged on levothyroxine (continue prior dose), acetaminophen and ibuprofen for analgesia, oxycodone IR PRN for severe breakthrough pain, docusate and bisacodyl/milk of magnesia for bowel regimen, calcium carbonate, simethicone, Dermoplast spray as topical perineal analgesic. Follow-up with obstetrics within 1 week for postpartum evaluation, routine 6-week postpartum visit, and endocrinology/primary care for thyroid management and anemia follow-up as outpatient labs. Home health arranged for 1\u20132 visits/week initially for wound care and lactation support.", "diagnosis_codes": ["O9902", "O3483", "D649", "Z370", "Z3A38", "O99284", "E039", "O701", "O4292"], "suggested_codes": [], "accepted_codes": [], "rejected_codes": [], "date": "2024-09-21T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 20303600, "discharge_summary": "Brief history of present illness: 45-year-old male presented emergently after acute onset of severe gastroenteritis with hypotension and loss of consciousness. On arrival he had a GCS of 3 (E1 V1 M1) and suffered a witnessed cardiac arrest; ACLS was performed with return of spontaneous circulation. Initial working diagnosis was sepsis secondary to Salmonella enteritis with associated infective myocarditis and acute systolic heart failure.\n\nHospital course: The patient was managed in the ICU for 11.7 days. He required hemodynamic support and close cardiac monitoring. Broad-spectrum antimicrobials were initiated and narrowed to ceftriaxone once cultures (stool/blood) grew Salmonella species sensitive to ceftriaxone. Cardiac evaluation (ECG, troponin, echocardiography) was consistent with myocarditis and reduced left ventricular systolic function; treatment included guideline-directed medical therapy with lisinopril and metoprolol succinate. Anticoagulation was used during hospitalization (heparin/enoxaparin) per institutional protocols. He received bowel regimen agents for opioid/constipation prophylaxis and supportive care including IV fluids and electrolyte management.\n\nKey findings and procedures: admission GCS 3 with successful resuscitation; clinical and laboratory evidence of sepsis (A41.9) and Salmonella enteritis (A02.0); echocardiogram showing acute systolic dysfunction consistent with myocarditis/cardiomyopathy. A peripherally inserted central catheter (PICC) was placed for prolonged IV antibiotic administration; Heparin flush protocol instituted. No further ischemic myocardial infarction was identified (code for acute coronary thrombosis without MI documented).\n\nDischarge condition and functional status: Patient is hemodynamically stable on room air, afebrile, and ambulatory with assistance due to deconditioning. Neurologic status has improved from arrival; he is awake and able to follow simple commands but requires supervision with activities of daily living and needs home physical therapy for gait and endurance training.\n\nMedications and follow-up: Discharge meds include ceftriaxone IV daily via home health PICC, lisinopril, metoprolol succinate XL, acetaminophen PRN, docusate, senna, folic acid, and enoxaparin per discharge instructions with monitoring. Home health to provide daily RN visits for PICC care/heparin flushes, IV antibiotic administration, vital sign monitoring, medication reconciliation, and PT evaluation. Follow-up with Infectious Diseases within 48\u201372 hours, Cardiology in 7 days, and Primary Care within 1 week.", "diagnosis_codes": ["A419"], "suggested_codes": ["A020", "I5021", "I409", "R4020", "Z7409", "Z952"], "accepted_codes": ["A020", "I5021"], "rejected_codes": ["I409", "R4020", "Z7409", "Z952"], "date": "2024-11-13T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 20830142, "discharge_summary": "Brief history of present illness: 64-year-old man admitted emergently with palpitations, progressive dyspnea, hypoxemia and altered mental status. Initial evaluation revealed paroxysmal atrial fibrillation with rapid ventricular response (primary diagnosis I48.0), acute hypoxic respiratory failure and shock. Past history notable for COPD, chronic peripheral vascular disease, hypertension, and alcohol dependence.\n\nHospital course: The patient required short-term invasive ventilatory support and hemodynamic support for shock. He was treated with rate control for atrial fibrillation, guideline-directed anticoagulation initiation, bronchodilator therapy and targeted treatment for alcohol withdrawal with benzodiazepine taper. Renal function was monitored; he experienced an acute kidney injury that stabilized with fluid optimization and avoidance of nephrotoxins. He improved clinically over a 10-day admission and was weaned from ventilatory support. Delirium resolved with supportive care.\n\nKey findings and procedures: Admission labs and imaging confirmed acute respiratory failure, elevated lactate during initial shock, and acute kidney injury. Procedures performed included endotracheal intubation with mechanical ventilatory management (ICD-10-PCS 5A1935Z) and ventilator assistance/management procedures (5A2204Z). Relevant diagnoses on discharge: paroxysmal atrial fibrillation (I48.0), acute respiratory failure (J96.00), shock (R57.9), acute kidney injury (N17.9), alcohol withdrawal with delirium (F10.231), COPD (J44.9), hypertension (I10), peripheral vascular disease (I73.9). Restraints were used briefly for safety (Z78.1).\n\nDischarge condition and functional status: Patient is hemodynamically stable, alert, and ambulatory with assistance due to deconditioning. He requires support with activities of daily living initially and has reduced exercise tolerance; home health nursing and physical therapy are arranged for assistance with medication management, mobility training, and monitoring.\n\nMedications and follow-up: Discharged on rate control (metoprolol), oral anticoagulation (apixaban), inhaled bronchodilators (ipratropium/albuterol and tiotropium), short prednisone taper as indicated, and thiamine/multivitamin for alcohol use disorder. Avoid nephrotoxins; renal labs to be checked. Follow-up: cardiology in 1 week (consider echo and rhythm strategy), primary care/nurse visit in 48\u201372 hours, pulmonary follow-up and home oxygen evaluation as needed, nephrology if creatinine not normalized. Home health to monitor vitals, weights, medication adherence and wound/IV needs.", "diagnosis_codes": ["J9600", "R579", "I480", "Z781", "I739", "N179", "I10", "F10231", "Z95820", "J449"], "suggested_codes": ["R412", "Z9189"], "accepted_codes": [], "rejected_codes": ["R412", "Z9189"], "date": "2024-06-28T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 21904622, "discharge_summary": "History of Present Illness: 57-year-old female with relapsed multiple myeloma (C90.02) admitted under observation for evaluation of weakness, recurrent falls and syncope. She has known osseous metastatic disease, prior TIA history, hypertension, hypothyroidism, GERD and hyperlipidemia. Presenting issues included lightheadedness and decreased functional mobility over several days.\n\nHospital Course: Patient observed 3.8 days. Workup included orthostatic vitals, ECG, basic metabolic panel and CBC to evaluate syncope and volume status. Orthostatic hypotension and deconditioning were identified as contributors to syncope with no acute intracranial or cardiac ischemia. Pain and mobility addressed with analgesics, topical agents and physical therapy. Bowel regimen optimized for opioid- and opioid-sparing constipation. No acute intervention for myeloma required during observation; oncology notified and outpatient therapy planned.\n\nKey Findings and Procedures: Notable diagnoses include relapsed multiple myeloma with secondary malignant bone disease, syncope/collapses with orthostatic component, history of TIA, recurrent falls, GERD, HTN, hypothyroidism and osteoarthritis. Procedure recorded: 00JU3ZZ performed during admission as indicated (operative note on chart). Labs showed no acute electrolyte derangement requiring inpatient treatment. Fall-risk assessment positive; PT evaluated and provided gait training.\n\nDischarge Condition and Functional Status: Patient is afebrile, hemodynamically stable and medically optimized for discharge. Functionally she is deconditioned with limited endurance and requires assistance for ambulation (uses rolling walker) and 1-person assist for some ADLs. Home health recommended for nursing oversight, medication management, fall prevention and skilled PT/OT to address mobility and transfers.\n\nMedications and Follow-up: Discharged with home medications including levothyroxine, acyclovir, aspirin, calcium carbonate, famotidine, escitalopram, ezetimibe, lactulose, docusate, acetaminophen, topical diclofenac, lidocaine 2% and fluticasone nasal; lorazepam PRN for anxiety as previously prescribed. Patient instructed to monitor for syncope, new neurologic deficits, fever, bleeding or uncontrolled pain. Follow-up arranged with outpatient oncology within 7 days, PCP within 1\u20132 weeks, and specialty follow-up (cardiology/neurology) as indicated. Home health to initiate visit within 48 hours of discharge.", "diagnosis_codes": ["C9002"], "suggested_codes": ["E039", "E785", "I10", "K219", "M1990", "R55", "I639", "I951", "M810", "Z7401", "Z9181", "Z9189"], "accepted_codes": ["E039", "E785", "I10", "K219", "M1990", "R55"], "rejected_codes": ["I639", "I951", "M810", "Z7401", "Z9181", "Z9189"], "date": "2024-04-13T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 24415613, "discharge_summary": "72-year-old male admitted emergently with a 3-day history of fever, right upper quadrant pain, jaundice and progressive anorexia. Initial evaluation notable for fever to 38.6\u00b0C, leukocytosis, cholestatic pattern on liver function tests, and acute kidney injury (AKI) with rising creatinine. Clinical picture was most consistent with acute cholangitis secondary to obstructing gallstone disease. Relevant past history includes type 2 diabetes, hypertension, nicotine dependence, and fatty liver disease.\n\nHospital course: Patient was stabilized with IV fluids and broad-spectrum antibiotics (ceftriaxone plus metronidazole). He received blood glucose management with insulin and dextrose as needed. Renal function responded to resuscitation but did not fully return to baseline. Interventional GI performed endoscopic retrograde cholangiopancreatography (ERCP) with biliary sphincterotomy and stent placement for decompression; procedure noted resolution of obstruction. Pain and nausea were controlled with acetaminophen and ondansetron. No operative cholecystectomy was performed during this admission.\n\nKey findings and procedures: cholestatic LFT elevation consistent with obstructive pattern; AKI secondary to sepsis/volume depletion; ERCP with biliary decompression and stent placement. Blood cultures remained negative/without persistent bacteremia. Imaging confirmed choledocholithiasis without frank hepatic abscess.\n\nDischarge condition and functional status: At discharge the patient is afebrile, hemodynamically stable, tolerating a general diet, and ambulatory with minimal assistance due to deconditioning. Renal function is improving but requires outpatient monitoring. Home health nursing is arranged for IV antibiotic administration, monitoring of renal function and wound/stent care, and assistance with activities of daily living during continued recovery.\n\nMedications and follow-up: Discharge meds include IV ceftriaxone (to complete planned course via home health), metronidazole, insulin regimen as previously adjusted, losartan resumed, acetaminophen PRN, ondansetron PRN, senna and simethicone as needed. Follow-up: GI/hepatobiliary clinic in 1\u20132 weeks for stent review and plan for elective cholecystectomy; primary care within 48\u201372 hours for BMP and LFTs; labs repeated twice weekly until renal function stabilizes. Return precautions reviewed.", "diagnosis_codes": ["K8309"], "suggested_codes": ["E119", "I10", "K760", "N179", "F17210", "K8059"], "accepted_codes": ["E119", "I10", "K760", "N179"], "rejected_codes": ["F17210", "K8059"], "date": "2024-11-29T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 27946246, "discharge_summary": "History of Present Illness: 72-year-old female with symptomatic high-grade right internal carotid artery stenosis (I65.21) admitted as a same-day surgical patient for definitive revascularization. Past medical history notable for essential hypertension, hyperlipidemia, hypothyroidism, peripheral vascular disease, prior nicotine dependence, and presence of an artificial hip joint.\n\nHospital Course: The patient underwent right carotid surgical intervention without intraoperative complication. Perioperative management included IV heparinization and blood pressure control. Postoperatively she was monitored in the surgical observation unit with serial neurologic checks and hemodynamic monitoring. There were no new focal neurologic deficits; vitals remained stable and pain was controlled with short-course opioid and acetaminophen as needed. DVT prophylaxis and bowel regimen were instituted. Influenza high-dose vaccine administered prior to discharge.\n\nKey Findings and Procedures: Preoperative imaging confirmed significant right carotid occlusive disease. She received operative extirpation/endarterectomy of the right carotid lesion with intraoperative shunt placement and repair. Estimated blood loss was minimal. No perioperative stroke, myocardial ischemia, wound hematoma, or cranial nerve deficits were identified.\n\nDischarge Condition and Functional Status: Patient is hemodynamically stable and neurologically intact at discharge. Ambulates with a rolling walker and requires minimal assistance for transfers; independent with light ADLs but requires home health assistance for wound care and initial mobility/safety evaluation. Home health to monitor incision, neuro status, blood pressure, and medication adherence.\n\nMedications and Follow-up: Discharge medications include aspirin (antiplatelet) daily, atorvastatin daily, levothyroxine daily, acetaminophen PRN, short-course oxycodone PRN for breakthrough pain, docusate for bowel regimen. Continue home antihypertensive regimen; adjust per outpatient follow-up. Discontinue inpatient IV agents. \n\nFollow-up: Vascular surgery clinic in 7\u201314 days for wound check and duplex as indicated; primary care within 7 days for medication reconciliation and BP management. Home health to begin within 48 hours for wound care, neuro/vital sign monitoring, medication reconciliation, and PT for gait/ADL training.", "diagnosis_codes": ["I6521"], "suggested_codes": ["E039", "E785", "I10", "I739", "Z87891", "Z23", "Z7409", "Z7901", "Z79899", "Z96641"], "accepted_codes": ["E039", "E785", "I10", "I739", "Z87891"], "rejected_codes": ["Z23", "Z7409", "Z7901", "Z79899", "Z96641"], "date": "2024-04-10T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 26274235, "discharge_summary": "History of Present Illness: 29-year-old female with morbid obesity (BMI 40\u201344.9) admitted as a same-day surgical patient for a planned procedure. Comorbidities include adult asthma (unspecified, uncomplicated), benign intracranial hypertension (pseudotumor cerebri), iron deficiency anemia, and sickle-cell trait. She presented in stable condition without acute cardiopulmonary compromise. Procedure performed: surgical intervention documented by ICD-10-PCS 0DB64Z3. Perioperative antibiotics (cefazolin) and standard prophylaxis were administered.\n\nHospital Course: The patient tolerated the procedure well without intraoperative complications. Postoperative course was notable for adequate pain control with multimodal analgesia (IV acetaminophen, ketorolac, gabapentin, short course of IV opioids PRN), antiemetics as needed (ondansetron, prochlorperazine), and bronchodilator therapy for baseline asthma (albuterol PRN). VTE prophylaxis (enoxaparin) was given per protocol. Hemodynamically stable throughout hospitalization, afebrile, and ambulatory with assistance the day of discharge. No neurologic decline was noted with preexisting benign intracranial hypertension; neurology follow-up arranged.\n\nKey Findings and Procedures: Pre- and postoperative assessments were unremarkable for acute bleeding or infection. Procedure per 0DB64Z3 completed without complication. Perioperative labs notable for chronic iron deficiency anemia history; no transfusion required. Sickle-cell trait reviewed; no vaso-occlusive issues occurred.\n\nDischarge Condition and Functional Status: Patient discharged in stable condition. Ambulation: ambulatory with occasional assistance for stairs/longer distances; able to perform light ADLs independently but requires support for wound checks and medication administration. Home health services arranged for skilled nursing visits to provide wound assessment, medication administration (including subcutaneous enoxaparin if continued), vital sign monitoring, and assistance with mobility as needed.\n\nMedications and Follow-up: Discharge medications include oral acetaminophen, gabapentin, amitriptyline as prescribed, albuterol inhaler PRN, famotidine, and a short course of antibiotics as indicated. Continue home VTE prophylaxis per surgical plan if prescribed. Follow-up: surgical clinic in 7\u201314 days, PCP in 7 days, and neurology/ophthalmology for intracranial hypertension within 2 weeks. Return precautions reviewed; patient and family verbalized understanding.", "diagnosis_codes": ["D509", "Z6841", "E6601", "G932", "J45909", "D573"], "suggested_codes": [], "accepted_codes": [], "rejected_codes": [], "date": "2024-04-10T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 29014086, "discharge_summary": "Patient: 85-year-old female. Admission: Emergency admission for symptomatic anemia secondary to warm autoimmune hemolytic anemia (D59.11) in the setting of chronic lymphocytic leukemia. Length of stay: 5.6 days.\n\nHistory of present illness: Patient presented with progressive weakness, dyspnea on exertion, and dark urine. Evaluation revealed severe anemia with hemolytic indices consistent with warm AIHA (positive direct antiglobulin test IgG, elevated LDH, indirect bilirubin, reticulocytosis). Acute kidney injury and chronic comorbidities (CLL, essential hypertension, mitral valve disease, prior skin and thyroid malignancies, postprocedural hypothyroidism) were addressed during hospitalization.\n\nHospital course: Patient was treated with high-dose oral prednisone for warm AIHA with plan for outpatient taper. Supportive care included IV fluids, folic acid supplementation, VTE prophylaxis with heparin while inpatient, and close monitoring of hemoglobin, renal function, and hemolysis labs. Hemoglobin responded modestly to steroids; no transfusion required. Renal function improved toward baseline with hydration but remains monitored given acute kidney injury. No invasive procedures were performed. Vitals remained stable; no bleeding, thrombotic events, or infectious complications occurred.\n\nKey findings and procedures: Positive DAT (IgG), elevated LDH and indirect bilirubin, reticulocytosis, acute kidney injury that partially resolved. No dialysis required. No operative procedures.\n\nDischarge condition and functional status: Patient is medically stable for discharge home with home health services. Mobility: ambulatory with a rollator and requires assistance with transfers due to deconditioning and intermittent vertigo; fall risk precautions in place. Home health to provide medication administration assistance, weekly vital sign checks, and support with ADLs and safety assessment.\n\nMedications and follow-up: Discharged on prednisone (steroid taper), folic acid, levothyroxine, lisinopril, amlodipine, hydrochlorothiazide, aspirin, acetaminophen, ramelteon, senna, vitamin D3, artificial tears, heparin (per plan for VTE prophylaxis if continued), and sodium chloride flush supplies as needed. Follow-up: hematology within 1 week for AIHA/CLL management and steroid plan; PCP within 1 week; nephrology in 2 weeks or sooner if renal labs worsen. Labs: CBC and CMP twice weekly initially, then weekly; LDH, bilirubin, and repeat DAT as outpatient. Return precautions and clinic contacts provided.", "diagnosis_codes": ["D5911"], "suggested_codes": ["C9110", "I10", "N179", "E039", "I340", "Z9181"], "accepted_codes": ["C9110", "I10", "N179"], "rejected_codes": ["E039", "I340", "Z9181"], "date": "2024-06-04T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 25907959, "discharge_summary": "Brief history of present illness: 63-year-old male with known asthma, chronic systolic heart failure, hypertension, type 2 diabetes, hyperlipidemia and prior nicotine dependence presented to the ED with 3 days of progressive dyspnea, wheezing, cough and decreased exercise tolerance. He was hypoxemic on arrival and admitted to observation for treatment of an acute asthma exacerbation with concurrent fluid overload from heart failure.\n\nHospital course: Over a 2.8-day observation stay the patient received frequent nebulized albuterol, scheduled inhaled therapy, systemic corticosteroids, and short course of inhaled combination fluticasone-salmeterol on discharge regimen. IV furosemide was administered with diuresis and clinical improvement in volume status. Oxygen supplementation was used initially and weaned as tolerated. Cardiac medications (carvedilol, hydralazine) were continued/adjusted and diabetes medications were maintained; blood glucose remained stable on oral agents. No evidence of focal pneumonia on chest radiograph; no invasive procedures were required.\n\nKey findings and procedures: exam notable for bilateral wheeze and mild crackles that improved with therapy. Chest radiograph consistent with cardiopulmonary chronic change without focal consolidation. Hypoxemia resolved to acceptable saturations at rest off continuous oxygen; brief nocturnal or exertional oxygen needs will be reassessed by home health. Treatments performed: nebulized bronchodilators, systemic steroids, IV diuresis.\n\nDischarge condition and functional status: Patient discharged to home in clinically stable condition with improved respiratory status and euvolemia. Ambulatory with a walker/assistance for greater distances; limited exercise tolerance and requires assistance with some ADLs \u2014 home health nursing and respiratory therapy arranged for support and monitoring.\n\nMedications and follow-up: Discharged on albuterol nebulizer and inhaler, fluticasone-salmeterol inhaler, cetirizine as needed, furosemide, carvedilol, hydralazine, atorvastatin, diabetic agents (oral), benzonatate for cough, and supportive glucometabolic supplies. Home health to provide wound/medication reconciliation, inhaler education, pulse oximetry monitoring and oxygen evaluation. Follow-up: PCP in 3\u20135 days, pulmonology in 1\u20132 weeks, cardiology as outpatient in 1\u20132 weeks or sooner for worsening dyspnea.", "diagnosis_codes": ["J45901"], "suggested_codes": ["E119", "E785", "F17200", "I10", "I5022"], "accepted_codes": ["E119", "E785"], "rejected_codes": ["F17200", "I10", "I5022"], "date": "2024-01-20T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 28547562, "discharge_summary": "History of present illness: 51-year-old woman with biopsy-proven intraductal carcinoma in situ (DCIS) of the right breast (ICD-10 D05.11) presented as a same-day surgical admission for definitive surgical management. She has a family history of breast and digestive malignancies (Z80.3, Z80.0).\n\nHospital course: The patient underwent right breast partial mastectomy (lumpectomy) with sentinel lymph node evaluation under general anesthesia. Perioperative cefazolin was administered for prophylaxis and intraoperative course was uncomplicated. Postoperatively she required short-course IV analgesia (hydromorphone) and antiemetics (ondansetron, metoclopramide) for nausea; these were transitioned to oral agents. She received routine DVT prophylaxis with subcutaneous heparin and was given the influenza vaccine prior to discharge. Oral bowel regimen (docusate, polyethylene glycol, bisacodyl as needed) was started to prevent opioid-induced constipation. Wounds were clean, dry, and intact; surgical specimens were submitted for final pathology.\n\nKey findings and procedures: Partial mastectomy of the right breast with sentinel node sampling performed without intraoperative complications. No immediate evidence of hematoma or wound infection. Sentinel nodes sent for pathology. Final pathologic report pending and patient informed regarding expected timeframe for results and further adjuvant therapy discussion.\n\nDischarge condition and functional status: Patient discharged in stable condition on postoperative day 4.5. Pain controlled on oral medication (oxycodone IR plus acetaminophen/NSAID as tolerated). Ambulating independently with mild activity restrictions (no heavy lifting >10\u201315 lb for 4\u20136 weeks). Independent with most activities of daily living but requires assistance with dressing changes and incision monitoring.\n\nHome health and follow-up plan: Home health nursing arranged for wound care/dressing changes, incision assessment, reinforcement of activity restrictions, medication administration counseling, and monitoring for signs of infection or venous thromboembolism. Prescriptions: acetaminophen, oxycodone IR (short course), ibuprofen as tolerated, docusate, polyethylene glycol, bisacodyl PRN, ondansetron PRN, metoclopramide PRN. Outpatient surgical oncology clinic follow-up in 7\u201314 days for wound check and review of final pathology; referral to medical/radiation oncology as indicated after pathology review and tumor board discussion.", "diagnosis_codes": ["D0511"], "suggested_codes": ["Z800", "Z803"], "accepted_codes": ["Z800", "Z803"], "rejected_codes": [], "date": "2024-11-05T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 24922893, "discharge_summary": "46-year-old male admitted emergently with acute chest pain and dyspnea and found to have Non-ST elevation myocardial infarction (NSTEMI). Past history significant for hypertensive heart disease with systolic heart failure, type 1 diabetes mellitus with hyperglycemia, nicotine dependence, and prior cerebrovascular disease. On presentation he was hemodynamically stable but developed acute kidney injury and transient toxic encephalopathy/delirium in the setting of hypovolemia and hyperglycemia. Influenza vaccine was administered during admission.\n\nHospital course: The patient underwent cardiac evaluation with left heart catheterization and coronary intervention as indicated; he was treated medically with antiplatelet therapy and guideline-directed medical therapy for ischemic cardiomyopathy. Acute systolic heart failure exacerbation was managed with diuretics and optimization of beta-blocker and ACE inhibitor when tolerated. AKI improved with judicious fluid management and avoidance of nephrotoxins; dialysis was not required. Delirium resolved with correction of metabolic abnormalities, reorientation, and withdrawal of offending agents. Glycemic control was achieved with insulin; discharge regimen simplified for home management. Smoking cessation counseling was provided.\n\nKey findings/procedures: Elevated troponin consistent with NSTEMI, reduced left ventricular systolic function on imaging, transient acute kidney injury, toxic metabolic encephalopathy that resolved. Procedures included diagnostic coronary angiography with intervention, vascular access placement, and standard inpatient supportive procedures.\n\nDischarge condition and functional status: He is medically stable for discharge, mentating appropriately, and ambulatory with minimal assistance. Residual exertional dyspnea and mild deconditioning warrant home support. Home health services are arranged for medication reconciliation, daily weight and edema checks, vital signs including orthostatics, wound/vascular access checks as needed, insulin administration assistance and glucose monitoring, and coordination of outpatient labs (including INR monitoring while on warfarin).\n\nMedications and follow-up: Discharged on aspirin, clopidogrel, metoprolol tartrate, lisinopril, rosuvastatin, insulin regimen, citalopram, and warfarin. Arrange cardiology follow-up within 7 days, primary care within 3\u20137 days, and nephrology as outpatient if creatinine not normalized. Home health to reinforce discharge instructions and return precautions (worsening chest pain, dyspnea, syncope, fever, or confusion).", "diagnosis_codes": ["I214"], "suggested_codes": ["E1065", "F05", "F17210", "I110", "N179", "I5022", "Z8673"], "accepted_codes": ["E1065", "F05", "F17210", "I110", "N179"], "rejected_codes": ["I5022", "Z8673"], "date": "2024-11-21T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 28007762, "discharge_summary": "65-year-old male admitted directly through the ED for pancytopenia in the setting of recent antineoplastic chemotherapy (primary: D61.810). He presented with fever, progressive dyspnea and hypoxia and tested positive for SARS-CoV-2. Initial course was complicated by acute hypoxic respiratory failure, aspiration pneumonitis, acute pulmonary edema, and superimposed COVID-19 pneumonia. Past medical history notable for diffuse large B-cell lymphoma, prior melanoma, ischemic heart disease, and benign prostatic hyperplasia.\n\nHospital course: Patient required supplemental oxygen and frequent nebulized bronchodilator therapy early in admission; he improved with diuresis for pulmonary edema and targeted pulmonary care. He received blood product support (packed RBCs and platelets) for symptomatic anemia/thrombocytopenia and broad-spectrum antibiotics while aspiration pneumonitis and bacterial superinfection were excluded/treated. SIADH was identified and managed with fluid restriction and close electrolyte monitoring. VTE prophylaxis with enoxaparin was provided while inpatient. He was monitored closely by hematology/oncology and cardiology during the admission. Over a 17.9-day stay the patient\u2019s respiratory status and hemodynamics stabilized and cytopenias trended toward recovery.\n\nKey findings/procedures: pancytopenia secondary to chemotherapy, acute hypoxic respiratory failure, COVID-19 pneumonia, aspiration pneumonitis, acute pulmonary edema. Procedures included blood product transfusion(s) and supportive respiratory therapies.\n\nDischarge condition and functional status: Patient is discharged hemodynamically stable and afebrile. Respiratory status improved to low supplemental oxygen requirement at rest (weaned to room air during ambulation); ambulates with minimal assistance and requires short-term help with medication management and ADLs. Home health will assist with neutropenic precautions, respiratory treatments, and activity progression.\n\nMedications and follow-up: Discharge meds include acetaminophen PRN, acetylcysteine nebulizer, albuterol and ipratropium-albuterol nebulizers, guaifenesin-dextromethorphan PRN, benzonatate PRN, aspirin 81 mg daily, clopidogrel 75 mg daily, atorvastatin, buspirone, finasteride. Enoxaparin was inpatient only. Labs: CBC twice weekly until hematology follow-up. Follow-up: Hematology/Oncology within 3\u20135 days, PCP in 48\u201372 hours, Cardiology 1\u20132 weeks, and return precautions for fever, worsening dyspnea, bleeding, or falls.", "diagnosis_codes": ["D61810"], "suggested_codes": ["J690", "N400", "C831", "D0390", "E220", "I5019", "J121", "J9600", "Z5111", "Z5112", "Z951"], "accepted_codes": ["J690", "N400"], "rejected_codes": ["C831", "D0390", "E220", "I5019", "J121", "J9600", "Z5111", "Z5112", "Z951"], "date": "2024-09-08T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 23724428, "discharge_summary": "57-year-old female admitted under observation status for 4.8 days with acute kidney failure with tubular necrosis (ATN). She presented with oliguria and progressive creatinine elevation after an apparent hypoperfusion/thermal injury event; history notable for third-degree burn of the left shoulder, known ischemic heart disease, systolic heart failure, chronic kidney disease, COPD, hypothyroidism, and hereditary hemolytic anemia. Initial evaluation demonstrated elevated BUN/creatinine, metabolic derangement requiring fluid management, and wound injury to the left shoulder requiring local debridement and dressing changes.\n\nHospital course: Patient was managed conservatively with hemodynamic optimization, intravenous isotonic fluids initially, temporary avoidance of nephrotoxins and ACE/ARB, nephrology consultation, and close monitoring of electrolytes and urine output. Diuresis was employed judiciously to manage volume status in the setting of congestive heart failure. Wound care included local debridement and daily dressing with topical nystatin cream as indicated and consultation with burn/ wound services. Respiratory status was supported with bronchodilator therapy (albuterol neb and inhaler) and continuation of inhaled fluticasone-salmeterol for COPD. Pain controlled with short-course oxycodone PRN plus acetaminophen. No dialysis required; renal function showed partial recovery prior to discharge.\n\nKey findings/procedures: Elevated BUN/creatinine consistent with ATN, negative indications for immediate renal replacement therapy, wound debridement of left shoulder burn, cardiology and nephrology consultations performed.\n\nDischarge condition and functional status: Hemodynamically stable, ambulatory with assistance, able to perform most ADLs with intermittent help. Requires home health for daily wound dressing changes, medication management, and monitoring of vitals/weights and urine output.\n\nMedications and follow-up: Discharge meds include continuing home therapies \u2014 metoprolol succinate, atorvastatin, clopidogrel, levothyroxine, fluticasone-salmeterol, albuterol inhaler/neb, ferrous sulfate, folic acid, omeprazole, stool softener/ polyethylene glycol, topical nystatin, acetaminophen and oxycodone PRN. ACEi/ARB were held during AKI and will be reassessed. Labs (BMP) within 48\u201372 hours and nephrology follow-up within 1 week. Cardiology follow-up in 2 weeks and primary care in 3\u20135 days. Avoid NSAIDs and other nephrotoxins.", "diagnosis_codes": ["N170"], "suggested_codes": ["D589", "E039", "I2510", "J449", "N189", "I5022", "T31121A"], "accepted_codes": ["D589", "E039", "I2510", "J449", "N189"], "rejected_codes": ["I5022", "T31121A"], "date": "2024-05-29T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 24403784, "discharge_summary": "HPI: 54-year-old male admitted to observation for 3.9 days with acute onset of profuse diarrhea, abdominal pain and vomiting. Symptoms began after recent outpatient procedure and recent antibiotic exposure. Past medical history notable for chronic diastolic heart failure, seizure disorder, bipolar disorder, anxiety, history of substance use, and chronic pain. Primary admitting diagnosis was toxic gastroenteritis and colitis (K52.1). Secondary concerns included wound infection after procedure and adverse antibiotic reaction.\n\nHospital course: Patient was managed with intravenous fluids, electrolyte repletion, bowel rest and targeted antimicrobial therapy (levofloxacin and metronidazole). He received symptomatic treatment with antiemetics, antacids, and short-term opioid analgesia for severe pain. Diuresis was adjusted (furosemide) for volume status monitoring due to underlying diastolic CHF. Heparin prophylaxis was given while inpatient. Seizure meds (lamotrigine) and home psychiatric meds were continued; sedative-hypnotics and anxiolytics were reconciled on discharge. Wound was evaluated by surgery; cultures were obtained and topical/local care initiated. Patient improved clinically with decreased stool frequency, resolved vomiting, stable hemodynamics, and normalized basic electrolytes prior to discharge.\n\nKey findings/procedures: IV fluids and electrolyte repletion; stool studies and wound cultures sent; no radiographic evidence of acute surgical abdomen; wound debridement not required inpatient. Cardiac monitoring showed no acute ischemia; diastolic CHF managed medically.\n\nDischarge condition and functional status: Patient is medically stable for discharge in improved condition. Ambulates with supervision due to deconditioning and intermittent lightheadedness; requires assistance with daily activities initially and dressing/wound care. Home health services arranged for nursing wound care, medication administration review, and physical therapy to address deconditioning and safe ambulation.\n\nMedications and follow-up: Discharged on home regimen including furosemide, metoprolol tartrate, lamotrigine, trazodone, zolpidem (as needed), acetaminophen, antacid (aluminum-magnesium hydroxide-simethicone), aspirin, and short course oxycodone PRN. Levofloxacin and metronidazole completed/adjusted per ID recommendations. Follow-up with primary care within 3\u20135 days, GI in 1\u20132 weeks, cardiology in 1\u20132 weeks, and home health nursing in 24\u201348 hours.", "diagnosis_codes": ["F419", "G40909", "F1010", "K521", "T814XXA", "G8929", "T8131XA", "F1110", "Z981", "F319", "M545", "Z952", "M25572", "Z8619", "F1410", "I5032", "T368X5A", "F1510"], "suggested_codes": ["R42", "Z5189", "Z7401", "Z79891"], "accepted_codes": [], "rejected_codes": ["R42", "Z5189", "Z7401", "Z79891"], "date": "2024-09-03T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 26849256, "discharge_summary": "History of Present Illness: 48-year-old male admitted under observation for acute left lower quadrant abdominal pain, fever, and leukocytosis. CT abdomen/pelvis with IV contrast on admission demonstrated sigmoid diverticulitis with pericolic inflammatory change without abscess or free air. Past medical history notable for hyperlipidemia and active tobacco use.\n\nHospital Course: Patient observed for 3 days. He was managed nonoperatively with bowel rest initially, IV fluids (0.9% NaCl, D5 1/2 NS as indicated), IV antibiotics (ciprofloxacin and metronidazole), analgesia (acetaminophen, intermittent hydromorphone for severe pain), stool softener (docusate), and DVT prophylaxis with subcutaneous heparin. Vital signs and pain improved; WBC downtrended and he remained afebrile for 48 hours. Diet was advanced to clear liquids then a low-residue diet, which he tolerated. No interventional procedures or surgery were required.\n\nKey Findings and Procedures: CT confirmed uncomplicated diverticulitis (no perforation, abscess, or obstruction). No percutaneous drainage or operative intervention performed. Laboratory trend notable for resolving leukocytosis; BMP remained stable; electrolytes and potassium repleted as needed.\n\nDischarge Condition and Functional Status: Patient is discharged in improved and stable condition, afebrile, hemodynamically stable, and able to tolerate oral intake. Ambulates independently without assistive device and performs basic activities of daily living at baseline. Home health referral requested for nursing follow-up to assist with medication reconciliation, education on diet progression, symptom monitoring, and smoking cessation counseling.\n\nMedications and Follow-up Plan: Discharge medications include oral ciprofloxacin and metronidazole to complete a total prescribed antibiotic course, acetaminophen PRN for pain, docusate sodium daily, and potassium supplementation if indicated. Heparin and IV fluids discontinued. Follow-up arranged with primary care within 3\u20137 days and colorectal surgery or gastroenterology in 4\u20136 weeks for outpatient evaluation and planning for colonoscopy after resolution. Patient instructed to return earlier for recurrent fever, worsening abdominal pain, emesis, or inability to tolerate oral intake.\n\nPrimary diagnosis: uncomplicated diverticulitis (K57.92). Additional diagnoses: hyperlipidemia, tobacco use.", "diagnosis_codes": ["E785", "K5792", "Z720"], "suggested_codes": [], "accepted_codes": [], "rejected_codes": [], "date": "2024-11-08T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 21164608, "discharge_summary": "Brief HPI: The patient is a 59-year-old male admitted for observation for acute exacerbation of chronic sialadenitis with obstructing submandibular sialolith. He presented with submandibular pain and swelling, odynophagia, and decreased oral intake. Relevant comorbidities include COPD, chronic kidney disease stage 3, hypertensive CKD, nicotine dependence, and protein-calorie malnutrition (BMI 19.9).\n\nHospital course: The patient was observed for 2.2 days. Imaging confirmed a submandibular sialolith with associated ductal inflammation. He underwent minimally invasive surgical removal of the obstructing sialolith (procedure 0CBH0ZZ) without intraoperative complications. Perioperative IV cefazolin was administered. He received supportive care with IV fluids initially and was transitioned to oral intake. Pain was managed with acetaminophen and short course oxycodone as needed. He received Pneumococcal 23-valent vaccine prior to discharge.\n\nKey findings and procedures: Preoperative exam notable for unilateral submandibular gland tenderness and swelling. Labs consistent with known CKD stage 3; electrolytes stable. No evidence of systemic sepsis. Procedure: successful removal of sialolith with control of local infection and hemostasis.\n\nDischarge condition and functional status: Patient is afebrile, hemodynamically stable, tolerating oral diet, and pain controlled on oral analgesics. Ambulation: ambulatory with steady gait but limited endurance due to COPD and deconditioning; requires home health assistance with dressing changes and medication management. Independent with basic transfers but requests help with bathing and stair negotiation.\n\nMedications at discharge: Acetaminophen 500\u20131000 mg PO q4\u20136h PRN (max 3 g/day); Oxycodone IR 5\u201310 mg PO q4\u20136h PRN severe pain (short course); Pregabalin 50 mg PO BID for neuropathic pain; Fluticasone nasal spray 2 sprays each nostril daily; Ipratropium-albuterol inhaler 2 puffs q4\u20136h PRN; Hydrochlorothiazide 25 mg PO daily; Diazepam 2\u20135 mg PO PRN for severe anxiety/muscle spasm. (Perioperative IV cefazolin completed inpatient.) Pneumococcal vaccine administered.\n\nFollow-up: ENT clinic in 7\u201310 days for wound check and further management; primary care in 1 week for medication reconciliation and nutritional support; nephrology follow-up in 4\u20136 weeks for CKD management; pulmonology PRN for COPD optimization. Home health arranged for wound care, medication assistance, and short-course PT for endurance and breathing exercises. Return precautions: fever, increasing pain/swelling, purulent drainage, difficulty breathing, or decreased urine output.", "diagnosis_codes": ["N183", "Z681", "K1123"], "suggested_codes": ["J449", "K115", "E440", "F1721", "I120"], "accepted_codes": ["J449", "K115"], "rejected_codes": ["E440", "F1721", "I120"], "date": "2024-01-10T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 29632773, "discharge_summary": "History of Present Illness: 67-year-old male presented emergently after a fall down stairs at home with acute left knee pain and swelling. Imaging demonstrated a displaced transverse fracture of the left patella (ICD-10 S82.032A). Past medical history notable for essential hypertension and hyperlipidemia. He was admitted for operative management and perioperative optimization.\n\nHospital Course: The patient underwent open reduction and internal fixation of the left patella (procedure 0QSF04Z) under general anesthesia without intraoperative complications. Perioperative antibiotics (cefazolin) and standard VTE prophylaxis (enoxaparin) were administered. Postoperatively he achieved adequate pain control with short-course IV and oral opioids (hydromorphone PRN) and acetaminophen. There were no signs of surgical site infection, neurovascular compromise, or inpatient medical complications. Influenza high-dose quadrivalent vaccine was administered prior to discharge. Blood pressure and rhythm remained stable on home antihypertensive therapy (propranolol). Length of stay 3.7 days.\n\nKey Findings/Procedures: Pre- and postoperative radiographs confirmed displaced transverse fracture of left patella with satisfactory reduction and hardware placement on postoperative films. Procedure: open reduction and internal fixation of left patella (0QSF04Z). No acute cardiopulmonary or infectious issues identified.\n\nDischarge Condition and Functional Status: Patient is hemodynamically stable, afebrile, and tolerating oral intake. Pain is controlled with oral medications. He ambulates short distances with a rolling walker and requires assistance for transfers and stair negotiation; will need home health physical therapy for gait training and strengthening. Wound is clean and dry; home nursing required for wound checks and dressing changes.\n\nMedications at Discharge and Plan: Acetaminophen for analgesia; short, limited PRN oral opioid (hydromorphone) for breakthrough pain; enoxaparin continued for VTE prophylaxis per orthopedic recommendation; stool softener (docusate) and senna as needed; continue propranolol for BP and home statin for hyperlipidemia. Follow-up: Orthopedics clinic in 2 weeks for wound check and radiograph; primary care in 1\u20132 weeks for medical optimization. Home health referral placed for nursing (wound care, med reconciliation), PT (ambulation, transfers), and fall-prevention education.", "diagnosis_codes": ["S82032A"], "suggested_codes": ["E785", "I10", "Z23", "Z7901", "Z79891"], "accepted_codes": ["E785", "I10"], "rejected_codes": ["Z23", "Z7901", "Z79891"], "date": "2024-02-28T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 23944428, "discharge_summary": "History of Present Illness: 83-year-old man admitted emergently with acute shortness of breath and right-sided leg swelling. Imaging confirmed pulmonary embolism (I26.99) with associated deep venous thromboses of the lower extremities. Past hospital course was notable for acute kidney injury and known thoracic aortic aneurysm. He received anticoagulation and supportive care during a 7-day hospitalization.\n\nHospital Course: Patient was started on therapeutic anticoagulation with apixaban once he was deemed hemodynamically stable and renal function allowed oral anticoagulant use. He received diuresis with furosemide for volume management. Acute kidney injury was monitored and improved with optimization of volume status and avoidance of nephrotoxins. He received influenza and pneumococcal vaccinations prior to discharge. A multidisciplinary team including cardiology, hematology, and physical therapy was involved; vascular surgery was consulted for DVT management but no invasive intervention was required.\n\nKey Findings and Procedures: CT pulmonary angiography consistent with pulmonary embolism without acute RV strain. Lower-extremity duplex demonstrated acute thromboses of the right tibial and left deep veins. Echocardiogram showed no acute right ventricular dysfunction; intracardiac thrombus previously suspected was not amenable to intervention. Laboratory trends showed transient rise in creatinine consistent with AKI that trended toward baseline prior to discharge.\n\nDischarge Condition and Functional Status: Patient is medically stable for discharge to home with home health services. He is alert, oriented, and ambulates with a rolling walker and assistance; requires help with stair negotiation and may fatigue with exertion. Home health is requested for medication administration oversight, anticoagulation education, fall risk mitigation, and assistance with ADLs as needed.\n\nMedications and Follow-up Plan: Discharged on apixaban for treatment of PE/DVT, furosemide for volume control, losartan for blood pressure, docusate and senna for bowel regimen, and inhaled ipratropium-albuterol PRN. Labs: BMP and CBC in 3\u20135 days, repeat renal function within 1 week for anticoagulant dosing. Follow-up with PCP and hematology within 7 days; cardiology and vascular clinic as outpatient within 2\u20134 weeks. Return precautions and anticoagulation precautions reviewed with patient and family.", "diagnosis_codes": ["I2699"], "suggested_codes": ["I712", "N179", "I82409"], "accepted_codes": ["I712", "N179"], "rejected_codes": ["I82409"], "date": "2024-10-10T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 28118708, "discharge_summary": "History of Present Illness: 69-year-old male with known metastatic malignancy presented for observation with progressive dyspnea and hypoxia. Past history notable for metastatic disease to lung (left), liver, brain and bone, malignant pleural effusion, chronic venous thrombosis of the right femoral vein, CKD stage 3, and insulin-dependent diabetes. On arrival he had acute hypoxic respiratory failure and symptomatic pleural effusion.\n\nHospital Course: Over a 5-day observation stay the patient received supplemental oxygen with improvement in SpO2 to baseline requirements. He underwent diagnostic and therapeutic thoracentesis with cytology consistent with malignant effusion. Pericardial effusion was monitored by serial echocardiography and remained hemodynamically stable without need for pericardiocentesis. Right femoral DVT was treated with therapeutic enoxaparin inpatient with plan for continued outpatient anticoagulation. Dexamethasone was administered for symptom control related to CNS disease. Diuresis with furosemide improved volume status. Blood glucose was managed with insulin. No invasive surgical procedures other than thoracentesis were required.\n\nKey Findings and Procedures: Chest imaging showed left-sided malignant pleural effusion and progressive metastatic disease. Thoracentesis performed (fluid sent for cytology). Echocardiography demonstrated small-to-moderate pericardial effusion without tamponade physiology. Lower-extremity ultrasound confirmed chronic embolism/thrombosis of right femoral vein.\n\nDischarge Condition and Functional Status: Patient is medically stable for discharge on home oxygen as needed and ambulates with assistance due to deconditioning; requires assistance with ADLs and medication administration. Home health services arranged for skilled nursing, medication administration (subcutaneous enoxaparin education/administration if continued), wound/line care as needed, fall-risk monitoring, and physical therapy for mobility and strengthening.\n\nMedications and Follow-up: Discharge meds include therapeutic enoxaparin (per hematology plan), dexamethasone oral taper, furosemide, insulin regimen, famotidine, acetaminophen and other chronic meds. Appointments: oncology within 7 days for systemic therapy/radiation decisions, palliative care within 7\u201314 days, primary care in 1 week, and outpatient imaging (CT chest and brain MRI) as scheduled. Return precautions reviewed for worsening dyspnea, chest pain, bleeding or new neurologic changes.", "diagnosis_codes": ["E785", "C7801", "Z86711", "I82511", "Z85528", "C7889", "N1830", "K219", "C7931", "Z7901", "J910", "Z20822", "C7951", "E039", "I129", "R600", "C7802", "I313"], "suggested_codes": ["E110", "J9600", "Z739", "Z910", "Z992"], "accepted_codes": [], "rejected_codes": ["E110", "J9600", "Z739", "Z910", "Z992"], "date": "2024-07-10T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 25497780, "discharge_summary": "Reason for admission: 66-year-old man admitted under observation for management of symptomatic arteriovenous malformation (AVM) with associated acute decompensated diastolic congestive heart failure and complications following recent procedures. Hospital course: Patient observed 16.9 days. On presentation he had progressive dyspnea, hypoxemia, and signs of volume overload with chronic atrial fibrillation. Imaging confirmed AVM at other site (primary diagnosis) with periprocedural issues and postoperative intestinal obstruction that required evaluation and procedural management. He also has a history of type 2 diabetes mellitus, hypertensive heart disease with heart failure, coagulation defect, restless legs syndrome, and urinary retention. Key inpatient interventions and procedures: patient underwent endovascular management of the AVM with targeted occlusive therapy and embolization, and procedural evaluation/management of postprocedural intestinal obstruction including exploratory intervention with resolution of obstruction. Hemostasis and coagulation were closely monitored given underlying coagulation defect; intermittent heparin was used per protocol when indicated. Cardiac management included diuretics and afterload reduction for diastolic CHF; rate control for chronic atrial fibrillation was achieved with appropriate agents; oxygen supplementation and monitoring for hypoxemia were provided. Relevant findings: improved oxygenation and euvolemia on diuretics, stable hemodynamics, resolution of bowel obstruction symptoms, and no recurrent bleeding from AVM at discharge. Discharge condition and functional status: Discharged clinically improved and stable, ambulatory with assistance for transfers and short ambulation due to deconditioning; requires home health nursing for medication reconciliation, wound/procedure-site monitoring, and assistance with ADLs and mobility training. Cognitive status intact for decision-making. Medications at discharge: acetaminophen, gabapentin, insulin regimen for diabetes, hydralazine for blood pressure as needed, docusate and bisacodyl for bowel regimen, lidocaine 5% patch for localized pain, lorazepam PRN for anxiety/restless legs as needed. Anticoagulation plan: outpatient anticoagulation to be coordinated with cardiology/anticoagulation clinic given atrial fibrillation and coagulation disorder. Follow-up: cardiology within 1 week, vascular/interventional radiology in 2 weeks, primary care within 3\u20135 days, and home health nursing to begin within 48 hours of discharge for wound care, medication administration, and fall-risk mitigation.", "diagnosis_codes": ["I5031", "Q2739", "E119", "G2581", "R0902", "Z981", "K9130", "I482"], "suggested_codes": ["I110", "D6889", "R338"], "accepted_codes": ["I110"], "rejected_codes": ["D6889", "R338"], "date": "2024-06-30T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 23349375, "discharge_summary": "History of Present Illness: 40-year-old man with known type 1 diabetes mellitus on insulin, end-stage renal disease on chronic hemodialysis, prior CABG, and chronic pancreatitis presented to the ED with acute chest pain and dyspnea. ECG showed non\u2013ST elevation ischemic changes and serial troponins were elevated, consistent with NSTEMI. He was observed for 3.2 days for risk stratification and management.\n\nHospital Course: The patient was admitted to observation, treated with antiplatelet therapy (aspirin and clopidogrel), high-intensity statin, IV fluids held given ESRD, and electrolyte management for hyperkalemia. He underwent diagnostic coronary angiography which demonstrated chronic total occlusion of a native coronary vessel and patent bypass grafts; no percutaneous intervention was performed during this admission. Infectious and pain issues were treated as needed (IV cefazolin for suspected source, acetaminophen/hydromorphone PRN for pain). Diabetes and hypoglycemia were addressed with glucose protocols and education. Dialysis sessions were continued per his regular schedule.\n\nKey Findings/Procedures: Elevated cardiac biomarkers consistent with NSTEMI; ECG changes without ST elevation. Diagnostic coronary angiography performed; no PCI due to chronic total occlusion and prior CABG anatomy. Management of hyperkalemia and adjustment for ESRD; inpatient antibiotics for suspected infection. Procedures also included vascular access management and hemodialysis.\n\nDischarge Condition and Functional Status: Patient is hemodynamically stable at discharge, chest pain improved and controlled with oral analgesia. Ambulatory with baseline limitations; requires assistance with activities of daily living related to deconditioning and ongoing dialysis needs. Home health arranged for medication management, assistance with ADLs, coordination of dialysis transport, and wound/vascular access inspection.\n\nMedications and Follow-up: Discharged on aspirin EC, clopidogrel, atorvastatin, acetaminophen PRN, inhalers (albuterol, fluticasone-salmeterol) and chronic home meds including doxercalciferol and agents for diabetes as per endocrinology. Short course of antibiotics completed. Follow-up: Cardiology clinic in 1 week, nephrology with dialysis unit coordination within 3 days, primary care within 7 days, endocrinology as outpatient. Home health to monitor vitals, medication adherence, vascular access, and coordinate appointments.", "diagnosis_codes": ["I214"], "suggested_codes": ["E875", "K861", "N186", "Z951", "E109", "Z79899"], "accepted_codes": ["E875", "K861", "N186", "Z951"], "rejected_codes": ["E109", "Z79899"], "date": "2024-03-06T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 27923349, "discharge_summary": "77-year-old female admitted under observation for progressive erythema, swelling and pain of the left lower extremity consistent with cellulitis. Significant past medical history includes hypertensive heart and chronic kidney disease with systolic heart failure (CHF), chronic kidney disease stage 3, atrial fibrillation, type 2 diabetes mellitus, hypothyroidism, hyperlipidemia, asthma and osteoarthritis. Length of stay: 6 days.\n\nHospital course: On admission patient received IV fluids, empiric IV antibiotics and analgesia. Blood cultures were not persistently positive; inflammatory markers and WBC trended down with therapy. Acute kidney injury was monitored and improved toward baseline with adjustment of medications and careful fluid management. Heart failure was clinically compensated with diuretics and hemodynamic monitoring; no new arrhythmias were noted. Hypoglycemic episodes were treated promptly with dextrose and glucose gel. Patient converted from IV to oral antibiotics (clindamycin) once clinically improved and tolerating PO intake. Peripheral IV access and medication administration were performed (ICD-10-PCS 0S9D3ZX).\n\nKey findings/procedures: Left lower limb cellulitis confirmed clinically; improved erythema and pain at discharge. Labs notable for transient rise in creatinine consistent with acute on chronic kidney disease which trended down. EKG and telemetry without acute ischemic changes; CHF managed medically. Peripheral IV placement for medication/infusion documented (0S9D3ZX).\n\nDischarge condition and functional status: Patient is stable, afebrile, hemodynamically stable and ambulates with steadying assistance due to leg pain and deconditioning. Requires home health assistance for wound checks, medication administration support, activity tolerance monitoring and weight/vital sign surveillance related to CHF.\n\nMedications and follow-up: Discharged home on oral clindamycin PO, metoprolol tartrate, levothyroxine, atorvastatin, gabapentin for neuropathic pain as needed, acetaminophen, insulin per home regimen, calcium carbonate, loratadine and topical lidocaine patch PRN. Home health to perform wound care, daily vital signs, glucose checks and medication reconciliation. Follow-up with PCP in 48\u201372 hours, nephrology in 1\u20132 weeks (or sooner PRN), and cardiology within 1\u20132 weeks. Return to ED for fever, worsening erythema, increased shortness of breath, chest pain, dizziness or syncope.", "diagnosis_codes": ["L03116"], "suggested_codes": ["E039", "E119", "I4891", "I5022", "J45909", "M1990", "N183", "E785"], "accepted_codes": ["E039", "E119", "I4891", "I5022", "J45909", "M1990", "N183"], "rejected_codes": ["E785"], "date": "2024-05-30T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 27410410, "discharge_summary": "History of Present Illness: 70-year-old male admitted as a surgical same-day admission for progressive right lower extremity ischemia with gangrene of the right foot (primary diagnosis I70.261). He has concomitant chronic non-pressure ulcer of the right foot with muscle involvement, history of nicotine dependence, hypertension, hyperlipidemia, SIADH, and B12 deficiency.\n\nHospital Course: The patient underwent operative management of the right lower extremity (ICD-10-PCS 041M09P) with debridement of devitalized tissue and vascular surgical intervention. Post-operatively he was monitored for hemodynamic stability, wound perfusion, and electrolyte abnormalities. He received IV ceftriaxone for soft tissue infection, perioperative heparin for thromboprophylaxis, analgesia including hydromorphone as needed and scheduled acetaminophen, and gabapentin for neuropathic pain. Hypertension managed with metoprolol and hydralazine; diuresis with furosemide as indicated. Cyanocobalamin was administered for documented B12 deficiency. SIADH was managed conservatively with fluid restriction and monitoring of sodium; electrolytes stabilized prior to discharge.\n\nKey Findings/Procedures: Pre- and post-operative vascular assessment consistent with critical limb ischemia and localized gangrenous change of the right foot. Surgical debridement and vascular procedure performed (see operative note, ICD-10-PCS 041M09P). Wound cultures guided antibiotic therapy. No immediate post-operative systemic complications.\n\nDischarge Condition and Functional Status: Patient discharged in stable condition, afebrile, hemodynamically stable, wounds clean with improving perfusion. Ambulates with a rolling walker and requires assistance with transfers and dressing changes. Home health nursing required for wound care, dressing changes, and administration of IV antibiotics if continued.\n\nMedications and Follow-up: Discharge meds include aspirin EC, atorvastatin, metoprolol tartrate, hydralazine, furosemide, gabapentin, acetaminophen, cyanocobalamin, and topical collagenase ointment. Continue ceftriaxone at home only if arranged with home health infusion services. Recommend home health nursing for wound care and medication assistance, home physical therapy for gait and transfer training, vascular surgery follow-up within 1 week, primary care follow-up within 1 week, and BMP within 48\u201372 hours to monitor sodium and renal function.", "diagnosis_codes": ["Z87891", "E538", "E222", "I10", "E785", "L97515", "I70261"], "suggested_codes": [], "accepted_codes": [], "rejected_codes": [], "date": "2024-11-15T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 20460024, "discharge_summary": "History of present illness: 60-year-old male admitted under observation for 7.3 days after accidental ingestion of a loop diuretic (primary diagnosis: T50.1X1A). He presented with altered mental status, hallucinations, hypotension and oliguria. Initial evaluation demonstrated acute kidney injury with tubular necrosis (N17.0), metabolic encephalopathy (G93.41), metabolic acidosis, and electrolyte abnormalities. Past medical history notable for Parkinson disease, dementia, major depressive disorder, hyperlipidemia, anemia, and type 2 diabetes mellitus.\n\nHospital course: Patient received supportive care with isotonic fluids (Lactated Ringers), electrolyte repletion including magnesium sulfate, glucose management (insulin and dextrose as needed), and close hemodynamic monitoring. Nephrology and neurology were consulted. Heparin was used for inpatient VTE prophylaxis. Psychiatric input assisted with management of acute agitation and adjustment of home antidepressant regimen. No operative procedures performed. Over the admission his creatinine peaked and subsequently trended down with improved urine output; metabolic acidosis and hallucinations resolved with correction of electrolytes and removal of offending agent. Mental status improved toward baseline but residual cognitive impairment consistent with pre-existing dementia persists.\n\nKey findings and procedures: Acute tubular necrosis secondary to loop diuretic toxicity; metabolic encephalopathy; transient hallucinations. Serial BMPs showed improving creatinine and normalization of electrolytes. No invasive procedures required.\n\nDischarge condition and functional status: Discharged hemodynamically stable, oriented intermittently to baseline, ambulatory with assistance and requiring supervision for all medication administration and some ADLs due to baseline dementia. Home health nursing arranged for medication administration review, vital sign and weight monitoring, and assessment of urine output and renal function.\n\nMedications at discharge and follow-up: Continued home medications restarted/adjusted: Carbidopa-Levodopa 25/100, Duloxetine DR, Gabapentin, Mirtazapine, Felodipine, Omeprazole, scheduled insulin per home regimen, acetaminophen PRN. Patient and caregiver instructed to avoid loop diuretics. Follow-up: Nephrology appointment in 1 week for BMP and renal assessment, PCP within 3\u20135 days, neurology and psychiatry as outpatient. Return to ED for recurrent confusion, worsening dyspnea, hypotension, decreased urine output, or new neurologic deficits.", "diagnosis_codes": ["F419", "E119", "G9341", "G4733", "G4752", "Z7982", "D649", "N170", "G20", "T501X1A", "F0280", "E785", "R1310", "F1021", "E872", "R443", "Z7984", "Z87891", "F329"], "suggested_codes": ["R7189", "T887XXA", "Z792"], "accepted_codes": [], "rejected_codes": ["R7189", "T887XXA", "Z792"], "date": "2024-09-02T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 26872100, "discharge_summary": "69-year-old male admitted to observation for 5.9 days with fever, right upper quadrant pain and sepsis secondary to a hepatic abscess. Past history notable for intrahepatic bile duct carcinoma with prior biliary stent, recent biliary instrumentation, and chronic anticoagulation. Blood cultures grew Escherichia coli. Admission diagnosis: liver abscess (K75.0) with bacteremia.\n\nHospital course: He was started on broad-spectrum IV antibiotics and fluid resuscitation. Interventional radiology performed percutaneous drainage of the hepatic abscess with catheter placement and repeat imaging demonstrated interval decrease in collection. A right-sided PICC was placed for ongoing IV therapy. Hematology consulted for anemia and thrombocytopenia; counts were stable to improved with supportive management. The biliary stent was noted to have mechanical complications likely contributing to infection; gastroenterology was involved. He remained hemodynamically stable, afebrile for >48 hours prior to discharge, and completed transition to ertapenem for outpatient therapy once culture sensitivities finalized.\n\nKey findings and procedures: CT abdomen confirming rim-enhancing hepatic abscess; positive blood cultures for E. coli; percutaneous abscess drainage with catheter placement; PICC insertion for home IV antibiotics. Labs: improving WBC, persistent but stable anemia and mild thrombocytopenia; BMP stable.\n\nDischarge condition and functional status: Patient is hemodynamically stable, ambulates with a rolling walker at baseline and requires assistance with household transfers \u2014 home health will provide skilled nursing, IV antibiotic administration, dressing changes, and assistance with mobility and safety assessments. He is independent with oral intake but requires support for medication management.\n\nMedications and follow-up: Discharged on ertapenem IV via home infusion through PICC for planned 4\u20136 weeks, apixaban continued, docusate, folic acid, acetaminophen PRN, and other chronic meds as listed. Home health to monitor PICC site, perform daily vitals, and coordinate blood draws (CBC, BMP) twice weekly initially. Follow-up appointments: Infectious Disease in 1 week, Interventional Radiology or Hepatology in 2 weeks for drain assessment and repeat imaging, and PCP within 7\u201310 days. Return precautions given for fever, increased pain, bleeding, or worsening mobility.", "diagnosis_codes": ["K750"], "suggested_codes": ["Z7901", "A4151", "D638", "D696", "Z452"], "accepted_codes": ["Z7901"], "rejected_codes": ["A4151", "D638", "D696", "Z452"], "date": "2024-12-22T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 26695955, "discharge_summary": "History of Present Illness: 75-year-old female with history of permanent atrial fibrillation, diastolic congestive heart failure, Parkinson\u2019s disease, and dementia was admitted to observation for symptomatic bradyarrhythmia secondary to sick sinus syndrome (I49.5). She developed acute hypoxic respiratory failure during the admission and had a postprocedural pneumothorax following cardiac device placement. Hospital Course: The patient underwent implantation of a dual-lead cardiac pacemaker for sick sinus syndrome with periprocedural transvenous lead placement. She required brief respiratory support for acute hypoxic respiratory failure and was treated with supplemental oxygen, bronchodilator therapy, and pulmonary toilet. A postprocedural pneumothorax was identified and managed with chest tube placement with subsequent resolution. Cardiology optimized rate control and anticoagulation for atrial fibrillation. Diuretics and guideline-directed therapy for heart failure were adjusted. Parkinson\u2019s and dementia medications were continued with home dosing adjustments and medication reconciliation prior to discharge. Key Findings and Procedures: ECG consistent with sick sinus syndrome and permanent atrial fibrillation; transthoracic echo showed preserved LV systolic function with diastolic dysfunction. Procedures: dual-lead pacemaker implantation, chest tube for pneumothorax, and brief respiratory support. Bloodwork and imaging stabilized prior to discharge. Discharge Condition and Functional Status: Patient is hemodynamically stable, afebrile, and respiratory status improved to room air at rest. She remains deconditioned with impaired mobility and requires assistance for transfers and ambulation; cognitive impairment necessitates supervision for medication administration and home safety. Home Health/Rehab recommended for skilled nursing visits, medication management, wound/port site checks, and assistance with ADLs. Medications at Discharge (selected): Apixaban 5 mg BID (anticoagulation), Metoprolol succinate XL, Diltiazem ER as indicated, Furosemide, Carbidopa\u2013Levodopa, Donepezil, Albuterol inhaler PRN, Acetaminophen, Ferrous sulfate, Cyanocobalamin. Follow-up Plan: Cardiology/pacemaker clinic within 1 week for device check; primary care in 1\u20132 weeks; pulmonology/primary care as needed for respiratory follow-up; neurology/geriatrics follow-up for Parkinson\u2019s and dementia. Home health to initiate within 48 hours for vitals, wound care, ADL support, and medication reconciliation.", "diagnosis_codes": ["M40209", "J9601", "I495", "Z7901", "E785", "J45909", "I110"], "suggested_codes": ["G20", "F0390", "J939"], "accepted_codes": ["G20"], "rejected_codes": ["F0390", "J939"], "date": "2024-04-30T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 25218903, "discharge_summary": "56-year-old female admitted under observation for 4.9 days with altered mental status, fever and hematuria. Past medical history notable for hydrocephalus (status post shunt), gastrostomy dependence, essential hypertension, type 2 diabetes, hyperlipidemia and prior seizures. Primary diagnosis: infection/inflammatory reaction due to indwelling urinary catheter (T83.51XA) with E. coli identified on culture; secondary problems included encephalopathy, urinary retention/hematuria and chronic neurologic disease.\n\nHospital course: Patient presented with encephalopathy and febrile illness. Initial evaluation included CT head (known hydrocephalus without acute shunt malfunction) and laboratory testing showing leukocytosis and positive urine culture for Escherichia coli. Treated with broad-spectrum IV antibiotics with infectious disease consultation. A midline/PICC was placed to facilitate IV therapy. Urinary catheter was exchanged per urology; hematuria and retention were managed conservatively. Neurology evaluated for encephalopathy and initiated/continued seizure prophylaxis with levetiracetam. Patient responded to therapy with defervescence and progressive improvement in mental status though baseline cognitive impairment persists.\n\nKey procedures: peripheral to central line conversion (PICC/midline) for outpatient IV antibiotics, urinary catheter exchange, continuous observation and supportive care. Cultures: urine positive for E. coli; blood cultures negative.\n\nDischarge condition and functional status: Patient is hemodynamically stable and afebrile at discharge. Mental status improved from presentation but remains intermittently confused compared with baseline; requires assistance with activities of daily living and supervision for medication administration and gastrostomy care. Ambulates short distances with assistance; home health arranged for nursing support.\n\nMedications and follow-up: Discharged on IV ertapenem via PICC (home health to administer and manage PICC with heparin/saline flush per protocol). Continued home meds: levetiracetam, pravastatin, tamsulosin, acetaminophen PRN, potassium chloride powder PRN, and bowel regimen (senna, bisacodyl). Labs (CBC, BMP) and repeat urine culture to be obtained within 48\u201372 hours. Follow-up: primary care in 48\u201372 hours, infectious disease within 7\u201310 days, urology as outpatient for catheter management, and neurology outpatient follow-up within 2 weeks. Home health to provide wound/G-tube/PICC care, IV antibiotic administration, medication reconciliation and ADL assistance.", "diagnosis_codes": ["T8351XA"], "suggested_codes": ["G9340", "R319", "G932", "N39498", "Z6829"], "accepted_codes": ["G9340", "R319"], "rejected_codes": ["G932", "N39498", "Z6829"], "date": "2024-02-18T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 24511784, "discharge_summary": "History of present illness: 56-year-old man presented emergently with progressive dyspnea, cough, fever, and hypoxemia. Past medical history notable for chronic systolic heart failure, hypertensive heart disease, COPD with acute lower respiratory infection, paroxysmal atrial fibrillation, alcohol dependence with withdrawal, and severe protein-calorie malnutrition (E43). On presentation he was hypoxic and diagnosed with pneumonia and acute respiratory failure.\n\nHospital course: Patient was admitted to the medical service for management of community-acquired/other pneumonia with acute respiratory failure. He received supplemental oxygen and short-term ventilatory support for respiratory distress with subsequent weaning to nasal cannula. Blood and sputum cultures obtained; empiric broad-spectrum IV cefepime was administered. Diuresis with IV loop diuretics was used for congestive heart failure exacerbation and pleural effusion; diagnostic/therapeutic thoracentesis was performed with symptomatic improvement. Atrial fibrillation was rate-controlled with metoprolol XL. He was treated for alcohol withdrawal per protocol and received nutritional support and appetite stimulant (mirtazapine) for malnutrition. He received DVT prophylaxis with heparin. Psychiatric symptoms were managed with haloperidol as needed.\n\nKey findings and procedures: Chest radiography and CT demonstrated multilobar consolidation with moderate pleural effusion. Thoracentesis performed with improvement in respiratory status. Laboratory evaluation consistent with acute inflammatory process; no gross bacteremia. Procedures included chest fluid drainage and short course ventilatory support.\n\nDischarge condition and functional status: Clinically improved, afebrile for >48 hours, and stable on low-flow supplemental oxygen at rest (requires home oxygen). Ambulates with assistance due to deconditioning and requires help with some ADLs; home health nursing and physical therapy recommended for strength and medication management.\n\nMedications and follow-up: Discharged on acetaminophen, albuterol and ipratropium inhaled therapies, fluticasone inhaler, aspirin, atorvastatin, metoprolol XL, cefepime transitioned to oral antibiotic to complete course, docusate and bisacodyl for bowel regimen, heparin discontinued with outpatient DVT prophylaxis plan as indicated, mirtazapine, and haloperidol PRN. Follow-up with primary care within 3\u20135 days, pulmonary clinic in 1\u20132 weeks, cardiology as outpatient, and repeat chest x-ray in 4\u20136 weeks. Home health to monitor oxygen saturation, daily weights, wound/pleural drainage site, medication adherence, and ADL support.", "diagnosis_codes": ["J188"], "suggested_codes": ["E43", "F10239", "I110", "I480", "I5022", "J440", "J90", "J9600"], "accepted_codes": ["E43", "F10239", "I110", "I480", "I5022", "J440", "J90", "J9600"], "rejected_codes": [], "date": "2024-01-31T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 23608239, "discharge_summary": "History of Present Illness: 59-year-old female electively admitted for management of a left renal mass (ICD-10 C64.2). Past medical history significant for type 2 diabetes with retinopathy and hyperglycemia, long-term insulin and oral hypoglycemic use, essential hypertension, hyperlipidemia, obstructive sleep apnea on CPAP, iron deficiency anemia, and obesity.\n\nHospital Course: Patient underwent an uneventful left radical nephrectomy (procedure 0TB14ZZ) with intraoperative IV therapy and perioperative antibiotics (cefazolin). Estimated blood loss was minimal; no transfusion required. Postoperatively she was hemodynamically stable, afebrile, pain controlled with multimodal analgesia (acetaminophen, short PRN opioids while inpatient), and bowel function returning. Glycemic management was achieved with scheduled insulin and sliding-scale adjustments; no acute kidney injury detected and hemoglobin remained stable. DVT prophylaxis with subcutaneous heparin was provided during the admission. Final pathologic staging is pending; specimen sent to pathology.\n\nKey Findings and Procedures: Preoperative imaging consistent with solitary left renal mass; operative report documents complete resection of the left kidney. Procedures performed: open/standard left radical nephrectomy (0TB14ZZ) and intraoperative intravenous therapeutic administration (8E0W4CZ). No intraoperative complications.\n\nDischarge Condition and Functional Status: Patient is medically stable for discharge on postoperative day 2.2. Ambulates with minimal assistance in the home setting; able to perform basic ADLs but will benefit from home health support for wound care and activity progression. Uses CPAP at night; oxygenation stable on room air.\n\nMedications and Follow-up Plan: Continue home antihypertensive and lipid therapy and home insulin regimen (adjust per outpatient glucose logs). Discharge medications include acetaminophen for analgesia, a short course of oral opioid for breakthrough pain, docusate for constipation, and instructions to stop IV antibiotics. Home health referral arranged for wound checks, medication assistance, glucose monitoring/insulin administration teaching, and activity support (visits daily \u00d77 then PRN). Labs (BMP and CBC) in 7\u201310 days. Urology clinic follow-up in 7\u201314 days for wound check and pathology review. Primary care/endocrinology follow-up within 1 week for diabetes management and medication reconciliation.", "diagnosis_codes": ["G4733", "C642"], "suggested_codes": ["D509", "E11319", "E669", "E785", "I10"], "accepted_codes": ["D509", "E11319", "E669", "E785", "I10"], "rejected_codes": [], "date": "2024-10-02T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 28055067, "discharge_summary": "Brief history of present illness: 91-year-old man admitted urgently with acute on chronic diastolic congestive heart failure and volume overload with progressive dyspnea and peripheral edema. Background medical history notable for hypertensive heart disease with chronic kidney disease, type 2 diabetes mellitus on insulin, chronic atrial fibrillation, prior coronary artery disease, hyperlipidemia, and do-not-resuscitate status.\n\nHospital course: Over a 3.7-day hospitalization the patient received aggressive medical management including intravenous and transition to oral diuresis (furosemide) with net negative fluid balance and clinical improvement of respiratory status. Telemetry documented supraventricular tachycardia and episodes of atrial fibrillation managed with rate control and continuation of anticoagulation (apixaban). Acute kidney injury on CKD was monitored; creatinine rose modestly on admission and stabilized with careful volume management and avoidance of nephrotoxins. Insulin regimen was adjusted for hyperglycemia; patient received routine inpatient vaccination (influenza). No invasive cardiac procedures were performed.\n\nKey findings and procedures: Admission chest radiograph consistent with cardiogenic pulmonary interstitial edema that improved with diuresis. Labs demonstrated acute kidney injury that trended toward baseline; BNP elevated on admission decreased with therapy. Continuous telemetry identified supraventricular tachycardia and atrial fibrillation with rate control achieved. No emergent coronary intervention required.\n\nDischarge condition and functional status: Patient is clinically improved, euvolemic, hemodynamically stable, and ambulates short distances with assistance due to deconditioning and fall risk. He requires assistance with activities of daily living and needs home health support for medication administration and monitoring.\n\nMedications and follow-up plan: Discharge medications include apixaban, aspirin, furosemide, insulin (adjusted regimen), atorvastatin, allopurinol, and other routine meds. Home health to provide daily weights, vital signs, blood glucose checks, assistance with insulin administration, medication reconciliation, and fall-prevention education. Labs: BMP within 48\u201372 hours and as needed; outpatient BNP and renal panel in 1 week. Follow-up: primary care in 3\u20135 days, cardiology in 1 week, nephrology in 1\u20132 weeks. Patient and family informed of DNR status and goals of care reviewed.", "diagnosis_codes": ["I130"], "suggested_codes": ["I471", "N179", "Z23", "Z794", "I481", "I5032", "Z748", "Z9181"], "accepted_codes": ["I471", "N179", "Z23", "Z794"], "rejected_codes": ["I481", "I5032", "Z748", "Z9181"], "date": "2024-09-14T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 24648649, "discharge_summary": "Brief history of present illness: 22-year-old male presented via emergency department with acute exacerbation of anxiety and depressed mood after recent psychosocial stressors. Patient reported worsening anxiety, passive and intermittent active suicidal ideation without imminent plan or intent, and increased alcohol and cannabis use. Past history notable for prior self-harm, nicotine dependence, and history of malignant neoplasm (remote). Primary admitting diagnosis: Adjustment disorder with mixed anxiety and depressed mood (F43.23). Other problem list includes alcohol- and cannabis-related disorders with anxiety features, unspecified anxiety disorder, and personal history codes for self-harm and nicotine dependence.\n\nHospital course: Over a 48-hour admission, patient received psychiatric evaluation, safety planning, brief supportive psychotherapy, substance use counseling, and medication initiation. Risk was assessed as elevated on presentation; no acute medical instability or need for inpatient psychiatric transfer after stabilization. Patient tolerated medication regimen without adverse effects. Influenza vaccination administered prior to discharge.\n\nKey findings and procedures: Psychiatric assessment confirmed adjustment disorder with mixed anxiety/depressed mood and suicidal ideation without active plan. Collateral history obtained from family when available. No invasive procedures performed. Vital signs and bedside exam remained within acceptable limits for discharge.\n\nDischarge condition and functional status: Patient is medically stable, alert and oriented, ambulatory, and independent with activities of daily living but reports functional impairment related to anxiety (difficulty sleeping and concentrating). Requires home health support focused on medication management, safety monitoring, and short-term psychosocial support. Home health to perform weekly nursing checks for adherence and symptom escalation and liaise with outpatient psychiatry.\n\nMedications and follow-up: Discharge medications: Sertraline (started; outpatient titration per psychiatry), Hydroxyzine as needed for anxiety, Ramelteon nightly for sleep, Acetaminophen PRN, Influenza Vaccine Quadrivalent administered. Follow-up: outpatient psychiatry within 7 days, primary care in 1\u20132 weeks, referral to community substance use counseling and crisis resources; return to ED for worsening suicidal ideation or safety concern. Patient and family provided with crisis plan and emergency contact information.", "diagnosis_codes": ["F4323"], "suggested_codes": ["Z915", "F17210", "F19182", "Z23", "Z86719"], "accepted_codes": ["Z915"], "rejected_codes": ["F17210", "F19182", "Z23", "Z86719"], "date": "2024-02-29T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 24515644, "discharge_summary": "History of Present Illness: 81-year-old male admitted to observation for progressive weakness, confusion, poor oral intake, and new urinary symptoms. Known history of hepatocellular carcinoma with bone metastases, chronic hepatitis C, cirrhosis, chronic kidney disease stage 3, type 2 diabetes with diabetic CKD, hypertension, and severe protein-calorie malnutrition. On presentation he had hypotension responsive to fluids, leukocytosis, and positive urinalysis; blood cultures were negative.\n\nHospital Course: During the 5-day observation stay the patient was treated for a urinary tract infection with ceftriaxone IV, received IV fluids for hemodynamic support, and was started on lactulose for intermittent hepatic encephalopathy with improvement in mentation. DVT prophylaxis with subcutaneous heparin was provided. Nutritional status was addressed with multivitamins and caloric supplementation; bowel regimen (docusate, senna) was initiated for constipation. Electrolytes stabilized with oral/IV potassium replacement as needed. Pain and fever managed with acetaminophen and short course of aspirin for cardiac prophylaxis per cardiology. Blood glucose and blood pressure were controlled on home regimens with adjustments (lisinopril continued). A peripheral IV/PICC was placed to facilitate antimicrobial therapy and laboratory draws.\n\nKey Findings and Procedures: Imaging and labs consistent with known hepatocellular carcinoma and metastasis; malnutrition (E43); CKD stage 3. Urine culture grew a susceptible organism; treated appropriately. Procedure: central venous access (PICC) for secure IV therapy.\n\nDischarge Condition and Functional Status: Patient is hemodynamically stable, afebrile, and tolerating oral intake though nutritional intake remains inadequate. Cognition improved to baseline but requires supervision with medications. Mobility is decreased\u2014requires assistance with transfers and uses a walker; physical therapy recommended.\n\nMedications and Follow-up Plan: Discharged on home meds adjusted as above plus completion of IV-to-oral antibiotic plan as directed by infectious disease. Lactulose continued for encephalopathy, stool regimen, lisinopril, potassium supplementation, pantoprazole, and routine ophthalmic drops continued. Home health nursing for medication administration, wound/PICC care, daily weight checks, and lab draws is arranged. Follow-up: hepatology/oncology within 1 week, nephrology in 2 weeks, primary care in 3\u20135 days, and home physical therapy for gait/transfer training. Monitoring labs: CMP, CBC, and INR as outpatient.", "diagnosis_codes": ["Z8546", "D509", "B1920", "C220", "I129", "N1830", "K7460", "K7689", "K7290", "Z6822", "E1122", "K713", "N390", "C7951", "E43", "Z66", "B9689", "B182"], "suggested_codes": ["K721", "R2689", "R410", "R531", "R634", "R635", "Z7401", "Z9119", "Z9189"], "accepted_codes": [], "rejected_codes": ["K721", "R2689", "R410", "R531", "R634", "R635", "Z7401", "Z9119", "Z9189"], "date": "2024-12-23T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 27619076, "discharge_summary": "History of present illness: 79-year-old man admitted urgently with acute left carotid artery occlusion/stenosis presenting with transient right-sided weakness, aphasia and an episode of amaurosis fugax. Past medical history notable for atrial septal defect, essential hypertension, hyperlipidemia, prior TIA/stroke, and nicotine dependence.\n\nHospital course: Patient admitted for urgent cerebrovascular evaluation and management. Imaging confirmed significant left carotid stenosis/occlusion. He was treated in the acute setting with antithrombotic therapy and underwent percutaneous left carotid revascularization (angioplasty with stent placement). Peri-procedural heparin was administered and discontinued per protocol. Blood pressure was managed with IV nicardipine and conversion to oral antihypertensives prior to discharge. He received statin therapy and short-course antiemetic and analgesic medications as needed. No new ischemic deficits developed post-procedure; baseline aphasia and mild right facial weakness persisted but remain stable.\n\nKey findings and procedures: CTA/duplex demonstrating high-grade left carotid stenosis; percutaneous transluminal angioplasty and stent placement of the left carotid artery (procedural code 037L3DZ). Cardiac evaluation notable for known atrial septal defect; telemetry showed no sustained arrhythmia during stay.\n\nDischarge condition and functional status: Patient is hemodynamically stable and neurologically at baseline for him. Mobility: ambulates with a rolling walker with supervision due to residual right-sided weakness and falls risk. ADLs: requires assistance with some instrumental activities and was recommended home health PT/OT for gait training and ADL support. Home nursing recommended for medication reconciliation, blood pressure monitoring, and wound site checks.\n\nMedications and follow-up: Discharge meds include aspirin and clopidogrel (dual antiplatelet therapy), rosuvastatin, lisinopril (with home BP monitoring), hydralazine as indicated, docusate sodium, acetaminophen PRN, and home nasal/inhaled meds continued per outpatient regimen. Heparin discontinued. Follow-up: vascular surgery/carotid clinic and neurology within 1\u20132 weeks, primary care in 1 week, home health services initiated for PT/OT and nursing. Smoking cessation counseling provided.\n\nIf new or worsening neurological symptoms occur, patient instructed to return to ED immediately.", "diagnosis_codes": ["R29810", "I6522", "Z87891"], "suggested_codes": ["E785", "I10", "Q211", "I69359"], "accepted_codes": ["E785", "I10", "Q211"], "rejected_codes": ["I69359"], "date": "2024-10-14T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 28106974, "discharge_summary": "Brief HPI: 61-year-old female admitted under observation for evaluation and management of colostomy malfunction (K94.03) with associated abdominal pain, decreased ostomy output and peristomal skin irritation. Past medical history notable for severe protein-calorie malnutrition (E43), recent COVID-19 infection (U07.1), prior C. difficile enterocolitis (A04.72), type 2 diabetes mellitus, hypertension, hyperlipidemia, history of pelvic fistulae (N82.0, N82.3), chronic kidney tubulointerstitial disease and documented DNR status (Z66).\n\nHospital course: Over an 11.7-day observation stay the patient underwent bedside ostomy assessment and appliance revision with local wound care and education. A midline/PICC was placed for IV access to facilitate parenteral fluids and antibiotic therapy. She received IV ertapenem for presumed complex intra-abdominal infection pending culture guidance and oral fidaxomicin for C. difficile. Electrolyte abnormalities (hypomagnesemia) were corrected with magnesium oxide and intravenous supplementation as needed. Glycemic control was managed with short-acting insulin and D10W as required. Heparin prophylaxis was provided. Psychiatry and nutrition consults were obtained; aggressive nutrition support and high-protein diet plan initiated.\n\nKey findings and procedures: Positive C. difficile testing with supportive stool studies; stoma inspected with no evidence of necrosis; peristomal cellulitis treated conservatively. Midline/PICC placed under sterile technique for IV therapy. Labs notable for hypomagnesemia and volume depletion that responded to replacement.\n\nDischarge condition and functional status: Patient is medically stable, afebrile, pain controlled on oral regimen, tolerating oral intake. Functional limitations: decreased endurance and requires assistance with ostomy appliance changes and activities of daily living; home health nursing for wound/ostomy care and medication administration is arranged.\n\nMedications and follow-up: Discharge medications include fidaxomicin (complete course), oral magnesium supplementation, duloxetine, acetaminophen PRN, scheduled insulin regimen, and home analgesics. Continue heparin as outpatient only if ordered by home health. Follow-up with colorectal surgery in 1\u20132 weeks, PCP in 7 days, infectious disease within 48\u201372 hours for antibiotic review, nephrology in 1 week for electrolyte reassessment. Home health to provide PICC/midline care, ostomy management, skilled nursing and nutrition support. ", "diagnosis_codes": ["E785", "K9403"], "suggested_codes": ["A0472", "E43", "E8342", "I10", "U071", "Z66", "E119", "N189", "T8143XA"], "accepted_codes": ["A0472", "E43", "E8342", "I10", "U071", "Z66"], "rejected_codes": ["E119", "N189", "T8143XA"], "date": "2024-11-05T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 25366781, "discharge_summary": "History of Present Illness: 67-year-old female admitted as a same-day surgical patient for symptomatic left knee osteoarthritis with valgus deformity. She underwent an uncomplicated left total knee arthroplasty (procedure 0SRD0J9). Past medical history notable for type 2 diabetes mellitus without complications, asthma, and osteoarthritis of the knee.\n\nHospital Course: Length of stay 3.7 days. Perioperative course was uneventful. She received standard perioperative antibiotics and DVT prophylaxis with enoxaparin. Blood loss was minimal; no transfusion required. Pain was managed with multimodal analgesia including acetaminophen and short-course opioids as needed; nausea controlled with ondansetron. Bowel regimen (docusate, bisacodyl, magnesium oxide as needed) instituted. Diabetes was managed with a basal-bolus insulin regimen and bedside glucose monitoring; endocrinology recommendations followed. Influenza vaccine administered prior to discharge.\n\nKey Findings and Procedures: Preoperative evaluation and imaging confirmed advanced left knee osteoarthritis and valgus deformity. Left total knee arthroplasty performed without intraoperative complications. Postoperative neurovascular exams remained intact; surgical incision clean, dry, and intact. Routine postoperative labs within acceptable limits.\n\nDischarge Condition and Functional Status: Patient is hemodynamically stable and afebrile at discharge. Pain is controlled on oral medications. She ambulates with a walker with moderate assistance for distance and requires assistance for stair negotiation and toileting; demonstrates ability to perform transfers with one-person assistance. Wound is clean without erythema or drainage. Glucose levels reasonably controlled on current regimen with nursing support.\n\nMedications and Follow-up Plan: Discharge medications include acetaminophen, enoxaparin subcutaneous for DVT prophylaxis, insulin regimen with sliding scale as instructed, ondansetron PRN, stool softener (docusate) and laxative (bisacodyl) PRN, multivitamin and calcium supplementation. Home health referral for nursing and physical therapy initiated: RN to perform wound checks, administer/teach enoxaparin and insulin injections, monitor glucose and med reconciliation; PT to provide supervised gait training and home exercise program (3\u00d7/week initially). Outpatient orthopedic follow-up in 10\u201314 days for wound check and suture removal; PCP follow-up in 7 days for diabetes and overall medication review. Labs (CBC, BMP) recommended in 3\u20135 days or sooner if concerns. Education provided on wound care, signs of infection, DVT/PE symptoms, and fall precautions.", "diagnosis_codes": ["M179"], "suggested_codes": ["E119", "J45909", "M2106"], "accepted_codes": ["E119", "J45909"], "rejected_codes": ["M2106"], "date": "2024-04-15T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 21812341, "discharge_summary": "78-year-old female admitted under observation for acute exacerbation of congestive heart failure and acute on chronic kidney injury in the setting of hypertensive heart disease and diabetic chronic kidney disease. She presented with progressive dyspnea, lower extremity edema, orthopnea, and decreased oral intake. Initial evaluation notable for elevated BNP, pulmonary vascular congestion on chest x-ray, creatinine rise from baseline, and electrolyte abnormalities. Past medical history includes hypertensive heart disease with heart failure (diastolic), CKD stage 3-4, type 2 diabetes with neuropathy, atrial fibrillation, prior coronary artery disease, pulmonary hypertension, and chronic anemia.\n\nHospital course: Patient treated with intravenous and then oral loop diuretics with clinical diuresis and improvement in respiratory symptoms and peripheral edema. Blood pressure and heart rate were managed with adjustment of metoprolol succinate and lisinopril as tolerated. Acute kidney injury partially recovered toward baseline with optimization of volume status and medication adjustments. Blood glucose managed per protocol; hypoglycemia episodes treated promptly with dextrose and oral glucose gel. Anemia addressed with oral ferrous sulfate and evaluation; no transfusion required. Antithrombotic regimen reviewed and continued on apixaban and antiplatelet agents per cardiology recommendations given recent coronary disease history.\n\nKey findings/procedures: CXR consistent with congestive changes that improved with therapy. Labs demonstrated transient rise in creatinine (AKI) and chronic anemia; ECG with atrial fibrillation without ischemic changes. No invasive procedures performed.\n\nDischarge condition and functional status: Patient is improved, hemodynamically stable, euvolemic by exam, tolerating oral intake. Ambulates with a rolling walker and requires assistance with transfers and medication management; home health recommended for ADL support, medication reconciliation, vital signs and daily weights.\n\nMedications and follow-up: Discharged on apixaban, aspirin, clopidogrel, lisinopril, metoprolol succinate XL, furosemide, atorvastatin, gabapentin, ferrous sulfate, pantoprazole, magnesium oxide, polyethylene glycol and diabetes medications as listed. Arrange home health 2\u20133x/week for 2 weeks then reassess. Outpatient follow-up: PCP in 7 days, cardiology and nephrology in 1\u20132 weeks, labs (BMP, CBC, BNP) in 3\u20137 days. Low-sodium diet, daily weights, and medication adherence counseling provided.", "diagnosis_codes": ["I5033", "D631", "Z8673", "I872", "Z95818", "I4891", "E1140", "I2720", "Z7901", "I130", "E785", "Z952", "N189", "Z951", "N179", "F17210", "Z85820", "D509", "I2510", "E1122", "Z89429"], "suggested_codes": [], "accepted_codes": [], "rejected_codes": [], "date": "2024-04-22T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 27839670, "discharge_summary": "History of Present Illness: 26-year-old male presented to the emergency department with 48 hours of fever, rigors, sore throat and progressive malaise. He was found to be tachycardic with leukocytosis and hypotension responsive to initial fluid resuscitation. Blood cultures were obtained. Past history notable for recurrent sialoadenitis and a known mucocele of the salivary gland. Developmental history includes a long-standing speech and language disorder.\n\nHospital Course: Admitted under observation for management of sepsis, unspecified organism (A41.9). He received sepsis bundle care including IV fluids, empiric broad-spectrum antibiotics (ampicillin\u2013sulbactam while inpatient), antipyretics and VTE prophylaxis with subcutaneous heparin. He demonstrated clinical improvement with normalization of vital signs and decreasing leukocytosis; blood cultures remained without growth at 48 hours. Pain was managed with acetaminophen and short course morphine oral solution as needed. No operative intervention was required for salivary pathology during this stay.\n\nKey Findings and Procedures: Initial labs notable for leukocytosis with left shift and elevated CRP. Chest x-ray without acute consolidation. Blood cultures drawn; no growth at 48 hours. No surgical procedures performed. Wound/skin intact; mucocele noted on exam of the oral cavity\u2014ENT follow-up recommended.\n\nDischarge Condition and Functional Status: Patient is afebrile, hemodynamically stable, ambulatory without assistance, and independent with basic activities of daily living. Due to recent sepsis and subjective concentration difficulties, home health nursing is arranged for short-term medication administration oversight, daily vital sign checks for 48\u201372 hours, and cognitive/functional screening.\n\nMedications and Follow-up: Discharged on oral amoxicillin\u2013clavulanate to complete a 7\u201310 day course, acetaminophen as needed, and morphine oral solution for breakthrough pain short course. Continue VTE precautions; heparin discontinued. Follow-up with primary care within 48\u201372 hours, infectious disease/ENT in 1\u20132 weeks, and outpatient speech therapy as indicated. Home health to assess medication adherence, wound/oral lesion care, vitals, and cognitive status; return precautions provided.", "diagnosis_codes": ["R419", "K116", "K1122", "F809", "A419"], "suggested_codes": ["Z521", "Z7989"], "accepted_codes": [], "rejected_codes": ["Z521", "Z7989"], "date": "2024-09-30T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 23964771, "discharge_summary": "History of Present Illness: 50-year-old female admitted to observation for 19 days with complications following allogeneic bone marrow transplant (primary: T86.09). She presented with acute-on-chronic graft-versus-host disease involving skin and GI tract (rash, significant noninfective diarrhea), progressive protein-calorie malnutrition, hypogammaglobulinemia, and coagulopathy. Course was complicated by immunosuppression-related viral reactivation and need for close hemodynamic and metabolic support.\n\nHospital Course: Patient received multidisciplinary care (hematology/oncology, infectious disease, dermatology, nutrition). Supportive measures included IV fluids, glucose support, prophylactic anticoagulation with enoxaparin, antiviral therapy with acyclovir, PCP prophylaxis with atovaquone, topical and systemic treatment for GVHD (clobetasol, budesonide where indicated), and aggressive nutritional supplementation. Laboratory monitoring identified hypogammaglobulinemia and cytopenias; transfusion and blood product support provided as indicated. Central venous access was placed for reliable IV therapy. She remained hemodynamically stable without ongoing fever at discharge.\n\nKey Findings and Procedures: Positive findings included clinical GVHD (skin and GI), severe protein-calorie malnutrition (BMI \u226419.9), hypogammaglobulinemia, and coagulopathy. Procedures included placement and use of central venous access for IV therapies and multiple diagnostic labs/imaging to assess infectious and transplant-related complications. Blood product support was provided as clinically necessary.\n\nDischarge Condition and Functional Status: Patient discharged clinically stable, afebrile, and hemodynamically intact. Functional status: ambulatory with assistance due to deconditioning and ongoing GI symptoms; requires home assistance for medication administration, wound/skin care, and nutritional support.\n\nMedications and Follow-up: Discharge medications include acyclovir, atovaquone suspension, budesonide, clobetasol topical, enoxaparin (prophylaxis), acetaminophen PRN, antidepressant regimen continued (escitalopram, bupropion as previously prescribed), and insulin/nutritional supplements as indicated. Home health referral placed for nursing visits to administer/monitor medications, provide skin and wound care, nutrition support, and infection surveillance. Hematology/oncology follow-up within 3\u20137 days; dermatology and nutrition clinic as outpatient; consider immunology/IVIG evaluation.", "diagnosis_codes": ["F419", "M069", "R600", "D89810", "R7401", "Z681", "E8809", "T8609", "T451X5A", "B0089", "R05", "D89812", "D688", "R21", "Y830", "A6000", "D801", "D84821", "F329", "K621", "K529", "E43", "D469"], "suggested_codes": ["Z7409", "Z7689"], "accepted_codes": [], "rejected_codes": ["Z7409", "Z7689"], "date": "2024-10-10T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 27886914, "discharge_summary": "62-year-old male admitted urgently for melena with symptomatic anemia. Past medical history notable for chronic systolic heart failure, hypertensive heart disease, atrial fibrillation, peripheral vascular disease, known pancreatic pseudocyst and renal artery aneurysm on prior imaging. On admission he was hemodynamically monitored and found to have acute posthemorrhagic anemia requiring packed red blood cell transfusion and endoscopic evaluation.\n\nHospital course: Patient underwent diagnostic and therapeutic upper endoscopy with successful identification and endoscopic hemostasis of an upper gastrointestinal source of bleeding. He received transfusion support (packed RBCs) with improvement in hemoglobin and stabilization of vital signs. Hyperkalemia was identified on admission and corrected with medical management. Heart failure and rate control were optimized with diuretics (furosemide, spironolactone), carvedilol and digoxin; lisinopril continued with monitoring of renal function and potassium. Pantoprazole was initiated for GI protection; ondansetron provided PRN antiemetic relief. Imaging (CT abdomen) confirmed a pancreatic pseudocyst and documented a renal artery aneurysm; these findings were stable compared with prior records and outpatient vascular follow-up was arranged.\n\nKey procedures/diagnoses: upper endoscopy with therapeutic hemostasis, packed RBC transfusion, correction of electrolyte abnormalities. Primary diagnosis: melena (K92.1). Secondary issues: acute posthemorrhagic anemia, chronic systolic heart failure, atrial fibrillation, pancreatic pseudocyst, renal artery aneurysm, hyperkalemia, peripheral vascular disease.\n\nDischarge condition and function: Patient is hemodynamically stable, afebrile, ambulating with minimal assistance, and tolerating oral intake. Home health services arranged for skilled nursing to assist with medication reconciliation and administration, daily weight monitoring and heart-failure symptom surveillance, PICC/IV flush care as needed, and outpatient laboratory draws (BMP, CBC) for electrolyte and hemoglobin monitoring.\n\nMedications at discharge: Aspirin, carvedilol, digoxin, ezetimibe, furosemide, lisinopril, ondansetron PRN, pantoprazole, simvastatin, spironolactone, trazodone. Anticoagulation for atrial fibrillation is held pending GI/cardiology reassessment.\n\nFollow-up: GI within 7 days for re-evaluation; cardiology within 7 days to reassess anticoagulation and heart-failure management; vascular surgery for renal artery aneurysm evaluation within 2 weeks; primary care within 1 week. Return precautions given for recurrent bleeding, worsening dyspnea, chest pain, or syncope.", "diagnosis_codes": ["K921"], "suggested_codes": ["D62", "E875", "I110", "I4891", "I5022", "I728", "I739", "K863"], "accepted_codes": ["D62", "E875", "I110", "I4891", "I5022", "I728", "I739", "K863"], "rejected_codes": [], "date": "2024-04-07T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 29962126, "discharge_summary": "Brief history of present illness: 34-year-old male presented emergently with a several-day history of worsening bloody diarrhea, crampy abdominal pain, decreased oral intake and weight loss. He has a known history of ulcerative colitis and presented dehydrated and tachycardic. Admission diagnosis: Ulcerative colitis, unspecified (K51.90) with associated severe protein-calorie malnutrition, anemia of chronic disease, enteropathic arthropathy (right ankle), and abnormal coagulation profile.\n\nHospital course: Admitted for IV fluids, bowel rest, VTE prophylaxis, and escalation of anti-inflammatory therapy. He received methylprednisolone IV with clinical improvement in stool frequency and pain and was transitioned to an oral prednisone taper prior to discharge. Supportive care included analgesia (acetaminophen), vitamin D supplementation, and nursing-assisted education for smoking cessation. Nutrition consulted and initiated caloric/protein supplementation; anemia addressed with iron evaluation and outpatient plan. Coagulation abnormalities were identified and monitored; no active bleeding or thrombotic event occurred.\n\nKey findings and procedures: Lower gastrointestinal endoscopic procedure documented (ICD-10-PCS 0DBN8ZX) with visualized diffuse colonic inflammation consistent with active ulcerative colitis; biopsies obtained. Labs notable for moderate anemia and abnormal coagulation indices on admission; both trended toward stability with treatment.\n\nDischarge condition and functional status: Patient is clinically improved, afebrile and hemodynamically stable at discharge. He ambulates with mild limitation from right ankle enteropathic arthropathy and requires intermittent assistance with medication management and home monitoring of stools and weight. Home health nursing is arranged for medication reconciliation, skilled monitoring of labs (CBC, CMP, coagulation studies), wound/skin checks as needed, and assistance with activities of daily living during recovery.\n\nMedications and follow-up: Discharged on oral prednisone taper (following IV methylprednisolone), acetaminophen PRN, prophylactic heparin as indicated per home health/clinic plan, vitamin D, and zolpidem PRN for sleep. Plan: GI follow-up within 1\u20132 weeks, primary care within 5\u20137 days, nutrition follow-up and outpatient rheumatology/orthopedics for ankle pain as needed. Home health to coordinate outpatient labs (CBC, coagulation profile) within 72 hours and report abnormalities to the treating physician.", "diagnosis_codes": ["K5190"], "suggested_codes": ["D638", "E43", "R791", "M0729"], "accepted_codes": ["D638", "E43", "R791"], "rejected_codes": ["M0729"], "date": "2024-01-09T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 22058345, "discharge_summary": "Mr. [LastName], a 75-year-old man, admitted electively and hospitalized for 6 days for infection of an internal right knee prosthesis (T84.53XA) complicated by MSSA sepsis, hyponatremia, and bacteremia. Presenting with fever, right knee pain and drainage. Initial blood cultures grew methicillin-susceptible Staphylococcus aureus; urine testing consistent with UTI. Past medical history notable for type 2 diabetes, CKD stage 3, hypertension, hyperlipidemia, and benign prostatic hyperplasia.\n\nHospital course: He was treated with IV fluids, electrolyte correction for hypo-osmolality/hyponatremia, glycemic management, and IV cefazolin. Repeat blood cultures became negative after initiation of therapy. Transesophageal echocardiogram raised concern for possible valve involvement; cardiology consulted. Nephrology and infectious disease were involved. A right-sided PICC was placed for continued outpatient IV antibiotics. Pain was managed with acetaminophen; bowel regimen started for opioid-sparing management. He remained hemodynamically stable and afebrile for >48 hours prior to discharge.\n\nKey findings and procedures: Positive MSSA bacteremia originating from prosthetic knee (T84.53XA), transient hyponatremia (E87.1) corrected, evidence suggestive of endocarditis (I38) under outpatient evaluation. Procedures: PICC placement for long-term antibiotics and irrigation/drainage procedures at the surgical site as indicated.\n\nDischarge condition and functional status: He is medically stable for discharge to home with home health. He ambulates with a rolling walker with assistance; requires help with transfers and wound care dressing changes. Home health to provide skilled nursing for IV cefazolin administration, PICC care/heparin flushes, daily wound assessment, medication management, and physical therapy for gait and strengthening.\n\nMedications and follow-up: Discharge meds include IV cefazolin via PICC (planned 4\u20136 week course per ID), acetaminophen, atorvastatin, aspirin EC, hydrochlorothiazide, insulin per sliding scale, finasteride, docusate and bisacodyl as bowel regimen. Outpatient follow-up: Infectious Disease within 48\u201372 hours, Orthopedics 7\u201310 days for prosthesis management, Cardiology for endocarditis evaluation within 1 week, Nephrology PRN, and primary care within 3\u20135 days. Home health to monitor labs (CBC, BMP, blood cultures if indicated) and report any fever, increased pain, or PICC complications immediately.", "diagnosis_codes": ["T8453XA"], "suggested_codes": ["A4101", "E119", "E785", "E871", "I38", "N183", "N390", "N400", "I10"], "accepted_codes": ["A4101", "E119", "E785", "E871", "I38", "N183", "N390", "N400"], "rejected_codes": ["I10"], "date": "2024-05-02T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 28064341, "discharge_summary": "History of Present Illness: 61-year-old man presented via ED with 5 days of fevers, cough, dyspnea and malaise. SARS-CoV-2 PCR positive (U07.1). On arrival he was hypoxic requiring supplemental oxygen. Past medical history notable for type 2 diabetes, hypertension, hyperlipidemia and prior nicotine dependence.\n\nHospital Course: Admitted emergently for acute viral pneumonia with hypoxic respiratory failure. Treated with dexamethasone, supportive oxygen, prophylactic enoxaparin, and glycemic optimization with insulin. Received a course of inhalation/respiratory support with low-flow nasal cannula; he improved steadily and was weaned to room air on day 3. Hyponatremia (hypo-osmolality) noted on admission was corrected with careful fluid management and monitoring. He remained afebrile for 48 hours prior to discharge. No invasive ventilatory support or central line placement was required.\n\nKey Findings and Procedures: Initial chest radiograph showed bilateral interstitial/airspace opacities consistent with viral pneumonia. Labs notable for SARS-CoV-2 positive, initial sodium low with gradual normalization, and elevated inflammatory markers that trended down with therapy. Blood glucose required inpatient insulin titration. Influenza high-dose quadrivalent vaccine administered prior to discharge.\n\nDischarge Condition and Functional Status: He is hemodynamically stable, afebrile, and ambulates with minimal assistance at baseline home mobility. Respiratory status improved; the patient is stable on room air at rest and with light activity but may have exertional dyspnea. Independent with activities of daily living with occasional assistance for stair ambulation; home health should assess mobility, oxygen needs, and fall risk.\n\nMedications and Follow-up: Discharged on dexamethasone to complete prescribed course, insulin regimen for diabetes, losartan for BP control, atorvastatin, acetaminophen as needed, and enoxaparin prophylaxis per short-term plan. Glucose gel and glucagon provided for hypoglycemia rescue. Plan for primary care follow-up in 3\u20135 days, pulmonary clinic in 2\u20134 weeks, and endocrinology as outpatient for insulin titration. Patient counseled on COVID isolation, return precautions, and when to seek urgent care for worsening dyspnea, chest pain, or confusion.", "diagnosis_codes": ["Z87891", "E119", "J9601", "J1289", "I10", "U071", "E785", "E871"], "suggested_codes": [], "accepted_codes": [], "rejected_codes": [], "date": "2024-09-18T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 25210937, "discharge_summary": "32-year-old GxP patient with pre-existing type 1 diabetes mellitus admitted urgently in labor and underwent repeat low transverse cesarean delivery for previous cesarean scar. Admission complicated by labile glycemic control, gestational hypertension without significant proteinuria, hypothyroidism, and peripartum anxiety/depressive symptoms. Length of stay: 4.1 days. Baby well; mother prepared for discharge to home with home health support.\n\nHistory of present illness: Patient with long-standing type 1 diabetes presented in active labor. Peripartum course notable for hyper- and hypoglycemic episodes requiring IV dextrose and insulin titration. She also developed postoperative pain and mild wound erythema without systemic signs of infection. Mental health history significant for new/worsening depressive and anxiety symptoms in the peripartum period.\n\nHospital course: Cesarean delivery (repeat low transverse) performed without intraoperative complications. Postop analgesia and VTE prophylaxis instituted (enoxaparin). Glycemic management included basal-bolus insulin adjustments and short-acting regular insulin coverage with IV D10/D50 used for symptomatic hypoglycemia when needed. Thyroid replacement continued. Wound observed; no abscess or dehiscence. Psychiatry consulted and bupropion XL restarted; supportive counseling provided. Patient educated on newborn care, insulin administration, and recognition/treatment of hypoglycemia.\n\nKey findings and procedures: Repeat low transverse cesarean delivery; perioperative labs showed variable glucose values requiring titration; wound without deep infection; stable hemodynamics; no thromboembolic events.\n\nDischarge condition and functional status: Stable, afebrile, hemodynamically stable, ambulating with assistance, able to perform most self-care tasks but benefits from home health assistance for wound checks, insulin administration support/teaching, and postpartum mood monitoring. Pain controlled on oral analgesics.\n\nMedications and follow-up: Continue home insulin regimen with adjusted dosing (basal-bolus with regular insulin for coverage) and glucose monitoring q4\u20136h and PRN for hypoglycemia; enoxaparin for VTE prophylaxis as outpatient for 7 days; bupropion XL resumed; continue levothyroxine; acetaminophen/ibuprofen for pain; stool softener. Arrange home health nursing for wound care, insulin teaching, and glucose checks; OB follow-up in 1 week, endocrinology within 1 week, and postpartum psychiatry/therapy within 7\u201314 days. Return precautions reviewed.", "diagnosis_codes": ["O2402", "O9952"], "suggested_codes": ["E039", "Z794", "F530", "L03116", "O13", "Z9189"], "accepted_codes": ["E039", "Z794"], "rejected_codes": ["F530", "L03116", "O13", "Z9189"], "date": "2024-05-06T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 26479276, "discharge_summary": "58-year-old male admitted to observation for symptomatic hypotension attributed to antihypertensive medication effect (primary Dx: I95.2) after a syncopal episode at home. Past medical history notable for type 2 diabetes mellitus without complications, essential hypertension, chronic gastritis, and baseline anemia. Presentation: lightheadedness, presyncopal episode, documented systolic blood pressures in the 80s\u201390s mmHg; finger-stick glucose was low on arrival and corrected in ED.\n\nHospital course: Over a 3.1-day observation stay the patient received intravenous isotonic fluid resuscitation (normal saline boluses), glucose correction with D50, oral glucose gel and glucagon as needed for documented hypoglycemia, and insulin adjusted per sliding scale for hyperglycemia after initial correction. Cosyntropin stimulation testing was performed to evaluate possible adrenal insufficiency given persistent hypotension; results were pending at discharge but acute adrenal crisis was not identified. Antihypertensive medications were held while hemodynamics stabilized. Hematology labs showed mild normocytic anemia and abnormalities in blood chemistry that trended toward baseline with supportive care. No invasive procedures were required.\n\nKey findings and procedures: hypotension due to adverse effect of antihypertensive agents, transient hypoglycemia requiring D50 and glucagon, IV fluid resuscitation, cosyntropin stimulation test performed, laboratory monitoring including CBC and BMP, and telemetry monitoring without arrhythmia.\n\nDischarge condition and functional status: hemodynamically stable at discharge with systolic BP consistently >110 mmHg off offending agents; able to ambulate independently in the room and perform basic ADLs. Recommended home health to assist with medication reconciliation, twice-daily vital signs (BP and pulse) and blood glucose monitoring for the next 7\u201314 days, and assistance with diabetes education and nutrition counseling as needed.\n\nMedications and follow-up: Discharge meds include aspirin 81 mg daily, insulin per adjusted regimen, glucagon emergency kit and glucose gel PRN, and instructions to withhold prior antihypertensive agents pending PCP/primary care review. Outpatient follow-up with PCP within 48\u201372 hours, endocrinology in 1\u20132 weeks, and repeat labs (BMP, CBC) in 2\u20133 days. Return precautions given for recurrent hypotension, syncope, chest pain, or recurrent hypoglycemia.", "diagnosis_codes": ["I952"], "suggested_codes": ["D649", "E119", "I10", "K2970", "E162"], "accepted_codes": ["D649", "E119", "I10", "K2970"], "rejected_codes": ["E162"], "date": "2024-06-07T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 24444590, "discharge_summary": "History of present illness: 29-year-old female presented urgently at 37 weeks gestation for maternal care for suspected poor fetal growth and onset of spontaneous labor. Antenatal record significant for growth concern; patient developed active labor with variable fetal heart rate decelerations consistent with an intrapartum cord complication.\n\nHospital course: Continuous fetal monitoring and maternal/fetal assessment performed. Labor progressed to a spontaneous vaginal delivery of a single live neonate at 37 0/7 weeks. Delivery was complicated by a cord abnormality identified intrapartum, managed expectantly with resuscitative measures as needed. The patient sustained a second-degree perineal laceration which was repaired in the delivery suite under local anesthesia. Postpartum recovery was uncomplicated. Pain controlled with oral analgesics. Bowel regimen initiated to prevent constipation. Lactation consultant provided feeding support. Varicella vaccine administered prior to discharge.\n\nKey findings and procedures: suspected fetal growth restriction (O36.5930), intrapartum cord complication (O69.89x0), spontaneous vaginal delivery at 37 weeks (Z37.0, Z3A.37). Perineal examination confirmed a second-degree laceration (O70.1) and primary repair was performed. Vital signs and bleeding stable throughout admission. No infectious or hemodynamic complications.\n\nDischarge condition and functional status: Patient is medically stable for discharge. Ambulation: ambulatory independently on flat surfaces with mild perineal discomfort. Activities of daily living: able to perform self-care and infant care but requires home health assistance for perineal wound care, medication administration guidance, and lactation support. Pain is controlled with oral medications; wound healing appropriate at discharge.\n\nMedications and follow-up: Discharge prescriptions include acetaminophen and ibuprofen for analgesia, docusate sodium and bisacodyl for bowel regimen, milk of magnesia PRN, calcium carbonate PRN, simethicone PRN, Dermoplast spray for topical perineal comfort. Varicella immunization documented. Arrange obstetric follow-up within 1 week for wound check and routine postpartum visit at 4\u20136 weeks; pediatric follow-up within 48\u201372 hours. Home health to provide wound care, pain management, breastfeeding support, medication reconciliation, and education. Return precautions: fever, heavy bleeding, worsening pain, or signs of wound infection; seek immediate care for newborn concerns.", "diagnosis_codes": ["Z3A37", "O365930", "Z370"], "suggested_codes": ["O6989X0", "O701", "Z23"], "accepted_codes": ["O6989X0", "O701"], "rejected_codes": ["Z23"], "date": "2024-02-22T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 28578257, "discharge_summary": "History of Present Illness: 66-year-old male with history of acute myeloblastic leukemia in remission after recent allogeneic stem cell transplant who presented emergently with fever, diarrhea, hypotension and concern for transplant-related complications. He was found to have graft-versus-host disease (GVHD), bacteremia with Staphylococcus species, right internal jugular venous thrombosis, and acute kidney injury (AKI).\n\nHospital Course: Patient was admitted directly to the acute care service for broad-spectrum IV antibiotics, hemodynamic support, diagnostic evaluation and supportive care. Blood cultures grew Staphylococcus; infectious disease recommended IV daptomycin. He received antiviral prophylaxis with acyclovir and topical/systemic therapy for GVHD (clobetasol cream and budesonide as indicated). Anticoagulation was initiated for right internal jugular thrombosis and transitioned to apixaban at discharge after stabilization. AKI was managed with fluid optimization and avoidance of nephrotoxins; renal function has partially recovered (creatinine improving but above baseline). Diarrhea and metabolic acidosis were treated supportively. Nutritional status monitored with supplementation including folic acid. He required placement of a central venous catheter for prolonged IV therapy and blood sampling; PICC line was placed without complication.\n\nKey Findings and Procedures: positive blood cultures for Staphylococcus species; imaging confirming right internal jugular venous thrombosis; evidence of GVHD; AKI (stage unspecified) with improving creatinine. Procedures: central venous access (PICC) placement and routine line care; infusion of IV antibiotics.\n\nDischarge Condition and Functional Status: He is afebrile and hemodynamically stable at discharge. Ambulates with minimal assistance in the hospital and performs basic ADLs with intermittent support; deconditioning present but improving. Home health nursing recommended for IV antibiotic administration, PICC care, wound/skin/GVHD assessments, and periodic vital sign/weight checks.\n\nMedications and Follow-up: Discharged on IV daptomycin via home infusion, apixaban for venous thrombosis, acyclovir prophylaxis, topical clobetasol and budesonide for GVHD, insulin as needed for hyperglycemia, and supportive meds (loperamide prn, folic acid). Follow-up arranged with Hematology/Oncology and Transplant clinic within 7 days, Infectious Disease within 3\u20135 days, Nephrology in 1\u20132 weeks, and Home Health RN for daily skilled care and lab draws (monitor CBC, CMP, creatinine, drug levels as indicated).", "diagnosis_codes": ["T865"], "suggested_codes": ["N179", "A419", "I8089", "T8650", "Z4802", "Z79899"], "accepted_codes": ["N179"], "rejected_codes": ["A419", "I8089", "T8650", "Z4802", "Z79899"], "date": "2024-09-03T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 24386563, "discharge_summary": "History of present illness: 51-year-old female admitted for planned right breast oncologic resection for biopsy-proven malignant neoplasm of overlapping sites of the right breast (C50.811). Past medical history notable for obesity, GERD, hypothyroidism (on levothyroxine), prior genetic risk for breast cancer, and ventral hernia. She was a same-day surgical admission and remained inpatient 4.5 days for perioperative management.\n\nHospital course: The patient underwent right mastectomy with sentinel lymph node biopsy and axillary sampling under general anesthesia. Intraoperative and immediate postoperative course was complicated by hypotension and an episode of supraventricular tachycardia (SVT). She received fluid resuscitation, brief vasopressor support, and rate control with medication with subsequent hemodynamic stabilization. She developed acute posthemorrhagic anemia and received packed red blood cell transfusion(s) with improvement in hemoglobin. She received standard perioperative antibiotics, DVT prophylaxis, antiemetic and multimodal analgesia. No evidence of surgical site infection; drains placed intraoperatively were managed and removed prior to discharge per surgery team. Final pathology pending; tumor noted to be estrogen receptor positive.\n\nKey findings and procedures: right mastectomy, sentinel lymph node biopsy/axillary sampling, intra-/postoperative transfusion for acute anemia, transient SVT treated medically.\n\nDischarge condition and functional status: Patient is hemodynamically stable, afebrile, and ambulatory with supervision at time of discharge. She requires assistance with dressing changes and short-distance ambulation due to postoperative pain and deconditioning; safe for discharge with home health skilled nursing and physical therapy.\n\nMedications at discharge: levothyroxine (continue home dose), oral analgesics (short course oxycodone PRN and scheduled acetaminophen), stool softener (docusate), antiemetic PRN (ondansetron), and oral antibiotics as prescribed. Influenza vaccine administered prior to discharge.\n\nFollow-up plan: Home health arranged for wound care/dressing changes, vital sign monitoring, medication reconciliation, and PT twice weekly. Surgical clinic follow-up in 7\u201310 days for wound check and pathology review; medical oncology appointment within 2\u20134 weeks to discuss adjuvant therapy; cardiology follow-up for SVT evaluation and PCP visit with CBC and metabolic panel within 72 hours to reassess anemia and electrolytes.", "diagnosis_codes": ["I471", "K439", "E890", "I959", "D62", "K219", "Z6838", "E669", "Z170", "Z1501", "Z923", "C50811"], "suggested_codes": ["Z511", "Z515", "Z521", "Z7489"], "accepted_codes": [], "rejected_codes": ["Z511", "Z515", "Z521", "Z7489"], "date": "2024-02-12T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 23812786, "discharge_summary": "History of Present Illness: 77-year-old man presented after a fall down stairs with closed injury to the right lower leg. Imaging demonstrated an unspecified fracture of the lower end of the right tibia (S82.301A). Past medical history notable for heart failure (I50.9), traumatic arthropathy (M12.50), and history of nicotine dependence (Z87.891).\n\nHospital Course: The patient was observed for 4.3 days. He underwent operative supplemental fixation of the right distal tibia (ICD-10-PCS 0QSG04Z) without intraoperative complication. Postoperatively he was managed with analgesia, DVT prophylaxis, and diuresis for congestive symptoms. He had transient alcohol withdrawal symptoms treated per CIWA protocol with diazepam taper. No signs of surgical site infection or cardiopulmonary decompensation occurred. Pain was controlled to allow participation in early physical therapy. Serial basic labs and chest exam remained stable.\n\nKey Findings and Procedures: Right distal tibial fracture confirmed on radiographs; operative supplemental fixation performed. Post-op x-ray acceptable alignment. No acute cardiopulmonary event. Evaluated by PT/OT for mobility and safety; baseline cognition intact.\n\nDischarge Condition and Functional Status: Hemodynamically stable, afebrile, and euvolemic for discharge. Ambulation: currently limited weight bearing on the right lower extremity (touch-down to non-weight bearing as instructed). Requires assistive device and caregiver support for transfers and ADLs; home health physical therapy will provide gait training and strengthening. Wound: surgical dressing intact; home health to perform dressing changes and incision checks.\n\nMedications and Follow-up: Discharge meds include acetaminophen, oxycodone IR PRN for breakthrough pain, gabapentin, enoxaparin for DVT prophylaxis, furosemide and lisinopril for heart failure, docusate and senna as bowel regimen, ondansetron PRN, and a short diazepam taper per discharge plan. Home health to monitor vitals, medication adherence, wound care, and fall prevention. Follow-up: Orthopedics in 7\u201310 days for wound check and repeat x-ray; Primary care/Cardiology within 7 days for CHF med reconciliation. Smoking cessation counseling provided.", "diagnosis_codes": ["M1250", "S82301A", "I509", "Z87891"], "suggested_codes": ["F1020", "Z794", "Z796"], "accepted_codes": [], "rejected_codes": ["F1020", "Z794", "Z796"], "date": "2024-02-29T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 26818978, "discharge_summary": "History of Present Illness: 30-year-old G?P? female admitted urgently for term (40 weeks) spontaneous vaginal delivery complicated by chorioamnionitis and a second-degree perineal laceration sustained during delivery. She has a history of pre-existing hypertension complicating childbirth that was monitored and managed during admission.\n\nHospital Course: Patient underwent vaginal delivery with oxytocin augmentation and prompt recognition of chorioamnionitis. She received appropriate intrapartum IV antibiotics (gentamicin and ampicillin) and supportive care with IV fluids and antiemetics. The second-degree perineal laceration was repaired in the delivery room under appropriate anesthesia; hemostasis was achieved. Postoperative course was uncomplicated. Vital signs stabilized, pain controlled with multimodal analgesia, and blood loss was within expected limits. Hypertension was monitored and remained controlled on her outpatient regimen; no antihypertensive escalation was required. Baby delivered live and stable; pediatric care and feeding established.\n\nKey Findings and Procedures: Term singleton live birth at 40 weeks; diagnosis included second-degree perineal laceration, chorioamnionitis, and pre-existing hypertension complicating childbirth. Procedures: vaginal delivery with primary repair of second-degree perineal laceration; administration of IV antibiotics and oxytocin. Relevant labs and clinical exam showed no ongoing sepsis, acceptable hemoglobin, and intact repair on exam.\n\nDischarge Condition and Functional Status: Patient is discharged in stable condition, afebrile for >24 hours, pain controlled on oral meds. She ambulates independently with mild perineal discomfort and is able to perform most ADLs and care for the newborn but will benefit from home health assistance for wound care, instruction in perineal hygiene, and bowel regimen support.\n\nMedications and Follow-up: Discharge meds \u2014 acetaminophen 500\u20131000 mg q4\u20136h PRN, ibuprofen 600 mg q6\u20138h PRN, docusate sodium 100 mg BID, bisacodyl 10 mg PRN, Dermoplast topical spray PRN, famotidine 20 mg BID PRN, calcium carbonate PRN, ondansetron 4 mg PRN. IV antibiotics completed inpatient; no further systemic antibiotics prescribed. Follow-up: OB postpartum visit in 1 week for wound/BP check; sooner if fever, worsening pain, purulent drainage, heavy bleeding, or severe headache/visual changes. Home health to provide wound checks, perineal care education, and postpartum support.", "diagnosis_codes": ["O701"], "suggested_codes": ["O10019", "O411XX1"], "accepted_codes": [], "rejected_codes": ["O10019", "O411XX1"], "date": "2024-06-08T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 29894331, "discharge_summary": "Brief history of present illness: 38-year-old man with history of combined liver and kidney transplant status who presented emergently with fever, diarrhea, progressive dyspnea and declining urine output. Hospital evaluation revealed CMV infection (B25.9) with pancytopenia and rising creatinine consistent with acute kidney injury on chronic graft dysfunction and features of hepatorenal physiology. He required inpatient IV antiviral therapy and renal support.\n\nHospital course: Over a 5.8-day admission the patient received IV ganciclovir with loading and transition plan for outpatient therapy, broad supportive care for viral enteritis, and targeted management of cytopenias including folic acid and transfusion support as indicated. He developed worsening azotemia requiring temporary hemodialysis via a tunneled central venous catheter placed for vascular access. Infectious disease, nephrology and transplant hepatology were consulted and coordinated care. Pancytopenia and diarrhea improved with therapy; he remained hemodynamically stable without vasopressor support.\n\nKey findings and procedures: Positive CMV PCR with clinical CMV disease; laboratory evidence of pancytopenia (neutropenia, anemia, thrombocytopenia); acute rise in creatinine consistent with AKI on chronic graft dysfunction. Procedures: placement of temporary dialysis catheter and initiation of hemodialysis. Vascular access and line care education completed.\n\nDischarge condition and functional status: Patient is medically stable for discharge. Ambulates short distances with minimal assistance and requires home support for activities of daily living and medication administration. Oxygen not required at rest.\n\nMedications and follow-up plan: Discharge medications include IV/infusion plan for ganciclovir (home infusion arrangement), prophylactic atovaquone, folic acid, analgesics and neuropathic agents (gabapentin), insulin as needed, anticoagulation/heparin per dialysis protocol, and scheduled outpatient immunosuppression adjustments by transplant clinic. Home health nursing arranged for IV antiviral administration, dialysis coordination, wound/line care, medication reconciliation, and lab draws (CBC, CMP, CMV PCR twice weekly initially). Follow-up appointments: transplant nephrology and hepatology within 3\u20137 days, infectious disease within 1 week, and primary care within 1\u20132 weeks. Return precautions reviewed.", "diagnosis_codes": ["B259"], "suggested_codes": ["N179", "R197", "Z944", "D6181", "Z9481", "Z992"], "accepted_codes": ["N179", "R197", "Z944"], "rejected_codes": ["D6181", "Z9481", "Z992"], "date": "2024-03-02T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 23908704, "discharge_summary": "History of Present Illness: 72-year-old female admitted as a same-day surgical patient for transcatheter aortic valve replacement (TAVR) for symptomatic severe nonrheumatic aortic stenosis (I35.0). Past medical history notable for hypertensive chronic kidney disease (I12.9), type 2 diabetes with diabetic CKD (E11.22), chronic kidney disease unspecified (N18.9), left bundle branch block (I44.7), first-degree AV block (I44.0), hyperlipidemia (E78.5), obstructive sleep apnea, asthma, and family history of ischemic heart disease.\n\nHospital Course: The patient underwent successful percutaneous replacement of the aortic valve (ICD-10-PCS 02RF38Z) without immediate complication. Postoperative course was uncomplicated over a 2.4-day stay. She remained hemodynamically stable, euvolemic, and afebrile. Continuous telemetry showed no high-grade AV block; no pacemaker was required. Vascular access site was clean, without hematoma or active bleeding. A post-procedure transthoracic echocardiogram demonstrated a well-seated prosthetic aortic valve with improved transvalvular gradients and no significant paravalvular leak. Renal function remained stable for baseline CKD; electrolytes monitored and managed while on diuretics.\n\nKey Findings/Procedures: Severe aortic stenosis treated with percutaneous prosthetic aortic valve replacement (TAVR). Relevant comorbid diagnoses as listed above. No immediate conduction disturbances requiring pacing; access site intact.\n\nDischarge Condition and Functional Status: Patient discharged in stable condition. Ambulates with supervision and uses a cane at baseline; requires assistance with medication management and light household tasks\u2014home health to assist with safety/fall risk assessment, activity progression, and medication reconciliation. Skin/wound status: access site clean and dry; home health to perform dressing checks.\n\nMedications and Follow-up: Discharged on dual antiplatelet therapy (Aspirin and Clopidogrel), atorvastatin and ezetimibe for lipid management, losartan, metoprolol succinate XL, bumetanide and spironolactone for volume control, allopurinol, famotidine, docusate, senna, ondansetron PRN, and acetaminophen PRN. Monitor BMP and renal function within 48\u201372 hours post-discharge and as needed. Cardiology follow-up in 1 week, primary care/renal clinic in 1\u20132 weeks. Home health to monitor vitals, weights, wound site, medication adherence, and to report chest pain, syncope, fever, worsening dyspnea, or new leg swelling immediately.", "diagnosis_codes": ["G4733", "I440", "Z8249", "Z006", "I129", "J45909", "I350"], "suggested_codes": ["E1122", "E785", "I447"], "accepted_codes": ["E1122", "E785", "I447"], "rejected_codes": [], "date": "2024-09-25T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 27218059, "discharge_summary": "History of Present Illness: 53-year-old man admitted electively for symptomatic severe nonrheumatic aortic stenosis complicated by acute on chronic diastolic (congestive) heart failure. He presented with progressive dyspnea on exertion, lower extremity edema, and decreased exercise tolerance. Past history notable for hypertension with hypertensive heart disease, COPD, prior TIA, obesity, and chronic kidney disease. Hospital Course: The patient underwent open surgical aortic valve replacement with placement of a prosthetic valve. He required short-term postoperative invasive ventilation and ICU monitoring. Postoperatively he developed acute posthemorrhagic anemia requiring transfusion and transient acute kidney injury managed with fluid optimization and avoidance of nephrotoxins; renal function trended toward baseline. He had mild atelectasis treated with incentive spirometry and pulmonary toilet; COPD exacerbation addressed with bronchodilator therapy. He received appropriate VTE prophylaxis and stress ulcer prophylaxis. Psychiatry/social work involved for baseline anxiety/depression and discharge planning. Key Findings and Procedures: Preoperative echocardiography demonstrated severe aortic stenosis with preserved LV systolic function and diastolic dysfunction. Procedures performed: surgical aortic valve replacement (prosthetic), arterial and central line placement, and temporary postoperative mechanical ventilation. Post-op chest radiograph notable for small bibasilar atelectasis. Hemoglobin stabilized after transfusion; creatinine improved from peak value. Discharge Condition and Functional Status: At discharge he is medically stable, hemodynamically euvolemic, and afebrile. Ambulates with a rolling walker and assistance due to deconditioning; requires help with some ADLs and stair negotiation. Home health services arranged for skilled nursing wound checks, IV line care if needed, medication reconciliation, and home physical therapy for gait/balance and progressive mobility training. Medications at Discharge: Aspirin EC 81 mg daily, furosemide 20\u201340 mg daily as needed for volume overload, albuterol inhaler 2 puffs PRN, escitalopram 10 mg daily (home med resumed), famotidine 20 mg BID, acetaminophen 500 mg PRN, and stool regimen (bisacodyl PRN). Follow-up Plan: Cardiac surgery clinic in 7\u201314 days, cardiology in 1 week, nephrology as outpatient in 1 week for AKI follow-up, and primary care in 1 week. Return to ED for chest pain, dyspnea at rest, fever, or signs of wound infection.", "diagnosis_codes": ["I350"], "suggested_codes": ["D62", "F419", "I110", "N179", "E669", "F339", "I5020", "I69398", "J441", "J9841", "Z9189"], "accepted_codes": ["D62", "F419", "I110", "N179"], "rejected_codes": ["E669", "F339", "I5020", "I69398", "J441", "J9841", "Z9189"], "date": "2024-11-11T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 28883548, "discharge_summary": "History of Present Illness: The patient is an 83-year-old woman admitted under observation for acute onset left-eye ptosis and complete external ophthalmoplegia. Presentation included diplopia and progressive eyelid droop over several days. Past medical history notable for type 2 diabetes mellitus, essential hypertension, hyperlipidemia, obstructive sleep apnea with home CPAP, prior cardiac pacemaker, and depression.\n\nHospital Course: The patient was observed for 4.8 days. Neurology and ophthalmology were consulted. Workup included neuroimaging and laboratory testing which excluded acute hemorrhage or large-vessel ischemia. Laboratory evaluation demonstrated hyponatremia consistent with euvolemic SIADH; sodium improved with fluid restriction and careful monitoring. Blood glucose was managed with sliding-scale and basal insulin while inpatient. Pacemaker interrogation confirmed appropriate function. The patient received supportive eye care (lubricating drops and intermittent patching) and analgesia as needed. No acute respiratory or hemodynamic compromise occurred; telemetry remained stable.\n\nKey Findings and Procedures: Primary diagnosis: left-sided total (external) ophthalmoplegia/third nerve palsy. Significant comorbid diagnoses: SIADH, type 2 diabetes mellitus, essential hypertension, hyperlipidemia, obstructive sleep apnea, and presence of cardiac pacemaker. Procedures performed: pacemaker interrogation and continuous cardiac monitoring; intravenous fluid and electrolyte management; bedside ophthalmologic examination and documentation of extraocular movement deficit.\n\nDischarge Condition and Functional Status: Patient is medically stable for discharge to home with home health services. Ambulates short distances with a rolling walker; requires assistance with transfers and some ADLs due to visual impairment and deconditioning. Fall risk precautions in place; home health instructed to assist with mobility, medication administration, and activities of daily living.\n\nMedications and Follow-up: Discharge medications include acetaminophen PRN, amoxicillin-clavulanate (as prescribed), artificial tears and eyelid care, aspirin, atorvastatin, lisinopril, insulin regimen for diabetes, escitalopram, and clonazepam PRN for anxiety/sleep. Home health to monitor vitals, daily weights, blood glucose, and sodium levels; coordinate outpatient neurology/ophthalmology follow-up within 1 week and primary care within 3\u20135 days. Continue CPAP at home. Return precautions reviewed.", "diagnosis_codes": ["H4922", "H02402", "H4912", "F329", "H4902", "E119", "G4733", "I10", "Z794", "Z950", "E785", "H4932", "Z20822"], "suggested_codes": ["E221"], "accepted_codes": [], "rejected_codes": ["E221"], "date": "2024-02-28T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 27965965, "discharge_summary": "86-year-old female admitted to observation for evaluation and management of symptomatic iron\u2011deficiency anemia and new abdominal pain. Prior history notable for malignant neoplasm of ascending colon with known hepatic metastases, essential hypertension, bilateral knee osteoarthritis, right hip arthroplasty, chronic nicotine use (history), and baseline cognitive vulnerability. On presentation she had progressive fatigue and decreased oral intake; imaging and endoscopic evaluation confirmed an obstructing-appearing mass in the ascending colon with hepatic lesions consistent with metastases.\n\nHospital course: Patient was observed for three days for peri-procedural management and symptom control. She underwent operative intervention (right-sided colon resection/segmental excision and regional lymphadenectomy; ICD\u201110\u2011PCS 0FB23ZX) with concurrent liver-directed procedure(s) (ICD\u201110\u2011PCS 3E0U33Z, 3E0U3BZ). Intraoperative course was uncomplicated. Postoperatively she recovered in the observation unit with return of bowel function by postoperative day 2. Pain was managed with short\u2011course opioid therapy and transition to scheduled nonopioid agents as tolerated. She experienced transient delirium likely multifactorial (medication effect and hospitalization); this improved after holding sedating agents and optimizing hydration and sleep-wake measures. No transfusion was required. Pathology and final oncology staging are pending.\n\nKey findings/procedures: ascending colon malignancy with radiologic hepatic metastases; surgical resection of colon mass with regional lymphadenectomy and liver-directed procedure as above. Relevant ICD\u201110 diagnoses at discharge include C18.2 (ascending colon malignancy), C78.7 (secondary liver malignancy), I10, iron\u2011deficiency anemia, and medication adverse effect noted during stay.\n\nDischarge condition and functional status: Patient is stable, afebrile, hemodynamically stable, ambulating with a walker and requires assistance with activities of daily living and home mobility. Wound sites clean, dry, intact; requires home wound checks and medication management.\n\nMedications and follow-up: Discharged on aspirin, chlorthalidone, cyanocobalamin, ferrous sulfate, montelukast, omeprazole, short\u2011term morphine sulfate/oxycodone as needed, sertraline, and routine sodium chloride flushes as indicated. Home health nursing to initiate within 24\u201348 hours for wound care, med reconciliation, and assistance with ADLs; home PT/OT for mobility and fall\u2011risk assessment. Surgical clinic follow-up in 7\u201310 days; oncology follow\u2011up in 1\u20132 weeks for staging/treatment planning; PCP in 1 week with CBC and CMP prior to visit.", "diagnosis_codes": ["C182"], "suggested_codes": ["C787", "D509", "I10", "M170", "Z96641", "F068", "G9340", "Y579"], "accepted_codes": ["C787", "D509", "I10", "M170", "Z96641"], "rejected_codes": ["F068", "G9340", "Y579"], "date": "2024-08-15T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 20135684, "discharge_summary": "History of present illness: 31-year-old female presented to the emergency department with 3 weeks of progressive daily headaches, described as throbbing and worse with Valsalva, associated with transient visual obscurations and pulsatile tinnitus. She has a history of asthma and GERD. On arrival she was hemodynamically stable. Neurologic exam demonstrated bilateral optic disc edema consistent with papilledema.\n\nHospital course: Patient was observed for intracranial pressure management and diagnostic evaluation. Non-contrast head CT showed no acute hemorrhage. Given clinical concern for benign intracranial hypertension (pseudotumor cerebri), a diagnostic and therapeutic lumbar puncture was performed with measured elevated opening pressure and removal of CSF, which produced partial symptomatic relief. Acetazolamide was initiated for medical management of increased intracranial pressure. Subcutaneous heparin was administered for inpatient DVT prophylaxis. Bowel regimen (senna and bisacodyl) was provided due to anticipated acetazolamide-related constipation. COVID-19 exposure was noted; patient advised on testing and precautions; home health instructed to use appropriate PPE.\n\nKey findings and procedures: bilateral papilledema on fundoscopic exam; elevated opening pressure on lumbar puncture; therapeutic CSF removal (lumbar puncture) performed. No focal neurologic deficit; CT head without acute intracranial hemorrhage.\n\nDischarge condition and functional status: Patient discharged in stable condition on the same day of observation with improving headache and preserved baseline mobility. She is independent with basic ADLs but reports intermittent headache limiting prolonged activity; home health will assist with medication management, visual monitoring, and fall-risk assessment.\n\nMedications and follow-up plan: Discharge medications include acetazolamide (for intracranial hypertension), acetaminophen PRN for pain, senna and bisacodyl for bowel regimen. Heparin was given inpatient for prophylaxis and is not continued at discharge. Home health nurse to provide medication reconciliation, teach acetazolamide side effects, and perform vision checks. Follow-up with neurology within 7 days and ophthalmology within 48\u201372 hours for papilledema surveillance. Return immediately for worsening vision, new focal deficits, severe unrelieved headache, or fever.", "diagnosis_codes": ["G932", "J45909", "Z20822"], "suggested_codes": ["H471", "K590", "R51"], "accepted_codes": [], "rejected_codes": ["H471", "K590", "R51"], "date": "2024-07-12T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 26921533, "discharge_summary": "History of present illness: 75-year-old female admitted emergently with fever, cough, dyspnea and confusion; testing positive for influenza (PCR) and urinalysis consistent with urinary tract infection. Past history notable for prior ischemic stroke with residual aphasia, type 2 diabetes with chronic kidney disease, hypertension, hyperlipidemia, and trigeminal neuralgia.\n\nHospital course: Length of stay 3.5 days. On admission she was treated with oseltamivir for influenza and initiated on IV ceftriaxone for presumed urosepsis. Empiric fluids (lactated Ringer\u2019s) and supportive care were provided. Blood cultures remained negative; urine culture grew Escherichia coli. She received enoxaparin for VTE prophylaxis and short-acting insulin for inpatient glycemic control. Creatinine was elevated on admission consistent with acute kidney injury on chronic kidney disease and improved toward baseline with fluids and avoidance of nephrotoxins. Blood pressure and glucose were stabilized with adjustment of home antihypertensives and insulin. No invasive procedures were required.\n\nKey findings and procedures: Positive influenza PCR; urine culture positive for E. coli; transient AKI with improving creatinine; no bacteremia. Continuous monitoring and supportive care; no imaging or surgical procedures during this admission.\n\nDischarge condition and functional status: Patient is afebrile, hemodynamically stable, ambulatory with assistance, and oriented to person though with baseline expressive aphasia. She requires assistance with activities of daily living and medication management; home health services arranged for skilled nursing visits to assist with medication administration, vitals and glucose checks, and ADL support. No supplemental oxygen required at discharge.\n\nMedications and follow-up plan: Discharged on completing appropriate oral antibiotic per culture and sensitivity to finish a 7-day total course; oseltamivir to complete 5 days; home regimen including acetaminophen PRN, aspirin, atorvastatin, carbamazepine ER, lisinopril and antihypertensives as previously listed, and insulin with home glucose monitoring. Patient/family instructed on sick-call parameters, return precautions, and hypoglycemia protocol (glucose gel/glucagon available). Labs (BMP) to be checked within 48\u201372 hours and repeated creatinine with primary care. Follow-up appointments: primary care within 3\u20135 days, nephrology within 1\u20132 weeks, and neurology/stroke clinic as outpatient. Home health will coordinate medication reconciliation and wound/continence care as needed.", "diagnosis_codes": ["J101"], "suggested_codes": ["E1122", "E785", "N179", "N390", "G501", "I10", "I639"], "accepted_codes": ["E1122", "E785", "N179", "N390"], "rejected_codes": ["G501", "I10", "I639"], "date": "2024-06-13T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 21263143, "discharge_summary": "History of present illness: 61-year-old male admitted for observation for acute upper gastrointestinal pain and melena, found to have a duodenal ulcer (ICD-10 K26.9). Admission complicated by acute kidney injury on chronic kidney disease, concerns for kidney transplant rejection, and metabolic acidosis. Past medical history notable for kidney transplant, type 2 diabetes with CKD, hypertension, hyperlipidemia, gout, cirrhosis, and prior pericardial effusion.\n\nHospital course: Patient observed for 6.8 days. He was kept NPO initially, started on IV pantoprazole and transitioned to high-dose oral PPI once tolerating diet. Hemodynamic status remained stable without need for transfusion. Nephrology evaluated for AKI and transplant rejection (T86.11); immunosuppression was adjusted in collaboration with transplant team and mycophenolate sodium DR continued as outpatient. Endoscopic evaluation was performed with therapeutic intervention for the duodenal ulcer; pathology/therapeutic details in the chart. Cardiology consulted for small, noninflammatory pericardial effusion and recommended outpatient follow-up. Glycemic control was managed with insulin in-hospital and discharge plan includes home glucose monitoring and insulin therapy adjustments.\n\nKey findings and procedures: Diagnostic endoscopy with therapeutic intervention for duodenal ulcer; renal function decline addressed by nephrology with medication adjustments; pericardial effusion observed on imaging; metabolic acidosis managed medically. Relevant procedure codes recorded in chart.\n\nDischarge condition and functional status: Patient is clinically stable, afebrile, hemodynamically stable, tolerating a soft oral diet, and ambulatory with baseline assistance. Home health recommended for medication reconciliation, daily vital signs and blood glucose checks, assistance with activities of daily living as needed, and assistance coordinating outpatient labs and appointments.\n\nMedications and follow-up: Discharged on pantoprazole, mycophenolate sodium DR, insulin regimen with glucose supplies, atorvastatin, carvedilol, aspirin, allopurinol, acetaminophen PRN, ondansetron PRN, atovaquone suspension, and other chronic meds. Avoid NSAIDs. Follow-up with transplant nephrology within 3\u20135 days, GI in 1\u20132 weeks, cardiology in 2\u20134 weeks, and primary care within 48\u201372 hours via home health. Labs (BMP, CMP, CBC) to be checked twice weekly until renal function stabilizes; return immediately for recurrent bleeding, chest pain, shortness of breath, or oliguria.", "diagnosis_codes": ["K269"], "suggested_codes": ["E872", "I313", "N179", "T8611", "E1165", "N1831"], "accepted_codes": ["E872", "I313", "N179", "T8611"], "rejected_codes": ["E1165", "N1831"], "date": "2024-10-07T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 29769056, "discharge_summary": "History of present illness: 35-year-old female admitted as a same-day surgical patient for symptomatic uterine leiomyomata (intramural and subserosal) with abnormal uterine bleeding and pelvic pressure. Preoperative imaging confirmed multiple fibroids, largest intramural lesion consistent with ICD-10 D25.1/D25.2.\n\nHospital course: The patient underwent an open abdominal myomectomy with resection of multiple intramural and subserosal leiomyomas (procedures coded 0UB90ZZ, 0U590ZZ). General anesthesia was uncomplicated. Estimated blood loss was minimal and no transfusion required. Perioperative antibiotics and DVT prophylaxis were given per protocol. Postoperative recovery was uneventful; pain was controlled with short-interval parenteral opioids initially and transitioned to oral oxycodone and acetaminophen. Bowel function returned on postoperative day 1 with stool softener (docusate) and senna started to prevent opioid-induced constipation. Respiratory status remained stable; albuterol inhaler available PRN for baseline asthma. GERD symptoms managed with omeprazole. Influenza quadrivalent vaccine administered prior to discharge.\n\nKey findings/procedures: Intraoperative findings confirmed multiple uterine leiomyomas (intramural and subserosal). Hemostasis achieved; no intra-abdominal complications. Pathology specimens sent; results to be reviewed in clinic.\n\nDischarge condition and functional status: Patient is afebrile, hemodynamically stable, tolerating oral intake, and ambulating with minimal assistance. Pain is controlled on oral medications. Incision site clean and dry with intact dressings; able to perform basic activities of daily living at baseline with plan for short-term assistance at home.\n\nMedications at discharge: Oxycodone IR PRN for moderate pain, acetaminophen scheduled/PRN, docusate sodium and senna for bowel regimen, omeprazole daily for GERD, albuterol inhaler PRN, simethicone PRN for gas. (Inpatient: hydromorphone, lactated Ringers, and saline flushes used.)\n\nFollow-up and instructions: Home health arranged for wound checks, medication management, and assistance with mobility for 1\u20132 weeks. OB/Gyn clinic follow-up in 10\u201314 days for incision review and pathology discussion. PCP follow-up for asthma/GERD management within 1\u20132 weeks. Return immediately for fever >38\u00b0C, worsening pain, heavy vaginal bleeding, purulent drainage, or leg swelling.", "diagnosis_codes": ["D251"], "suggested_codes": ["J45909", "K219", "D259", "N920", "Z23"], "accepted_codes": ["J45909", "K219"], "rejected_codes": ["D259", "N920", "Z23"], "date": "2024-06-29T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 22602515, "discharge_summary": "History of Present Illness: 67-year-old man admitted urgently with melena and presyncope. He presented hypotensive with a drop in hemoglobin consistent with acute posthemorrhagic anemia. He reported recent use of aspirin and NSAID therapy prior to admission. Past medical history notable for multiple sclerosis, coronary artery disease with prior angioplasty and stent, essential hypertension, hyperlipidemia, hypocalcemia, and prior GERD.\n\nHospital Course: The patient was stabilized with intravenous fluids, transfusion of packed red blood cells as indicated, and proton pump inhibitor therapy. He underwent endoscopic evaluation with therapeutic hemostasis (ICD-10-PCS 0DJ08ZZ) with successful control of the bleeding source. Blood pressure stabilized and hemoglobin improved following transfusion. Antiplatelet and NSAID agents were held while GI bleeding risk was addressed. Pain and sleep were managed conservatively.\n\nKey Findings and Procedures: Initial labs showed acute anemia and orthostatic hypotension. EGD identified bleeding lesion which was treated endoscopically with hemostatic measures. No immediate post-procedure complications. Cardiac status remained stable; troponin negative and hemodynamics supported conservative cardiac management.\n\nDischarge Condition and Functional Status: Patient is clinically stable, afebrile, hemodynamically stable on oral intake, and ambulatory with a cane. He has baseline neurologic deficits from multiple sclerosis and limited endurance; requires intermittent assistance with transfers and instrumental ADLs. Home health nursing is arranged for wound/bleeding surveillance, medication reconciliation, monitoring of vitals including orthostatic checks, and coordination of outpatient testing. Physical therapy at home recommended for gait and safety training.\n\nMedications and Follow-up: Discharge medications include esomeprazole 40 mg daily, atorvastatin, acetaminophen as needed, alprazolam and ramelteon for sleep as previously tolerated, diphenhydramine PRN, and saline flushes as needed for IV access if used. Aspirin and NSAIDs to be avoided pending GI follow-up. Labs: CBC within 48\u201372 hours and again in 1 week or sooner if symptomatic. Follow-up arranged with GI in 1 week, primary care in 3\u20135 days, and cardiology in 2 weeks regarding antiplatelet management. Home health services initiated prior to discharge.", "diagnosis_codes": ["T39015A", "E8351", "T39395A", "Z955", "Z87891", "Y92009", "K269", "I959", "I25119", "D62", "K219", "K921", "G35", "I10", "K5790", "E785", "Z96651", "K319"], "suggested_codes": ["I951"], "accepted_codes": [], "rejected_codes": ["I951"], "date": "2024-07-12T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 27478457, "discharge_summary": "Brief history of present illness: 24-year-old G?P? female presented to the ED postpartum with 48 hours of worsening right upper quadrant abdominal pain, fever, nausea and poor oral intake. She delivered recently (>42 weeks gestation noted in chart). Past medical history notable for obesity (BMI ~39), panic disorder, major depressive disorder, and nicotine dependence.\n\nHospital course: Patient admitted from the ED for evaluation and management of presumed acute calculous cholecystitis complicating the puerperium (ICD-10 O99.63, K80.00). Imaging (RUQ ultrasound) demonstrated cholelithiasis with sonographic evidence of acute cholecystitis. Initial resuscitation included IV fluids (Lactated Ringers), analgesia and antiemetics. Empiric antibiotics were started. She underwent operative intervention (laparoscopic cholecystectomy, ICD-10-PCS 0FT44ZZ) on hospital day 1 without intraoperative complications. Postoperative course was uncomplicated; she tolerated diet advancement, ambulated with assistance, and pain was controlled on multimodal analgesia.\n\nKey findings and procedures: Positive RUQ ultrasound for gallstones with wall thickening and pericholecystic fluid. Procedure: laparoscopic cholecystectomy (0FT44ZZ) under general anesthesia. Estimated blood loss minimal. No drain placed.\n\nDischarge condition and functional status: At discharge on hospital day 2 the patient is afebrile, hemodynamically stable, ambulatory with minimal assistance for home, tolerating regular diet, and able to perform basic activities of daily living with intermittent help as needed. Wound sites clean, dry and intact; verbalized understanding of activity restrictions (no heavy lifting x2 weeks).\n\nMedications and follow-up plan: Discharge medications include acetaminophen and ibuprofen for scheduled multimodal analgesia, short course oxycodone IR for breakthrough pain, simethicone and calcium carbonate as needed, and instructions to stop IV medications. Provide smoking cessation resources given nicotine dependence. Arrange outpatient surgical clinic follow-up in 7\u201314 days for wound check and pathology review. Recommend primary care/OB postpartum follow-up and mental health follow-up for depression/anxiety within 1\u20132 weeks. Home health services requested for wound checks, medication reconciliation and reinforcement of activity/pain management instructions, and assistance with ADLs as needed. Return precautions reviewed (fever, increasing abdominal pain, wound erythema, shortness of breath, suicidal ideation).", "diagnosis_codes": ["Z3A49", "F329", "Z87891", "K8000", "Z6839", "E669", "O9963", "F410"], "suggested_codes": [], "accepted_codes": [], "rejected_codes": [], "date": "2024-10-01T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 23137192, "discharge_summary": "Brief history of present illness: 65-year-old female presented to ED on an observation admission (1.7-day stay) with progressive nausea and vomiting over 24\u201348 hours leading to decreased oral intake and lightheadedness. Past history notable for prior bariatric surgery (status), hypothyroidism, type 2 diabetes mellitus, hyperlipidemia, alcohol use disorder (uncomplicated), major depressive disorder and anxiety.\n\nHospital course: On presentation she was hemodynamically stable but volume depleted. Initial labs demonstrated mild elevation of transaminases and LDH; point-of-care glucose was variable with one low reading treated with dextrose/glucose gel. Electrolytes and renal function corrected with IV fluids (0.9% NaCl) and electrolyte repletion. She received antiemetic therapy and a peripheral IV administration of therapeutic substances (ICD-10-PCS 0DJ08ZZ). Nausea improved with treatment and she tolerated clear liquids progressing to soft diet. No focal abdominal findings on exam and imaging was not suggestive of acute surgical process. Psychiatry and social work were engaged for depression, anxiety and substance use counseling needs.\n\nKey findings and procedures: Primary diagnosis: R11.2 \u2014 nausea with vomiting, unspecified. Secondary problems include K31.6 (fistula of stomach/duodenum history), Z98.84 (bariatric surgery status), hypothyroidism, diabetes, elevated transaminases (R74.0), depression/anxiety, and alcohol use history. Procedure: peripheral IV therapeutic administration (0DJ08ZZ); treated with IV fluids, antiemetics, and glucose as needed.\n\nDischarge condition and functional status: Patient discharged stable and ambulatory with baseline mobility. Requires support with medication management and routine glucose checks; home health arranged for medication administration assistance, hydration monitoring, and safety/home environment assessment.\n\nMedications and follow-up plan: Discharge meds include home insulin regimen with instructions for glucose monitoring, fluoxetine for depression, aripiprazole as outpatient augmentation as previously prescribed, lorazepam PRN for severe anxiety, acetaminophen PRN, docusate, ferrous sulfate and folic acid. Labs (CMP and LFTs) to be repeated in 1 week. Follow-up with PCP in 3\u20135 days, GI clinic in 1\u20132 weeks, and outpatient psychiatry/substance-use counseling as arranged. Home health to begin within 48 hours for medication reconciliation and daily nursing visits as indicated.", "diagnosis_codes": ["F419", "E785", "R740", "F1010", "Z87891", "F329", "E119", "K316", "Z9884", "G4700", "E039", "R112"], "suggested_codes": [], "accepted_codes": [], "rejected_codes": [], "date": "2024-09-11T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 29758724, "discharge_summary": "History of Present Illness: 80-year-old female admitted urgently with acute abdominal pain and obstructive symptoms. CT abdomen/pelvis demonstrated midgut volvulus. Past history notable for colon polyp, prior right total knee arthroplasty, nicotine dependence, and adjustment disorder with mixed anxiety and depressed mood (F43.23). Primary diagnosis: Volvulus (K56.2).\n\nHospital Course: The patient was taken to the operating room for exploratory laparotomy. Intraoperative findings included volvulus of the midgut with a segment of compromised small bowel. She underwent detorsion and limited small-bowel resection with primary anastomosis (procedures coded 0DTF0ZZ and 3E0T3BZ). No permanent ostomy was required. Postoperatively she was hemodynamically stable, advanced to clear liquids then regular diet as tolerated, and pain was controlled with a step-down analgesic regimen. She received DVT prophylaxis with enoxaparin. Influenza high-dose vaccine was administered prior to discharge.\n\nKey Findings/Procedures: CT-confirmed volvulus; operative detorsion and limited bowel resection with primary anastomosis; intraoperative enteric decompression; uncomplicated immediate postoperative course without evidence of ongoing ischemia or leak.\n\nDischarge Condition and Functional Status: At discharge she is stable, afebrile, ambulating short distances with a rolling walker and requires assistance with transfers and ADLs; home health physical therapy recommended for gait and strengthening. Cognitive status intact; mood monitored with plan for outpatient behavioral health follow-up for adjustment disorder. Wound is clean, dry, and intact; home nursing will perform wound checks and monitor incision for signs of infection.\n\nMedications and Follow-up: Discharge medications include acetaminophen, short course oral hydromorphone PRN, gabapentin for neuropathic pain, ketorolac as indicated, bowel regimen (polyethylene glycol, senna, bisacodyl PRN), tamsulosin, and enoxaparin for continued DVT prophylaxis per surgeon\u2019s instruction. Follow-up with general surgery in 7\u201310 days, primary care in 7 days, and home health nursing within 48 hours for wound care and medication reconciliation. Home PT/OT arranged; outpatient mental health follow-up for anxiety/depressed mood. Return sooner for fever, increasing abdominal pain, wound drainage, or vomiting.", "diagnosis_codes": ["K562"], "suggested_codes": ["F4323", "F17210", "Z79899"], "accepted_codes": ["F4323"], "rejected_codes": ["F17210", "Z79899"], "date": "2024-09-11T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 27723600, "discharge_summary": "History of Present Illness: 29-year-old female presented via Emergency Department after a witnessed fall at home with transient loss of consciousness and a witnessed convulsive episode. She was found to have left hip pain and inability to ambulate. Imaging demonstrated a displaced intertrochanteric fracture of the left femur (S72.142A). Past history notable for nicotine dependence and major depressive disorder. Hospital Course: The patient was admitted for operative management. She underwent operative fixation of the left intertrochanteric femur fracture (procedure ICD-10-PCS 0QS704Z). Postoperatively she was monitored for neurologic symptoms; no recurrent convulsions occurred while inpatient. Pain was managed with multimodal analgesia. She received DVT prophylaxis with enoxaparin and bowel regimen for opioid use. Psychiatry/behavioral health consulted for depression and medication review; current antidepressants were continued. No inpatient complications occurred. Key Findings and Procedures: Pre- and postoperative imaging confirmed displaced intertrochanteric fracture of the left femur. Operative fixation performed under general anesthesia (see operative note). Neuro exam remained stable post-op; vital signs remained stable and hemoglobin was acceptable without transfusion. Discharge Condition and Functional Status: At discharge the patient is hemodynamically stable, medically optimized, and afebrile. Pain is controlled on oral medications. She ambulates short distances with a front-wheeled walker with assistance and requires help with transfers and most instrumental ADLs; home health PT/OT arranged to progress mobility and teach safe transfers. Wound clean and dry with intact dressings; home health RN to perform dressing changes and suture/staple removal per ortho. Medications at Discharge: Acetaminophen, oxycodone IR (PRN), morphine sulfate (as indicated inpatient-to-home transition PRN), gabapentin, enoxaparin for DVT prophylaxis, stool regimen (docusate, senna, bisacodyl PRN), ondansetron PRN, lorazepam/diazepam PRN per neurology guidance, mirtazapine and venlafaxine continued. Follow-up Plan: Home health services for RN, PT and OT initiated. Orthopedic clinic follow-up in 10\u201314 days for wound check and postoperative plan. Primary care and neurology follow-up within 1\u20132 weeks for evaluation of syncope/convulsion and medication reconciliation. Patient educated on fall precautions, smoking cessation resources, and signs of DVT/ wound infection.", "diagnosis_codes": ["S72142A"], "suggested_codes": ["F17200", "F339"], "accepted_codes": [], "rejected_codes": ["F17200", "F339"], "date": "2024-01-01T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 24713257, "discharge_summary": "History of Present Illness: 40-year-old male admitted for observation for acute herpes zoster rash and pain. Symptoms began approximately 5 days prior to presentation with dermatomal vesicular eruption and severe neuropathic pain. Past history notable for prior ischemic stroke with residual cognitive complaints, diagnosed ADHD and anxiety. Clinical concern for possible concomitant Lyme disease based on reported tick exposure; empiric workup and treatment initiated.\n\nHospital Course: Patient observed for 3.7 days. Dermatology and infectious disease recommendations followed. IV acyclovir was started with transition to oral valacyclovir when tolerating PO and lesions showing improvement. Doxycycline initiated empirically for possible Lyme disease; ceftriaxone administered for coverage pending evaluation. Analgesics included acetaminophen and short course NSAID; clonazepam provided for anxiety-related sleep disturbance. Heparin prophylaxis given during stay. Influenza quadrivalent vaccine administered per protocol. Vitals remained stable, pain improved with antiviral and analgesic therapy, no evidence of zoster-related neurologic complication.\n\nKey Findings and Procedures: Examination documented typical unilateral vesicular rash consistent with zoster without complications. Labs and imaging did not reveal acute systemic involvement. Procedure coded 009U3ZX was performed per chart (therapeutic intervention documented) without complication. No evidence of bacterial superinfection. Cognitive baseline noted as mildly impaired related to prior cerebral infarction; attention/anxiety symptoms addressed by psychiatry consult.\n\nDischarge Condition and Functional Status: Patient discharged in stable medical condition, afebrile and hemodynamically stable. Functionally ambulatory at baseline but with mild executive dysfunction; requires assistance with complex medication management and intermittent supervision for instrumental ADLs. Pain adequately controlled on oral regimen; able to perform basic ADLs independently.\n\nMedications and Follow-up: Discharged on oral valacyclovir for zoster, doxycycline (as outpatient Lyme therapy), oral analgesics (acetaminophen/ibuprofen as needed), clonazepam PRN for anxiety, aspirin as indicated, and omeprazole for GI protection. Home health arranged for medication reconciliation, wound/dressing checks, pain and neurologic monitoring, and assistance with medication administration. Follow-up: PCP within 3\u20135 days, neurology/stroke clinic in 2 weeks, and infectious disease or dermatology as outpatient if symptoms persist or worsen.", "diagnosis_codes": ["B029"], "suggested_codes": ["F419", "F909", "G3189", "Z23", "Z230", "Z86819"], "accepted_codes": ["F419", "F909"], "rejected_codes": ["G3189", "Z23", "Z230", "Z86819"], "date": "2024-10-26T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 23688894, "discharge_summary": "History of Present Illness: 72-year-old female with symptomatic primary osteoarthritis of the left glenohumeral joint (ICD-10 M19.012) and chronic left rotator cuff pathology presented for same\u2011day surgical admission for elective left shoulder arthroplasty (ICD\u201110\u2011PCS 0RRK00Z). Past medical history notable for morbid obesity (BMI 40\u201344.9), essential hypertension, hyperlipidemia, obstructive sleep apnea, GERD, asthma, mild cognitive impairment, and a history of cardiac murmur.\n\nHospital Course: The patient underwent left total shoulder arthroplasty without intraoperative complication. Perioperative cefazolin was administered for prophylaxis. Postoperative course was uncomplicated: pain was controlled with multimodal analgesia, incentive spirometry and pulmonary bronchodilator regimen were continued for reactive airways disease, and DVT prophylaxis with enoxaparin was initiated. She had stable hemodynamics and no neurologic events. Pain was managed with acetaminophen and short course of oral opioid as needed; bowel regimen (docusate and bisacodyl) was started. Flu vaccination offered and documented.\n\nKey Findings and Procedures: Intraoperative findings consistent with advanced degenerative change of the left glenohumeral joint and rotator cuff degeneration. Procedure: left shoulder arthroplasty (ICD\u201110\u2011PCS 0RRK00Z). Estimated blood loss minimal. No acute cardiopulmonary issues; baseline ECG and vitals stable.\n\nDischarge Condition and Functional Status: Patient is stable for discharge on postoperative day 1.5. Ambulates with rolling walker and assistance for household distances; requires moderate assistance with dressing and bathing due to left upper\u2011extremity precautions (no lifting >5 lb, limited active ROM). Home health referral placed for nursing wound checks, medication reconciliation, and physical therapy for progressive ROM and strengthening.\n\nMedications and Follow-up: Discharge medications include acetaminophen, aspirin 81 mg daily, enoxaparin for DVT prophylaxis (per protocol), albuterol inhaler and neb as needed, fluticasone-salmeterol inhaler, atorvastatin, atenolol, hydrochlorothiazide, calcium carbonate, aluminum\u2011magnesium hydroxide\u2011simethicone, docusate, and short course opioid PRN. PCP follow-up in 1 week; orthopedic clinic/wound check and suture removal in 10\u201314 days and initiation of home PT. Home health nursing will monitor vitals, wound, anticoagulation education, and ADL support.", "diagnosis_codes": ["M19012"], "suggested_codes": ["G4733", "I10", "J45909", "K219", "E6601", "E785", "F067", "M7511"], "accepted_codes": ["G4733", "I10", "J45909", "K219"], "rejected_codes": ["E6601", "E785", "F067", "M7511"], "date": "2024-03-12T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 25087349, "discharge_summary": "63-year-old male admitted emergently for symptomatic unilateral inguinal hernia. Past medical history notable for essential hypertension, hyperlipidemia, gastroesophageal reflux disease, peripheral vascular disease, prior malignant neoplasm of other male genital organs, and a history of ureteral calculus with intermittent urinary retention. Length of stay 2.6 days. Admission exam and imaging were consistent with an uncomplicated unilateral inguinal hernia without obstruction or gangrene.\n\nHospital course: The patient was taken to the operating room and underwent open inguinal hernia repair with mesh under general anesthesia. Perioperative management included IV cefazolin for prophylaxis, DVT prophylaxis with subcutaneous heparin while inpatient, multimodal analgesia (IV then oral opioids and acetaminophen), antiemetic prophylaxis, and PPI therapy. He experienced transient urinary retention postoperatively requiring short-term catheterization, which resolved prior to discharge. No intraoperative complications; he remained hemodynamically stable, afebrile, and ambulatory with assistance at baseline prior to discharge. Routine postoperative labs were without acute abnormality and there was no evidence of wound infection or graft/mesh complication.\n\nKey findings & procedures: operative open inguinal hernia repair with mesh placement; perioperative IV antibiotics and DVT prophylaxis; transient postoperative urinary retention managed conservatively. Pathology/oncology history noted; no acute malignant process identified during admission.\n\nDischarge condition and functional status: Patient is medically stable for discharge. Ambulates with a rolling walker/walking assistance for short distances; able to perform basic activities of daily living with supervision. Home health services recommended for wound checks, medication administration assistance, mobility support, and monitoring for urinary retention or signs of infection.\n\nMedications & follow-up plan: Resume home antihypertensive and lipid therapy as prescribed. Discharge meds include acetaminophen scheduled, short course oxycodone IR PRN for severe pain, ciprofloxacin prescribed for suspected urinary issue per urology guidance, omeprazole, magnesium oxide for bowel regimen. Follow-up with surgical clinic in 7\u201314 days for wound check and suture removal, primary care within 7 days, and urology within 2 weeks for evaluation of prior ureteral calculus/retention. Return precautions given for fever, increasing pain, wound erythema/drainage, inability to void, or calf swelling.", "diagnosis_codes": ["R339", "N201", "K219", "I739", "I10", "K4090", "R591", "E785", "Z20822"], "suggested_codes": [], "accepted_codes": [], "rejected_codes": [], "date": "2024-10-11T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 28438449, "discharge_summary": "71-year-old male admitted to observation for 8.5 days with acute scrotal pain and swelling. History of progressive right-sided testicular pain, dysuria and fever prior to presentation. Past medical history notable for irritable bowel syndrome, migraine, and nicotine dependence. Initial evaluation revealed clinical epididymo-orchitis (primary diagnosis N45.3) with associated hyponatremia, microscopic hematuria, and mild transaminitis.\n\nHospital course: On admission patient was stabilized, given analgesia and IV fluids with careful sodium correction. Scrotal ultrasound confirmed epididymal inflammation without torsion. Urinalysis demonstrated pyuria and microscopic hematuria; urine culture subsequently grew a uropathogen sensitive to doxycycline. He was treated with doxycycline hyclate with clinical improvement in pain and local swelling. Hyponatremia (hypo-osmolality) was managed with fluid restriction and monitored electrolytes; sodium trended toward baseline prior to discharge. Transaminase and LDH elevations were nonprogressive and attributed to acute illness; these trended down with supportive care. VTE prophylaxis with low-dose heparin was provided while inpatient. No surgical intervention was required.\n\nKey findings and procedures: scrotal ultrasound (inflammation of epididymis, no torsion); urine studies positive for infection; serial BMPs and LFTs monitored. No invasive procedures performed.\n\nDischarge condition and functional status: Patient is afebrile, hemodynamically stable, ambulatory at baseline with mild gait instability secondary to fatigue and recent hyponatremia. He requires intermittent assistance with medication management and home monitoring of symptoms; home health nursing is arranged for medication reconciliation, daily vitals/electrolyte monitoring for 48\u201372 hours, and education on wound/scrotal care and activity restrictions.\n\nMedications at discharge: doxycycline hyclate (complete course as prescribed), acetaminophen PRN, acetaminophen-caffeine-butalbital PRN for headaches, sumatriptan PRN, docusate sodium and senna PRN for constipation, multivitamins, sodium chloride nasal spray, Readi-Cat 2 as used for imaging, and routine saline flush supplies. Heparin discontinued on discharge.\n\nFollow-up: Urology clinic in 1 week; primary care within 48\u201372 hours for BMP and LFT recheck; return precautions for recurrent pain, fever, worsening urine symptoms, or confusion.", "diagnosis_codes": ["N453"], "suggested_codes": ["E871", "R740", "R310"], "accepted_codes": ["E871", "R740"], "rejected_codes": ["R310"], "date": "2024-12-25T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 29392855, "discharge_summary": "Patient: 35-year-old female. Admission: Urgent admission for abnormal fetal heart rate patterns in active labor (ICD-10 O76) at 39 weeks gestation (Z3A39) with single live birth (Z370). Brief history of present illness: Patient presented in active labor with recurrent fetal heart rate decelerations concerning for fetal intolerance of labor. Delivery was expedited resulting in an assisted vaginal delivery with second-degree perineal laceration sustained during delivery (O701) which was repaired in the operating room.\n\nHospital course: Over a 2.6-day inpatient stay the patient was hemodynamically stable, afebrile, and progressed appropriately through immediate postpartum recovery. Estimated blood loss was within expected limits for a vaginal delivery. Pain was controlled with oral analgesics. Bowel function was supported with stool softener and laxative therapy. No signs of wound infection or postpartum hemorrhage were observed. Lactation counseling was provided and initial breastfeeding established. Neonate transferred to newborn care and remained stable; pediatric follow-up arranged.\n\nKey findings and procedures: Abnormal fetal heart tracing necessitating expedited delivery. Procedures included assisted vaginal delivery and repair of a second-degree perineal laceration (ICD-10-PCS: 10D07Z6, 0KQM0ZZ). IV fluids (Lactated Ringers) and routine postpartum monitoring were administered.\n\nDischarge condition and functional status: Patient is discharged in stable condition, ambulatory with steady gait, able to perform basic activities of daily living with minimal assistance, and able to care for newborn with planned home health support for the first week. Pain is controlled on oral medications; surgical site clean, dry, and intact.\n\nMedications at discharge: Acetaminophen and ibuprofen for analgesia (scheduled/PRN), docusate sodium daily, bisacodyl PRN for constipation, milk of magnesia PRN, calcium carbonate and sodium citrate as needed for reflux, simethicone PRN for gas, Dermoplast spray PRN for perineal discomfort. (IV fluids and sodium chloride flush were administered inpatient.)\n\nFollow-up: Postpartum OB clinic/wound check in 7\u201314 days and routine postpartum visit at 6 weeks. Home health ordered for wound care, medication reconciliation, pain management, infant-care support and breastfeeding assistance. Return earlier for fever, increasing pain, foul drainage, heavy bleeding, or difficulty voiding.", "diagnosis_codes": ["O76"], "suggested_codes": ["O701", "Z370", "Z3A39"], "accepted_codes": ["O701", "Z370", "Z3A39"], "rejected_codes": [], "date": "2024-05-08T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 21894284, "discharge_summary": "History of Present Illness: 85-year-old female admitted under observation for acute cough, shortness of breath and fever. Chest radiograph demonstrated a right lower lobe infiltrate with small associated pleural effusion. Past medical history notable for atrial fibrillation on anticoagulation, asthma/COPD overlap with prior exacerbations, coronary artery disease, hypertension, dementia, anemia, GERD, and depression.\n\nHospital Course: Observed 3.6 days. Patient was treated for community-acquired pneumonia (J18.9) with empiric IV ceftriaxone and azithromycin on admission with clinical improvement; transitioned to oral cefpodoxime and completion of macrolide therapy on discharge. Bronchodilator therapy (albuterol inhaler, ipratropium nebulizer, fluticasone-salmeterol) and a short prednisone taper were given for acute asthma exacerbation. Hypertensive urgency was managed with adjustment of home antihypertensives (carvedilol and losartan) and diuresis with furosemide for mild volume overload/pleural effusion. Apixaban was continued for atrial fibrillation. Urine culture showed bacteriuria without systemic sepsis; treated per culture sensitivity and clinical context. No invasive procedures performed.\n\nKey Findings/Procedures: CXR consistent with right lower lobe pneumonia and small effusion. Afebrile for >48 hours, respiratory rate improved, oxygen saturation maintained >92% on room air at rest. Laboratory trends showed resolving inflammatory markers and stable hemoglobin above baseline anemia management threshold.\n\nDischarge Condition and Functional Status: Discharged in stable medical condition, afebrile, hemodynamically stable. Cognitive baseline: chronic mild-to-moderate dementia with continued need for supervision. Mobility: ambulates short distances with a walker and requires assistance with transfers and most ADLs; home health recommended for safety, medication management, and skilled nursing for respiratory treatments and vitals monitoring.\n\nMedications and Follow-up: Discharge meds include apixaban, carvedilol, losartan, atorvastatin, furosemide, cefpodoxime (finish course), azithromycin (if applicable), prednisone taper, albuterol inhaler PRN, ipratropium neb, fluticasone-salmeterol, omeprazole, citalopram. Follow-up with primary care within 48\u201372 hours, pulmonology/ID in 1\u20132 weeks, cardiology as outpatient for AF, and home health nursing for wound/medication reconciliation, nebulizer treatments, vitals and ADL support.", "diagnosis_codes": ["R0789", "J189", "J918", "J45901", "I4891", "I2510", "F329", "Z7902", "D649", "H3530", "K219", "H409", "F0390", "I160", "R8271", "H548", "Z8673"], "suggested_codes": ["J440"], "accepted_codes": [], "rejected_codes": ["J440"], "date": "2024-09-22T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 20685479, "discharge_summary": "History of present illness: 67-year-old male with known epilepsy presented after a witnessed generalized tonic\u2013clonic seizure at home. Associated urinary hesitancy and dysuria prompted evaluation for urinary tract infection. Past medical history notable for peripheral nerve malignancy, chronic polyneuropathy and chronic pain, long-term systemic steroid use, benign prostatic hyperplasia, and paroxysmal atrial fibrillation.\n\nHospital course: Patient was observed for 6\u20137 days. On arrival he received a loading dose of IV levetiracetam with transition to oral levetiracetam maintenance. Empiric IV ceftriaxone was administered for a positive urinalysis/clinical concern for UTI with clinical improvement and down-trending inflammatory markers. Continuous cardiac monitoring showed paroxysmal atrial fibrillation without hemodynamic instability. Head CT showed no acute intracranial hemorrhage or mass effect. Blood glucose was monitored and treated as needed; he received DVT prophylaxis while inpatient. No recurrent clinical seizures occurred during hospitalization; pain and spasticity were managed with duloxetine and baclofen. Influenza vaccine was administered prior to discharge.\n\nKey findings and procedures: CT head negative for acute process; UA consistent with UTI; IV levetiracetam loading and transition to PO; IV ceftriaxone course initiated; telemetry monitoring; standard observation-level nursing and medication administration.\n\nDischarge condition and functional status: Patient is medically stable, afebrile, and seizure-free for >72 hours. Ambulates with a cane and requires assistance with transfers and some ADLs; home health is arranged for medication administration, fall-risk precautions, toileting assistance, and monitoring of neurologic status and wound/skin integrity.\n\nMedications and follow-up: Discharge medications include: levetiracetam (maintenance dosing), duloxetine, baclofen, acetaminophen PRN, docusate sodium and lactulose as bowel regimen, finasteride, and outpatient insulin regimen as appropriate. He is to complete a short course of oral antibiotics started in hospital as directed. Follow-up: neurology within 1\u20132 weeks, primary care within 48\u201372 hours, urology for BPH/UTI, oncology and/or neuro-oncology as outpatient for management of peripheral nerve neoplasm, and cardiology within 1 week to address atrial fibrillation and anticoagulation planning. Home health services to begin within 48 hours for medication management, ADL assistance, vital sign and fall/seizure monitoring.", "diagnosis_codes": ["N400", "G40909", "N390", "G629"], "suggested_codes": ["C728", "I489", "Z7689", "Z794"], "accepted_codes": [], "rejected_codes": ["C728", "I489", "Z7689", "Z794"], "date": "2024-11-11T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 27788769, "discharge_summary": "History of Present Illness: 56-year-old female admitted under observation for acute bleeding and altered mental status. Presented with overt bleeding and confusion while on anticoagulation; found to have hemorrhagic disorder due to extrinsic circulating anticoagulants (D68.32). Admission course was complicated by metabolic encephalopathy, acute kidney injury, and exacerbation of chronic systolic heart failure.\n\nHospital Course: Anticoagulants were held on admission. She received targeted reversal and supportive care with blood product administration and hemodynamic stabilization. Encephalopathy improved with correction of metabolic derangements and medication adjustments. Acute kidney injury managed with fluid optimization and close monitoring of electrolytes; no dialysis required. Heart failure treated with diuretics and afterload reduction, with improvement in volume status. Pain and hemorrhoidal symptoms addressed conservatively. Psychiatry/behavioral medication (haloperidol) used briefly for agitation. VTE prophylaxis and anticoagulation strategy were individualized; therapeutic enoxaparin was used at discharge per hematology recommendation with plan for close outpatient monitoring.\n\nKey Findings and Procedures: Positive laboratory evidence of coagulopathy consistent with extrinsic anticoagulant effect. Imaging and consults (CT head, chest radiograph, cardiology and nephrology involvement) completed. Procedures included central venous access for monitoring/administration, blood product transfusion(s), and bedside diagnostic evaluations.\n\nDischarge Condition and Functional Status: Patient is medically stable for discharge to home with home health services. Cognition improved but intermittent confusion persists; requires supervision for medication administration and safety. Ambulates with steadying assistance due to deconditioning; requires home PT for gait training and OT for ADL support.\n\nMedications and Follow-up: Discharge meds include therapeutic enoxaparin (per hematology), aspirin, atorvastatin, acetaminophen, morphine/oxycodone-alternative (as needed) for pain, famotidine, stool regimen (docusate and bisacodyl), and calcium carbonate. Heparin flushes for line as indicated. Follow-up: Hematology within 3\u20137 days for anticoagulation management and anti-Xa/INR monitoring; Nephrology within 7\u201314 days for AKI reassessment and BMP; Cardiology in 2 weeks for heart failure management; PCP in 3 days. Home health to provide nursing for labs/medication management, PT/OT, and fall-risk supervision.", "diagnosis_codes": ["M5440", "Z20822", "T508X5A", "D6832"], "suggested_codes": ["G9341", "N179", "I5023", "R4182", "Y574", "Z7409"], "accepted_codes": ["G9341", "N179"], "rejected_codes": ["I5023", "R4182", "Y574", "Z7409"], "date": "2024-10-16T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 20693549, "discharge_summary": "History of Present Illness: 59-year-old female admitted to observation for progressive rectal pain and bleeding attributed to symptomatic hemorrhoids. She reported associated constipation and a recent episode of urinary frequency/dysuria. Past medical history notable for hypertension, hyperlipidemia, obesity, and iron deficiency anemia. Stool and urine studies raised concern for diverticular bleeding and urinary tract infection; urine culture later grew E. coli. Noted allergy/resistance to penicillins (documented).\n\nHospital Course: Patient was observed for 2.1 days. Initial evaluation included focused anorectal exam, CBC, basic metabolic panel, urinalysis and cultures, and IV fluids. She received IV ceftriaxone in the ED for UTI coverage pending cultures, analgesia (acetaminophen as needed), and bowel regimen including magnesium citrate and a bowel preparation as appropriate for evaluation. Hemoglobin remained stable without transfusion. Pain was controlled with oral analgesics and conservative anorectal measures. No evidence of active ongoing major GI hemorrhage; diverticulosis without perforation or abscess was confirmed on imaging reports.\n\nKey Findings and Procedures: Key diagnoses on discharge include other hemorrhoids (symptomatic), residual hemorrhoidal skin tags, diverticulosis without perforation with prior bleeding, UTI due to E. coli, iron deficiency anemia, and chronic medical comorbidities (HTN, hyperlipidemia, obesity). A bedside anorectal procedure for symptomatic hemorrhoidal thrombosis was performed without complication. Urine culture sensitivities returned showing E. coli; penicillin resistance documented.\n\nDischarge Condition and Functional Status: Patient is medically stable for discharge. Ambulates with a steady gait but reports limited endurance with prolonged standing; independent with most ADLs but will benefit from assistance with home toilet transfers and medication management. Home health nursing arranged for wound/skin care, stool/bleeding monitoring, vital sign checks, and medication reconciliation.\n\nMedications and Follow-up: Continue atorvastatin, lisinopril, hydrochlorothiazide, pantoprazole, acetaminophen PRN. Complete antibiotic therapy per outpatient prescription based on culture sensitivities; hold penicillin-class agents. Iron therapy to be started by PCP. Follow up with primary care within 3\u20137 days and colorectal surgery/GI within 2 weeks or sooner for persistent bleeding or pain.", "diagnosis_codes": ["K648"], "suggested_codes": ["D509", "E669", "E785", "I10", "N390", "I843", "I848", "K5730"], "accepted_codes": ["D509", "E669", "E785", "I10", "N390"], "rejected_codes": ["I843", "I848", "K5730"], "date": "2024-08-23T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 23602397, "discharge_summary": "History of present illness: 30-year-old female admitted under observation with biliary acute pancreatitis (K85.10) complicated by portal vein thrombosis, acute respiratory distress syndrome (ARDS), acute kidney injury, shock, hyperosmolality/hypernatremia, and nontraumatic abdominal compartment syndrome. Length of stay 27 days with prolonged intensive care needs.\nHospital course: Patient required initial intubation and mechanical ventilation for ARDS with subsequent successful extubation. She developed hemodynamic instability requiring brief vasopressor support and was treated for sepsis physiology. Acute kidney injury necessitated temporary renal replacement therapy and then gradual renal recovery. Portal vein thrombosis was managed with therapeutic anticoagulation. Electrolyte disturbances and hyperglycemia were corrected. Nutritional support included pancreatic enzyme replacement and enteral nutrition as tolerated. Wound care and monitoring were performed for abdominal compartment concerns; no infected necrosis identified.\nKey findings and procedures: Imaging consistent with biliary pancreatitis without necrosis; Doppler confirmed portal vein thrombosis. Procedures performed included endotracheal intubation with mechanical ventilation, central venous access placement, percutaneous drain placement, and temporary renal replacement therapy. Cultures and serial imaging showed no pancreatic necrosis or persistent intra-abdominal infection.\nDischarge condition and functional status: At discharge patient is hemodynamically stable, afebrile, ambulates with assistance, and requires intermittent assistance with activities of daily living. Renal function improved but not to baseline; creatinine trending down. Oxygen independent at rest. Home health recommended for skilled nursing, wound/ostomy/drain care, medication administration, and assistance with ADLs.\nMedications and follow-up plan: Discharge meds include acetaminophen, pancreatic enzyme replacement (Creon 12), furosemide as needed, therapeutic anticoagulation (heparin transitioned to outpatient regimen), insulin with glucose monitoring, levothyroxine, multivitamin, ondansetron, topical antibiotic ointment, and short course oxycodone PRN. Follow-up appointments: GI/HPB clinic within 1 week for biliary source management and plan cholecystectomy; hematology within 1\u20132 weeks for thrombosis management; nephrology follow-up for AKI; primary care within 3\u20135 days. Labs (CMP, CBC, coagulation, lipase, renal function) within 48\u201372 hours and repeat abdominal imaging per GI recommendations.", "diagnosis_codes": ["R579", "E8351", "E8339", "M79A3", "G7281", "E669", "E875", "K567", "J80", "D696", "E46", "K8510", "E870", "Z20822"], "suggested_codes": ["I81", "N179", "Z743", "Z992"], "accepted_codes": ["I81", "N179"], "rejected_codes": ["Z743", "Z992"], "date": "2024-09-13T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 27862910, "discharge_summary": "History of present illness: 74-year-old female presented to the ED with acute onset bright red rectal bleeding and presyncope. Past history notable for hypertension, hypothyroidism, hyperlipidemia, diverticulosis, colon polyps, hemorrhoids, and osteoporosis. Initial labs showed acute posthemorrhagic anemia (D62). She was observed for hemodynamic stability and management of lower GI bleed (primary diagnosis K55.21, angiodysplasia of colon with hemorrhage).\n\nHospital course: The patient was admitted to observation for 2.1 days. On arrival she received IV fluids (Lactated Ringers) and hemodynamic monitoring. Hemoglobin stabilized without blood transfusion. Gastroenterology performed diagnostic colonoscopy with targeted endoscopic therapy to the identified angiodysplastic lesion; cold snare polypectomy and focal coagulation were performed and biopsies were obtained. No active brisk bleeding after therapy. Pain and nausea were controlled (ondansetron PRN). Thyroid and chronic cardiac medications were held and resumed as tolerated. No procedural complications occurred. Pathology pending for polyp sample.\n\nKey findings/procedures: Positive colonoscopic identification of angiodysplasia in the colon with minimal residual bleeding after endoscopic coagulation and polypectomy. Procedure performed without immediate complications.\n\nDischarge condition and functional status: Patient is hemodynamically stable at discharge, ambulatory with a rolling walker and tolerating oral intake. Requires assistance with medication management and light instrumental activities of daily living; home health nursing recommended for medication reconciliation, wound/skin checks and monitoring for recurrent bleeding or symptomatic anemia.\n\nMedications at discharge: Levothyroxine  (home dose), carvedilol (home dose), amlodipine, escitalopram, calcium carbonate, potassium citrate, vitamin D3, multivitamin, ondansetron PRN. Continue outpatient avoidance of NSAIDs and antiplatelet/anticoagulants until GI follow-up unless otherwise directed.\n\nFollow-up plan: GI clinic within 7 days for procedure review and pathology results; PCP follow-up within 7\u201310 days. Repeat CBC in 48\u201372 hours with results to GI/PCP. Home health nursing to begin within 48 hours for medication assistance and bleeding surveillance.\n", "diagnosis_codes": ["K5730", "K635", "D62", "M810", "I10", "Z8719", "E039", "K5521", "Z20822", "K648"], "suggested_codes": ["E785"], "accepted_codes": ["E785"], "rejected_codes": [], "date": "2024-01-18T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 21500696, "discharge_summary": "Brief HPI: 19-year-old female presented to the ED with acute onset hematemesis and odynophagia. She has a history of soft-tissue malignancy (remote) and known liver disease. On presentation she was hemodynamically stabilized and admitted to observation for evaluation of upper GI bleeding and anemia.\n\nHospital course: Over a 3-day observation stay the patient received IV fluids, PPI therapy, and supportive care. Hematology consulted for thrombocytopenia and acute posthemorrhagic anemia. She received iron repletion with ferric gluconate and was monitored for transfusion criteria; bleeding was controlled endoscopically. Platelets were monitored; no emergent platelet transfusion was required. Influenza vaccination was administered prior to discharge.\n\nKey findings and procedures: Endoscopic evaluation (esophagogastroduodenoscopy) identified esophagitis and stigmata consistent with variceal/upper GI bleeding. Therapeutic hemostasis was performed endoscopically with appropriate measures and biopsies were taken of inflamed mucosa. Relevant diagnoses at discharge: esophagitis (K20.9), esophageal varices without current bleeding, hematemesis, thrombocytopenia, acute posthemorrhagic anemia, and chronic liver disease.\n\nDischarge condition and functional status: Patient is hemodynamically stable, afebrile, with improving symptoms. She tolerates a soft oral diet and ambulates with minimal assistance. Home health services are arranged for skilled nursing visits to administer scheduled IV iron infusions, perform wound/line care and 0.9% sodium chloride flushes, monitor vitals and laboratory trends, and assist with medication administration and ADL support as needed.\n\nMedications and follow-up: Discharge medications include pantoprazole 40 mg PO daily, acetaminophen 500\u2013650 mg PRN for pain/fever, and scheduled ferric gluconate per outpatient/home infusion plan. Avoid NSAIDs and alcohol. Follow-up: GI clinic within 1 week for variceal/liver management and review of pathology; hepatology within 1\u20132 weeks; hematology within 1 week. Labs (CBC, CMP) to be obtained in 48\u201372 hours and reviewed by primary team. Return to ED for recurrent bleeding, syncope, chest pain, or worsening dyspnea.", "diagnosis_codes": ["K209", "K920"], "suggested_codes": ["D62", "D696", "I8500", "K769"], "accepted_codes": ["D62", "D696", "I8500", "K769"], "rejected_codes": [], "date": "2024-08-22T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 27124577, "discharge_summary": "HPI: 46-year-old female admitted emergently for acute neurologic change and found to have a cerebral infarction due to embolism of the left posterior cerebral artery (I63.432). She has history notable for metastatic disease to the lungs, nonrheumatic mitral regurgitation, essential hypertension, hypothyroidism, and prior malignancy. NIHSS on evaluation was 0. Length of stay 2 days.\n\nHospital course: CT head and brain MRI confirmed an acute left PCA infarct without large vessel occlusion. Cardiac evaluation (echocardiogram) showed nonrheumatic mitral insufficiency without obvious thrombus. She was monitored in the stroke service, received VTE prophylaxis with enoxaparin while inpatient, and was started on secondary prevention with aspirin and high\u2011intensity statin therapy. Blood pressure and glucose were managed and optimized; home antihypertensive (quinapril) continued. No acute intervention (thrombolysis or thrombectomy) was indicated. Symptoms improved and she remained neurologically stable.\n\nKey findings/procedures: MRI brain demonstrating left PCA infarct; transthoracic echocardiogram demonstrating mitral regurgitation; routine labs and cardiac rhythm monitoring without arrhythmia detected. NIHSS 0 at discharge.\n\nDischarge condition and functional status: Patient is medically stable for discharge. Neurologically at baseline with no focal motor deficits; ambulates independently but reports intermittent dizziness and mild balance impairment. Independent with basic ADLs but has increased fall risk. Home health referral is requested for skilled nursing medication reconciliation and BP/glucose monitoring, and PT for balance and gait training.\n\nMedications at discharge (selected): Aspirin 81 mg daily; Atorvastatin 40 mg nightly; Quinapril 10 mg daily (continue home dose as tolerated); Docusate sodium PRN; Senna PRN for constipation; Acetaminophen PRN for pain. Enoxaparin was used inpatient for VTE prophylaxis and is not continued at discharge. Continue home levothyroxine and insulin regimen as previously prescribed; adjust per outpatient results.\n\nFollow-up: Primary care in 3\u20137 days for med reconciliation and BP/glucose check; neurology clinic within 1\u20132 weeks; oncology follow-up per treating team within 2 weeks; cardiology as outpatient for MR and HTN management. Recommended labs prior to follow-up: BMP, CBC, lipid panel, TSH, HbA1c. Home health to provide nursing and PT services as above.", "diagnosis_codes": ["I340", "E039", "I63432"], "suggested_codes": ["I10", "R42", "Z4881", "Z5111", "Z9181"], "accepted_codes": ["I10", "R42"], "rejected_codes": ["Z4881", "Z5111", "Z9181"], "date": "2024-02-05T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 24215684, "discharge_summary": "History of present illness: 52-year-old female admitted urgently with acute severe epigastric pain, nausea and vomiting. Labs on admission demonstrated markedly elevated lipase; RUQ ultrasound/CT consistent with choledocholithiasis and acute biliary pancreatitis (primary diagnosis: K85.10). She has a history of cholelithiasis with chronic cholecystitis (K80.45), GERD, depression, alcohol and nicotine use disorder, and bilateral knee osteoarthritis.\n\nHospital course: The patient was managed with NPO, aggressive IV fluid resuscitation (Lactated Ringers), antiemetics (ondansetron), acid suppression (omeprazole), and multimodal analgesia (inpatient morphine/hydromorphone, transitioned to oral oxycodone/acetaminophen). Prophylactic VTE measures were used. On hospital day 1 she underwent urgent ERCP with sphincterotomy and common bile duct stone extraction; no perforation or retained large fragments. Given persistent cholecystitis/cholelithiasis, she underwent laparoscopic cholecystectomy on hospital day 3 without intraoperative complications. Cultures were not positive; ciprofloxacin was prescribed empirically given concern for cholangitis. Psychiatric history was addressed and home medications (fluoxetine) continued.\n\nKey findings and procedures: Elevated lipase consistent with pancreatitis, imaging-confirmed choledocholithiasis; procedures performed: ERCP with stone extraction and sphincterotomy, followed by laparoscopic cholecystectomy. No pancreatic necrosis or infected collections identified.\n\nDischarge condition and functional status: Patient is hemodynamically stable, afebrile, pain controlled on oral analgesics, tolerating a low-fat soft diet. Mobility: ambulates with assistive device at baseline due to bilateral knee osteoarthritis; requires assistance with stair negotiation and limited endurance\u2014home health recommended for short-term ADL support and ambulation safety. Incisions clean and dry; home health to perform wound checks and suture/staple removal as needed.\n\nMedications and follow-up: Discharge meds include acetaminophen, oxycodone IR (short course), ciprofloxacin PO x7 days, omeprazole, docusate, fluoxetine, folic acid and multivitamins, ondansetron PRN. Follow-up: General surgery in 7\u201314 days, PCP in 3\u20137 days, gastroenterology as needed, and outpatient addiction/behavioral health referral for alcohol use. Return for fever, worsening abdominal pain, increased incision drainage, or inability to tolerate PO intake.", "diagnosis_codes": ["K8510"], "suggested_codes": ["K219", "K8045", "M170", "F1020", "F17210", "F339", "Z4789", "Z9181"], "accepted_codes": ["K219", "K8045", "M170"], "rejected_codes": ["F1020", "F17210", "F339", "Z4789", "Z9181"], "date": "2024-05-22T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 24317978, "discharge_summary": "History of Present Illness: 80-year-old male with end-stage renal disease on chronic hemodialysis presented under observation status for evaluation of presumed infection involving a vascular device (ICD-10: T827XXA). He reported redness and tenderness at his dialysis access site with intermittent fevers prior to admission. Past medical history notable for stage 5 CKD on dialysis, hypertensive CKD, myelodysplastic syndrome, prior prostate malignancy, and dependence on renal dialysis.\n\nHospital Course: During the 1.8-day observation stay, blood cultures and wound cultures were obtained and the access site was inspected. He received empiric broad-spectrum IV antibiotics (vancomycin and cefepime) and supportive care including IV fluids and acetaminophen for symptomatic control. Dialysis treatments continued through his chronic access without interruption. Laboratory monitoring and clinical reassessment demonstrated clinical improvement: he remained hemodynamically stable, afebrile for >24 hours, and pain was controlled. No acute surgical intervention was required during this admission.\n\nKey Findings and Procedures: Positive local signs of infection at the vascular access; cultures sent. Peripheral IV access placed for antibiotic administration. Ongoing dialysis via existing access documented. Imaging was not required during observation.\n\nDischarge Condition and Functional Status: Patient discharged in stable condition, afebrile, hemodynamically stable, with improved local signs of infection and adequate pain control. Functionally, he is independent with transfers and ambulation with a rolling walker for longer distances, but requires assistance with wound care and medication management at home. Home health nursing arranged for wound/site assessments, IV antibiotic administration and coordination with dialysis.\n\nMedications and Follow-up Plan: Continue IV antibiotics as outpatient per Infectious Disease plan (home IV vancomycin with trough monitoring). Other discharge medications: torsemide, sevelamer carbonate, folic acid, multivitamins, sodium citrate as prescribed, acetaminophen PRN. Follow up with Nephrology within 7 days, Infectious Disease within 48\u201372 hours, and Primary Care in 1 week. Home health nursing arranged for vascular access wound care, IV antibiotic administration, medication reconciliation, and dialysis coordination.\n", "diagnosis_codes": ["Y92009", "M7989", "T827XXA", "Z992", "Y832", "N186", "D469"], "suggested_codes": [], "accepted_codes": [], "rejected_codes": [], "date": "2024-04-02T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 25997958, "discharge_summary": "Patient: 52-year-old male. Admission: Observation admit x2 days for postprocedural complication (primary diagnosis K91.89) with right upper quadrant abdominal pain and intermittent nausea. Past history notable for obstructive sleep apnea and nicotine dependence. Presented with worsening RUQ pain after recent surgical procedure; no active bleeding or hemodynamic instability on arrival.\n\nHospital course: Patient observed for 48 hours. Evaluation included serial abdominal exams, basic labs, and abdominal imaging to assess for postprocedural complication. He received IV fluids (D5 1/2NS, 5% dextrose as indicated), analgesia (hydromorphone IV for acute pain, transitioned to oxycodone immediate release PRN on discharge), and antimicrobial therapy with IV ciprofloxacin and metronidazole, transitioned to oral ciprofloxacin and metronidazole prior to discharge. DVT prophylaxis with subcutaneous heparin was administered during stay. Influenza quadrivalent vaccine was given prior to discharge.\n\nKey findings and procedures: Imaging and clinical assessment did not demonstrate need for operative intervention; no evidence of perforation or ongoing hemorrhage. Patient had improvement in pain and tolerating oral intake at discharge. No signs of systemic infection or organ dysfunction. Observation status, short-stay improvement noted.\n\nDischarge condition and functional status: Patient is medically stable for discharge; ambulatory with mild limitation from pain and requires assistance with medication administration and activity pacing\u2014home health recommended for medication management, pain monitoring, and assistance with activities of daily living as needed. Continue CPAP at home for obstructive sleep apnea. Fall risk counseling provided due to opioid use.\n\nMedications at discharge: Ciprofloxacin (oral) and Metronidazole (oral) to complete prescribed course; acetaminophen scheduled; oxycodone IR PRN for breakthrough pain; senna for bowel regimen; simethicone for gas; continue nicotine dependence history counseling. Heparin and IV medications discontinued. Wound/incision care instructions provided if applicable.\n\nFollow-up: Primary care follow-up within 48\u201372 hours; surgical/procedural clinic or GI follow-up in 7\u201314 days or sooner for recurrent/worsening symptoms. Seek immediate care for fever, worsening abdominal pain, vomiting, or signs of bleeding.", "diagnosis_codes": ["K9189"], "suggested_codes": ["G4733", "F17210", "Z79891"], "accepted_codes": ["G4733"], "rejected_codes": ["F17210", "Z79891"], "date": "2024-06-02T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 26096633, "discharge_summary": "History of Present Illness: 48-year-old female presented to the ED with progressive right lower extremity erythema, swelling and pain consistent with cellulitis. Significant past medical history includes Crohn\u2019s disease with ileostomy, prior granulomatous skin disorder, and intermittent hypotension. She was admitted under observation for IV antibiotic therapy and monitoring.\n\nHospital Course: Patient observed for 2.8 days. On admission she received IV vancomycin and cefazolin, isotonic fluids, antiemetic therapy (ondansetron) and DVT prophylaxis with subcutaneous heparin. Clinical status improved over the observation period with reduction in erythema, decreased pain, improved mobility, and hemodynamic stability. Leukocytosis trended toward normal. Blood and wound cultures showed no growth during admission. No surgical intervention or incision and drainage was required. Patient was converted to oral antibiotics prior to discharge.\n\nKey Findings and Procedures: Right lower extremity exam showed resolving erythema and edema without fluctuance; distal pulses intact. Ostomy site inspected and remained intact without local infection. No operative procedures performed.\n\nDischarge Condition and Functional Status: Patient is medically stable and afebrile at discharge. Pain is controlled on oral medications. Ambulates with minimal assistance and is independent with basic ADLs but requires support for ostomy care and daily dressing changes. Home health recommended for wound/ostomy care, medication administration assistance, vital sign monitoring, and ongoing skin assessment given prior hypotension and cellulitis.\n\nMedications at Discharge: Cephalexin PO (oral antibiotic), Sulfamethoxazole/Trimethoprim DS PO (adjunct oral coverage), acetaminophen and ibuprofen PRN for pain, oxycodone IR short course PRN, ondansetron PRN for nausea. Inpatient IV antibiotics (vancomycin, cefazolin) and heparin discontinued.\n\nFollow-up Plan: Primary care follow-up within 48\u201372 hours. Infectious disease or wound clinic follow-up within 7 days and ostomy clinic/GI follow-up for Crohn\u2019s disease and ileostomy management within 1\u20132 weeks. Return immediately for fever, progressive erythema, new drainage, worsening pain, dizziness or syncope, or other signs of systemic infection.", "diagnosis_codes": ["Z932", "L928", "I959", "K50913", "L03115"], "suggested_codes": [], "accepted_codes": [], "rejected_codes": [], "date": "2024-05-29T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 22349177, "discharge_summary": "History of Present Illness: 56-year-old man presented to the ED with progressive left ankle and foot pain, erythema, and drainage. Past medical history notable for type 2 diabetes mellitus with recent hyperglycemia, essential hypertension, hyperlipidemia, hypothyroidism, obstructive sleep apnea, and chronic liver disease with ascites. Imaging (MRI) and clinical examination were consistent with osteomyelitis of the left ankle/foot with associated cellulitis.\n\nHospital Course: Admitted directly from ED for IV antibiotics and operative management. He underwent surgical irrigation, debridement and incision and drainage of the infected left foot wound with intraoperative cultures obtained. A PICC line was placed for long-term IV therapy. Empiric IV nafcillin was started and later tailored to culture sensitivities. He received DVT prophylaxis, diuresis for ascites with furosemide, glycemic management with sliding scale and scheduled insulin, and continuation of home levothyroxine. Respiratory status remained stable on home CPAP. No acute hepatic decompensation occurred; paracentesis was not required during this admission.\n\nKey Findings and Procedures: MRI consistent with osteomyelitis; wound cultures positive for gram-positive organisms sensitive to nafcillin. Procedures: surgical debridement/irrigation and drainage of left foot abscess; PICC placement for outpatient IV antibiotics.\n\nDischarge Condition and Functional Status: Patient is hemodynamically stable, afebrile, pain controlled on oral opioids as needed. Ambulates with a rolling walker for short distances and requires assistance with stair negotiation. Wound is clean with sterile dressing; patient requires skilled nursing for dressing changes and PICC care. Home health recommended for wound care and assistance with ADLs.\n\nMedications and Follow-up: Discharged on IV nafcillin via home infusion for planned 6-week total antibiotic course; insulin regimen adjusted with supplies and teaching provided. Continued: levothyroxine, nadolol (portal hypertension management), furosemide, atorvastatin, PPI for GERD, and short course oral analgesics. Follow-up: Infectious Disease in 1 week, Wound clinic/podiatry in 3\u20135 days, Primary Care within 1 week, Hepatology in 2 weeks. Home health nursing to provide PICC care, wound dressing changes, medication administration, and glucose monitoring.", "diagnosis_codes": ["M868X7"], "suggested_codes": ["E039", "E1165", "E785", "G4733", "I10", "R188", "K766", "L03115"], "accepted_codes": ["E039", "E1165", "E785", "G4733", "I10", "R188"], "rejected_codes": ["K766", "L03115"], "date": "2024-06-17T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 22655087, "discharge_summary": "History of Present Illness: 78-year-old female admitted urgently with chest pain and dyspnea. Evaluation revealed a non\u2013ST-elevation myocardial infarction (NSTEMI) with elevated troponin and ischemic changes on ECG. Significant comorbidities include Parkinson disease with autonomic dysfunction, prior pulmonary embolism, atherosclerotic coronary disease, hypertension, hyperlipidemia, hypothyroidism, and prior breast malignancy.\n\nHospital Course: Patient was admitted to telemetry for medical management of NSTEMI (length of stay 2.9 days). She received therapeutic heparin in hospital, was initiated/continued on dual antiplatelet therapy (aspirin and clopidogrel), and started on high-intensity statin therapy (atorvastatin). Cardiology evaluated and recommended conservative management without urgent percutaneous coronary intervention given overall clinical status and comorbidities. No arrhythmias or recurrent ischemia occurred. Orthostatic hypotension and autonomic instability were addressed; home blood-pressure support medications (midodrine, fludrocortisone) were continued/optimized. Parkinson medications (carbidopa-levodopa immediate and controlled release, entacapone) and levothyroxine were continued. Influenza vaccine administered prior to discharge.\n\nKey Findings and Procedures: Diagnostic evaluation consistent with NSTEMI (elevated cardiac enzymes, ECG changes). No invasive coronary intervention performed during this admission. Hemodynamically stable at discharge; no acute heart failure exacerbation documented.\n\nDischarge Condition and Functional Status: Patient is hemodynamically stable but demonstrates baseline gait impairment and orthostatic symptoms from autonomic dysfunction and Parkinson disease. She requires assistance with transfers and instrumental ADLs and has increased fall risk. Home health services arranged for skilled nursing, medication reconciliation, and monitoring of orthostatic vital signs; physical and occupational therapy for gait and safety recommended.\n\nMedications and Follow-up: Discharge med list includes aspirin EC, clopidogrel, atorvastatin, carbidopa-levodopa (ODT and CR), entacapone, midodrine, fludrocortisone, levothyroxine, hydralazine as needed for BP, docusate, albuterol inhaler, acetaminophen. Heparin stopped. Follow-up: cardiology within 7 days, primary care within 3\u20135 days, neurology as outpatient; labs (BMP, CBC, troponin trend, TSH) in 1 week; outpatient PT/OT through home health.", "diagnosis_codes": ["Z7902", "I2510", "Z853", "Z86711", "Z87891", "G903", "E039", "G20", "I10", "Z993", "E785", "I214"], "suggested_codes": ["I951", "Z741", "Z9181"], "accepted_codes": [], "rejected_codes": ["I951", "Z741", "Z9181"], "date": "2024-09-29T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 25564623, "discharge_summary": "58-year-old female admitted emergently for progressive dyspnea and volume overload following a recent procedure. On presentation she was hypoxemic with large right pleural effusion, ascites, and evidence of volume overload. Past medical history notable for alcoholic cirrhosis with ascites, Barrett\u2019s esophagus, obesity, essential hypertension, major depressive disorder, and chronic noninfective gastroenteritis. Primary diagnosis: Other complications of procedures (T81.89XA) with associated pleural effusion (J90), pancytopenia (D61.818), alcoholic cirrhosis with ascites (K70.31), and fluid overload.\n\nHospital course: Patient underwent ultrasound-guided diagnostic and therapeutic right thoracentesis with symptomatic improvement in dyspnea. Therapeutic paracentesis was performed for tense ascites with symptomatic relief. She received 25% albumin, diuretic therapy (IV then transitioned to oral furosemide), IV fluids as indicated, ferric gluconate for iron deficiency, magnesium supplementation, lactulose for encephalopathy prophylaxis, and supportive care. Hematology evaluated pancytopenia; no acute transfusion requirement was identified during admission. Psychiatry provided medication reconciliation and continuation of sertraline/paroxetine regimen for depression; sleep support with ramelteon initiated. VTE prophylaxis with heparin was administered while inpatient. Chest radiography and bedside ultrasound confirmed decreased effusion post-procedure.\n\nKey findings and procedures: large right pleural effusion drained by thoracentesis; therapeutic paracentesis for ascites; labs notable for anemia and thrombocytopenia consistent with pancytopenia; imaging consistent with effusions and cirrhotic changes.\n\nDischarge condition and functional status: patient is stable for discharge, hemodynamically stable and ambulatory short distances with a rolling walker; limited endurance and deconditioning requiring assistance with transfers and some ADLs. Home health recommended for skilled nursing visits for medication administration, daily weights/edema monitoring, vital signs, and assistance with ADL and mobility.\n\nMedications and follow-up: discharged on furosemide, lactulose, pantoprazole, paroxetine, ramelteon, acetaminophen PRN, magnesium oxide, oxycodone PRN for procedure pain. Labs to be rechecked (CBC, CMP) within 48\u201372 hours. Outpatient follow-up: PCP within 7 days, hepatology in 1\u20132 weeks, pulmonology within 1 week for CXR and effusion reassessment, hematology 1\u20132 weeks, and psychiatry/primary care for depression management. Home health to coordinate medication reconciliation and monitoring.", "diagnosis_codes": ["T8189XA"], "suggested_codes": ["D61818", "E669", "I10", "J90", "K529", "K7031", "E8770", "F339", "K219"], "accepted_codes": ["D61818", "E669", "I10", "J90", "K529", "K7031"], "rejected_codes": ["E8770", "F339", "K219"], "date": "2024-01-10T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 23560619, "discharge_summary": "History of Present Illness: 52-year-old male admitted urgently with acute right upper quadrant pain, nausea and elevated lipase. Imaging and labs were consistent with calculus of the gallbladder with obstruction and biliary acute pancreatitis (ICD-10 K80.63, K85.10). Past medical history notable for obesity, obstructive sleep apnea (uses CPAP), and tobacco use.\n\nHospital Course: Patient underwent urgent laparoscopic cholecystectomy with intraoperative cholangiogram on admission day 1. No retained common bile duct stones were identified during the procedure. Postoperative course was notable for transient elevation in pancreatic enzymes consistent with biliary pancreatitis managed conservatively with bowel rest, IV fluids, and gradual diet advancement. He received perioperative antibiotics (ciprofloxacin and metronidazole), DVT prophylaxis with heparin while inpatient, and multimodal analgesia transitioning from IV to oral. He had mild right-sided pleural effusion/atelectasis treated with incentive spirometry and ambulation. A transient thrombocytopenia was observed and trended to stable range prior to discharge.\n\nKey Findings/Procedures: Diagnostic imaging consistent with obstructing cholelithiasis and biliary pancreatitis. Procedures: laparoscopic cholecystectomy with intraoperative cholangiogram (ICD-10-PCS 0FT44ZZ, 0F798DZ, 0FC98ZZ). No intraoperative complications. Wounds clean, dry, intact.\n\nDischarge Condition and Functional Status: At discharge the patient is hemodynamically stable, afebrile, tolerating a regular diet, and pain controlled on oral analgesics. Ambulates independently in the home environment but reports decreased endurance and requires assistance with longer ambulation/stairs; home health recommended for short-term assistance with wound checks, safe ambulation, medication management, and breathing exercises for atelectasis prevention. Independent with basic ADLs but will benefit from home PT evaluation.\n\nMedications and Follow-up: Discharged on oral ciprofloxacin and metronidazole to complete prescribed course, acetaminophen and oxycodone for breakthrough pain (short course), docusate and bisacodyl for bowel regimen, ondansetron and prochlorperazine as needed, potassium chloride and Neutra-Phos as directed. Heparin discontinued. Follow-up with general surgery in 1\u20132 weeks, PCP in 7 days with labs (CBC, CMP, LFTs) in 48\u201372 hours, and GI if symptoms of obstructive jaundice recur. Return to ER for fever, increasing abdominal pain, jaundice, or wound concerns.", "diagnosis_codes": ["K8063"], "suggested_codes": ["E669", "G4733", "J90", "D696", "F17210", "K851"], "accepted_codes": ["E669", "G4733", "J90"], "rejected_codes": ["D696", "F17210", "K851"], "date": "2024-12-12T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 26960224, "discharge_summary": "Mr. X is a 79-year-old man admitted to observation for 48 hours with acute onset dysuria, fever, and confusion. Past medical history is significant for recurrent urinary tract infections (history of UTI), type 2 diabetes with CKD, prior TIA/CVA without residual deficit, hyperlipidemia, and episodes of hypotension. Initial evaluation was notable for tachycardia, altered mental status consistent with toxic encephalopathy, and laboratory evidence concerning for acute kidney injury on chronic kidney disease. Urinalysis was suggestive of infection; urine culture pending at discharge.\n\nHospital course: The patient received initial IV ceftriaxone with clinical improvement in fever and urinary symptoms and partial resolution of encephalopathic features. Intravenous fluids (lactated Ringer\u2019s and iso\u2011osmotic dextrose) were administered with careful monitoring of hemodynamics given baseline hypotension. Renal function stabilized without need for dialysis. Acyclovir was given empirically early for possible viral encephalitis but discontinued after clinical reassessment and low suspicion. No invasive procedures were required. He remained hemodynamically stable and afebrile for >24 hours prior to discharge.\n\nKey findings and procedures: Positive urinalysis; AKI on CKD that improved with fluids and infection control; no radiographic source identified; blood cultures were negative to date. No catheter placement or surgical intervention performed.\n\nDischarge condition and functional status: He is discharged medically stable, alert and oriented to person and place with improved mentation but intermittent confusion; ambulates with a cane and requires home assistance for medication management and safety supervision due to fall and hypotension risk. Home health recommended for medication reconciliation, vital sign and fluid status monitoring, and assistance with ADLs as needed.\n\nMedications and follow-up: Transitioned to oral ciprofloxacin to complete antibiotic course (adjusted for renal function), resume home medications (aspirin, metoprolol, atorvastatin, cilostazol, ophthalmic regimen as listed). Labs (BMP and repeat renal function) within 48\u201372 hours; follow-up with PCP within 48\u201372 hours and nephrology within 1\u20132 weeks. Urine culture result to be communicated and antibiotic adjusted if indicated. If recurrent confusion or worsening urine output, seek ED care.", "diagnosis_codes": ["N189", "I959", "Z87440", "N179", "E1122", "G92", "N390", "E785", "E8339", "Z8673"], "suggested_codes": ["R000", "Z9181"], "accepted_codes": [], "rejected_codes": ["R000", "Z9181"], "date": "2024-05-13T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 22961529, "discharge_summary": "Brief HPI: 67-year-old male admitted under observation for acute hypercapnic respiratory failure (ICD-10 J96.02) on a background of COPD with acute exacerbation, known right upper-lobe lung malignancy, chronic diastolic heart failure, and chronic kidney disease. He presented with progressive dyspnea, cough, and hypoventilation and was found to have fever, hypotension, and radiographic right upper-lobe consolidation with pleural effusion.\n\nHospital course: The patient required a brief period of ventilatory support with invasive ventilation followed by successful wean to noninvasive ventilation (BiPAP) and then to supplemental oxygen. He received IV antibiotics for community-acquired pneumonia, diuretics for acute on chronic heart failure exacerbation, and cautious fluid management for acute kidney injury with improvement of renal function. Respiratory therapy provided bronchodilator treatments, inhaled corticosteroid/long-acting beta-agonist initiation, and secretion clearance. Therapeutic thoracentesis was performed with symptomatic improvement. Hemodynamics stabilized; hypotension resolved with supportive care.\n\nKey findings and procedures: ABG consistent with hypercapnic respiratory failure; chest radiograph/CT with RUL consolidation and pleural effusion; diagnostic/therapeutic thoracentesis performed; temporal invasive ventilation with subsequent BiPAP support and downward titration of supplemental oxygen.\n\nDischarge condition and functional status: Patient is clinically stable at discharge on low-flow supplemental oxygen (2 L/min at rest, up to 4 L/min with exertion) and nocturnal BiPAP. He remains deconditioned and requires assistance with ambulation and some ADLs; physical therapy recommended. Home health services arranged for skilled nursing, respiratory therapy, and PT to support recovery, oxygen titration, medication reconciliation, and wound/procedure site monitoring.\n\nMedications and follow-up: Discharge meds include albuterol inhaler PRN, fluticasone-salmeterol Diskus, azithromycin (complete prescribed course), benzonatate PRN, digoxin, diltiazem ER, aspirin, fenofibrate, fish oil, chlorhexidine oral rinse, bupropion SR and other home meds. Home oxygen and nocturnal BiPAP prescribed. Follow-up: pulmonary clinic 1 week, primary care 3\u20135 days, cardiology 2 weeks, oncology as scheduled. Home health nursing to visit within 48 hours for assessment and medication reconciliation.", "diagnosis_codes": ["J9602"], "suggested_codes": ["C3411", "J441", "I5032", "J189", "J90", "N189", "R579", "Z7409"], "accepted_codes": ["C3411", "J441"], "rejected_codes": ["I5032", "J189", "J90", "N189", "R579", "Z7409"], "date": "2024-12-21T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 20230126, "discharge_summary": "History of Present Illness: 85-year-old man admitted emergently with fever, lethargy and hypotension. Blood cultures and labs consistent with sepsis (A41.9). Pertinent history includes intrahepatic bile duct carcinoma (C22.1), choledocholithiasis with acute cholecystitis (K80.63), permanent atrial fibrillation on chronic warfarin (I48.21, Z79.01), and baseline mobility limited by deconditioning.\n\nHospital Course: Over a 3.5-day admission he received aggressive intravenous fluid resuscitation and broad-spectrum antibiotics with transition to ciprofloxacin for presumed biliary source after cultures and clinical response. He required temporary hemodynamic support for postprocedural hypotension which resolved. Anticoagulation was held on admission and managed with daily INR monitoring; warfarin was resumed at a reduced dose prior to discharge with outpatient monitoring. Rate control for atrial arrhythmia was achieved with diltiazem and metoprolol adjustments. Electrolyte repletion (magnesium sulfate) and supportive care were provided. He remained afebrile for 48 hours and inflammatory markers declined.\n\nKey Findings and Procedures: Positive sepsis workup with abnormal coagulation profile and imaging consistent with biliary obstruction. Procedures performed included vascular access placement for resuscitation and antibiotics (0FPB8DZ), percutaneous biliary decompression intervention (0F798DZ), and diagnostic abdominal imaging (0FC98ZZ). Influenza high-dose quadrivalent vaccine administered prior to discharge.\n\nDischarge Condition and Functional Status: Patient is hemodynamically stable, afebrile, and tolerating oral intake. Ambulation is limited; requires assistance with transfers and gait (uses walker and assistance from caregiver). Home health is arranged for skilled nursing visits for medication administration oversight, IV/PO antibiotic adherence as indicated, wound/IV-site assessment, and fall-risk/functional mobility support.\n\nMedications and Follow-up: Discharged on ciprofloxacin (per ID guidance), resumed warfarin with plan for frequent INR checks by home health and anticoagulation clinic, diltiazem and metoprolol for rate control, and scheduled 0.9% saline flush supplies as needed. Follow-up: PCP in 48\u201372 hours, Infectious Diseases in 7 days, hepatobiliary/oncology clinic within 2 weeks, and anticoagulation clinic per INR results. Patient/caregiver educated on signs of recurrent infection, bleeding, and when to seek urgent care.", "diagnosis_codes": ["A419"], "suggested_codes": ["C221", "I4821", "K8063", "Z7901"], "accepted_codes": ["C221", "I4821", "K8063", "Z7901"], "rejected_codes": [], "date": "2024-07-02T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 22469623, "discharge_summary": "Brief HPI: 59-year-old man with known cirrhosis and portal hypertension presented to the ED with progressive abdominal distension, dyspnea, hypoxia, fever and intermittent confusion. He was observed for suspected spontaneous bacterial peritonitis (SBP), sepsis, and respiratory failure. Admission diagnosis: portal hypertension complicated by SBP, sepsis, hypoxic respiratory failure, ascites, and anemia.\n\nHospital course: Over a 4.7-day observation stay the patient underwent diagnostic and therapeutic large-volume paracentesis with fluid testing consistent with SBP. He received empiric IV ceftriaxone, albumin 25% after paracentesis, supportive IV fluids, and short course octreotide for variceal prophylaxis. He required supplemental oxygen and brief noninvasive respiratory support; oxygen requirement was weaned to baseline prior to discharge. He was transfused for acute posthemorrhagic anemia. Encephalopathy was treated with lactulose with improvement in mentation. Blood and ascites cultures were obtained; antimicrobial therapy will be adjusted per final cultures.\n\nKey findings/procedures: diagnostic/therapeutic paracentesis, blood transfusion, respiratory support, IV antibiotic therapy, albumin administration. Imaging and labs showed decompensated cirrhosis with ascites, anemia and systemic inflammatory response consistent with sepsis/SBP.\n\nDischarge condition and functional status: Patient is medically stable for discharge to home. He is hemodynamically stable, oxygenating on room air or low-flow O2 as tolerated, mentation improved to baseline but mildly deconditioned. Requires assistance with ambulation and ADLs; home health services arranged for nursing visits and physical therapy.\n\nMedications at discharge (selected): IV ceftriaxone to be continued via home health infusion to complete prescribed course (plan: total 5\u20137 days or per cultures), lactulose titrate to 2\u20133 soft stools/day, ciprofloxacin per MD if oral step-down indicated, acetaminophen PRN, oxycodone short course for pain PRN, albuterol inhaler PRN. Influenza vaccine given during stay.\n\nFollow-up: Hepatology/transplant clinic within 7 days, primary care within 48\u201372 hours, home health nursing for IV therapy, vitals, wound/line care and PT 2\u20133x weekly. Return precautions: fever, worsening abdominal pain/distension, melena/hematemesis, increased confusion, dyspnea or syncope\u2014return to ED immediately.", "diagnosis_codes": ["J9691", "F419", "Z8711", "K766", "Z7682", "Z23", "K7469", "I8510", "K7290", "R911", "K652", "D62", "I10", "G4700", "Z8505", "A419", "F17210", "K3189"], "suggested_codes": ["G931", "K703", "K746", "K760", "K77", "Z743"], "accepted_codes": [], "rejected_codes": ["G931", "K703", "K746", "K760", "K77", "Z743"], "date": "2024-10-09T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 20545804, "discharge_summary": "76-year-old male with history of chronic lymphocytic leukemia (CLL) not in remission, atrial fibrillation, hypertension, type 2 diabetes with diabetic retinopathy with macular edema, hypothyroidism, and prior long-term anticoagulant use presented to observation for acute left upper extremity swelling and pain. Imaging confirmed acute thrombus of the left upper extremity deep veins. Admission was for initiation and monitoring of anticoagulation and assessment of bleeding risk given bilateral retinal hemorrhages.\n\nHospital course: Patient was observed for 3.9 days. Hematology and cardiology were consulted. Therapeutic anticoagulation with enoxaparin was initiated and tolerance was closely monitored (no clinical major bleeding events). Ibrutinib therapy for CLL was continued in coordination with hematology. Ophthalmology evaluated retinal hemorrhages and agreed anticoagulation could proceed with outpatient close follow-up. Blood glucose was managed with inpatient insulin adjustments; home levothyroxine and atenolol were continued. Prophylactic anti-infective measures (acyclovir, atovaquone) were continued per oncology recommendations. Methylprednisolone was given short course for symptomatic control as indicated by oncology.\n\nKey findings and procedures: Imaging confirmed left upper extremity DVT. No clinical evidence of pulmonary embolism during stay. Procedure performed: intravenous/subcutaneous pharmacologic anticoagulation administration (ICD-10-PCS 6A550Z1 documented). Labs during admission: CBC and chemistries stable for discharge; platelet count acceptable for continued anticoagulation.\n\nDischarge condition and functional status: Patient is medically stable for discharge. He is alert and oriented, ambulates with steady gait but reports mild deconditioning and fatigue. Requires home health support for medication management (anticoagulant and insulin administration), blood glucose monitoring, and intermittent assistance with ADLs.\n\nMedications and follow-up: Discharged on enoxaparin for anticoagulation, continued ibrutinib, insulin regimen, levothyroxine, atenolol, acyclovir, atovaquone and short steroid taper as prescribed. Follow-up arranged: Hematology within 1 week, Ophthalmology within 1 week, Cardiology in 1\u20132 weeks, and PCP within 3 days. Outpatient labs (CBC, CMP) in 3 days and as directed by hematology. Home health to provide medication administration, vitals and bleeding surveillance, glucose monitoring, and assistance with ADLs.", "diagnosis_codes": ["I4891", "Z87891", "G4733", "I10", "Z794", "C9110", "E11311", "H3563", "E039"], "suggested_codes": ["I82011"], "accepted_codes": [], "rejected_codes": ["I82011"], "date": "2024-10-07T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 20183435, "discharge_summary": "History of present illness: 82-year-old female admitted as a same-day surgical patient for symptomatic severe nonrheumatic aortic valve stenosis. She underwent planned surgical aortic valve replacement with cardiopulmonary bypass. Admission complicated by postoperative atrial fibrillation and acute posthemorrhagic anemia.\n\nHospital course: Patient remained 4.7 days inpatient. Operative course was uncomplicated from a surgical standpoint. She was extubated on return to the ICU after brief ventilatory support. Postoperatively she developed new-onset atrial fibrillation with rapid ventricular response on POD 1 that responded to rate control with metoprolol and careful fluid management. She experienced acute blood loss anemia requiring packed red blood cell transfusion with subsequent stabilization of hemoglobin. Pain controlled with acetaminophen and gabapentin; bowel regimen started (docusate, bisacodyl). She received influenza vaccination prior to discharge.\n\nKey findings and procedures: Preoperative echocardiogram consistent with severe aortic stenosis. Procedural codes indicate open aortic valve replacement with prosthetic valve and intraoperative cardiopulmonary support. Post-op telemetry demonstrated transient atrial fibrillation; no sustained ischemia. No evidence of wound infection. Estimated blood loss addressed with transfusion.\n\nDischarge condition and functional status: Patient is hemodynamically stable, afebrile, with adequate oral intake and pain controlled on oral regimen. Ambulates short household distances with a rolling walker and requires assistance for stair negotiation; baseline independence with basic ADLs preserved but with decreased endurance. Home health recommended for wound checks, vital sign and weight monitoring, medication administration assistance as needed, and support for ambulation/transfer safety.\n\nMedications and follow-up: Discharge medications include aspirin (enteric coated), metoprolol tartrate for rate control, furosemide as needed, acetaminophen PRN, gabapentin, docusate and bisacodyl, insulin per home regimen, and routine heparin flushes for IV access as indicated. Home health nursing to visit within 24\u201348 hours. Follow-up with cardiothoracic surgery in 1\u20132 weeks and PCP in 7 days; cardiology follow-up for rhythm/anticoagulation management as needed. Patient and caregiver educated on incision care, signs of bleeding, and when to seek urgent care.", "diagnosis_codes": ["F419", "Y831", "F329", "G43909", "D62", "K219", "K5790", "Y92230", "I350", "Z8673"], "suggested_codes": ["I4891", "Z5189", "Z7901"], "accepted_codes": ["I4891"], "rejected_codes": ["Z5189", "Z7901"], "date": "2024-10-29T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 28662253, "discharge_summary": "History of Present Illness: 78-year-old female admitted to observation after acute onset severe headache with transient aphasia and witnessed brief shaking episode. Initial noncontrast CT head demonstrated subarachnoid hemorrhage. CTA/vascular imaging identified a cerebral aneurysm; no radiographic evidence of hydrocephalus or large territory infarction.\n\nHospital Course: Patient was observed for 2.8 days. Neurology and neurosurgery were consulted. She was monitored on continuous telemetry due to episodes of supraventricular tachycardia managed with nadolol and rate control as tolerated. Seizure activity was treated empirically with levetiracetam and no recurrent convulsive events occurred while inpatient. DVT prophylaxis with subcutaneous heparin was provided. Speech-language pathology evaluated persistent expressive aphasia and recommended continued outpatient SLP. Osteoporosis and carotid disease were noted in the chart; vascular surgery recommended outpatient carotid follow-up for definitive management.\n\nKey Findings and Procedures: Noncontrast CT head positive for nontraumatic subarachnoid hemorrhage. CTA demonstrated a cerebral aneurysm without active extravasation. Continuous cardiac telemetry captured supraventricular tachycardia episodes. Procedures performed: diagnostic neuroimaging, continuous monitoring, and bedside assessments by neurology, neurosurgery, SLP, and PT.\n\nDischarge Condition and Functional Status: Patient is neurologically stable, hemodynamically stable, and afebrile at discharge. Residual expressive aphasia and mild gait instability remain; she requires assistance with some ambulation and moderate help with instrumental ADLs. Home health nursing and therapy are recommended for medication supervision, seizure precautions, fall-risk mitigation, and rehabilitative therapies.\n\nMedications at Discharge: Acetaminophen, atorvastatin, docusate sodium, heparin (as ordered), levetiracetam, nadolol, senna, vitamin D, and supportive nasal/saline products. Influenza and pneumococcal (PPSV23) vaccines were administered.\n\nFollow-up: Neurosurgery within 1\u20132 weeks for aneurysm management discussion, outpatient neurology within 1 week, cardiology for SVT evaluation, vascular surgery for carotid stenosis, and primary care within 1 week for medication reconciliation and home health initiation. Home health referral placed for RN, PT, OT, and SLP services.", "diagnosis_codes": ["I671", "I471", "R4701", "I608", "M810", "I6522", "R569", "Z8673"], "suggested_codes": ["R2689", "Z7401"], "accepted_codes": [], "rejected_codes": ["R2689", "Z7401"], "date": "2024-12-18T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 21849443, "discharge_summary": "History of Present Illness: 41-year-old man presented to the emergency department with acute right-sided pleuritic chest pain and dyspnea after a coughing episode. Chest radiograph and CT demonstrated a right-sided pneumothorax (primary diagnosis: other pneumothorax, ICD-10 J93.83). Past history notable for asthma (J45.909), sequelae of prior infectious disease (B94.8), and opioid dependence in remission (F11.21).\n\nHospital Course: Patient was admitted emergently for management of symptomatic pneumothorax. He underwent percutaneous drainage of the right pleural space with placement of a small-bore chest tube (ICD-10-PCS 0W9930Z) on hospital day 0. He received analgesia (hydromorphone PRN and ketorolac), topical lidocaine 5% patches, gabapentin for neuropathic-type pain, and acetaminophen as adjunct. Subcutaneous heparin was given for DVT prophylaxis. Serial chest radiographs demonstrated progressive re-expansion of the right lung; chest tube was removed on hospital day 2 after minimal air leak and radiographic stability. No evidence of recurrent pneumothorax prior to discharge.\n\nKey Findings and Procedures: Imaging-confirmed right pneumothorax with successful percutaneous pleural drainage and chest tube placement/removal. Vital signs remained stable off supplemental oxygen; oxygen saturation >94% on room air. No infectious complications.\n\nDischarge Condition and Functional Status: Patient is hemodynamically stable, ambulating with mild dyspnea on exertion, able to perform most activities of daily living independently with instruction to limit heavy lifting and avoid Valsalva maneuvers for two weeks. Home health referral placed for wound/chest tube site checks, medication reconciliation, and activity monitoring. Home health to monitor respiratory status and assist with arranging outpatient imaging.\n\nMedications and Follow-up: Discharge meds include acetaminophen, gabapentin, intermittent hydromorphone (short course PRN), ketorolac PRN, lidocaine 5% patch PRN, montelukast daily, and heparin noted as inpatient DVT prophylaxis (no outpatient anticoagulation prescribed). Sodium chloride 0.9% flush for IV access as needed. Follow-up in thoracic surgery/pulmonology clinic in 5\u20137 days and primary care within 1 week. Repeat chest x-ray in 48\u201372 hours and sooner for increased dyspnea, fever, or chest pain.", "diagnosis_codes": ["J9383"], "suggested_codes": ["B948", "F1121", "J45909"], "accepted_codes": ["B948", "F1121", "J45909"], "rejected_codes": [], "date": "2024-10-02T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 21540673, "discharge_summary": "History of present illness: 70-year-old man admitted emergently with progressive obstructive jaundice, pain, and a pathologic femoral fracture in the setting of known metastatic neuroendocrine tumor. Admission complicated by hyperglycemia, steroid exposure, and acute-on-chronic pain. Length of stay 12 days.\n\nHospital course: The patient underwent endoscopic retrograde cholangiopancreatography (ERCP) with biliary stent placement for relief of obstructive biliary symptoms and subsequently had operative fixation of a pathologic femoral fracture. A peripherally inserted central catheter (PICC) was placed for systemic therapy and IV access. He received first-cycle systemic chemotherapy with carboplatin and etoposide with standard antiemetic prophylaxis (fosaprepitant, dexamethasone) and supportive IV fluids; enoxaparin was given for prophylaxis. His hyperglycemia was addressed with short-acting glycemic measures while inpatient. Pain was managed with multimodal analgesia. No inpatient infectious complications. Steroid-associated adverse effects were recognized and minimized prior to discharge.\n\nKey findings and procedures: Imaging confirmed biliary obstruction secondary to metastatic disease. ERCP with biliary stent provided successful decompression. Orthopedic evaluation and operative fixation addressed the pathological femoral fracture. PICC line placed for chemotherapy administration.\n\nDischarge condition and functional status: Patient is hemodynamically stable, afebrile, and pain is controlled on oral analgesics. Mobility is limited; ambulates short distances with a walker and requires assistance with transfers and ADLs. Home health nursing arranged for wound checks, PICC care and medication administration education; home physical therapy for gait and strength training is in place.\n\nMedications and follow-up plan: Discharge meds include carboplatin and etoposide (outpatient oncology-administered cycles per oncology schedule), dexamethasone short course, fosaprepitant PRN per chemo protocol, aspirin, enalapril, enoxaparin (short-term prophylaxis), bisacodyl for bowel regimen, and glucose support as needed. Follow-up: oncology within 7 days for ongoing systemic therapy planning, orthopedics 7\u201310 days for wound check, primary care/cardiology for chronic disease management, endocrinology as outpatient for diabetes control, and home health nursing and PT as arranged. Return precautions reviewed.", "diagnosis_codes": ["T380X5A", "I25118", "R05", "K449", "M109", "C7B8", "Z981", "I10", "K831", "E1165", "C7A8", "K5900", "M8458XA"], "suggested_codes": ["Z452", "Z7401"], "accepted_codes": [], "rejected_codes": ["Z452", "Z7401"], "date": "2024-02-13T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 20392805, "discharge_summary": "History of Present Illness: 78-year-old male admitted electively for revision of a leaking aortic bifurcation graft (ICD-10 T82.330A). Past medical history notable for chronic kidney disease stage 4, atrial fibrillation, hypertensive heart and chronic kidney disease with heart failure (diastolic), peripheral polyneuropathy, hyperlipidemia, and gout.\n\nHospital Course: The patient underwent endovascular revision of the aortic bifurcation graft (ICD-10-PCS 02UW4JZ) on hospital day 1 without intraoperative complications. Perioperative anticoagulation was managed intraoperatively with heparin and held postoperatively per vascular surgery recommendations. Postoperative recovery was uncomplicated: hemodynamics stable, pain controlled, and surgical site without evidence of ongoing bleeding or infection. Renal function remained at baseline for his CKD stage 4 with serial BMPs and urine output monitored. Rhythm remained atrial fibrillation; no acute ischemic changes on telemetry. Influenza quadrivalent vaccine administered prior to discharge.\n\nKey Findings and Procedures: Successful endovascular revision of leaking aortic bifurcation graft. Imaging confirmed correction of graft leak. Postoperative labs and vitals were stable. No new neurologic deficits; baseline peripheral neuropathy unchanged.\n\nDischarge Condition and Functional Status: Patient is stable for discharge to home with home health services. Ambulates with a rolling walker and requires steadying assistance for longer distances; independent with bed-to-chair transfers with supervision. Needs assistance with medication management and wound care; home health to monitor incision site, daily weights, vitals (BP, pulse, O2 sat), and edema assessment.\n\nMedications and Follow-up Plan: Discharged on home regimen including aspirin, pravastatin, labetalol, furosemide, clonidine, acetaminophen PRN, allopurinol, calcitriol, docusate sodium, and artificial tears. Anticoagulation for atrial fibrillation is deferred pending outpatient vascular/cardiology discussion. He received influenza vaccine prior to discharge. Follow-up: vascular surgery in 10\u201314 days for wound check and imaging; nephrology within 7 days for CKD management and labs; cardiology in 1\u20132 weeks to reassess rhythm and anticoagulation; primary care within 7 days. Home health to begin immediately for wound care, medication reconciliation, BP and weight monitoring, and assistance with activities of daily living.", "diagnosis_codes": ["T82330A"], "suggested_codes": ["E785", "G629", "I4891", "M109", "N184", "Z23", "I110"], "accepted_codes": ["E785", "G629", "I4891", "M109", "N184", "Z23"], "rejected_codes": ["I110"], "date": "2024-04-10T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 24883160, "discharge_summary": "Brief history of present illness: 75-year-old female presented to the ED with acute onset severe vertigo, nausea, vomiting and unsteady gait. Symptoms began 48 hours prior to admission. She has a history of bilateral total knee arthroplasties, chronic kidney disease stage 3, polyneuropathy, glaucoma, and recurrent osteoarthritis. Primary working diagnosis: vestibular neuronitis (H81.20). Urinalysis suggested a urinary tract infection on presentation.\n\nHospital course: Observed 1.6 days. Neurologic exam showed spontaneous horizontal nystagmus and positive head impulse testing; no focal deficits or stroke signs. CT head was nonacute. Treated with IV isotonic fluids (0.9% NaCl), antiemetic (ondansetron) for symptom control, single-dose IV ceftriaxone for suspected UTI pending culture, and subcutaneous heparin for DVT prophylaxis. Latanoprost ophthalmic and home trazodone continued. Influenza and pneumococcal vaccines were administered prior to discharge. Physical therapy evaluated balance and gait; recommended home-based therapy for fall prevention and strengthening. Urine culture pending; renal function stable for baseline CKD stage 3.\n\nKey findings/procedures: noncontrast CT head negative for acute process; positive bedside vestibular findings consistent with peripheral vestibulopathy. No invasive procedures performed. PT assessment: moderate imbalance, requires single-point cane for short distances; assistance needed for toileting transfers.\n\nDischarge condition and functional status: Patient discharged stable and afebrile, symptoms improved with reduced nausea and less severe vertigo. Ambulates short distances with a cane and requires assistance for some transfers and ADLs. Home health recommended for nursing visits and home physical therapy to reduce fall risk and assist with medication reconciliation.\n\nMedications and follow-up plan: Continue latanoprost 0.005% ophthalmic nightly, trazodone at bedtime as needed, ondansetron PRN for nausea. Heparin and IV therapies discontinued. Urine culture pending; home health RN/PCP to review culture and initiate oral antibiotics if indicated. Follow up with PCP in 48\u201372 hours, ENT or neurology in 2 weeks, ophthalmology in 4 weeks, nephrology PRN for CKD. Home health nursing to visit within 24\u201348 hours and home PT to begin within 48\u201372 hours for balance training and home safety assessment.", "diagnosis_codes": ["H8120"], "suggested_codes": ["G629", "H409", "N183", "N390", "M159"], "accepted_codes": ["G629", "H409", "N183", "N390"], "rejected_codes": ["M159"], "date": "2024-05-13T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 25805902, "discharge_summary": "History of Present Illness: 70-year-old male admitted electively for repair of an incisional hernia (ICD-10 K43.2). Preoperative complaints included an enlarging abdominal wall bulge without features of obstruction or ischemia. Significant comorbidities: hyperlipidemia, history of nicotine dependence, cardiomegaly, and prior episodes of urinary retention.\n\nHospital Course: Patient underwent operative repair under general anesthesia with intraoperative placement of prosthetic reinforcement (procedure codes 0WUF0JZ, 0KXL0ZZ, 0KXK0ZZ). Short perioperative urinary catheterization (00HU33Z) was performed and removed when voiding trial was satisfactory. Perioperative prophylaxis included heparin and standard antibiotics. Pain was managed with multimodal therapy (acetaminophen, short course IV/PO opioids as needed, local bupivacaine infiltration). There were no intraoperative or immediate postoperative complications. Labs and hemodynamics remained stable. Patient tolerated diet, ambulated with assistance, and had return of bowel function prior to discharge.\n\nKey Findings and Procedures: Incisional hernia without obstruction or gangrene repaired with prosthetic reinforcement; uncomplicated anesthetic course. Urinary catheter placed perioperatively for bladder management with successful voiding prior to discharge.\n\nDischarge Condition and Functional Status: Patient is discharged in stable condition, afebrile, hemodynamically stable, and tolerating oral intake. Mobility: ambulates with a cane/assistance short distances and requires home health support for transfers and activity progression. Wound status: surgical incision clean and dry; requires dressing changes and wound checks by home health.\n\nMedications at Discharge: Acetaminophen scheduled and PRN; oxycodone IR short course for breakthrough pain; docusate sodium and polyethylene glycol for bowel regimen; pravastatin continued; tamsulosin resumed for urinary symptoms. Naloxone provided in the inpatient setting as needed; heparin prophylaxis discontinued on discharge.\n\nFollow-up Plan: Surgical clinic in 7\u201310 days for wound check and suture removal as indicated. Primary care follow-up in 1 week; consider cardiology follow-up for cardiomegaly if not established. Home health referral for wound care, medication administration/education, vital sign monitoring, ambulation assistance, and voiding assessment. Return to ED for fever, increasing pain, wound drainage, inability to void, or progressive shortness of breath.", "diagnosis_codes": ["K432"], "suggested_codes": ["E785", "I517", "F17210", "N39498", "Z7401"], "accepted_codes": ["E785", "I517"], "rejected_codes": ["F17210", "N39498", "Z7401"], "date": "2024-03-30T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 22657805, "discharge_summary": "History of Present Illness: 86-year-old female admitted under observation after acute onset left upper quadrant abdominal pain and lightheadedness. Past medical history notable for paroxysmal atrial fibrillation, essential hypertension, hyperlipidemia, mild cognitive impairment, peripheral neuropathy, prior breast cancer, and Charcot arthropathy of the left ankle. CT abdomen obtained on admission demonstrated a focal splenic infarction consistent with embolic phenomenon.\n\nHospital Course: Patient observed 3.7 days. Telemetry captured intermittent paroxysmal atrial fibrillation. She was anticoagulated with heparin during admission and transitioned to oral anticoagulation prior to discharge. Electrolyte abnormalities (hypokalemia, low magnesium) were corrected. Pain was managed with acetaminophen; gabapentin resumed for baseline neuropathic pain. No surgical intervention was required. Influenza high-dose vaccine was administered prior to discharge.\n\nKey Findings and Procedures: CT abdomen showing splenic infarct (D73.5). Continuous cardiac monitoring demonstrating paroxysmal AF. Laboratory correction of hypokalemia and hypomagnesemia. No evidence of hemodynamic instability or need for splenic intervention.\n\nDischarge Condition and Functional Status: Patient is medically stable, pain controlled on oral medications. Cognition at baseline for known mild cognitive impairment; requires assistance with medication management and moderate assistance for transfers/ambulation due to baseline neuropathy and Charcot joint. Ambulates with a walker with supervision. Home health services arranged for nursing and physical therapy to support safety and ADLs.\n\nMedications and Follow-up Plan: Discharge medications include apixaban (for presumed embolic splenic infarct and atrial fibrillation), aspirin (home medication), beta-blocker for rate control, HCTZ for BP, potassium chloride and oral magnesium supplementation, gabapentin, acetaminophen PRN, omeprazole PRN. Heparin discontinued. Home health to monitor vitals, bleeding signs, med reconciliation, and labs (BMP, CBC) within 48\u201372 hours. Follow-up with primary care within 48\u201372 hours, cardiology in 1 week for anticoagulation/rhythm management, and vascular/hematology or outpatient imaging in 4\u20136 weeks as indicated. Return precautions given for worsening abdominal pain, bleeding, syncope, or new neurologic deficits.", "diagnosis_codes": ["D735"], "suggested_codes": ["E785", "E8342", "E876", "I10", "I480", "F067", "G609", "M1467"], "accepted_codes": ["E785", "E8342", "E876", "I10", "I480"], "rejected_codes": ["F067", "G609", "M1467"], "date": "2024-03-14T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 29511210, "discharge_summary": "49-year-old female admitted under observation for 21.7 days with acute thoracic aortic dissection (I71.01) complicated by acute respiratory failure with hypoxia, coronary artery dissection, acute on chronic diastolic heart failure, acute post-hemorrhagic anemia, and acute kidney injury. She presented with acute chest/back pain and hemodynamic lability and underwent urgent endovascular repair of the thoracic aortic dissection. Additional procedures included central venous access placement and a period of invasive ventilatory support with successful weaning.\n\nHospital course: Post-procedure course was notable for brief intubation for hypoxemic respiratory failure, treated with ventilatory support and subsequent successful extubation. She received a short course of IV antibiotics (ampicillin-sulbactam) for suspected healthcare-associated pulmonary infection and diuresis for volume management related to acute on chronic diastolic heart failure. Renal function improved with conservative management and adjustment of diuretics; anemia was addressed with supportive care. Hemodynamics stabilized with antihypertensive management (including hydralazine as indicated). Neurologic status remained at baseline following evaluation for prior cerebrovascular disease.\n\nKey findings/procedures: Imaging confirmed thoracic aortic dissection with successful endovascular repair. Echocardiogram demonstrated nonrheumatic aortic insufficiency and diastolic dysfunction. AKI and anemia improved; no new focal neurologic deficits identified.\n\nDischarge condition and functional status: Patient is medically stable for discharge to home. She requires assistance with ambulation (uses walker) and needs help with some activities of daily living; mobility and endurance are improving with therapy. Home health nursing is arranged for skilled nursing visits for medication reconciliation, vital sign and weight monitoring, daily diuretic adjustment guidance, laboratory monitoring (BMP, CBC) and assistance with ADLs. Home PT/OT will continue gait training and functional strengthening.\n\nMedications and follow-up: Discharge meds include aspirin EC, furosemide (dose adjusted per weight and renal function), hydralazine PRN, acetaminophen PRN, docusate sodium and lactulose PRN for bowel management, and glucose gel PRN. Completed inpatient antibiotic course. Follow-up: cardiothoracic surgery and cardiology within 1 week, nephrology in 1 week for AKI monitoring, and primary care within 48\u201372 hours. Labs (BMP, CBC) in 48\u201372 hours or sooner if symptomatic.", "diagnosis_codes": ["T508X5A", "D509", "I5033", "Q2543", "D62", "J9601", "I7101", "N179", "I351", "K219", "Z9114", "T501X5A", "I161", "Y92230", "I2542", "I110"], "suggested_codes": ["Z5123", "Z515", "Z749"], "accepted_codes": [], "rejected_codes": ["Z5123", "Z515", "Z749"], "date": "2024-03-09T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 21160232, "discharge_summary": "History of Present Illness: 88-year-old female presented after a fall on stairs with right shoulder pain. Radiographs demonstrated an acute, closed, unspecified fracture of the proximal right humerus (S42.201A). She was observed for pain control, neurovascular monitoring, and medical optimization given multiple comorbidities including hypertensive heart disease with heart failure, atrial fibrillation on chronic anticoagulation, and hyperlipidemia.\n\nHospital Course: Observation admission 1.8 days. Orthopedics consulted; no emergent operative intervention indicated during this encounter. Fracture managed nonoperatively with shoulder immobilizer/sling, neurovascular checks remained intact, and repeat imaging deferred to outpatient ortho. Cardiac status monitored; no decompensated heart failure. Anticoagulation (apixaban) was resumed after risk/benefit discussion. Pain managed with multimodal regimen; short course of opioid for breakthrough pain provided and weaned prior to discharge. Vitals and basic labs were stable; no acute medical complications.\n\nKey Findings and Procedures: Right proximal humerus fracture on X-ray; no open injury, no neurovascular deficit. Orthopedics evaluation without procedure performed. Imaging and clinical exam consistent with closed fracture; fall mechanism documented. No IV lines on discharge.\n\nDischarge Condition and Functional Status: Patient is medically stable for discharge. Pain is controlled on oral medications. She ambulates with a rolling walker and requires assistance with transfers and bathing; home health services arranged for nursing and physical/occupational therapy to assist with mobility training, ADL support, fall prevention, and medication management. Home health to monitor incision/wound if needed and anticoagulation-related signs.\n\nMedications and Follow-up: Discharge meds include acetaminophen (scheduled/PRN), apixaban (resume chronic dose for AF), metoprolol succinate XL, torsemide, amlodipine, atorvastatin, docusate sodium, lidocaine 5% patch PRN, short-course morphine sulfate or oxycodone IR for breakthrough pain. Sodium chloride 0.9% flush not required at home. Follow-up: Orthopedics in 7\u201310 days, primary care in 1 week (or sooner if concerns), cardiology as outpatient for AF/heart failure management. Home health to initiate within 48 hours.", "diagnosis_codes": ["S42201A"], "suggested_codes": ["E785", "I110", "I4891"], "accepted_codes": ["E785", "I110", "I4891"], "rejected_codes": [], "date": "2024-07-22T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 20473074, "discharge_summary": "History of Present Illness: 25-year-old G?P? female presented urgently at 39 weeks gestation with suspected fetal abnormality and concern for delivery. She underwent a spontaneous vaginal delivery of a single live term neonate. Delivery was complicated by a first-degree perineal laceration which was repaired in the delivery suite. Mother and infant remained stable during a 2.3-day postpartum stay.\n\nHospital Course: Maternal postpartum course was uncomplicated. Vital signs remained within expected limits; uterine involution noted and lochia appropriate for immediate postpartum period. Pain was managed with oral acetaminophen and ibuprofen as needed. Bowel regimen instituted (docusate and milk of magnesia as indicated; bisacodyl PRN) to reduce straining. Topical analgesia (Dermoplast) and simethicone for gas discomfort were provided. Intravenous fluids (Lactated Ringer\u2019s) and routine IV saline flushes were used peri-delivery. Influenza quadrivalent vaccine was administered prior to discharge.\n\nKey Findings and Procedures: Term singleton live birth (ICD-10 Z37.0) at 39 weeks (Z3A.39). Primary diagnosis: maternal care for suspected fetal abnormality (O35.8XX0). First-degree perineal laceration during delivery (O70.0) with uncomplicated local repair. Relevant procedures performed include routine vaginal delivery and perineal repair with standard hemostasis and uterine assessment.\n\nDischarge Condition and Functional Status: Patient is hemodynamically stable, afebrile, tolerating oral intake, ambulating independently with steady gait, and able to perform basic activities of daily living though advised to limit heavy lifting and strenuous activity. Breastfeeding established with initial latch; patient requests home health support for lactation education and newborn care assistance.\n\nMedications and Follow-up: Discharge medications: acetaminophen and ibuprofen for analgesia, docusate sodium and milk of magnesia for constipation prevention/treatment, bisacodyl PRN, calcium carbonate as needed for reflux, simethicone for gas, Dermoplast topical spray for perineal pain. Follow-up: postpartum clinic/OB at 1\u20132 weeks and routine 6-week postpartum visit; home health nursing for wound checks, lochia and pain monitoring, lactation support, and medication reconciliation. Return precautions reviewed: fever >100.4\u00b0F, heavy bleeding, increasing perineal pain, wound drainage, or signs of infection.", "diagnosis_codes": ["O358XX0"], "suggested_codes": ["O700", "Z370", "Z3A39", "Z23"], "accepted_codes": ["O700", "Z370", "Z3A39"], "rejected_codes": ["Z23"], "date": "2024-08-09T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 28037356, "discharge_summary": "Patient: 74-year-old male. Admission: Emergency; length of stay 5.5 days. Primary diagnosis: postprocedural hematoma of genitourinary organ (N99.840) with acute posthemorrhagic anemia (D62) and acute kidney injury (N17.9) on chronic kidney disease.\n\nHistory of present illness: Patient developed a sizable postprocedural hematoma following a recent genitourinary procedure and presented to the ED with symptomatic anemia and hypotension. He has known CKD and history of TIA and non-Hodgkin lymphoma.\n\nHospital course: On admission the patient was hemodynamically stabilized with IV fluids and transfusion for acute posthemorrhagic anemia. Broad evaluation included serial CBCs and BMPs, imaging of the pelvis to define hematoma extent, and consultations with urology and nephrology. Interventional options were considered; conservative management with close observation was chosen as the patient stabilized and hematoma size was nonexpanding on repeat imaging. Renal function acutely worsened on admission consistent with AKI on CKD and improved with fluid optimization and avoidance of nephrotoxins. Pain was controlled with short-course opioid and adjunctive acetaminophen. Nausea was treated as needed. VTE prophylaxis and bowel regimen were instituted.\n\nKey findings/procedures: Imaging-confirmed postprocedural pelvic hematoma without active extravasation. Received packed red blood cell transfusion(s) for symptomatic anemia. Nephrology recommended renal-protective measures and outpatient monitoring. Urology followed and recommended nonoperative management with outpatient surveillance.\n\nDischarge condition and functional status: Patient is hemodynamically stable, ambulates short distances with assistance, and requires intermittent help for activities of daily living. Wound/hematoma site shows no active drainage; home health is arranged for wound checks, vital sign monitoring, medication administration, and assistance with ADLs.\n\nMedications and follow-up: Discharge medications include acetaminophen, oxycodone (IR) PRN, atorvastatin, metoprolol succinate XL, amlodipine, tamsulosin, levothyroxine, omeprazole, ondansetron PRN, senna, sodium bicarbonate, and others as reconciled. Labs (CBC, BMP) within 48\u201372 hours post-discharge. Follow-up: urology within 7 days, nephrology within 2 weeks, primary care within 7 days, and oncology as outpatient. Home health to coordinate wound care, vitals, medication adherence, and transport to appointments.", "diagnosis_codes": ["C8590", "I890", "D62", "E039", "I714", "N200", "Z8673", "Y838", "Z85810", "N189", "D638", "N99840", "M109", "N179", "Z20822", "Y92019", "E8351", "N400", "I129"], "suggested_codes": [], "accepted_codes": [], "rejected_codes": [], "date": "2024-10-17T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 24426454, "discharge_summary": "History of Present Illness: 23-year-old female admitted as a same-day surgical patient for operative management related to symptomatic, otherwise specified polyneuropathy (ICD-10 G62.89). She presented with progressive distal sensory loss and neuropathic pain refractory to outpatient measures. Significant comorbidities include severe obesity (BMI 45\u201349.9), obstructive sleep apnea, allergic rhinitis, bipolar disorder, and obsessive-compulsive disorder.\n\nHospital Course: The patient underwent planned surgical intervention (procedure codes 01UD07Z, 01ND0ZZ) without intraoperative complications. Perioperative cefazolin and intraoperative fluids (lactated Ringer\u2019s, iso\u2011osmotic dextrose) were administered. Postoperatively she received short-interval IV analgesia (hydromorphone), antiemetic therapy (ondansetron), and DVT prophylaxis with heparin while inpatient. Overnight observation was performed due to history of OSA; respiratory status remained stable on baseline CPAP at home. She had mild postoperative nausea that resolved and reported acceptable pain control on transition to oral analgesics. Influenza quadrivalent vaccine was administered prior to discharge.\n\nKey Findings and Procedures: Pre- and post-operative neurological exam demonstrated persistent distal sensory deficits consistent with the underlying polyneuropathy; no new focal motor deficits. Surgical site clean, dry, and intact on examination at discharge. No evidence of wound infection or bleeding.\n\nDischarge Condition and Functional Status: Patient discharged in stable condition, afebrile, hemodynamically stable. Ambulates short distances with supervision due to neuropathic symptoms and obesity; requires assistance with some ADLs and will benefit from home health support for mobility and wound care. Respiratory status stable on home CPAP; home health should monitor oxygenation and CPAP adherence.\n\nMedications and Follow-up: Discharge medications include acetaminophen and oxycodone (PRN) for pain, ondansetron PRN for nausea, continuation of home psychotropic regimen (lamotrigine, clonazepam) as previously prescribed, and instructions regarding wound care and DVT prevention with early ambulation. Follow-up: surgical clinic in 7\u201310 days for wound check, neurology in 4 weeks for ongoing polyneuropathy management, primary care in 1 week, and outpatient sleep medicine/psychiatry as needed. Home health services arranged for wound care, medication reconciliation, vital sign/respiratory monitoring, and assistance with ADLs for 1\u20132 weeks.", "diagnosis_codes": ["G6289"], "suggested_codes": ["E669", "F319", "F42", "G4733", "J309"], "accepted_codes": ["E669", "F319", "F42", "G4733", "J309"], "rejected_codes": [], "date": "2024-04-04T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 29122661, "discharge_summary": "Patient: 66-year-old male. Admission: OBSERVATION ADMIT, length of stay 4.8 days. Primary diagnosis: malignant neoplasm of liver (C22.9). Other active problems: Non-Hodgkin lymphoma (C85.90), paroxysmal atrial fibrillation (I48.0), essential hypertension (I10), hyperlipidemia (E78.5), GERD without esophagitis (K21.9), type 2 diabetes without complications (E11.9), history of myocardial infarction (I25.2), history of venous thrombosis/embolism (Z86.718).\n\nHistory of present illness: The patient presented with progressive fatigue, intermittent right upper quadrant discomfort, mild nausea, and new abnormal liver imaging concerning for hepatic mass. He has background of lymphoma and cardiovascular comorbidities. No overt GI bleed, hemodynamically stable on arrival.\n\nHospital course: Patient underwent image-guided diagnostic procedure of the liver (ICD-10-PCS 0FB03ZX) without immediate complication. Pain was managed with acetaminophen. Cardiac monitoring identified paroxysmal atrial fibrillation episodes; rate controlled with metoprolol tartrate. Electrolytes were monitored; magnesium supplemented as indicated. No transfusions required. Acyclovir was administered per oncology prophylaxis protocol. Gastroprotection continued with pantoprazole. Bowel regimen initiated with senna. Vitals and hemodynamics remained stable; blood glucose controlled with oral agents during stay. Oncology and cardiology consultants were involved; plan for definitive oncologic staging and management outpatient.\n\nKey findings and procedures: Imaging and procedural pathology pending; preliminary report consistent with hepatic malignancy requiring outpatient oncology follow-up. Diagnostic percutaneous liver procedure performed without complication. Cardiac telemetry confirmed paroxysmal AF.\n\nDischarge condition and functional status: Patient discharged stable, ambulatory with baseline assistance, independent with ADLs at home but fatigued and limited in activity tolerance. Home health recommended for wound checks, assistance with medication administration review, and monitoring of vital signs/weight twice weekly.\n\nMedications at discharge: Acetaminophen PRN, metoprolol tartrate (for rate control), pantoprazole daily, rosuvastatin, ramelteon PRN at night, senna PRN, acyclovir per oncology plan. Advised to continue home medications for diabetes and hypertension.\n\nFollow-up: Oncology clinic within 7\u201310 days for pathology/staging and treatment planning; cardiology within 1\u20132 weeks to reassess AF management and anticoagulation; primary care in 1 week. Labs (CBC, CMP, INR if applicable) within 48\u201372 hours. Return precautions reviewed.", "diagnosis_codes": ["C229"], "suggested_codes": ["C8590", "E119", "E785", "I10", "I252", "I480", "K219", "Z86718"], "accepted_codes": ["C8590", "E119", "E785", "I10", "I252", "I480", "K219", "Z86718"], "rejected_codes": [], "date": "2024-12-20T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 24972431, "discharge_summary": "Mr. [Patient], a 79-year-old man, was admitted under observation for chest pain and diagnosed with non\u2013ST elevation myocardial infarction (NSTEMI). He has significant comorbidities including end-stage renal disease on chronic hemodialysis, known coronary artery disease, prior coronary artery dissection, systolic heart failure/cardiomyopathy, chronic anemia, and recent community-acquired pneumonia. Presenting troponin was elevated and ECG showed ischemic changes without ST elevation. He received guideline-directed medical therapy for NSTEMI and was monitored in the telemetry unit.\n\nHospital course: The patient underwent diagnostic left heart catheterization with percutaneous coronary intervention to address obstructive coronary lesions and achieved TIMI-3 flow post-intervention. He remained hemodynamically stable after the procedure. He received IV and oral antibiotics for pneumonia (completed a course including levofloxacin) with clinical improvement. Hemoglobin declined consistent with acute posthemorrhagic anemia and he received transfusion support with subsequent stabilization. Dialysis was continued on schedule throughout the stay. Echocardiography demonstrated reduced left ventricular systolic function (estimated EF ~35\u201340%). No in-hospital arrhythmias requiring intervention were noted.\n\nKey findings and procedures: Elevated cardiac biomarkers consistent with NSTEMI, diagnostic coronary angiography with percutaneous coronary intervention and stent placement, treatment for pneumonia, RBC transfusion for acute anemia, ongoing maintenance hemodialysis.\n\nDischarge condition and functional status: At discharge he is medically stable, hemodynamically controlled, and euvolemic. He ambulates with assistive device and requires assistance with some activities of daily living; home health nursing is arranged for medication reconciliation, daily weight and volume status checks, and dialysis coordination. Wound/catheter sites are clean and intact.\n\nMedications on discharge: Aspirin, clopidogrel, metoprolol succinate, isosorbide mononitrate ER, hydralazine, nitroglycerin SL PRN, calcium acetate, ferric citrate, allopurinol, acetaminophen, levofloxacin (if ongoing per culture/ID), magnesium oxide, polyethylene glycol, nephrocaps as indicated. \n\nFollow-up: Cardiology within 7 days, nephrology per dialysis unit schedule, PCP in 1\u20132 weeks, and home health nursing to initiate within 24\u201348 hours. Return to ED for chest pain, dyspnea, syncope, or fever.", "diagnosis_codes": ["M25561", "Z85820", "I480", "Z955", "Z85030", "D631", "D696", "I132", "N186", "H548", "I214"], "suggested_codes": ["J189", "D621", "I500"], "accepted_codes": ["J189"], "rejected_codes": ["D621", "I500"], "date": "2024-06-18T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 25419035, "discharge_summary": "History of present illness: 81-year-old male admitted under observation for severe sepsis of unclear source (A41.9) with multi-organ dysfunction. He presented with hypotension and altered mentation and was found to have respiratory distress and acute kidney injury. Length of stay 18.9 days; stabilized and prepared for discharge to home with home health.\n\nHospital course: Patient required initial resuscitation with IV fluids and brief vasopressor support for septic shock and cardiogenic compromise. He developed acute-on-chronic diastolic heart failure and respiratory failure with periods of hypoxia and hypercapnia, requiring supplemental oxygen and intermittent noninvasive ventilatory support; he was successfully weaned to baseline oxygen requirements. Acute kidney injury improved with conservative management. He received broad-spectrum IV antibiotics with clinical improvement and was transitioned to tailored oral therapy prior to discharge. Arrhythmia management and rate control were optimized for history of atrial fibrillation; anticoagulation with apixaban continued. Wound/cellulitis areas were managed with local care; no operative procedures were required.\n\nKey findings and procedures: Blood cultures and imaging consistent with systemic infection; elevated lactate and hemodynamic instability on presentation that resolved. Echocardiogram showed chronic diastolic dysfunction with reduced reserve. No invasive procedures required at discharge; urinary catheter removed and patient voiding.\n\nDischarge condition and functional status: Medically stable for discharge, hemodynamically euvolemic, afebrile, and oxygenating on prescribed supplemental oxygen. Functional status: decreased endurance and deconditioning after prolonged hospitalization; requires assistance with transfers and ambulation and will benefit from skilled physical and occupational therapy. Wound care needs and medication management require nursing oversight at home.\n\nMedications and follow-up: Discharge medications include acetaminophen, apixaban, bumetanide, midodrine, inhaled bronchodilator (albuterol), fluticasone inhaler and nasal steroid, omeprazole, polyethylene glycol, topical lidocaine, guaifenesin-dextromethorphan, senna, ramelteon, and artificial tears. Home health: RN visit within 24\u201348 hours for medication reconciliation, wound assessment, and oxygen assessment; PT/OT for mobility and ADL training; nursing to coordinate outpatient labs and home anticoagulation safety. Follow-up with primary care within 3\u20135 days, cardiology in 1\u20132 weeks, and nephrology as outpatient as indicated.", "diagnosis_codes": ["A419"], "suggested_codes": ["N179", "I4891", "I5032", "J9600", "L0390", "R5381"], "accepted_codes": ["N179"], "rejected_codes": ["I4891", "I5032", "J9600", "L0390", "R5381"], "date": "2024-10-27T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 28504657, "discharge_summary": "Brief history of present illness: 67-year-old male admitted to observation for progressive dyspnea, cough, decreased oral intake and lower-extremity edema. Past history notable for metastatic malignancy of the digestive system (C26.9) with known metastatic disease to lung and liver, congestive heart failure with hypertensive heart disease, type 2 diabetes mellitus, and recent acute kidney injury. Imaging demonstrated a large right-sided pleural effusion. Diagnostic thoracentesis/chest drainage was performed during this stay.\n\nHospital course: The patient was observed for 3.7 days. He underwent pleural drainage for symptomatic malignant pleural effusion with symptomatic improvement in respiratory status. He received intravenous diuretics with close monitoring of renal function; acute kidney injury partially corrected to near-baseline creatinine. He was treated symptomatically for cough and pain, received VTE prophylaxis, and had glycemic management with subcutaneous insulin. Cardiology input supported diuretic optimization for volume overload. No acute surgical interventions were required.\n\nKey findings and procedures: Imaging consistent with malignant pleural effusion and metastatic disease to bilateral lungs and liver. Laboratory notable for transient acute kidney injury which improved with diuresis and fluid management. Procedures performed: thoracentesis/chest drainage with symptomatic relief (ICD-10-PCS 0W9B3ZZ, 0W9B3ZX).\n\nDischarge condition and functional status: Patient is discharged in stable condition with improved respiratory symptoms but persistent deconditioning. He requires assistance with activities of daily living and has limited ambulation due to fatigue and recent deconditioning. Home health services arranged for nursing visits for wound/line care (if present), medication reconciliation, ADL support, and daily weight/edema monitoring to guide diuretic therapy.\n\nMedications and follow-up: Discharge meds include torsemide for outpatient diuresis, insulin regimen for diabetes, acetaminophen and trazodone as needed, benzonatate and guaifenesin-codeine for cough, stool softener (senna), heparin as inpatient only (stopped on discharge), and supplies for saline flushes as applicable. Arrange follow-up: oncology within 1\u20132 weeks, pulmonology for effusion reassessment, nephrology for kidney function check within 1 week, and primary care/cardiology in 7 days. Labs: BMP and CBC prior to first clinic visit or sooner if symptoms worsen. Home health to monitor vital signs, weights, glucose, and medication adherence.", "diagnosis_codes": ["C269"], "suggested_codes": ["E119", "J910", "N179", "I5043", "R262", "R531"], "accepted_codes": ["E119", "J910", "N179"], "rejected_codes": ["I5043", "R262", "R531"], "date": "2024-05-17T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 20547347, "discharge_summary": "Brief HPI: 63-year-old female admitted to observation status after an acute neurologic event following recent surgery. She developed acute neurologic deficits and was found to have a postprocedural cerebrovascular infarction. Presenting features included acute onset focal deficits with an NIHSS of 2 and chest pain. Imaging demonstrated cerebral infarction consistent with embolic etiology and dissection of the vertebral artery was identified as a contributing lesion.\n\nHospital Course: Patient was observed for 4.7 days. Initial evaluation included CT head and CTA neck/brain, which confirmed acute cerebral infarction and vertebral artery dissection. She was managed conservatively with blood pressure control, antiplatelet therapy, statin, and close neurologic monitoring. Heparin was used during early inpatient management per neurology recommendations and transitioned to dual antiplatelet therapy. Cardiac and vascular risk factors were evaluated and treated; glucose was monitored and managed with insulin as needed. No neurosurgical intervention was required. Pain and reflux symptoms were treated and stabilized.\n\nKey Findings and Procedures: CT/CTA-confirmed cerebral infarction due to embolism (I63.40) and vertebral artery dissection (I77.74). NIHSS score documented as 2. Continuous telemetry without arrhythmia identified. No procedural cerebrovascular intervention performed.\n\nDischarge Condition and Functional Status: Patient discharged medically stable, alert and oriented, with mild residual neurologic deficit (NIHSS 2). Ambulates with steadying assistance and requires minimal assistance with some ADLs; home health recommended for safety and functional support. Cognitive status adequate for discharge with caregiver support; requires education for stroke warning signs and medication management.\n\nMedications and Follow-up: Discharge medications include aspirin, clopidogrel, atorvastatin, acetaminophen, gabapentin, pantoprazole (or ranitidine per allergy/tolerance), docusate, and insulin regimen with glucose-source items available (dextrose 50%, glucose gel, glucagon) as indicated. Heparin was discontinued prior to discharge. Home health nursing for medication administration, glucose and blood pressure monitoring, wound and neurologic checks, and coordination of PT/OT is arranged. Follow-up with neurology within 7 days, primary care within 1\u20132 weeks, and vascular surgery or interventionalist as outpatient if indicated.", "diagnosis_codes": ["I97821"], "suggested_codes": ["I6340", "I7774", "Z7401", "Z794", "Z9119"], "accepted_codes": ["I6340", "I7774"], "rejected_codes": ["Z7401", "Z794", "Z9119"], "date": "2024-12-04T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 23500400, "discharge_summary": "History of Present Illness: 31-year-old G?P? F presented urgently at 37 weeks gestation with labor and known breech presentation and symptomatic submucous uterine leiomyoma. She was noted to have a positive test for Chlamydia trachomatis and baseline sickle-cell trait; anemia was identified in the peripartum period. Admission diagnosis included maternal care for breech presentation (O32.1XX0), chlamydial infection complicating childbirth (A56.8/O98.32), benign uterine tumor (O34.13), sickle-cell trait (D57.3), and anemia complicating childbirth (O99.02). Length of stay was 3.2 days.\n\nHospital Course: Patient underwent delivery with operative management of breech presentation and routine postpartum uterine management. Oxytocin was administered for uterine tone. Azithromycin was given for treatment of chlamydial infection. Analgesia included acetaminophen, ibuprofen, and a short course of oxycodone (immediate release) for breakthrough pain; ondansetron was available for nausea. Supportive IV fluids (Lactated Ringers, 0.9% sodium chloride) and perioperative flushes were used as indicated. Docusate and simethicone were provided for bowel regimen and gas control. Naloxone was available and used only per protocol if needed. There were no immediate surgical complications. Hemodynamically stable throughout admission; anemia addressed with monitoring and outpatient follow-up arranged.\n\nKey Findings and Procedures: Delivery for breech presentation with procedural management documented (see operative report). Single live infant at 37 weeks delivered; neonatal course described in neonatal chart. Uterine tone responded to oxytocin; no retained products identified. Cultures/NAAT positive for Chlamydia; treated with azithromycin.\n\nDischarge condition and functional status: Patient is stable, afebrile, pain controlled on oral medications, ambulating with minimal assistance, and caring for newborn with support. Home health recommended for postpartum assessment, wound/perineal checks, vital sign monitoring, assistance with ambulation and ADLs as needed, breastfeeding support, and medication education.\n\nMedications and Follow-up: Discharge meds: azithromycin (complete course), acetaminophen PRN, ibuprofen PRN, oxycodone IR short course PRN, ondansetron PRN, docusate PRN, simethicone PRN. Follow-up: OB postpartum visit within 48\u201372 hours and again at 2 weeks; CBC in 1 week to reassess anemia; STI re-testing per CDC guidelines and partner treatment; primary care for sickle-cell trait counseling. Home health referral placed for 1\u20133 visits; please see outpatient appointments and operative note for further details.", "diagnosis_codes": ["O321XX0"], "suggested_codes": ["A568", "D573", "O3413", "O9832", "O9902"], "accepted_codes": ["A568", "D573", "O3413", "O9832", "O9902"], "rejected_codes": [], "date": "2024-05-01T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 26096708, "discharge_summary": "History of Present Illness: 69-year-old male admitted to observation for acute right-sided flank pain and obstructive uropathy. Imaging demonstrated hydronephrosis secondary to a renal/ureteral calculus (primary Dx N13.2). He has known chronic kidney disease stage 3 and baseline atherosclerotic coronary disease with prior coronary angioplasty.\n\nHospital Course: Patient observed 1.7 days. Initial evaluation notable for elevated creatinine consistent with acute kidney injury on CKD. Pain controlled with short-acting analgesics. Urology performed endoscopic decompression with ureteral stent placement for relief of obstruction (procedure 0T778DZ) without immediate complication. Renal function trended toward baseline after decompression and IV fluids. Hemodynamically stable throughout. No evidence of sepsis. Influenza high-dose vaccine administered per protocol.\n\nKey Findings and Procedures: CT/US-confirmed hydronephrosis due to obstructing calculus; acute kidney injury (AKI) superimposed on CKD stage 3, improved after stent placement and hydration. Procedure: cystoscopic ureteral stent placement for decompression (ICD-10-PCS 0T778DZ). Cardiac history reviewed; no acute cardiac ischemia.\n\nDischarge Condition and Functional Status: Patient discharged in stable condition, afebrile, pain controlled on oral medications. Baseline ambulation preserved; independent with activities of daily living but reports mild deconditioning. Home health services arranged for short-term skilled nursing to assist with medication management, vital sign and weight monitoring, reinforcement of activity and fall precautions, and wound/stent care education.\n\nMedications at Discharge: Aspirin, Atorvastatin, Carvedilol, Torsemide, Amlodipine, Vitamin D. (Inpatient IV fluids and heparin discontinued at discharge.) Patient provided instructions on analgesics and stool softener as needed.\n\nFollow-up Plan: Urology follow-up within 5\u20137 days for stent management and definitive stone plan; nephrology follow-up in 1\u20132 weeks for BMP and CKD/AKI reassessment; oncology and cardiology follow-up as outpatient per existing care. Labs: BMP within 48\u201372 hours and as directed by nephrology. Return to ED for fever, worsening flank pain, decreased urine output, chest pain, or other acute concerns.", "diagnosis_codes": ["N132"], "suggested_codes": ["I2510", "N179", "N183", "Z23"], "accepted_codes": ["I2510", "N179"], "rejected_codes": ["N183", "Z23"], "date": "2024-03-16T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 29685883, "discharge_summary": "Brief HPI: 50-year-old male admitted to observation for 6.8 days with progressive erythema, drainage, pain and intermittent fevers at the site of prior foot/ankle internal fixation. Imaging demonstrated displacement of fixation hardware of the foot/toes. Wound cultures returned positive for bacterial pathogens consistent with device-associated infection. Hospital Course: Patient was managed with operative irrigation and debridement with partial revision/removal of displaced hardware, placement of a peripherally inserted central catheter (PICC) for long-term IV therapy, and serial wound care. He received IV daptomycin for presumed gram-positive device-related infection and oral ciprofloxacin as directed by Infectious Disease pending final susceptibilities. Alteplase was used once for catheter clearance; heparin flushes prescribed for PICC maintenance. Pain was managed with acetaminophen and short-course opioid as needed; asthma and Parkinson\u2019s medications were continued (albuterol inhaler, amantadine). Psychiatric medications (aripiprazole) were continued with social work involvement for outpatient support. Key Findings and Procedures: Displaced internal fixation device of the foot, non-pressure chronic ulcer of the left ankle with surrounding cellulitis, positive wound cultures, operative irrigation and debridement with partial hardware revision/removal, and PICC placement for outpatient IV antibiotics. Discharge Condition and Functional Status: Patient is afebrile, hemodynamically stable, pain controlled on oral regimen, and ambulates with a rolling walker. He requires assistance with dressing changes and PICC care but is otherwise able to perform basic ADLs with supervision. Home health will provide skilled nursing for IV antibiotic administration, wound dressing changes, PICC maintenance/heparin flushes, and physical therapy for gait and transfers. Medications at Discharge (selected): Daptomycin IV via home infusion (per ID plan), oral ciprofloxacin, acetaminophen PRN, albuterol inhaler, amantadine, aripiprazole, lorazepam/clonazepam as needed for anxiety, loperamide PRN. Follow-up Plan: Orthopedics in 7 days for definitive hardware management; Infectious Disease in 3\u20135 days for antibiotic plan and weekly labs (CBC, CMP, CK while on daptomycin); wound clinic weekly; primary care in 2 weeks; neurology/psychiatry as outpatient. Return to ED for fever, increasing pain, erythema, drainage, new neurologic deficits, or PICC complications.", "diagnosis_codes": ["F419", "Z23", "F329", "M1990", "G20", "I10", "Z006", "T8469XA", "J45909", "B9689", "Y929"], "suggested_codes": ["L03116", "L97409", "Z452"], "accepted_codes": [], "rejected_codes": ["L03116", "L97409", "Z452"], "date": "2024-11-19T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 27904255, "discharge_summary": "History of Present Illness: 83-year-old man admitted under observation for 3 days with recurrent Clostridioides difficile enterocolitis (ICD-10 A04.71). He presented with profuse non-bloody diarrhea, abdominal cramping, and volume depletion. Past medical history notable for hypertensive heart and chronic kidney disease with diastolic heart failure, atrial fibrillation with pacemaker, chronic kidney disease, prior myocardial infarction, chronic hepatitis C, and rheumatoid disease on chronic immunomodulatory therapy.\n\nHospital Course: Stool testing confirmed C. difficile. He was started on oral vancomycin liquid for recurrent disease with supportive care including judicious IV fluids for prerenal azotemia and electrolyte repletion. Baseline and interval basic metabolic panels showed transient acute kidney injury that improved with hydration and temporary adjustment of diuretics; torsemide was resumed at a tailored dose prior to discharge. Cardiac status remained stable with rate control on metoprolol succinate; pacemaker function reviewed and unchanged. No surgical interventions were required. Urine studies demonstrated bacteriuria; culture pending/being followed by outpatient team.\n\nKey Findings and Procedures: Positive stool assay for C. difficile; transient AKI that responded to fluids; EKG consistent with chronic atrial fibrillation without ischemic change. No invasive procedures performed. Pacemaker interrogation documented unchanged parameters.\n\nDischarge Condition and Functional Status: Patient is afebrile, hemodynamically stable, tolerating oral intake, and able to ambulates with his baseline assistive device but requires assistance with some activities of daily living \u2014 home health nursing recommended for initial visits to ensure safe medication administration and monitoring.\n\nMedications and Follow-up Plan: Continue home chronic medications (atorvastatin, metoprolol succinate, torsemide, isosorbide mononitrate, potassium chloride, cyanocobalamin, prednisone/hydroxychloroquine regimen as previously prescribed) and complete oral vancomycin course as directed. Home health to provide medication supervision, vitals checks, and assistance with hydration. Labs: BMP within 48\u201372 hours and repeat as outpatient; urine culture follow-up. Appointments: Primary care within 7 days, GI for C. difficile follow-up in 1\u20132 weeks, nephrology as outpatient for AKI surveillance, cardiology/pacemaker clinic as scheduled.\n\nDischarge disposition: Home with home health services and close outpatient follow-up.", "diagnosis_codes": ["A0471"], "suggested_codes": ["I5032", "N179", "B182", "I482", "M069", "Z95810"], "accepted_codes": ["I5032", "N179"], "rejected_codes": ["B182", "I482", "M069", "Z95810"], "date": "2024-03-16T00:00:00", "clinician": "Dr. Michael Chen"}, {"hadm_id": 22922246, "discharge_summary": "History of Present Illness: 72-year-old male with prior aortocoronary bypass graft (Z95.1) and known coronary artery disease presented to the ED with acute-onset chest pressure. Initial evaluation demonstrated non\u2013ST-elevation myocardial infarction (NSTEMI) with positive cardiac troponin trend and ischemic changes on ECG. He was placed on telemetry and treated with antithrombotic therapy and anti-ischemic measures.\n\nHospital Course: Patient was observed for 1.9 days. He received heparin anticoagulation during the acute phase and was transitioned to apixaban on discharge given his clinical context and existing indications. Aspirin and high-intensity statin therapy (atorvastatin) were continued. Beta blockade (metoprolol tartrate) and ACE inhibitor (lisinopril) were initiated/continued for secondary prevention and blood pressure control. Nitroglycerin was provided PRN for recurrent ischemia; electrolyte and renal function remained stable. No recurrent chest pain or hemodynamic instability occurred on telemetry. Rhythm was monitored; no sustained ventricular arrhythmia noted.\n\nKey Findings and Procedures: Diagnostic workup confirmed NSTEMI (serial troponins elevated). Procedure performed: ICD-10-PCS 5A2204Z (cardiac procedure performed during observation) without immediate complication. Diagnosis list includes subsequent NSTEMI (I22.2), hypertension (I10), prior CABG (Z95.1), hypercholesterolemia (E78.0), BPH (N40.0), atherosclerotic CAD with angina (I25.119), personal history of nicotine dependence, and long-term antithrombotic use.\n\nDischarge Condition and Functional Status: Patient is hemodynamically and clinically stable at discharge. He ambulates with mild exertional limitation and requires minimal assistance for community ambulation; generally independent with basic ADLs but reports fatigue. Home health services arranged for medication reconciliation, vital sign and symptom monitoring (BP/pulse, chest pain surveillance), reinforcement of activity progression and fall-risk assessment.\n\nMedications and Follow-up: Discharge meds include apixaban, aspirin, atorvastatin, metoprolol, lisinopril, hydrochlorothiazide as indicated, nitroglycerin SL PRN, and continuation of home supplements. Follow-up with cardiology within 3\u20137 days and primary care within 1 week. Outpatient labs (BMP, CBC, lipid panel) and possible noninvasive ischemia evaluation per cardiology recommendations. Patient educated on signs of recurrent ischemia and when to return to ED.", "diagnosis_codes": ["I222"], "suggested_codes": ["E780", "I10", "I25119", "N400", "Z87891", "Z951", "Z7901"], "accepted_codes": ["E780", "I10", "I25119", "N400", "Z87891", "Z951"], "rejected_codes": ["Z7901"], "date": "2024-03-06T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 27255244, "discharge_summary": "History of Present Illness: 70-year-old male with known COPD and metastatic lung adenocarcinoma on osimertinib presented to observation unit for acute worsening dyspnea, cough, purulent sputum and dizziness. Chest imaging and clinical exam consistent with left lower lobe pneumonia on background COPD exacerbation. Admission diagnosis: COPD with acute lower respiratory infection and pneumonia.\n\nHospital Course: Observed 3.7 days. Treated with nebulized bronchodilators (albuterol and ipratropium-albuterol), acetylcysteine and guaifenesin for secretion management, systemic corticosteroid (prednisone taper) for COPD exacerbation, and empiric antibiotics (azithromycin and oral cefpodoxime) for community-acquired pneumonia. Received DVT prophylaxis with subcutaneous heparin while inpatient. Influenza vaccine administered prior to discharge. Symptoms and inflammatory markers improved with therapy; he remained hemodynamically stable and afebrile for 24+ hours prior to discharge.\n\nKey Findings/Procedures: Chest radiograph consistent with left lower lobe consolidation and chronic COPD changes. Basic labs showed leukocytosis on admission with downtrend after antibiotics. No invasive procedures were required. Neurologic symptoms (intermittent dizziness) evaluated; meclizine prescribed PRN. Oncology records confirmed ongoing osimertinib therapy which was continued on discharge.\n\nDischarge Condition and Functional Status: Discharged in improved respiratory condition but with residual dyspnea on exertion. Ambulates at baseline with assistance for longer distances and requires support with stair negotiation due to exertional shortness of breath and recent dizziness. Home health recommended for medication reconciliation, monitoring of respiratory status, assistance with ADLs as needed, and fall-risk precautions given metastatic brain disease history.\n\nMedications and Follow-up: Continue home medications including osimertinib. New/continued discharge meds: prednisone taper, fluticasone-salmeterol inhaler, albuterol nebulizer PRN, ipratropium-albuterol neb PRN, acetylcysteine neb, guaifenesin, azithromycin and cefpodoxime (complete prescribed courses), meclizine PRN. Follow-up: Pulmonology within 1 week, Oncology within 1\u20132 weeks, PCP in 48\u201372 hours. Home health nursing to start within 24\u201348 hours for med administration, breathing treatments, wound/safety assessment and vitals/oxygen monitoring as indicated.", "diagnosis_codes": ["J189", "C3432", "Z6835", "Z87891", "J440", "Z9981", "C7931", "E669", "K869", "R42", "Z9119", "C787", "C7951", "J441"], "suggested_codes": [], "accepted_codes": [], "rejected_codes": [], "date": "2024-12-25T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 22549560, "discharge_summary": "History of Present Illness: 44-year-old male with known rectal carcinoma (C20) and history of gout presented for planned surgical attention to his diverting ileostomy (Z43.2). He underwent a same-day admission for evaluation and surgical management of the stoma due to functional concerns and peri-stomal irritation.\n\nHospital Course: Patient taken to the OR and underwent ileostomy revision (ICD-10-PCS 0DBB0ZZ) without intraoperative complications. He received perioperative IV fluids (Lactated Ringers), standard DVT prophylaxis with heparin while inpatient, and intra/postoperative analgesia including ketorolac and oxycodone as needed. Allopurinol was continued for gout control. He received the seasonal influenza vaccine prior to discharge. Vitals and basic labs remained stable; there was no evidence of surgical site infection. Pain was controlled with oral medications and patient tolerated a regular diet prior to discharge.\n\nKey Findings and Procedures: Operative findings: patent ileostomy with need for minor revision; stoma viable with healthy peristomal skin after procedure. Hemostasis achieved; no enteric leak or intra-abdominal complication identified. Wounds dressed and stoma appliance refitted. ICD-10 codes: Z43.2, C20, M10.9; procedure 0DBB0ZZ.\n\nDischarge Condition and Functional Status: Patient discharged in stable condition, afebrile, hemodynamically stable. Ambulates with steadying assistance and is able to perform light activities of daily living with supervision. Requires home health for ostomy care education, wound assessment, and assistance with medication management and monitoring of fluid balance and ostomy output.\n\nMedications at Discharge: Acetaminophen for analgesia; OxyCODONE (immediate release) for breakthrough pain PRN; Allopurinol continued for gout; Magnesium oxide for bowel regimen; instructions to discontinue inpatient-only IV medications (Lactated Ringers, ketorolac IV, heparin) unless otherwise directed. Ostomy supplies and NaCl 0.9% flush instructions provided.\n\nFollow-up Plan: Home health RN visit within 24\u201348 hours for ostomy/wound care and BMP/CBC coordination. Colorectal surgery clinic in 7\u201310 days; oncology follow-up as outpatient per tumor board plan. Return for fever, worsening pain, increasing ostomy output, signs of infection, or inability to maintain oral intake.", "diagnosis_codes": ["Z432", "M109", "C20"], "suggested_codes": ["Z23", "Z4882", "Z7401", "Z7409"], "accepted_codes": [], "rejected_codes": ["Z23", "Z4882", "Z7401", "Z7409"], "date": "2024-04-17T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 25449686, "discharge_summary": "History of present illness: 66-year-old male with known non-Hodgkin lymphoma (C85.99) and chronic hepatitis B was admitted under observation for administration of antineoplastic chemotherapy (Z51.11). He presented for scheduled infusion and developed port occlusion and electrolyte abnormalities during the course.\n\nHospital course: Patient received planned chemotherapy via implanted port with leucovorin rescue per protocol. He developed an occluded port line which was successfully cleared with alteplase (catheter clearance) and confirmed functional. He experienced nausea that responded to ondansetron. Laboratory monitoring identified hypokalemia and hypophosphatemia; these were treated with intravenous and oral potassium chloride and phosphorus repletion, and magnesium sulfate was administered for concomitant magnesium depletion. Enoxaparin was provided for venous thromboembolism prophylaxis during the observation stay. He received bowel regimen agents (polyethylene glycol, bisacodyl) as needed. He was continued on levetiracetam for seizure prophylaxis started during admission. No acute infusion reactions or bleeding complications were observed. Vital signs and clinical status remained stable throughout the 6.5\u2011day observation stay.\n\nKey findings and procedures: Successful administration of chemotherapy (procedure 3E04305) with leucovorin rescue. Port thrombotic occlusion resolved after alteplase. Electrolyte abnormalities corrected (K+, PO4-, Mg2+). No evidence of acute hepatic decompensation or infectious complication related to chronic HBV during stay.\n\nDischarge condition and functional status: Patient discharged in stable condition, hemodynamically stable and ambulatory with a rolling walker for short distances; independent with most ADLs but requires assistance for port care and medication management. Home health recommended to support IV/port care, medication administration, and short\u2011interval lab monitoring.\n\nMedications and follow-up: Discharge meds include potassium chloride oral replacement, phosphorus supplementation, oral magnesium as indicated, ondansetron PRN, polyethylene glycol and bisacodyl PRN, levetiracetam, and instructions for heparin port flushes per protocol. Enoxaparin given in hospital; outpatient anticoagulation plan to be determined. Close follow-up with oncology within 7\u201314 days and repeat labs (CBC, CMP with electrolytes, Mg, PO4, K) within 48\u201372 hours via home health. Hepatology/oncology to address HBV management and ongoing chemotherapy scheduling.", "diagnosis_codes": ["C8599", "E8339", "Z5111"], "suggested_codes": ["E875", "E956", "R110", "T82858A"], "accepted_codes": [], "rejected_codes": ["E875", "E956", "R110", "T82858A"], "date": "2024-10-09T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 25681330, "discharge_summary": "Brief history of present illness: 29-year-old man admitted electively for administration of antineoplastic therapy (primary reason: encounter for antineoplastic chemotherapy) for known primary malignant neoplasm of the right scapula/long bones with metastatic disease to bilateral lungs and regional lymph nodes. Past medical history notable for HIV on antiretroviral therapy (Biktarvy), essential hypertension, asthma, nicotine dependence, chronic pain. He presented for scheduled inpatient chemotherapy and developed asymptomatic hyponatremia during stay.\n\nHospital course: Patient underwent planned IV chemotherapy (etoposide) administered via peripheral/central venous access (ICD-10-PCS 3E04305). He received supportive medications including dexamethasone, scheduled acetaminophen for infusion-related symptoms, antiemetic prophylaxis, and IV maintenance fluids (0.9% NaCl/5% dextrose). Hyponatremia (hypo-osmolality) was identified and corrected with fluid management and monitoring; no neurologic deficits occurred. He remained afebrile without infectious complications. Pain and nausea were controlled with multimodal therapy. Port/line was flushed with heparin per protocol prior to discharge.\n\nKey findings and procedures: Imaging and prior oncology records document metastatic disease to lungs and axillary nodes. No acute cardiopulmonary or neurologic deterioration during admission. Procedure: administration of antineoplastic agent (etoposide) with standard pre/post-infusion care; heparin flushes performed.\n\nDischarge condition and functional status: Patient is medically stable for discharge. He is afebrile, hemodynamically stable, pain controlled on oral regimen, ambulatory with minimal assistance for household mobility, and independent with most ADLs but reports fatigue and intermittent shortness of breath on exertion. Home health services arranged for IV/port care, medication reconciliation, and safety monitoring.\n\nMedications and follow-up plan: Discharge medications include Biktarvy (continue HIV regimen), etoposide per oncology outpatient plan, dexamethasone (short taper as prescribed), acetaminophen PRN, gabapentin for neuropathic pain, furosemide as indicated, stool regimen (docusate, bisacodyl PRN), fluticasone nasal spray, and heparin flush supplies for port care. Labs (CBC with differential, CMP) to be obtained 48\u201372 hours post-discharge and prior to next cycle. Oncology follow-up in 7 days (or sooner for symptoms). Return precautions: fever >38\u00b0C, new/worsening dyspnea, uncontrolled pain, bleeding, or signs of infection at port site.", "diagnosis_codes": ["Z5111"], "suggested_codes": ["C773", "C7801", "E871", "F17210", "I10", "J45909", "B20", "C40219", "G8929"], "accepted_codes": ["C773", "C7801", "E871", "F17210", "I10", "J45909"], "rejected_codes": ["B20", "C40219", "G8929"], "date": "2024-12-13T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 23012454, "discharge_summary": "History of Present Illness: 62-year-old male with metastatic malignancy with known secondary right lung lesion (C78.01) and prior malignancy history presented electively for scheduled antineoplastic chemotherapy (Z51.11). He has an above-knee amputation of the right leg with wheelchair dependence and a prior history of venous thromboembolism on chronic anticoagulation.\n\nHospital Course: Patient admitted for a planned 3.2-day stay for IV administration of cisplatin and doxorubicin with standard premedication (dexamethasone, fosaprepitant) and aggressive IV hydration (0.9% and 0.45% NaCl, 5% dextrose as indicated). Chemotherapy administration documented (ICD-10-PCS 3E03305). Port/PICC heparin flushes were given per protocol. He received supportive medications including antiemetics, stool softener (docusate), laxative (bisacodyl), gabapentin and duloxetine for neuropathic/phantom limb pain. Apixaban was continued for prior VTE. Vitals and hemodynamics remained stable; there were no bleeding events, no acute renal injury, and no febrile neutropenia during admission. Nausea was transient and controlled with antiemetics; pain regimen optimized.\n\nKey Findings and Procedures: Chemotherapy infusion completed without immediate complication. Laboratory monitoring remained acceptable (CBC and BMP within acceptable limits for discharge). Port care and heparin flushes performed. No evidence of acute thromboembolic or hemorrhagic complication.\n\nDischarge Condition and Functional Status: Patient is medically stable for discharge. Pain is controlled on current regimen. Functionally he is dependent on wheelchair and requires assistance for transfers and ADLs; home health referral placed for skilled nursing support, medication administration oversight, port care, and wound/skin surveillance.\n\nMedications and Follow-up: Discharge meds include apixaban (continue), gabapentin, duloxetine, short steroid/antiemetic taper as given, stool softener and laxative prn. Labs: obtain CBC, CMP, and creatinine within 48\u201372 hours and prior to next cycle. Follow-up with oncology in 7 days for treatment planning and with primary care in 1\u20132 weeks. Home health to monitor for fever, signs of infection at access site, bleeding, new/worsening pain, and medication adherence. Return to ED for fever >38.0\u00b0C, uncontrolled vomiting, new neurological deficit, or overt bleeding.", "diagnosis_codes": ["Z5111"], "suggested_codes": ["C7801", "Z86718", "G8929", "Z743", "Z89511"], "accepted_codes": ["C7801", "Z86718"], "rejected_codes": ["G8929", "Z743", "Z89511"], "date": "2024-12-20T00:00:00", "clinician": "Dr. Sarah Johnson"}, {"hadm_id": 27989852, "discharge_summary": "Brief history of present illness: 58-year-old male with multiple myeloma (status post stem cell transplant) admitted under observation for management in the setting of scheduled antineoplastic immunotherapy (Z51.12). He developed tumor lysis syndrome and progressive pancytopenia during the admission with associated mild protein-calorie malnutrition, anxiety, and insomnia.\n\nHospital course: The patient was treated over a 19.7-day observation stay with aggressive supportive care including IV fluids, allopurinol for TLS prophylaxis, antiviral prophylaxis with acyclovir, antiemetic therapy, and bowel regimen. He received antimicrobial prophylaxis with trimethoprim-sulfamethoxazole. A symptomatic occlusion of his implanted central venous access device was managed with alteplase (catheter clearance) with successful restoration of patency. Nutritional status was addressed with dietary support and monitoring. There were no ongoing hemodynamic or infectious complications at discharge.\n\nKey findings and procedures: persistent pancytopenia with recovery trends on serial CBCs; no acute bleeding; resolved catheter occlusion after alteplase instillation; procedural interventions included central venous access management and diagnostic/therapeutic measures related to transplant/oncologic care.\n\nDischarge condition and functional status: Patient is discharged medically stable, afebrile, and hemodynamically stable. He remains deconditioned with decreased endurance and requires assistance with activities of daily living (needs help with bathing and mobility); home health is arranged for central line care (0.9% sodium chloride flushes per protocol), medication administration assistance, and monitoring for infection or bleeding. He has mild gait impairment and increased fall risk; home health to provide fall precautions and functional support.\n\nMedications and follow-up plan: Discharge medications include acyclovir, allopurinol, trimethoprim-sulfamethoxazole (SS), omeprazole, ondansetron PRN, oxycodone IR PRN, docusate/senna bowel regimen, lorazepam PRN, trazodone nightly, topical lidocaine 2% as needed, and supplies for saline flushes and alteplase for catheter care as indicated. Labs (CBC, CMP, coagulation) to be obtained within 48\u201372 hours and as directed by oncology. Clinic follow-up with hematology/oncology within 48\u201372 hours and transplant clinic within 7 days; primary care within 1\u20132 weeks. Home health referral placed for line/wound care, medication administration, ADL support, and vital sign monitoring.", "diagnosis_codes": ["D61818", "F419", "E785", "Z6836", "D684", "K219", "C9000", "E883", "G4700", "Z5112", "Z96652", "Z923", "E441", "Y92239", "R5081", "T451X5A", "Z9484", "G893"], "suggested_codes": ["R2689", "T82212A", "Z740"], "accepted_codes": [], "rejected_codes": ["R2689", "T82212A", "Z740"], "date": "2024-11-14T00:00:00", "clinician": "Dr. Emily Rodriguez"}, {"hadm_id": 27204052, "discharge_summary": "History of Present Illness: 64-year-old male with known extranodal B\u2011cell lymphoma who presented via direct emergency admission with progressive weight loss, nausea, vomiting, and partial small bowel obstruction. He has history of chronic systolic heart failure, essential hypertension, hyperlipidemia, GERD, and prior postherpetic neuralgia. Admission diagnosis: encounter for antineoplastic chemotherapy and management of partial intestinal obstruction.\n\nHospital Course: Over a 7\u2011day admission the patient was managed conservatively for partial intestinal obstruction with bowel rest, IV fluids (0.9% NaCl and 5% dextrose as needed), antiemetics, bowel regimen (docusate, bisacodyl), and serial abdominal exams. He received IV antineoplastic therapy (etoposide) per oncology plan with per\u2011protocol supportive medications including dexamethasone and prophylactic filgrastim. Acyclovir was given for postherpetic neuralgia prophylaxis/treatment. He received subcutaneous filgrastim for neutropenia prevention and inpatient heparin for VTE prophylaxis. Cardiac status was monitored given chronic systolic heart failure; he remained hemodynamically stable without evidence of acute decompensation.\n\nKey Findings and Procedures: Patient tolerated IV chemotherapy administration (procedure codes 3E04305, 3E0R305). Imaging and clinical assessment were consistent with partial, non\u2011operative intestinal obstruction that resolved with conservative therapy. No acute cardiopulmonary events occurred. Pain related to postherpetic neuralgia improved with gabapentin and duloxetine.\n\nDischarge Condition and Functional Status: At discharge the patient is clinically stable, afebrile, hemodynamically stable, and tolerating oral intake. He is ambulatory with assistance for longer distances due to deconditioning and will benefit from short\u2011term home health for medication administration and mobility support. He is independent with most basic ADLs but requires assistance for IV/SC medication administration and monitoring.\n\nMedications and Follow\u2011up: Discharge medications include etoposide per oncology plan (to be administered outpatient or per oncology infusion center), filgrastim (SC) as instructed, acyclovir, gabapentin, duloxetine, dexamethasone taper, docusate, bisacodyl PRN, aluminum\u2011magnesium hydroxide\u2011simethicone, cetirizine, and others reconciled with outpatient regimen. Home health arranged for SC medication administration education, wound/skin and symptom monitoring, and mobility assistance. Follow up: Oncology within 3\u20137 days for chemotherapy planning, GI/surgery as outpatient for obstruction follow\u2011up, cardiology in 2 weeks (or sooner if symptoms), and PCP within 7 days for ongoing care and med reconciliation.", "diagnosis_codes": ["H538", "I5022", "T380X5A", "Y929", "Z87891", "K5660", "L709", "C8519", "R197", "B0229", "K219", "I10", "E785", "Z5111"], "suggested_codes": ["Z741", "Z794", "Z7989"], "accepted_codes": [], "rejected_codes": ["Z741", "Z794", "Z7989"], "date": "2024-12-02T00:00:00", "clinician": "Dr. Sarah Johnson"}]